
<html lang="en"     class="pb-page"  data-request-id="77e787d3-fd65-4729-8349-3baafc3ec451"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2021.64.issue-9;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c01936;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer" /></meta><meta name="dc.Creator" content="Yi  Gou" /></meta><meta name="dc.Creator" content="MeiRong  Chen" /></meta><meta name="dc.Creator" content="Shanhe  Li" /></meta><meta name="dc.Creator" content="JunGang  Deng" /></meta><meta name="dc.Creator" content="Jinlong  Li" /></meta><meta name="dc.Creator" content="GuiHua  Fang" /></meta><meta name="dc.Creator" content="Feng  Yang" /></meta><meta name="dc.Creator" content="GuoJin  Huang" /></meta><meta name="dc.Description" content="Anticancer agents that present nonapoptotic cell death pathways are required for treating apoptosis-resistant pancreatic cancer. Here, we synthesized three fluorescent dithiocarbazate–copper comple..." /></meta><meta name="Description" content="Anticancer agents that present nonapoptotic cell death pathways are required for treating apoptosis-resistant pancreatic cancer. Here, we synthesized three fluorescent dithiocarbazate–copper comple..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 16, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01936" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01936" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01936" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01936" /></link>
        
    
    

<title>Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01936" /></meta><meta property="og:title" content="Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0011.jpeg" /></meta><meta property="og:description" content="Anticancer agents that present nonapoptotic cell death pathways are required for treating apoptosis-resistant pancreatic cancer. Here, we synthesized three fluorescent dithiocarbazate–copper complexes, {[CuII(L)(Cl)] 1, [CuII2(L)2(NO3)2] 2, and [CuII2CuI(L)2(Br)3] 3}, to assess their antipancreatic cancer activities. Complexes 1–3 showed significantly greater cytotoxicity toward several pancreatic cancer cell lines with better IC50 than those of the HL ligand and cisplatin. Confocal fluorescence imaging showed that complex 3 was primarily localized in the mitochondria. Primarily, compound 3 also can be applied to in vivo imaging. Further studies revealed that complex 3 kills pancreatic cancer cells by triggering multiple mechanisms, including ferroptosis. Complex 3 is the first copper complex to evoke cellular events consistent with ferroptosis in cancer cells. Finally, it significantly retarded the ASPC-1 cells’ growth in a mouse xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01936"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01936">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01936&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01936&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01936&amp;href=/doi/10.1021/acs.jmedchem.0c01936" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 5485-5499</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01918" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01938" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yi Gou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yi Gou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Respiratory Disease, Affiliated Hospital of Guilin Medical University, Guilin 541001, Guangxi, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Gou">Yi Gou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2900-4983" title="Orcid link">http://orcid.org/0000-0002-2900-4983</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">MeiRong Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">MeiRong Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Respiratory Disease, Affiliated Hospital of Guilin Medical University, Guilin 541001, Guangxi, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=MeiRong++Chen">MeiRong Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shanhe Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shanhe Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin 541004, Guangxi, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shanhe++Li">Shanhe Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">JunGang Deng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">JunGang Deng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Respiratory Disease, Affiliated Hospital of Guilin Medical University, Guilin 541001, Guangxi, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=JunGang++Deng">JunGang Deng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jinlong Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jinlong Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Nantong University, Nantong 226019, Jiangsu, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jinlong++Li">Jinlong Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">GuiHua Fang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">GuiHua Fang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Nantong University, Nantong 226019, Jiangsu, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=GuiHua++Fang">GuiHua Fang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Feng Yang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Feng Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin 541004, Guangxi, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#3f59465e51587f525e56535d5047115847514a115a5b4a115c51"><span class="__cf_email__" data-cfemail="d2b4abb3bcb592bfb3bbbeb0bdaafcb5aabca7fcb7b6a7fcb1bc">[email protected]</span></a>. Phone: 86-15677339293.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Feng++Yang">Feng Yang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4201-1416" title="Orcid link">http://orcid.org/0000-0002-4201-1416</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">GuoJin Huang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">GuoJin Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Respiratory Disease, Affiliated Hospital of Guilin Medical University, Guilin 541001, Guangxi, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#c9f8fcf9fef0fcf0faf0fb89b8b8e7aaa6a4"><span class="__cf_email__" data-cfemail="92a3a7a2a5aba7aba1aba0d2e3e3bcf1fdff">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=GuoJin++Huang">GuoJin Huang</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01936&amp;href=/doi/10.1021%2Facs.jmedchem.0c01936" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 5485–5499</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 16, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 November 2020</li><li><span class="item_label"><b>Published</b> online</span>16 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01936" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01936</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5485%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYi%2BGou%252C%2BMeiRong%2BChen%252C%2BShanhe%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D9%26contentID%3Dacs.jmedchem.0c01936%26title%3DDithiocarbazate-Copper%2BComplexes%2Bfor%2BBioimaging%2Band%2BTreatment%2Bof%2BPancreatic%2BCancer%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5499%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01936"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">714</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01936" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Gou&quot;},{&quot;first_name&quot;:&quot;MeiRong&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Shanhe&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;JunGang&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Jinlong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;GuiHua&quot;,&quot;last_name&quot;:&quot;Fang&quot;},{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;GuoJin&quot;,&quot;last_name&quot;:&quot;Huang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;5485-5499&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01936&quot;},&quot;abstract&quot;:&quot;Anticancer agents that present nonapoptotic cell death pathways are required for treating apoptosis-resistant pancreatic cancer. Here, we synthesized three fluorescent dithiocarbazate–copper complexes, {[CuII(L)(Cl)] 1, [CuII2(L)2(NO3)2] 2, and [CuII2CuI(L)2(Br)3] 3}, to assess their antipancreatic cancer activities. Complexes 1–3 showed significantly greater cytotoxicity toward several pancreatic cancer cell lines with better IC50 than those of the HL ligand and cisplatin. Confocal fluorescence imaging showed that complex 3 was primarily localized in the mitochondria. Primarily, compound 3 also can be applied to in vivo imaging. Further studies revealed that complex 3 kills pancreatic cancer cells by triggering multiple mechanisms, including ferroptosis. Complex 3 is the first copper complex to evoke cellular events consistent with ferroptosis in cancer cells. Finally, it significantly retarded the ASPC-1 cells’ growth in a mouse xenograft model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01936&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01936" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01936&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01936" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01936&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01936" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01936&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01936&amp;href=/doi/10.1021/acs.jmedchem.0c01936" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01936" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01936" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01936%26sid%3Dliteratum%253Aachs%26pmid%3D33861929%26genre%3Darticle%26aulast%3DGou%26date%3D2021%26atitle%3DDithiocarbazate-Copper%2BComplexes%2Bfor%2BBioimaging%2Band%2BTreatment%2Bof%2BPancreatic%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D9%26spage%3D5485%26epage%3D5499%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (6)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=291912" title="Fluorescence">Fluorescence</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290653" title="Group 11 complexes">Group 11 complexes</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/jmcmar.2021.64.issue-9/20210513/jmcmar.2021.64.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Anticancer agents that present nonapoptotic cell death pathways are required for treating apoptosis-resistant pancreatic cancer. Here, we synthesized three fluorescent dithiocarbazate–copper complexes, {[Cu<sup>II</sup>(L)(Cl)] <b>1</b>, [Cu<sup>II</sup><sub>2</sub>(L)<sub>2</sub>(NO<sub>3</sub>)<sub>2</sub>] <b>2</b>, and [Cu<sup>II</sup><sub>2</sub>Cu<sup>I</sup>(L)<sub>2</sub>(Br)<sub>3</sub>] <b>3</b>}, to assess their antipancreatic cancer activities. Complexes <b>1–3</b> showed significantly greater cytotoxicity toward several pancreatic cancer cell lines with better IC<sub>50</sub> than those of the HL ligand and cisplatin. Confocal fluorescence imaging showed that complex <b>3</b> was primarily localized in the mitochondria. Primarily, compound <b>3</b> also can be applied to <i>in vivo</i> imaging. Further studies revealed that complex <b>3</b> kills pancreatic cancer cells by triggering multiple mechanisms, including ferroptosis. Complex <b>3</b> is the first copper complex to evoke cellular events consistent with ferroptosis in cancer cells. Finally, it significantly retarded the ASPC-1 cells’ growth in a mouse xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77408" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77408" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Studies conducted by Matrisian <i>et al.</i> revealed that in Western countries, pancreatic cancer would be the second leading cause of cancer death in the next decade.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It is the most malignant cancer and has an inferior prognosis, with a 5 year survival rate currently lower than 5%.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Contrary to the steady increase in most cancers’ survival rate, the progress in pancreatic cancer treatment has been slow.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Surgical resection remains the only viable option for long-term survival, but less than one in five patients receive surgical treatment due to local vascular metastasis or invasion.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Therefore, pancreatic cancer treatment, especially advanced pancreatic cancer, depends on systemic chemotherapy.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">As early as 1996, gemcitabine monotherapy was approved by the FDA as the standard of care for pancreatic cancer. Still, this treatment yields an overall 5 year survival rate of only 6.7%, one of the lowest of all cancer types.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Currently, two combination regimens with modest clinical activity, FOLFIRINOX (a combination of oxaliplatin, 5-fluoruracil, folinic acid, and irinotecan) and nab-paclitaxel/gemcitabine<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> have emerged as options for patients with pancreatic cancer. However, they are associated with substantial toxic side effects, such as neutropenia.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Hence, effective therapeutics for antipancreatic cancer chemotherapy are urgently needed.</div><div class="NLM_p">Metal-based agents exhibit potential for cancer treatment, presenting the possibility of unique drug action mechanisms through the rational selection of the central metal, the complex’s kinetic properties, the metal oxidation state, the number and type of ligands, and the coordination geometry adopted.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Copper, as an essential micronutrient for all organisms, plays crucial roles in critical biological functions, such as oxygen transport, energy metabolism, melanin synthesis, cell signaling, and enzyme activity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Furthermore, cancer cells and tissues take up more copper than normal cells. Thus, copper metabolism has been implicated in tumor metastasis, angiogenesis, and growth.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a></div><div class="NLM_p">Dithiocarbazate Schiff-base ligands, whose general structures are analogous to tridentate heterocyclic thiosemicarbazone and hydrazone ligands, have gained extensive attention recently for their antiproliferative, antiamoebic, and antibacterial activities.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> In many cases, small changes in the molecular structure of dithiocarbamate derivatives can lead to large differences in their biological activity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Moreover, these ligands possess both soft sulfur and hard nitrogen donor atoms, which can coordinate with various metal ions to form metal complexes with interesting physicochemical and enhanced biological properties.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Therefore, in the medicinal inorganic chemistry field, copper complexes with dithiocarbazate Schiff-base ligands show much promise as anticancer agents for future development.</div><div class="NLM_p">Recently, some copper complexes have been evaluated as antipancreatic cancer agents <i>in vitro</i> and <i>in vivo</i>.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30">(17−30)</a> For example, Sarkar <i>et al.</i> synthesized a 3-formylchromone Cu(II) complex with moderate antipancreatic cancer activity that induces apoptosis by inhibiting the NF-κB signaling pathway,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and the same authors also reported a Cu(II) complex of ketoprofen-salicylhydrazone, demonstrating that the complex has potent proapoptotic activity in COX-2 positive pancreatic cancer cells;<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Padhye <i>et al.</i> synthesized a nimesulide Schiff-base Cu(II) complex and reported that it downregulates the expression of the antiapoptotic proteins Bcl-xl and Bcl-2, leading to apoptosis in pancreatic cancer cells;<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Liu <i>et al.</i> reported that a Cu(I)–diethyldithiocarbamate complex can induce apoptosis in pancreatic cancer cells by inhibiting proteasome activity,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and Erxleben <i>et al.</i> prepared a dicopper(II) complex with moderate antipancreatic-cancer activity and confirmed that the complex interacts with cellular DNA and induces apoptosis in pancreatic cancer cells.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Furthermore, Basha <i>et al.</i> presented a tolfenamic acid–Cu(II) complex that showed effects on apoptosis and G2/M cell cycle arrest by inhibiting survivin in PANC-1 cells;<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and recently, Wang <i>et al.</i> reported a disulfiram–Cu(II) complex that induces autophagy-dependent apoptosis in pancreatic carcinoma cells.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">Mechanistic studies of the copper complexes reported above have revealed that they realize their antipancreatic cancer activities through induction of apoptosis or apoptosis-related pathways. However, pancreatic cancer cells can easily increase their resistance to apoptosis by changing the balance of antiapoptotic and proapoptotic proteins.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Actually, the resistance to apoptosis has largely led to pancreatic cancer treatment failure because most anticancer therapies, such as conventional chemotherapy and radiotherapy, mainly exert their anticancer effects by triggering apoptosis of cancer cells.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Therefore, the synthesis of copper complexes that can kill pancreatic cancer cells by multiple mechanisms or nonapoptotic cell death pathways (such as ferroptosis) may be of great significance.</div><div class="NLM_p">Ferroptosis is a recognized form of controlled cell death closely related to the occurrence, progression, and treatment of tumors.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Ferroptosis is significantly different from apoptosis, necrosis, and autophagy regarding inducing factors, morphological characteristics, and regulatory pathways.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> It mainly manifests as excessive oxidative stress and membrane lipid peroxidation, leading to cell death.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Due to its nonapoptotic nature, ferroptosis-based cancer treatments are expected to bypass the drawbacks, such as acquired apoptosis resistance, of traditional treatment methods mediated by apoptotic pathways.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Interestingly, cells that overexpress carcinogenic <i>RAS</i> (<i>KRAS</i>, <i>NRAS</i>, and <i>HRAS</i>) genes, such as pancreatic cancer cells with mutant <i>KRAS</i> genes, are more sensitive to ferroptosis.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a></div><div class="NLM_p last">Therefore, chemotherapies capable of inducing nonapoptotic cell death of pancreatic cancer cells, such as ferroptosis, warrant further investigation. Here, we synthesized three fluorescent copper complexes with the dithiocarbazate Schiff-base ligand {[Cu<sup>II</sup>(L)(Cl)] <b>1</b>, [Cu<sup>II</sup><sub>2</sub>(L)<sub>2</sub>(NO<sub>3</sub>)<sub>2</sub>] <b>2</b>, and [Cu<sup>II</sup><sub>2</sub>Cu<sup>I</sup>(L)<sub>2</sub>(Br)<sub>3</sub>] <b>3</b>, where HL is methyl 2-(di(pyridin-2-yl)methylene)hydrazinecarbodithioate} to evaluate the ability of antipancreatic cancer. Notably, the copper(I/II) complex <b>3</b> displayed an interesting mechanism that can induce pancreatic cancer cells’ ferroptosis.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Characterization of Copper Complexes</h3><div class="NLM_p">In many cases, anions can affect the crystal structure through the subtle tuning effect of their structural geometries as bonds or their bonding abilities or both to metal ions.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Here, we used different anions (Cl<sup>–</sup>, NO<sub>3</sub><sup>–</sup>, and Br<sup>–</sup>) to obtain three copper complexes with different structures (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Copper Complexes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Complex <b>1</b> crystallizes in the triclinic system with the space group <i>P</i>1̅. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A, the Cu(II) center is surrounded by two nitrogen atoms [Cu1–N2 = 1.963(6) Å and Cu1–N4 = 2.026(7) Å] and one sulfur atom [Cu1–S1 = 2.2376(11) Å] of an L ligand and one Cl [Cu1–Cl1 = 2.257(2) Å] and exhibits distorted square-planar coordination geometry. In the solid-state, the monomeric units of complex <b>1</b> are arranged in dimeric structures (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">Figure S1A</a>) such that the coordinated Cl of one monomeric unit interacts axially with the adjacent Cu1 center (Cu1···Cl1 = 2.833 Å). Moreover, as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">Figure S1B</a>, there are two minor occurrences of π···π stacking (center-to-center distances = 3.666 and 3.816 Å) in complex <b>1</b>, which link adjacent dimer units into a two-dimensional three-connected net with 6<sup>3</sup> hcb topology (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">Figure S1C</a>).</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Local coordination environments of <b>1–3</b>, H atoms are omitted for clarity. (A) Complex <b>1</b>. (B) Complex <b>2</b>, symmetry code: <i>i</i> = 1 – <i>x</i>, 1 – <i>y</i>, and 1 – <i>z</i>. (C) Complex <b>3</b>, symmetry code: <i>i</i> = −<i>x</i>, <i>y</i>, 1.5 – <i>z</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structure of complex <b>2</b> is shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B. The crystal structure shows that complex <b>2</b> exists as a centrosymmetric dimer in which each of the copper(II) ions adopts a five-coordinate geometry. The geometry polyhedron around the Cu1 center could be described as having a near-square-pyramidal geometry (τ = 0.067), with the copper center displaced from the S1/N2/N4/O1 basal plane (maximum displacement 0.083 Å for the N2 atom) by 0.28 Å toward the apical N3<sup><i>i</i></sup> (symmetry code <i>i</i> = 2 – <i>x</i>, 1 – <i>y</i>, 1 – <i>z</i>) atom. The longer apical bond length Cu1–N3<sup><i>i</i></sup> [2.373(2) Å] compared with the basal Cu–N distances [Cu1–N2 = 1.9704(18) Å and Cu1–N4 = 2.020(2) Å] is associated with the pseudo-Jahn–Teller effect on the Cu(II) ion.</div><div class="NLM_p">Complex <b>3</b> crystallizes in the monoclinic system with the space group <i>C</i>2/<i>c</i>. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C, there are three Br atoms, three Cu atoms, and two mononegative tridentate L ligands. The Cu1 or Cu1<sup><i>i</i></sup> (<i>i</i> = −<i>x</i>, <i>y</i>, 1.5 – <i>z</i>) center shows +2 oxidation and adopts a square-planar coordination geometry containing a bromide anion and the negative tridentate L ligand in the basal plane. The Cu2 atom has +1 oxidation and is situated in a trigonal-planar geometry surrounded by one Br anion and two N atoms (N3 and N3<sup><i>i</i></sup>) from two L ligands. The coexistence of Cu<sup>I</sup> and Cu<sup>II</sup> in complex <b>3</b> indicates that the Br<sup>–</sup> anion, which has a stronger reducing ability than Cl<sup>–</sup> and NO<sub>3</sub><sup>–</sup>, can promote the reduction of Cu<sup>II</sup> to Cu<sup>I</sup>. This coexistential phenomenon has been reported in a similar synthesis.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> All the Cu(II)–N/S distances in complex <b>3</b> are similar to those found in complexes <b>1</b> and <b>2</b> and those reported in the literature for similar complexes.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> In the solid state, as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">Figure S2</a>, the monomeric units of complex <b>3</b> link in a polymeric-chain-like fashion such that the coordinated S1 atom of one monomeric unit interacts axially with the neighboring Cu(II) center (Cu1···S1 = 2.887 Å).</div><div class="NLM_p last">In all Cu complexes, the Cu–N<sub>pyridine</sub> distances [Cu1–N4 = 2.026(7) Å in <b>1</b>, Cu1–N4 = 2.026(7) Å in <b>2</b>, and Cu1–N4 = 2.026(7) Å in <b>3</b>] are significantly longer than the Cu–N<sub>imine</sub> distances [Cu1–N2 = 1.963(6) Å in <b>1</b>, Cu1–N2 = 1.9704(18) Å in <b>2,</b> and Cu1–N2 = 1.976(4) Å in <b>3</b>], which can be attributed to the weaker π-back-bonding in the Cu–N<sub>pyridine</sub> bond compared with that in the Cu–N<sub>imine</sub> bond.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Also, our results show that inorganic anions with different coordinating abilities, sizes, and geometries can affect the HL ligand’s coordination versatility, thus influencing the structures of its metal complexes, and this phenomenon has been reported elsewhere.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Magnetic Measurements</h3><div class="NLM_p">Solid-state, variable-temperature, and magnetic susceptibility measurements were performed on powder samples of complexes <b>1–3</b> at a 2–300 K range in a 1 kOe magnetic field. The temperature dependence of 1/χ<sub>M</sub> (inverse molar magnetic susceptibility) and χ<sub>M</sub><i>T</i> (the product of the susceptibility and temperature) for complexes <b>1–3</b> are shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A. For <b>1</b>, the data above 2 K followed the Curie–Weiss law with <i>C</i> = 0.42 cm<sup>3</sup> K mol<sup>–1</sup> and θ = −2.11 K. The χ<sub>M</sub><i>T</i> value at 300 K is ∼0.42 cm<sup>3</sup> mol<sup>–1</sup>, which is close to the spin-only value of 0.38 cm<sup>3</sup> K mol<sup>–1</sup> for a magnetic Cu<sup>II</sup> ion with <i>S</i> = 1/2 and <i>g</i> = 2.0 and is relatively constant down to approximately 40 K.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Plots of χ<sub>M</sub><i>T vs T</i> for complexes <b>1–3</b>. The insets show the thermal dependence of inverse magnetic susceptibility. (B) Absorption spectra of the HL ligand (5 μM) and the copper complexes (5 μM) measured in water containing DMSO (10% v/v). (C) Fluorescence spectra of the HL ligand (5 μM) and the copper complexes (5 μM) recorded in water containing DMSO (10% v/v) followed by excitation at 415 nm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Below this temperature, it collapses to reach a minimum value of 0.21 cm<sup>3</sup> K mol<sup>–1</sup> at 2 K. For complexes <b>2</b> and <b>3</b>, the data above 2 and 12 K followed the Curie–Weiss law with <i>C</i> = 0.83 and 0.82 cm<sup>3</sup> K mol<sup>–1</sup> and θ = −1.06 and −4.74 K, respectively. The χ<sub>M</sub><i>T</i> values at 300 K are approximately 0.83 and 0.81 cm<sup>3</sup> K mol<sup>–1</sup>, respectively, which are close to the spin-only value of 0.75 cm<sup>3</sup> K mol<sup>–1</sup> for two magnetic Cu<sup>II</sup> ions with <i>S</i> = 1 and <i>g</i> = 2.0, and these decreases are also relatively constant down to approximately 21 and 40 K, respectively. They collapse below these temperatures to reach the minimum values of 0.51 and 0.10 cm<sup>3</sup> K mol<sup>–1</sup> at 2 K.</div><div class="NLM_p last">Based on these magnetic data, complexes <b>1</b> and <b>2</b> exhibit paramagnetic behavior at 2–300 K because of the long interion distance of the adjacent Cu<sup>II</sup> ions (Cu<sup>II</sup>···Cu<sup>II</sup> = 3.528 Å in <b>1</b> and 5.287 Å in <b>2</b>). While for complex <b>3</b>, the weak antiferromagnetic interactions between Cu<sup>II</sup> ions (Cu<sup>II</sup>···Cu<sup>II</sup> = 3.457 Å) should not be ignored below 12 K.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> UV–Vis and Fluorescence Spectra</h3><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B shows HL’s absorption spectra and its copper complexes <b>1–3</b>, as recorded in H<sub>2</sub>O [10% dimethyl sulfoxide (DMSO), v/v]. The HL ligand exhibits two intense absorption bands (∼280 and 346 nm) in a 250–700 range, which are assigned to n → π* and π → π* transitions. All the UV–vis absorption spectra of the complexes <b>1–3</b> present a low-energy absorption band at ∼413 nm, which is characteristic of metal–ligand charge transfer. The fluorescence spectra of these copper complexes along with the HL ligand were measured in water containing 10% DMSO (v/v) upon excitation at 415 nm (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). Copper(II) is paramagnetic (d<sup>9</sup> electronic arrangement) and can quench the fluorescence of adjacent fluorophores.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The Cu(II) complexes <b>1</b> and <b>2</b> show fluorescence emissions in the 450–650 nm region similar to the HL ligand, albeit with approximately two-times lower emission intensity (inset to <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). Interestingly, the fluorescence intensity of the mixed-valent copper(I/II) complex <b>3</b> is 26.6-, 58.1-, and 57.5-fold higher than those of the HL ligand, complex <b>1</b>, and complex <b>2</b>, respectively (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C), indicating that the presence of copper(I) in complex <b>3</b> plays an essential role in its prominent fluorescence intensity.</div><div class="NLM_p last">From the structural perspective, the coordination [Cu2–N3 2.034(4) Å] of copper(I) in complex <b>3</b> with the pyridine group on the ligand not only increases the rigidity of the entire molecule but also hinders the photoinduced electron transfer process produced by the N3-donor of the lone pair of electrons,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> leading to strong fluorescence. The fluorescence intensity of complex <b>2</b> is almost as low as that of complex <b>1</b> probably because the dimer complex <b>2</b> formed by the weaker Cu–N bond [Cu1–N3<sup><i>i</i></sup> 2.373(2) Å] decomposes into a monomer with a structure similar to that of complex <b>1</b> in solution. Notably, the HL ligand and its copper complexes exhibit fluorescence in the green region (450–650 nm) of the visible spectrum, which can be used for fluorescence-based bioimaging.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> <i>In Vitro</i> Potency</h3><div class="NLM_p">The <i>in vitro</i> anticancer activities of the free ligand and complexes <b>1–3</b> were evaluated after 48 h of drug treatment using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Three human pancreatic cancer cell lines, namely, BxPc-3, ASPC-1, and PANC-1, were used for evaluation. The widely used metal-based anticancer drug cisplatin [<i>cis</i>-diaminedichloroplatinum(II)] was employed as a positive control. The IC<sub>50</sub> values, which represent the concentration required to induce 50% cell viability, are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> (μM) Values of Copper Complexes against a Panel of Human Pancreatic Cancer Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±">cell growth inhibition, IC<sub>50</sub> ± SD (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="±">BxPc-3</th><th class="colsep0 rowsep0" align="center" char="±">ASPC-1</th><th class="colsep0 rowsep0" align="center" char="±">PANC-1</th><th class="colsep0 rowsep0" align="center" char="±">WI-38</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HL</td><td class="colsep0 rowsep0" align="char" char="±">38.61 ± 4.07</td><td class="colsep0 rowsep0" align="char" char="±">26.47 ± 3.11</td><td class="colsep0 rowsep0" align="char" char="±">46.38 ± 5.24</td><td class="colsep0 rowsep0" align="char" char="±">40.49 ± 4.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">5.33 ± 0.61</td><td class="colsep0 rowsep0" align="char" char="±">4.39 ± 0.58</td><td class="colsep0 rowsep0" align="char" char="±">4.73 ± 0.48</td><td class="colsep0 rowsep0" align="char" char="±">6.58 ± 0.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">0.86 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">0.46 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.73 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">2.13 ± 0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">0.74 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">0.41 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.62 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">2.06 ± 0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cisplatin</td><td class="colsep0 rowsep0" align="char" char="±">53.71 ± 6.14</td><td class="colsep0 rowsep0" align="char" char="±">67.23 ± 6.31</td><td class="colsep0 rowsep0" align="char" char="±">45.16 ± 4.97</td><td class="colsep0 rowsep0" align="char" char="±">18.73 ± 2.19</td></tr></tbody></table></div></div><div class="NLM_p">As revealed by the observed IC<sub>50</sub> values, the IC<sub>50</sub> values of the HL ligand were significantly higher than those of the copper complexes. Notably, all the copper complexes showed micromolar activities (0.41–5.33 μM) that are significantly better than cisplatin. The IC<sub>50</sub> values of complex <b>1</b> in BxPc-3, ASPC-1, and PANC-1 cells are 10.1-, 15.3-, and 9.5-fold lower (<i>p</i> < 0.01) than those of cisplatin, respectively. The IC<sub>50</sub> values of complex <b>2</b> are 62.4-, 146.1-, and 61.8-fold lower (<i>p</i> < 0.01) than those of cisplatin in BxPc-3, ASPC-1, and PANC-1 cells, respectively. Similarly, the IC<sub>50</sub> values of complex <b>3</b> are 72.6-, 163.9-, and 72.8-fold lower (<i>p</i> < 0.01) than those of cisplatin in BxPc-3, ASPC-1, and PANC-1 cells, respectively.</div><div class="NLM_p last">Based on the IC<sub>50</sub> values, some structure–activity relationship trends between the HL ligand and its copper complexes can be established. First, in general, the HL ligand’s anticancer activity is clearly improved by coordination with copper metals. Second, the potencies of complexes <b>1–3</b> against pancreatic cancer cells followed the order <b>3</b> ≈ <b>2</b> > <b>1</b>, suggesting that multinuclear copper complexes are likely to have anticancer potential than mononuclear copper complexes. Also, based on the excellent anticancer activity and fluorescent properties exhibited by complex <b>3</b>, we selected this complex for further <i>in vitro</i> and <i>in vivo</i> investigation.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Cellular and <i>in Vivo</i> Imaging Studies</h3><div class="NLM_p">Cell imaging of metal-based complexes can provide useful information regarding their potential biological applications. Several metal complexes with intrinsic fluorescence, for example, Ir(III), Re(I), and Zn(II) complexes, facilitate cell imaging in living cells.<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46−48)</a> However, Cu(II) is paramagnetic and thus quenches the fluorescence of adjacent fluorophores, which prevents the application of Cu(II) complexes for cell imaging in living cells.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Interestingly, as shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A–E, the imaging capability of complex <b>3</b> in ASPC-1 cells can be observed through confocal fluorescence microscopy.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A–E) Confocal fluorescence images of living ASPC-1 cells costained with complex <b>3</b> and DRAQ5, Golgi-Tracker Red, ER-Tracker Red, LysoTracker Red, or MitoTracker Deep Red FM. Scale bar: 10 μm. (A) Microscope images of the ASPC-1 cells incubated with complex <b>3</b> and far red nuclear stain DRAQ5: red fluorescence from DRAQ5 (λ<sub>ex</sub> = 638 nm), green fluorescence from complex <b>3</b> (λ<sub>ex</sub> = 405 nm). (B) Microscope images of the ASPC-1 cells incubated with complex <b>3</b> (green fluorescence, λ<sub>ex</sub> = 405 nm) and Golgi-Tracker Red (red fluorescence, λ<sub>ex</sub> = 589 nm). (C) Microscope images of the ASPC-1 cells incubated with complex <b>3</b> (green fluorescence, λ<sub>ex</sub> = 405 nm) and ER-Tracker Red (red fluorescence, λ<sub>ex</sub> = 587 nm). (D) Microscope images of the ASPC-1 cells incubated with complex <b>3</b> (green fluorescence, λ<sub>ex</sub> = 405 nm) and LysoTracker Red (red fluorescence, λ<sub>ex</sub> = 577 nm). (E) Microscope images of the ASPC-1 cells incubated with complex <b>3</b> (green fluorescence, λ<sub>ex</sub> = 405 nm) and MitoTracker Deep Red FM (red fluorescence, λ<sub>ex</sub> = 638 nm) and yellow fluorescence from merged the images. (F) <i>In vivo</i> fluorescence images (λ<sub>ex</sub> 455–495 nm, λ<sub>em</sub> 535 nm) of a BALB/c mouse after intraperitoneal injection of complex <b>3</b> (200 μL, 3 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further investigate the distribution of complex <b>3</b> in ASPC-1 cells, we conducted additional colocalization experiments using DRAQ5 (nuclear localization), Golgi-Tracker Red (golgi localization), ER-Tracker Red (endoplasmic reticulum localization), LysoTracker Red (lysosomal localization), and MitoTracker Deep Red FM (mitochondrial localization) dyes. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A–C, the red fluorescence signals of DRAQ5, Golgi-Tracker Red, and ER-Tracker Red displayed a very poor overlap with the green fluorescence of complex <b>3</b>, indicating that the copper complex does not localize in the nucleus, golgi, and endoplasmic reticulum. A small overlapping between the green fluorescence from complex <b>3</b> and the red fluorescence from LysoTracker Red was observed (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D), which confirmed that complex <b>3</b> was not primarily localized in the lysosome.</div><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E, colocalization studies using MitoTracker Deep Red FM revealed merging of the green and red signals to form yellow coloration, confirming the accumulation of the copper complex in the mitochondrial region. There are significant advantages of targeting mitochondria, namely, (1) as the powerhouse for eukaryotic cells, mitochondrial dysfunction can prevent the rapid growth of cancer cells and even lead to their death; (2) anticancer agents located in mitochondria can avoid nuclear excision repair mechanisms that can restore DNA-drug addicts; and (3) the mitochondria located in tumor cells are more susceptible to mitochondrial dysfunction than those in normal cells.<a onclick="showRef(event, 'ref42 ref49'); return false;" href="javascript:void(0);" class="ref ref42 ref49">(42,49)</a> Therefore, given the crucial roles of mitochondria in cancer cells, this can be considered a meaningful result.</div><div class="NLM_p last">To evaluate the <i>in vivo</i> imaging capabilities of complex <b>3</b>, we chose the BALB/c mouse as an animal model. A normal saline solution of complex <b>3</b> (0.2 mL, 3 mg/kg) was injected intraperitoneally into the mouse and imaged with 455–495 nm excitation and 535 nm emission. Immediately after injection, the <i>in vivo</i> fluorescence signal was very weak. However, after 30 min, a strong <i>in vivo</i> fluorescence was observed (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F), revealing the potential role of copper complexes in bioimaging, which is not limited to <i>in vitro</i> or live cells. After 4 h, although the <i>in vivo</i> fluorescence was weakened, it was still evident, indicating the long half-life circulation half-life of complex <b>3</b>. Further, based on fluorescence of complex <b>3</b>, the blood circulation half-life of complex <b>3</b> in BALB/c mice was calculated to be 1.52 h (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">Figure S3</a>).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Mechanism of Action of Complex <b>3</b></h3><div class="NLM_p">Proteomics analysis is a high-resolution and high-throughput process that can provide advanced information involved in disease or biological processes at the protein level, and this knowledge is useful for revealing the underlying anticancer mechanisms of a therapeutic agent.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Therefore, to gain an insight into the mechanism of action of complex <b>3</b>, tandem mass tag (TMT)-based proteomic analysis was conducted to investigate changes in the protein-expression profile of ASPC-1 cells under treatment with complex <b>3</b>.</div><div class="NLM_p">After quality validation, 6262 proteins were quantified. Of these, 157 proteins differentially accumulated in the complex <b>3</b>-treated group compared with the control group were observed based on the criteria: <i>p</i> < 0.05, ratio ≥ 1.5 (upregulated) or ratio ≤ 0.667 (downregulated). Of these differentially expressed proteins, 113 were upregulated, and 44 were downregulated. The gene ontology (GO) analysis results for the differentially expressed proteins are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">Figure S4</a>. Pathway analysis is the most direct way to systematically and comprehensively understand the biological processes of cells, the mechanisms or traits of diseases, and drug action mechanisms.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> With the established root proteins as the background, we investigated the significantly enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, which determine the signal transduction and metabolic pathways significantly affected by complex <b>3</b> treatment.</div><div class="NLM_p">The ten most significant pathways are the interleukin (IL)-17 signaling pathway, rheumatoid arthritis, chronic myeloid leukemia, fluid shear stress and atherosclerosis, ferroptosis, the mitogen-activated protein kinase (MAPK) signaling pathway, colorectal cancer, inflammatory bowel disease, cytokine–cytokine receptor interaction, and the B-cell receptor signaling pathway (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Of these, three pathways are clearly associated with proliferation, differentiation, migration, and death of ASPC-1 cells, including ferroptosis, MAPK signaling pathway, and cytokine–cytokine receptor interaction.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Pathway analysis of differentially expressed proteins was based on the KEGG database. (B) Western blot analysis of the protein expression levels of HMOX1 and ACSL4 in ASPC-1 cells. (C) Measurement of cellular lipid ROS levels in ASPC-1 cells by using BODIPY-C11 after exposure to complex <b>3</b> for 24 h. (D) Representative transmission electron microscopy images showing the mitochondria morphology of ASPC-1 cells treated with control and complex <b>3</b> (0.4 μM) for 24 h. (E) <i>In vitro</i> cytotoxicity of complex <b>3</b> against ASPC-1 cells in the absence and presence of ferroptosis inhibitor, liproxstatin-1 (1 μM), after 48 h incubation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ferroptosis is a recently regulated form of cell death and involves multiple pathological and physiological processes, such as cancer cell death, T-cell immunity, neurotoxicity, acute renal failure, and neurodegenerative diseases.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> This KEGG study found that the ferroptosis pathway is induced primarily by significant upregulation of heme oxygenase 1 (HMOX1), glutamate-cysteine ligase, prion protein PRNP, and solute carrier family 7 member 11 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">Figure S5</a>). Another indication that complex <b>3</b> can exert antitumor effects <i>via</i> the ferroptosis pathway was obtained by Western blotting. HMOX1 and acyl-CoA synthetase long-chain family member 4 (ACSL4), key proteins involved in ferroptosis, have been reported to increase when ferroptosis occurs.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53,54)</a> As expected, complex <b>3</b> treatment dose-dependently upregulated the protein levels of HMOX1 and ACSL4 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Ferroptosis is initiated by the accumulation of iron-dependent lipid peroxidation relying on reactive oxygen species (ROS).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Flow cytometry analyses, therefore, were conducted to evaluate the production levels of lipid ROS. From <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C we can see that complex <b>3</b> indeed induces lipid ROS production. Plenty of evidence revealed that mitochondria are involved in ferroptosis,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and in this study, the localization of complex <b>3</b> in the mitochondria (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E) indicates that the ferroptosis induced by complex <b>3</b> is probably mediated by the mitochondria. Morphologically, compared with normal mitochondria, mitochondria in the ferroptotic cells exhibit ultrastructural changes, such as volume reduction, reduced mitochondrial crista, increased mitochondrial membrane density, and ruptured outer mitochondrial membrane.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Therefore, transmission electron microscopy was applied to observe the mitochondria morphology. Compared with untreated cells, complex <b>3</b>-treated cells showed ruptured and smaller mitochondria (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D), which are morphological changes of ferroptotic cells. Also, we conducted cytotoxicity studies in the presence of liproxstatin-1, a ferroptosis inhibitor.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Coincubation with liproxstatin-1 decreases the toxicity of complex <b>3</b> against ASPC-1 cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E). Altogether, these data demonstrate that complex <b>3</b> is an inducer of ferroptosis. Notably, this represents the first time a copper complex that has been demonstrated to induce ferroptosis. The ferroptosis pathway bypasses the apoptosis inhibition and can overcome apoptotic resistance.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Since pancreatic cancer cells exhibit strong resistance to apoptosis, inducing ferroptosis in pancreatic cancer cells provides a promising strategy.</div><div class="NLM_p">Owing to the important roles of MAPK signaling in tumor cells, using MAPK signaling pathways as therapeutic targets is a promising cancer treatment strategy.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> This study found that the MAPK signaling pathway is disturbed by the upregulation of transcription factor AP-1 (JUN), growth arrest and DNA damage-inducible protein (GADD45B), proto-oncogene c-Fos (FOS), growth factor receptor-bound protein 2 (GRB2), heat shock 70 kDa protein 1A (HSPA1A), and NF-κB essential modulator as well as the downregulation of hepatocyte growth factor and transforming growth factor β-3 (TGFB3). Western blotting revealed that treatment of ASPC-1 cells causes a dose-dependent downregulation in the expression of TGFB3 and a dose-dependent increase in the expression of FOS (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). Also, we investigated the phosphorylation levels of ERK (P-ERK), a key factor in the MAPK pathway.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The result showed the P-ERK decreased in a time-dependent manner in ASPC-1 cells. The western blotting data also agree with the proteomics finding that complex <b>3</b> activates the MAPK signaling pathway.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Western blot analysis of the protein expression levels of TGFB3, FOS and P-ERK in ASPC-1 cells. (B) Antimigratory effect of on ASPC-1 cells by wound healing assay. Scale bar: 200 μm. (C) After treatment with or without complex <b>3</b> for 24 h, ASPC-1 cell invasion ability was detected by transwell assay. Scale bar: 200 μm. (D) Western blot analysis of the protein expression levels of MMP-2 and MMP-9 in ASPC-1 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The MAPK pathway is involved in various cellular functions, such as cell proliferation, metastasis, and apoptosis.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60,61)</a> Accumulating evidence has shown that the inhibition of the ERK signaling pathway in the MAPK pathway can suppress cell metastasis and promote cell apoptosis.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a> We, therefore, investigated the effect of complex <b>3</b> on metastasis and apoptosis in ASPC-1 cells. Migration and invasion have been reported to initiate the metastatic process.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Thus, we investigated the effect of complex <b>3</b> on cell migration and invasion using transwell migration and wound-healing assays. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B, in the absence of complex <b>3</b>, cells migrate rapidly, and the gap is significantly reduced. In contrast, fewer migratory cells and narrower migration distances are observed with the addition of complex <b>3</b>. The transwell invasion results in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B match those in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C. Furthermore, we investigated the expressions of extracellular matrix proteins, MMP-2 and MMP-9, which play an essential role in the degradation of the basal lamina and the extracellular matrix, and can promote tumor cell metastasis.<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a> As exhibited in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D, complex <b>3</b> could effectively inhibit the expression of MMP-2 and MMP-9. These data show that complex <b>3</b> inhibited the migration and invasion abilities of ASPC-1 cells.</div><div class="NLM_p">Also, using a dual propidium iodide (PI)/Annexin-V staining flow cytometry assay, we explored the occurrence of apoptosis in ASPC-1 cells treated for 24 h with complex <b>3</b>. It was observed in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A that complex <b>3</b> significantly induced ASPC-1 cells apoptosis dose-dependently. Based on the evidence of the localization of complex <b>3</b> in the mitochondria in ASPC-1 cells, we envisaged that the complex would likely involve the mitochondrial-mediated apoptotic pathway. Thus, the mitochondrial membrane potential of ASPC-1 cells was evaluated by flow cytometry using the JC-1 probe. JC-1 exists in its aggregates form with red fluorescence in healthy cells, whereas it forms “J-monomeric,” showing green fluorescence in necrotic/apoptotic cells. From <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B, treating ASPC-1 cells with complex <b>3</b> caused mitochondrial membrane potential (green fluorescence increase) loss dose-dependently. Mitochondrial apoptosis releases cytochrome <i>c</i> from the mitochondrial intermembrane space into the cytoplasm.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Therefore, the changes of cytochrome <i>c</i> in mitochondria were further examined. As presented in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C, complex <b>3</b> could lead to a dose-dependent decrease in the amount of cytochrome <i>c</i> in the mitochondria, confirming that treatment with complex <b>3</b> resulted in the mitochondrial release of cytochrome <i>c</i>. Subsequently, the activation of caspase-9 was initiated by the cytoplasmic cytochrome <i>c</i> and executed the apoptosis program (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D). These results indicated that complex <b>3</b> evoked the mitochondrial-mediated apoptotic pathway.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Flow cytometry analysis for apoptosis of ASPC-1 cells induced by complex <b>3</b> for 24 h. (B) Effects of complex <b>3</b> on mitochondrial membrane potential of ASPC-1 cells analyzed by flow cytometry and JC-1 staining. (C) Western blot analysis of the protein expression levels of cytochrome <i>c</i> in the mitochondria of ASPC-1 cells. (D) Western blot analysis of the protein expression levels of caspase-9 in the mitochondria of ASPC-1 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The cytokine–cytokine receptor interaction signaling pathway is involved in the proliferation, differentiation, and immunity of cells.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Dysfunction of cytokine–cytokine receptor interaction can cause cell death. KEGG analysis revealed that tumor necrosis factor receptor superfamily member 12A, pro-inflammatory cytokine IL-18, and growth/differentiation factor 15 are upregulated, and TGFB3 is downregulated in this pathway.</div><div class="NLM_p last">Collectively, the results demonstrate that complex <b>3</b> performs its anticancer functions by altering multiple pathways (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">Figure S6</a>), such as, ferroptosis, MAPK signaling, and cytokine–cytokine receptor interaction signaling.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Tumor Spheroid Assay and Xenograft Studies</h3><div class="NLM_p">Compared with monolayer tumor cells, multicell tumor spheroids adequately reflect several solid tumor characteristics, such as, the secretion of soluble mediators, specific hypoxic zones, proliferation gradients, and spatial architectures.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> In simulating the three-dimensional (3D) structure of malignant tissues and internal tumor microenvironments, multicellular tumor spheroids are significantly better than monolayer tumor cells. Therefore, recently, tumor spheroid systems have become widely used as models for simulating tumor tissues <i>in vivo</i>.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Here, ASPC-1 tumor spheroids were successfully cultured and used to evaluate the potential antisolid-tumor activity of complex <b>3</b>. <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> displays the inhibitory effects on the 3D ASPC-1 tumor spheroids following treatment with different concentrations of complex <b>3</b>. The tumor spheroids increase in size and are very compact in the control group. Conversely, as evaluated by cell membrane rupture, the tumor spheroids, surface disintegration, cell leakage, and loss of 3D structure are observed in the complex <b>3</b>-treated group at 0.4 μM and especially at 0.8 μM.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Morphology of 3D ASPC-1 tumor spheroids treated with complex <b>3</b> on at the indicated concentrations for 7 days. Scale bar: 500 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further evaluate the <i>in vivo</i> therapeutic efficacy of complex <b>3</b>, an ASPC-1 tumor-bearing mice model was created. The tumor volume and body weight of the mice were monitored every 3 days for 21 days. At the end of the experiments, as shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A, the tumor volumes in mice treated with complex <b>3</b> at 1.5 and 3 mg/kg were much smaller than the tumor volumes in mice treated with normal saline (vehicle control). Compared with the control group, the tumor volume after 21 days of treatment was 61.9 ± 6.73% for 1.5 mg/kg and 45.4 ± 4.28% for 3 mg/kg. Importantly, no significant weight loss (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B) or mortality was observed for complex <b>3</b>-treated mice during the post-treatment period.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Changes of tumor volume after intraperitoneal injection of complex <b>3</b> (1.5 and 3 mg/kg) in ASPC-1 tumor-bearing nude mice. *<i>p</i> < 0.05, **<i>p</i> < 0.001. (B) Effects of complex <b>3</b> on body weight of ASPC-1 tumor-bearing mice. (C) <i>Ex vivo</i> biodistribution studies of complex <b>3</b> at 2 h after injection. (D) H&E staining analysis of kidney, tumor, and liver treated with complex <b>3</b>. Scale bar: 50 μm. (E) Tumors are sectioned and stained with TUNEL. Apoptotic cells appear green. Scale bar: 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, the distribution of complex <b>3</b> in major organs of tumor-bearing mice was examined. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C, an <i>ex vivo</i> fluorescence imaging study showed strong signals in the tumor, kidney, and liver, indicating that complex <b>3</b> can effectively reach the tumor tissue, reduce side effects, and was mainly excreted through the liver and kidney system. Also, a weak fluorescent signal is observed in the brain, and complex <b>3</b> can cross the <i>in vitro</i> blood–brain barrier model at a ratio of about 17% (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">Figure S7</a>), suggesting that complex <b>3</b> was able to cross the blood–brain barrier.</div><div class="NLM_p last">Next, the hematoxylin and eosin (H&E) analysis of kidney, tumor, and liver was further adopted to assess <i>in vivo</i> safety and antitumor efficacy after treatment with complex <b>3</b>. There were no major histopathological changes in the liver and kidney sections (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>D), further confirming the <i>in vivo</i> tolerability of complex <b>3</b>. In contrast, obvious differences in the tumor tissue morphology were observed between the groups treated and the control group. Compared with the control, tumor cellularity was decreased, and nuclear shrinkage and fragmentation were observed in the complex <b>3</b>-treated groups (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>D). Likewise, TUNEL staining of tumor tissue sections showed that complex <b>3</b> produced obvious cell apoptosis, while there were almost no apoptotic cells observed in the control group (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>E). These data clearly suggested that complex <b>3</b> possessed potent antitumor activity against the growth of inoculated ASPC-1 tumors in mice with low toxicity.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10532" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10532" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Here, three new fluorescent dithiocarbazate–copper complexes with different coordination geometries were prepared based on anion adjustment, and their <i>in vitro</i> anticancer and imaging properties were investigated. The mixed-valent copper(I/II) complex <b>3</b> has good antipancreatic cancer ability <i>in vitro</i> and <i>in vivo</i> and can be used for bioimaging beyond living cells or <i>in vitro</i>. Further anticancer-mechanism studies demonstrated that complex <b>3</b> kills pancreatic cancer cells through multiple pathways, including ferroptosis, MAPK, and cytokine–cytokine receptor interaction pathways. Given the acquired or inherent resistance of pancreatic tumors or both to apoptosis-inducing chemical anticancer agents, compounds, such as, complex <b>3</b>, capable of killing pancreatic cancer cells through ferroptosis, are attractive preclinical candidates for treating chemoresistant malignant tumors.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Materials</h3><div class="NLM_p last">MTT, methyl hydrazinecarbodithioate, di(pyridin-2-yl)methanone, and CuCl<sub>2</sub>·2H<sub>2</sub>O/Cu(NO<sub>3</sub>)<sub>2</sub>·3H<sub>2</sub>O/CuBr<sub>2</sub> were procured from Sigma-Aldrich. All other solvents and reagents were obtained from commercial sources. C, H, and N elemental analyses were acquired using a LECO CHNS-932 analyzer. The Fourier transform infrared (FT-IR) spectrum (KBr pellets) was recorded in the region of 400–4000 cm<sup>–1</sup> on an InterSpec 2020 FT-IR spectrophotometer. Fluorescence spectra were recorded by a LS 45 PerkinElmer spectrofluorometer. Magnetic susceptibility data were measured on a Quantum Design MPMS3 SQUID. Atomic absorption spectroscopy measurements were taken on a AAnalyst 600 spectrometer (PerkinElmer). The relative purity of the HL ligand and its copper complexes used in this study was >95%, as examined by elemental analysis.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Synthesis of the Ligand and Complexes <b>1–3</b></h3><div class="NLM_p">The HL ligand was synthesized according to the literature procedure.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Briefly, the HL ligand was prepared by refluxing methyl hydrazinecarbodithioate (0.61 g, 5 mmol) and di(pyridin-2-yl)methanone (0.92 g, 5 mmol) for a period of 1 h in MeOH to obtain a yellow solution. Yellow shiny crystals of HL were generated through slow evaporation of the solvent at 4 °C, yield 1.09 g (76%). Calcd for C<sub>13</sub>H<sub>12</sub>N<sub>4</sub>S<sub>2</sub> (288.39): C, 54.14; H, 4.19; N, 19.43. Found: C, 54.08; H, 4.23; N, 19.37. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 14.95 (s, 1H), 8.86 (ddd, <i>J</i> = 4.8, 1.6, 1.0 Hz, 1H), 8.63 (ddd, <i>J</i> = 4.8, 1.6, 1.0 Hz, 1H), 8.13–7.86 (m, 3H), 7.67–7.58 (m, 2H), 7.54 (ddd, <i>J</i> = 7.2, 4.8, 1.6 Hz, 1H), 2.59 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 201.4, 155.1, 150.9, 149.1, 148.8, 144.6, 138.2, 137.9, 128.0, 125.7, 124.8, 124.0, 17.4 ppm (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">Figures S8 and S9</a>).</div><div class="NLM_p">The complexes, [Cu<sup>II</sup>(L)(Cl)] (<b>1</b>), [Cu<sup>II</sup><sub>2</sub>(L)<sub>2</sub>(NO<sub>3</sub>)<sub>2</sub>] (<b>2</b>) and [Cu<sup>II</sup><sub>2</sub>Cu<sup>I</sup>(L)<sub>2</sub>(Br)<sub>3</sub>] (<b>3</b>), were synthesized as described below. One mole equivalent of the HL ligand was added to ethanolic (40 mL) solution of either CuCl<sub>2</sub>·2H<sub>2</sub>O, Cu(NO<sub>3</sub>)<sub>2</sub>·3H<sub>2</sub>O, or CuBr<sub>2</sub> and refluxed for 0.5 h. The mixing solution was then allowed to cool to room temperature and filtered. Dark-green block crystals of these copper complexes were obtained through slow evaporation of the filtrate solvent.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> [Cu<sup>II</sup>(L)(Cl)] (<b>1</b>)</h4><div class="NLM_p last">Yield: 61%. Anal. Calcd for C<sub>13</sub>H<sub>11</sub>ClCuN<sub>4</sub>S<sub>2</sub> (386.37): C, 40.41; H, 2.87; N, 14.50. Found: C, 40.62; H, 2.93; N, 14.69. IR (KBr, cm<sup>–1</sup>): 3063m, 1591m, 1550m, 1491m, 1470m, 1414vs, 1328s, 1302s, 1260m, 1187m, 1159w, 1087vs, 996vs, 954m, 742m, 698s, 653m, 597w, 523w, 421w.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> [Cu<sup>II</sup>(L)(NO<sub>3</sub>)]<sub>2</sub> (<b>2</b>)</h4><div class="NLM_p last">Yield: 72%. Anal. Calcd for C<sub>26</sub>H<sub>22</sub>Cu<sub>2</sub>N<sub>10</sub>O<sub>6</sub>S<sub>4</sub> (825.86): C, 37.81; H, 2.68; N, 16.96. Found: C, 37.64; H, 2.53; N, 16.73. IR (KBr, cm<sup>–1</sup>): 3076m, 2360m, 1596m, 1471vs, 1380vs, 1283vs, 1157m, 1095s, 1009vs, 956m, 812w, 789m, 768w, 747m, 661w, 624w, 607w.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> [Cu<sup>II</sup><sub>2</sub>Cu<sup>I</sup>(L)<sub>2</sub>(Br)<sub>3</sub>] (<b>3</b>)</h4><div class="NLM_p last">Yield: 68%. Anal. Calcd for C<sub>26</sub>H<sub>22</sub>Br<sub>3</sub>Cu<sub>3</sub>N<sub>8</sub>S<sub>4</sub> (1005.11): C, 31.07; H, 2.21; N, 11.15. Found: C, 31.21; H, 2.33; N, 11.07. IR (KBr, cm<sup>–1</sup>): 2361w, 1588m, 1543w, 1403vs, 1331s, 1306m, 1208m, 1087s, 994s, 911m, 793m, 747w, 651w, 604w, 523w.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Cu Complex Crystal Structure Determination</h3><div class="NLM_p last">The X-ray crystallography data of complexes <b>1–3</b> were obtained on a Bruker SMART APEX2 with Mo Kα (λ = 0.71069) radiation at room temperature. The experimental structures of these copper complexes were obtained using the Olex-2 program.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Non-H atoms are refined anisotropic thermal parameters. Cambridge Crystal Data Center deposition numbers: 1964509 for <b>1</b>, 1964510 for <b>2,</b> and 1964511 for <b>3</b>. The selected crystallographic data for complexes <b>1–3</b> are reported in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">Tables S1 and S2</a>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Cell Cytotoxicity Assays</h3><div class="NLM_p">Human pancreatic cancer cells (BxPc-3, ASPC-1, and PANC-1) and human normal lung fibroblast cells (WI-38) were maintained in Dulbecco’s modified Eagle’s medium or RPMI-1640 culture containing 10% fetal bovine serum and 1% streptomycin/penicillin at 37 °C and 5% CO<sub>2</sub>.</div><div class="NLM_p last">The cytotoxicity of the copper complexes was investigated by MTT assay. In brief, the noncancer cells and cancer cells were seeded into 96-well plates at 5 × 10<sup>4</sup> cells/mL and then incubated at 37 °C and 5% CO<sub>2</sub>. After 24 h incubation, the cells were incubated with different concentrations (0–100 μM) of test compounds for 48 h. Then, 10 μL of MTT saline solution (5 mg/mL) was added to each well, and the plate was then incubated for 4 h at 37 °C and 5% CO<sub>2</sub>. The supernatant in each well of the 96-well plates was replaced by 100 μL of DMSO to dissolve the MTT-formazan. The absorbance was then read at 570 nm using an infinite M200 Pro microplate reader.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Cellular and <i>in Vivo</i> Imaging Assay</h3><div class="NLM_p">On the basis of the fluorescence properties of complex <b>3</b>, fluorescence cellular imaging using complex <b>3</b> was performed with a Zeiss LSM 510 confocal microscope using oil objective (63×). Briefly, ASPC-1 cells were treated with different DRAQ5 (nuclear localization), Golgi-Tracker Red (golgi localization), ER-Tracker Red (endoplasmic reticulum localization), LysoTracker Red (lysosomal localization), and MitoTracker Deep Red FM (mitochondrial localization) dyes under 37 °C and 5% CO<sub>2</sub> conditions followed by incubation with the copper complex <b>3</b> (10 μM) at 37 °C and 5% CO<sub>2</sub>. Complex <b>3</b>, DRAQ5, Golgi-Tracker Red, ER-Tracker Red, LysoTracker Red, and MitoTracker Deep Red FM were excited independently at 405, 638, 589, 587, 577, and 638 nm and their emissions detected at 524, 690, 617, 615, 590, and 665 nm, respectively.</div><div class="NLM_p last"><i>In vivo</i> imaging was carried out in male BALB/c mice (Hunan SJA Laboratory Animal Co., Ltd.) and an <i>in vivo</i> imaging system (UVP iBox, Scientia). All mouse experiments conformed to the Guidelines for the Care and Use of Laboratory Animals published by Guilin Medical University. The mouse was anesthetized with 7% chloral hydrate for imaging. After that, the saline solution of complex <b>3</b> (200 μL, 3 mg/kg) was injected into the mouse by intraperitoneal injection. Images were taken under conditions as follows: excitation filter 455–495 nm, emission filter 535/50 nm, and exposure time 2 s. The mouse was imaged again at 0 min, 30 min, 2 h, and 4 h for comparison. In addition, based on complex <b>3</b>’s fluorescence, the blood circulation half-life of complex <b>3</b> was calculated according to the method in the literature.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Proteomics Analysis</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Protein Extraction and TMT Labeling</h4><div class="NLM_p last">In order to establish a proteomics model for studying the anticancer mechanism of complex <b>3</b>, ASPC-1 cells were treated with complex <b>3</b> (0.4 μM) or vehicle control for 24 h. After incubation, cells were harvested and washed with cold phosphate buffered saline (PBS) twice. Then, the ASPC-1 cell samples were homogenized with SDT [4% sodium dodecyl sulfate (SDS), 100 mM Tris-HCl, pH 7.6] lysate buffer, followed by heating in a boiling H<sub>2</sub>O bath for 15 min. The mixture was centrifuged at 14,000<i>g</i> and 4 °C for 15 min to remove cell debris. The protein concentrations of the supernatants were quantified using the bicinchoninic acid (BCA) assay. The proteins (20 μg of protein for each sample) were separated on 12% SDS-polyacrylamide gel electrophoresis gel (constant voltage 250 V, 40 min). Next, filter-aided sample preparation digestion was performed for protein digestion. In brief, 200 μg of each protein was deterged, alkylated, incubated, and digested. Finally, the resulting peptides were collected and processed with a TMT kit according to the manufacturer’s protocol.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> High-pH Reverse Phase Fractionation and LC–MS/MS Analysis</h4><div class="NLM_p">High-pH reverse phase fractionation chromatography was carried out using an Agilent 1260 infinity II high-performance liquid chromatography system. Briefly, the samples first were incubated with buffer A (10 mM HCOONH<sub>4</sub>, 5% acetonitrile, pH 10.0). Subsequently, the mixtures were loaded onto a C18 column (Thermo Fisher Scientific) with buffer A and buffer B (10 mM HCOONH<sub>4</sub>, 85% acetonitrile, pH 10.0). During elution, the UV absorbance at 214 nm of the eluent was monitored. Forty fractions were collected every min and dried by vacuum centrifugation for liquid chromatography with tandem mass spectrometry (LC–MS/MS) analysis.</div><div class="NLM_p last">Nanoflow LC–MS/MS analysis of peptide samples was conducted on a Q Exactive mass spectrometer coupled to an Easy-nLC. Each fraction was dissolved in 0.1% formic acid. The peptide mixture was then separated on a reversed-phase C18 column at a flow rate of 300 nL/min. The chromatographic elution program was 6% solvent B (0.1% formic acid in 98% acetonitrile) for 3 min, then 6–28% over 42 min and returning to 38% solvent B over 5 min, and then maintaining 100% solvent B for the last 5 min. The separated peptides were directly conducted by Q Exactive plus on-line. The data-dependent top 10 method was chosen for MS data acquisition. The survey scans (350 to 1800 <i>m</i>/<i>z</i>) were acquired at a resolution of 70,000. The automatic gain control was set at 3 × 10<sup>6</sup>. The tryptic peptide ions (precursor ions) were selected for high-energy collision dissociation at a normalization collision-energy value of 30 to obtain MS/MS spectra. The fragment ions (product ions) were acquired at a resolution of 35,000.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Proteomic Data Analysis and Bioinformatics Analysis</h4><div class="NLM_p">The raw MS/MS data were input into Proteome Discoverer software (version 2.1) for data processing. Peptides were identified and quantified using Mascot 2.6 software and the Uniprot_HomoSapiens database (20386_20180905). The identification and quantitative analysis parameters were set as follows: enzyme (trypsin), max missed cleavages (2), instrument (ESI-TRAP), precursor mass tolerance (±10 ppm), fragment mass tolerance (0.05 Da), use average precursor mass (false), modification groups from quan method (TMT 10plex), dynamic modifications (oxidation and acetyl), static modifications (carbamidomethyl), and database pattern (decoy). For protein identification, the peptide false discovery rate was adjusted to ≤0.01.</div><div class="NLM_p last">GO annotation of differentially expressed proteins was derived from the Blast2GO database (<a href="http://www.geneontology.org" class="extLink">www.geneontology.org</a>). Differentially expressed proteins were classified by GO annotation based on three categories, including molecular functions, cellular compartments, and biological processes. KEGG pathway analysis of differentially expressed proteins was performed with KEGG Orthology and Links Annotation software and the online KEGG analysis database (<a href="http://www.genome.jp/kegg/pathway.html" class="extLink">www.genome.jp/kegg/pathway.html</a>). KEGG pathway enrichment and GO enrichment analyses were performed on the basis of the Fisher’s exact test.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Lipid ROS Production Measurement</h3><div class="NLM_p last">Cellular lipid ROS generation in the ASPC-1 cells was measured by BODIPY-C11 lipid probes (Thermo Fisher Scientific, USA). Briefly, ASPC-1 cells were exposed to complex <b>3</b> at the indicated concentrations. After 24 h, cells were washed and labeled with BODIPY-C11 (5 μM) for 15 min at 37 °C. Lipid ROS were determined on a flow cytometer (FACScan, Becton Dickinson) using channels for reduced dye and oxidized dyes simultaneously.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Antimetastatic Assay</h3><div class="NLM_p">The antimetastatic studies for copper complex <b>3</b> were conducted in ASPC-1 cells by the scratching wound healing assay and invasion assay. For the scratching wound healing assay, the ASPC-1 cells were seeded in a six-well plate and then cultured until they reached ∼90% confluence. Wounds gaps in the monolayer cells were generated using a sterile pipette tip. Then, the cellular debris were carefully removed with cold PBS and cultured in RPMI-1640 medium containing 1% fetal bovine serum (to minimize ASPC-1 cell proliferation during the assay) with or without complex <b>3</b> for 24 h.</div><div class="NLM_p last">The invasion assay was performed with ASPC-1 cells using Matrigel-coated 24-well transwells, which allow cells to migrate through a polycarbonate filter membrane (8.0 μm pores). In brief, 75 μL of a Matrigel working solution (1 mg/mL) was added to the upper surface and allowed to solidify at 37 °C for 1 h. Then, 750 μL of RPMI-1640 medium containing 10% fetal bovine serum were added to the lower well, and 100 μL of cell suspension at a density of 5 × 10<sup>4</sup> cells/well with or without complex <b>3</b> was plated in the upper chamber. After 24 h of incubation, the adherent cells on the undersurface of the insert were fixed in MeOH and stained with 0.1% crystal violet dye.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Cell Apoptosis</h3><div class="NLM_p last">Apoptosis analysis was carried out in ASPC-1 cancer cells and analyzed by the Annexin V fluorescein isothiocyanate (FITC) kit (Beyotime, Nanjing, China) and flow cytometry. In brief, the ASPC-1 cells (at a density 5 × 10<sup>4</sup> cells/well) were seeded in six-well plates and cultured for 24 h. After that, the cells were treated with the vehicle control or complex <b>3</b> (0.4 and 0.8 μM). After 24 h, the cells were harvested and stained with Annexin V-FITC/PI according to the manufacturer’s instructions. Cell apoptosis was immediately observed by flow cytometry.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Mitochondrial Membrane Potential</h3><div class="NLM_p last">The changes of mitochondrial membrane potential were analyzed by the JC-1 kit (Beyotime, Nanjing, China) and flow cytometry. In brief, cells were harvested and washed twice with cold-PBS, followed by resuspension in 5 mg/mL JC-1 solution and incubation at 37 °C for 0.5 h. After that, the cells were rinsed and suspended in PBS, and the JC-1 fluorescence was immediately observed by flow cytometry.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Western Blotting</h3><div class="NLM_p last">Western blotting analysis was carried out as previously described.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Proteins extracted from mitochondria or whole cells. The corresponding protein concentration was quantified by the BCA kit (Beyotime, Nanjing, China). Target proteins, including anti-β-actin (Abcam), anti-HMOX1 (Abcam), anti-ACSL4 (Abcam), anti-TGFB3 (Proteintech), anti-caspase-9 (Abcam), anti-c-Fos (Abcam), anti-phos-ERK1/2 (Abcam), anti-MMP-2 (Abcam), anti-MMP-9 (Abcam), and anti-cytochrome <i>c</i> (Abcam), were incubated with the corresponding primary antibodies and subsequently monitored using secondary antibodies conjugated to alkaline phosphatase.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Blood–Brain Barrier Model <i>in Vitro</i></h3><div class="NLM_p last">The blood–brain barrier model <i>in vitro</i> was established according to literature procedures.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Briefly, the human brain microvascular endothelial cells were seeded on the transwell upper side, and the ASPC-1 cells were cultured in the basolateral compartment of the transwell. After incubation for several days, when the resistance of the human brain microvascular endothelial cells on the upper side exceeded 250 Ω cm<sup>2</sup>, complex <b>3</b> (0.4 μM) was added to the upper side and incubated at 37 °C for 48 h. Then, the transportation ratio of complex <b>3</b> was measured by atomic absorption to determine the content of copper in the upper and lower chambers.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Tumor Spheroid Assay and Xenograft Studies</h3><div class="NLM_p">The inhibition of 3D tumor spheroid growths was evaluated by measuring the size of tumor spheroids following treatment with different concentrations of complex <b>3</b>. In brief, ASPC-1 cells were grown to ∼600 cells/well using an ultralow attachment and a round-bottom 96-well plate (Corning, Sigma-Aldrich). After 2 days of incubation, the selected spheroids were treated with 0.1% DMSO (control) or different concentrations of complex <b>3</b> for 7 days.</div><div class="NLM_p last"><i>In vivo</i> anticancer activity of complex <b>3</b> was assessed through the pancreatic cancer xenograft model. All mouse experiments conformed to the Guidelines for the Care and Use of Laboratory Animals published by Guilin Medical University. ASPC-1 cancer cells (4.0 × 10<sup>6</sup>) in a 200 μL suspension of serum-free medium were injected subcutaneously into the right flank of six-week male BALB/c mice (Hunan SJA Laboratory Animal Co., Ltd.). Body weight and tumor volume of the mice were monitored every 3 days. The tumor size (<i>V</i>) was calculated through caliper measurement as follows: <i>V</i> = (tumor length) × (tumor width)<sup>2</sup>/2. Tumor-bearing mice were randomly divided into two groups (<i>n</i> = 8/group) when the average tumor size reached 100 mm<sup>3</sup>. Mice in different treatment groups were intraperitoneally injected with normal saline and complex <b>3</b> (1.5 and 3 mg/kg) once every 3 days. The study was concluded on day 21 when the average tumor volume in the group reached 1000 mm<sup>3</sup>. In addition, organs (tumor, heart, spleen, lung, kidney, liver, and brain) were harvested and imaged after 2 h postinjection to investigate the distribution of complex <b>3</b>. At the time of necropsy, kidneys, livers, and tumors were collected and sectioned. Sections were then stained with H&E to facilitate histologic examination. In addition, the apoptotic level of tumor sections was assessed using the One Step TUNEL Apoptosis Assay Kit according to the manufacturer’s instructions (Beyotime, Nanjing, China).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Statistical Analysis</h3><div class="NLM_p last">All values were analyzed using SPSS software (SPSS Inc., Chicago, IL, USA) and are expressed as mean ± standard deviation. Statistical analysis comparisons between different groups were carried out using Student’s <i>t</i>-test. <i>p</i> < 0.05 was considered significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01936" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01936?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01936</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Views of the weak interactions of <b>1</b> and <b>3</b>; blood circulation curve, proteomics analysis, proposed cellular mechanism, and permeability across the blood–brain barrier of <b>3</b>; <sup>1</sup>H and <sup>13</sup>C NMR spectra of HL; fluorescence spectra of <b>3</b> under multiple excitation wavelengths; and the selected crystallographic data and related cytotoxicity for <b>1–3</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Crystallographic data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_003.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Crystallographic data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_004.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Crystallographic data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_005.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">checkCIF/PLATON report (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_006.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf">jm0c01936_si_001.pdf (1.6 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_002.csv">jm0c01936_si_002.csv (0.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_003.cif">jm0c01936_si_003.cif (248.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_004.cif">jm0c01936_si_004.cif (260.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_005.cif">jm0c01936_si_005.cif (536.87 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_006.pdf">jm0c01936_si_006.pdf (563.41 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01936" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48324" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48324" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng Yang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for the Chemistry and Molecular Engineering of Medicinal
Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin 541004, Guangxi, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4201-1416" title="Orcid link">http://orcid.org/0000-0002-4201-1416</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#abcdd2cac5ccebc6cac2c7c9c4d385ccd3c5de85cecfde85c8c5"><span class="__cf_email__" data-cfemail="402639212e27002d21292c222f386e27382e356e2524356e232e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">GuoJin Huang</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Respiratory Disease, Affiliated Hospital
of Guilin Medical University, Guilin 541001, Guangxi, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#31000401060804080208037140401f525e5c"><span class="__cf_email__" data-cfemail="80b1b5b0b7b9b5b9b3b9b2c0f1f1aee3efed">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Gou</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Respiratory Disease, Affiliated Hospital
of Guilin Medical University, Guilin 541001, Guangxi, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2900-4983" title="Orcid link">http://orcid.org/0000-0002-2900-4983</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">MeiRong Chen</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Respiratory Disease, Affiliated Hospital
of Guilin Medical University, Guilin 541001, Guangxi, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shanhe Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for the Chemistry and Molecular Engineering of Medicinal
Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin 541004, Guangxi, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">JunGang Deng</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Respiratory Disease, Affiliated Hospital
of Guilin Medical University, Guilin 541001, Guangxi, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinlong Li</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Nantong University, Nantong 226019, Jiangsu, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">GuiHua Fang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Nantong University, Nantong 226019, Jiangsu, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.G., M.C., and S.L. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77483" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77483" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the projects 22007023, 2017GXNSFEA198002, 2020GXNSFBA238003, and JC2019104.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">HL</td><td class="NLM_def"><p class="first last">methyl 2-(di(pyridin-2-yl)methylene)hydrazinecarbodithioate</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">TMT</td><td class="NLM_def"><p class="first last">tandem mass tag</p></td></tr><tr><td class="NLM_term">GO</td><td class="NLM_def"><p class="first last">gene ontology</p></td></tr><tr><td class="NLM_term">KEGG</td><td class="NLM_def"><p class="first last">Kyoto Encyclopedia of Genes and Genomes</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">reverse phase</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">ACSL4</td><td class="NLM_def"><p class="first last">acyl-CoA synthetase long-chain family member 4</p></td></tr><tr><td class="NLM_term">HMOX1</td><td class="NLM_def"><p class="first last">heme oxygenase 1</p></td></tr><tr><td class="NLM_term">GCLM</td><td class="NLM_def"><p class="first last">glutamate-cysteine ligase</p></td></tr><tr><td class="NLM_term">SLC7A11</td><td class="NLM_def"><p class="first last">solute carrier family 7 member 11</p></td></tr><tr><td class="NLM_term">JUN</td><td class="NLM_def"><p class="first last">transcription factor AP-1</p></td></tr><tr><td class="NLM_term">GADD45B</td><td class="NLM_def"><p class="first last">growth arrest and DNA damage-inducible protein</p></td></tr><tr><td class="NLM_term">FOS</td><td class="NLM_def"><p class="first last">proto-oncogene c-Fos</p></td></tr><tr><td class="NLM_term">GRB2</td><td class="NLM_def"><p class="first last">growth factor receptor-bound protein 2</p></td></tr><tr><td class="NLM_term">HSPA1A</td><td class="NLM_def"><p class="first last">heat shock 70 kDa protein 1A</p></td></tr><tr><td class="NLM_term">TGFB3</td><td class="NLM_def"><p class="first last">transforming growth factor β-3</p></td></tr><tr><td class="NLM_term">TNFRSF12A</td><td class="NLM_def"><p class="first last">tumor necrosis factor receptor superfamily member 12A</p></td></tr><tr><td class="NLM_term">IL18</td><td class="NLM_def"><p class="first last">pro-inflammatory cytokine interleukin-18</p></td></tr><tr><td class="NLM_term">GDF15</td><td class="NLM_def"><p class="first last">growth/differentiation factor 15</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">H&E</td><td class="NLM_def"><p class="first last">hematoxylin and eosin</p></td></tr><tr><td class="NLM_term">P-ERK</td><td class="NLM_def"><p class="first last">phosphorylation levels of ERK</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 73 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahib, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleshman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matrisian, L. M.</span></span> <span> </span><span class="NLM_article-title">Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2913</span>– <span class="NLM_lpage">2921</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-14-0155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1158%2F0008-5472.CAN-14-0155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=24840647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=2913-2921&author=L.+Rahibauthor=B.+D.+Smithauthor=R.+Aizenbergauthor=A.+B.+Rosenzweigauthor=J.+M.+Fleshmanauthor=L.+M.+Matrisian&title=Projecting+cancer+incidence+and+deaths+to+2030%3A+the+unexpected+burden+of+thyroid%2C+liver%2C+and+pancreas+cancers+in+the+United+States&doi=10.1158%2F0008-5472.can-14-0155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States</span></div><div class="casAuthors">Rahib, Lola; Smith, Benjamin D.; Aizenberg, Rhonda; Rosenzweig, Allison B.; Fleshman, Julie M.; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2913-2921</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the av. annual percentage changes in incidence and death rates.  Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common cancers, resp.  Lung cancer is projected to remain the top cancer killer throughout this time period.  However, pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, resp.  Advances in screening, prevention, and treatment can change cancer incidence and/or death rates, but it will require a concerted effort by the research and healthcare communities now to effect a substantial change for the future.  Cancer Res; 74(11); 2913-21. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHGt66quENkbVg90H21EOLACvtfcHk0ljgAl7mvFTrOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D&md5=893d688f1ccba88ee094b743f7e4f152</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0155%26sid%3Dliteratum%253Aachs%26aulast%3DRahib%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DAizenberg%26aufirst%3DR.%26aulast%3DRosenzweig%26aufirst%3DA.%2BB.%26aulast%3DFleshman%26aufirst%3DJ.%2BM.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DProjecting%2520cancer%2520incidence%2520and%2520deaths%2520to%25202030%253A%2520the%2520unexpected%2520burden%2520of%2520thyroid%252C%2520liver%252C%2520and%2520pancreas%2520cancers%2520in%2520the%2520United%2520States%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D2913%26epage%3D2921%26doi%3D10.1158%2F0008-5472.can-14-0155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggins, M.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(10)62307-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2FS0140-6736%2810%2962307-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21620466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BC3MjlvFOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2011&pages=607-620&author=A.+Vincentauthor=J.+Hermanauthor=R.+Schulickauthor=R.+H.+Hrubanauthor=M.+Goggins&title=Pancreatic+cancer&doi=10.1016%2Fs0140-6736%2810%2962307-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer</span></div><div class="casAuthors">Vincent Audrey; Herman Joseph; Schulick Rich; Hruban Ralph H; Goggins Michael</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">9791</span>),
    <span class="NLM_cas:pages">607-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Substantial progress has been made in our understanding of the biology of pancreatic cancer, and advances in patients' management have also taken place.  Evidence is beginning to show that screening first-degree relatives of individuals with several family members affected by pancreatic cancer can identify non-invasive precursors of this malignant disease.  The incidence of and number of deaths caused by pancreatic tumours have been gradually rising, even as incidence and mortality of other common cancers have been declining.  Despite developments in detection and management of pancreatic cancer, only about 4% of patients will live 5 years after diagnosis.  Survival is better for those with malignant disease localised to the pancreas, because surgical resection at present offers the only chance of cure.  Unfortunately, 80-85% of patients present with advanced unresectable disease.  Furthermore, pancreatic cancer responds poorly to most chemotherapeutic agents.  Hence, we need to understand the biological mechanisms that contribute to development and progression of pancreatic tumours.  In this Seminar we will discuss the most common and deadly form of pancreatic cancer, pancreatic ductal adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_Px7QoMFLVGhHGZei4OW9fW6udTcc2eYQ15gDXBao4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjlvFOmsg%253D%253D&md5=fb7f79c8c02f2f2bad5e5ad7a9b09096</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2962307-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252962307-0%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DA.%26aulast%3DHerman%26aufirst%3DJ.%26aulast%3DSchulick%26aufirst%3DR.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DGoggins%26aufirst%3DM.%26atitle%3DPancreatic%2520cancer%26jtitle%3DLancet%26date%3D2011%26volume%3D378%26spage%3D607%26epage%3D620%26doi%3D10.1016%2Fs0140-6736%2810%2962307-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2016</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.3322/caac.21332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.3322%2Fcaac.21332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=26742998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2016&doi=10.3322%2Fcaac.21332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2016</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States.  Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009-2012), much of which is because of recent rapid declines in prostate cancer diagnoses.  The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012.  Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease.  Among children and adolescents (aged birth-19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia.  Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKAn5ROFAaRS86Js-BCLiifW6udTcc2eYQ15gDXBao4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D&md5=2d4030a531945c5ebaaab181bfd80457</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21332%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202016%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2016%26volume%3D66%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cleary, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gryfe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guindi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallinger, S.</span></span> <span> </span><span class="NLM_article-title">Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors</span>. <i>J. Am. Coll. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1016/j.jamcollsurg.2004.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.jamcollsurg.2004.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=15110805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BD2c3htlWksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2004&pages=722-731&author=S.+P.+Clearyauthor=R.+Gryfeauthor=M.+Guindiauthor=P.+Greigauthor=L.+Smithauthor=R.+Mackenzieauthor=S.+Strasbergauthor=S.+Hannaauthor=B.+Taylorauthor=B.+Langerauthor=S.+Gallinger&title=Prognostic+factors+in+resected+pancreatic+adenocarcinoma%3A+analysis+of+actual+5-year+survivors&doi=10.1016%2Fj.jamcollsurg.2004.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors</span></div><div class="casAuthors">Cleary Sean P; Gryfe Robert; Guindi Maha; Greig Paul; Smith Lloyd; Mackenzie Robert; Strasberg Steven; Hanna Sherif; Taylor Bryce; Langer Bernard; Gallinger Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Surgeons</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">722-31</span>
        ISSN:<span class="NLM_cas:issn">1072-7515</span>.
    </div><div class="casAbstract">BACKGROUND:  Pancreatic cancer is a rapidly fatal disease with very few 5-year survivors even after aggressive surgical treatment.  Our objective was to determine the actual 5-year survival rate of patients with pancreatic adenocarcinoma who underwent a resection with curative intent in 5 teaching hospitals within the University of Toronto system.  We then sought to determine clinical and histopathologic features of 5-year survivors to determine factors associated with a favorable prognosis.  STUDY DESIGN:  A retrospective chart review was performed using surgeon and hospital databases to identify patients who had a surgical resection for pancreatic adenocarcinoma between January 1, 1988, and December 31, 1996.  RESULTS:  One hundred twenty-three patients who had a resection and a pathologic diagnosis of pancreatic adenocarcinoma with complete followup were identified from seven surgical practices.  Mean survival (+/- standard error) in this series was 31.7 +/- 3.5 months (median 13.6 months).  There were 18 5-year survivors (14.6%), including 5 patients (4.1%) who survived longer than 10 years.  The survivors included 13 patients who had undergone a Whipple resection, 4 who had undergone a distal pancreatectomy, and 1 who had undergone a total pancreatectomy.  Tumor size, lack of jaundice at presentation, negative nodal disease, low tumor grade, and a low tumor stage were all significant predictors of survival in univariate analysis (all p < 0.05).  Only tumor stage (hazard ratio [95% confidence interval]: stage IIA 1.5 [0.8 to 2.8], stage IIB 2.6 [1.4 to 4.7], stage III 1.8 [0.8 to 4.3]) and tumor grade (hazard ratio [95% confidence interval]: moderately differentiated 1.6 [0.9 to 2.9], and poorly differentiated 3.1 [1.6 to 6.2]) were independently associated with survival differences in a multivariate Cox proportional hazards model.  CONCLUSIONS:  We conclude that longterm survival from pancreatic adenocarcinoma is possible if the disease is identified in its early stages.  These and other similar data should provide further stimulus for the development and evaluation of novel screening strategies to improve early detection of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqP6DNXoczi8KL0FlyGHDofW6udTcc2eYEpxakSpYny7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3htlWksQ%253D%253D&md5=e9cc57f6bc22c656ed5e30112fbe1740</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jamcollsurg.2004.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jamcollsurg.2004.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DCleary%26aufirst%3DS.%2BP.%26aulast%3DGryfe%26aufirst%3DR.%26aulast%3DGuindi%26aufirst%3DM.%26aulast%3DGreig%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DMackenzie%26aufirst%3DR.%26aulast%3DStrasberg%26aufirst%3DS.%26aulast%3DHanna%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DB.%26aulast%3DLanger%26aufirst%3DB.%26aulast%3DGallinger%26aufirst%3DS.%26atitle%3DPrognostic%2520factors%2520in%2520resected%2520pancreatic%2520adenocarcinoma%253A%2520analysis%2520of%2520actual%25205-year%2520survivors%26jtitle%3DJ.%2520Am.%2520Coll.%2520Surg.%26date%3D2004%26volume%3D198%26spage%3D722%26epage%3D731%26doi%3D10.1016%2Fj.jamcollsurg.2004.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel reactive oxygen species inducers for the treatment of pancreatic ductal adenocarcinoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1576</span>– <span class="NLM_lpage">1594</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVyqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1576-1594&author=Y.+Kuangauthor=M.+Sechiauthor=S.+Nurraauthor=M.+Ljungmanauthor=N.+Neamati&title=Design+and+synthesis+of+novel+reactive+oxygen+species+inducers+for+the+treatment+of+pancreatic+ductal+adenocarcinoma&doi=10.1021%2Facs.jmedchem.7b01463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Kuang, Yuting; Sechi, Mario; Nurra, Salvatore; Ljungman, Mats; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1576-1594</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinazolinediones such as I were prepd. as inducers of reactive oxygen species (ROS) for potential use as antitumor agents for the treatment of pancreatic ductal adenocarcinoma (PDAC); the inhibition of human PDAC cells was detd. for all of the compds. and the toxicities of selected compds. to normal pancreatic cells, and the effects on various cellular systems was detd. for selected compds.  I was the most potent redox modulator candidate of the tested compds., inducing substantial ROS prodn. in PDAC cells.  Nascent RNA sequencing following treatments with quinazolinediones revealed induction of stress responses in nucleus, endoplasmic reticulum, and mitochondria of pancreatic cancer cells; the quinazolinedione also induced Nrf2-mediated oxidative stress and unfolded protein responses as demonstrated by dose-dependent increases in RNA synthesis of representative genes such as NQO1, HMOX1, DDIT3, and HSPA5.  At 5.0 μM, I blocked mitochondrial function by inhibiting mtDNA transcription and downregulating the mtDNA-encoded OXPHOS enzymes.  Treatment with I was well tolerated in vivo and significantly delayed tumor growth in mice; I was also tested in combination with the current pancreatic cancer agent gemcitabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4BeZNm8i3TLVg90H21EOLACvtfcHk0li6TwlwEnh4-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVyqtA%253D%253D&md5=ec0cb6c8914a7841c7ff8906cf53ef49</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01463%26sid%3Dliteratum%253Aachs%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DNurra%26aufirst%3DS.%26aulast%3DLjungman%26aufirst%3DM.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520reactive%2520oxygen%2520species%2520inducers%2520for%2520the%2520treatment%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1576%26epage%3D1594%26doi%3D10.1021%2Facs.jmedchem.7b01463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span> <span> </span><span class="NLM_article-title">Pancreatic adenocarcinoma</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1056/nejmra1404198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1056%2FNEJMra1404198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=25207767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Olt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=1039-1049&author=D.+P.+Ryanauthor=T.+S.+Hongauthor=N.+Bardeesy&title=Pancreatic+adenocarcinoma&doi=10.1056%2Fnejmra1404198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic adenocarcinoma</span></div><div class="casAuthors">Ryan, David P.; Hong, Theodore S.; Bardeesy, Nabeel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1049, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ1-TPh2I8RbVg90H21EOLACvtfcHk0li_INIi49jB_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Olt7rK&md5=c916814b3ce1e14f3a93b9a0b05cd286</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1404198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1404198%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DD.%2BP.%26aulast%3DHong%26aufirst%3DT.%2BS.%26aulast%3DBardeesy%26aufirst%3DN.%26atitle%3DPancreatic%2520adenocarcinoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D1039%26epage%3D1049%26doi%3D10.1056%2Fnejmra1404198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Von
Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ervin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiorean, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjulandin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laheru, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahary, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Cutsem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iglesias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renschler, M. F.</span></span> <span> </span><span class="NLM_article-title">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1304369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1056%2FNEJMoa1304369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=24131140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=1691-1703&author=D.+D.+Von%0AHoffauthor=T.+Ervinauthor=F.+P.+Arenaauthor=E.+G.+Chioreanauthor=J.+Infanteauthor=M.+Mooreauthor=T.+Seayauthor=S.+A.+Tjulandinauthor=W.+W.+Maauthor=M.+N.+Salehauthor=M.+Harrisauthor=M.+Reniauthor=S.+Dowdenauthor=D.+Laheruauthor=N.+Baharyauthor=R.+K.+Ramanathanauthor=J.+Taberneroauthor=M.+Hidalgoauthor=D.+Goldsteinauthor=E.+Van+Cutsemauthor=X.+Weiauthor=J.+Iglesiasauthor=M.+F.+Renschler&title=Increased+survival+in+pancreatic+cancer+with+nab-paclitaxel+plus+gemcitabine&doi=10.1056%2Fnejmoa1304369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span></div><div class="casAuthors">Von Hoff, Daniel D.; Ervin, Thomas; Arena, Francis P.; Chiorean, E. Gabriela; Infante, Jeffrey; Moore, Malcolm; Seay, Thomas; Tjulandin, Sergei A.; Ma, Wen Wee; Saleh, Mansoor N.; Harris, Marion; Reni, Michele; Dowden, Scot; Laheru, Daniel; Bahary, Nathan; Ramanathan, Ramesh K.; Tabernero, Josep; Hidalgo, Manuel; Goldstein, David; Van Cutsem, Eric; Wei, Xinyu; Iglesias, Jose; Renschler, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: In a phase 1-2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clin. activity was noted in patients with advanced pancreatic cancer.  We conducted a phase 3 study of the efficacy and safety of the combination vs. gemcitabine monotherapy in patients with metastatic pancreatic cancer.  METHODS: We randomly assigned patients with a Karnofsky performance-status score of 70 or more (on a scale from 0 to 100, with higher scores indicating better performance status) to nab-paclitaxel (125 mg per square meter of body-surface area) followed by gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 wk or gemcitabine monotherapy (1000 mg per square meter) weekly for 7 of 8 wk (cycle 1) and then on days 1, 8, and 15 every 4 wk (cycle 2 and subsequent cycles).  Patients received the study treatment until disease progression.  The primary end point was overall survival; secondary end points were progression-free survival and overall response rate.  RESULTS: A total of 861 patients were randomly assigned to nab-paclitaxel plus gemcitabine (431 patients) or gemcitabine (430).  The median overall survival was 8.5 mo in the nab-paclitaxel-gemcitabine group as compared with 6.7 mo in the gemcitabine group (hazard ratio for death, 0.72; 95% confidence interval [CI], 0.62 to 0.83; P<0.001).  The survival rate was 35% in the nab-paclitaxel-gemcitabine group vs. 22% in the gemcitabine group at 1 yr, and 9% vs. 4% at 2 years.  The median progression-free survival was 5.5 mo in the nab-paclitaxel-gemcitabine group, as compared with 3.7 mo in the gemcitabine group (hazard ratio for disease progression or death, 0.69; 95% CI, 0.58 to 0.82; P<0.001); the response rate according to independent review was 23% vs. 7% in the two groups (P<0.001).  The most common adverse events of grade 3 or higher were neutropenia (38% in the nab-paclitaxel-gemcitabine group vs. 27% in the gemcitabine group), fatigue (17% vs. 7%), and neuropathy (17% vs. 1%).  Febrile neutropenia occurred in 3% vs. 1% of the patients in the two groups.  In the nab-paclitaxel-gemcitabine group, neuropathy of grade 3 or higher improved to grade 1 or lower in a median of 29 days.  CONCLUSIONS: In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but rates of peripheral neuropathy and myelosuppression were increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCXpODbQZ6dLVg90H21EOLACvtfcHk0li_INIi49jB_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I&md5=b1169c7e9879c08061dd9e9389dc36fe</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1304369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1304369%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DErvin%26aufirst%3DT.%26aulast%3DArena%26aufirst%3DF.%2BP.%26aulast%3DChiorean%26aufirst%3DE.%2BG.%26aulast%3DInfante%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DSeay%26aufirst%3DT.%26aulast%3DTjulandin%26aufirst%3DS.%2BA.%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DSaleh%26aufirst%3DM.%2BN.%26aulast%3DHarris%26aufirst%3DM.%26aulast%3DReni%26aufirst%3DM.%26aulast%3DDowden%26aufirst%3DS.%26aulast%3DLaheru%26aufirst%3DD.%26aulast%3DBahary%26aufirst%3DN.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DIglesias%26aufirst%3DJ.%26aulast%3DRenschler%26aufirst%3DM.%2BF.%26atitle%3DIncreased%2520survival%2520in%2520pancreatic%2520cancer%2520with%2520nab-paclitaxel%2520plus%2520gemcitabine%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2Fnejmoa1304369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desseigne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ychou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouché, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimbaud, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bécouarn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adenis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raoul, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourgou-Bourgade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Fouchardière, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennouna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachet, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khemissa-Akouz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Péré-Vergé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assenat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauffert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoto-Grillot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducreux, M.</span></span> <span> </span><span class="NLM_article-title">FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>364</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1825</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1011923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1056%2FNEJMoa1011923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21561347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1817-1825&author=T.+Conroyauthor=F.+Desseigneauthor=M.+Ychouauthor=O.+Bouch%C3%A9author=R.+Guimbaudauthor=Y.+B%C3%A9couarnauthor=A.+Adenisauthor=J.-L.+Raoulauthor=S.+Gourgou-Bourgadeauthor=C.+de+la+Fouchardi%C3%A8reauthor=J.+Bennounaauthor=J.-B.+Bachetauthor=F.+Khemissa-Akouzauthor=D.+P%C3%A9r%C3%A9-Verg%C3%A9author=C.+Delbaldoauthor=E.+Assenatauthor=B.+Chauffertauthor=P.+Michelauthor=C.+Montoto-Grillotauthor=M.+Ducreux&title=FOLFIRINOX+versus+gemcitabine+for+metastatic+pancreatic+cancer&doi=10.1056%2Fnejmoa1011923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">FOLFIRINOX versus gemcitabine or metastatic pancreatic cancer</span></div><div class="casAuthors">Conroy, Thierry; Desseigne, Francoise; Ychou, Marc; Bouche, Olivier; Guimbaud, Rosine; Becouarn, Yves; Adenis, Antoine; Raoul, Jean-Luc; Gourgou-Bourgade, Sophie; de la Fouchardiere, Christelle; Bennouna, Jaafar; Bachet, Jean-Baptiste; Khemissa-Akouz, Faiza; Pere-Verge, Denis; Delbaldo, Catherine; Assenat, Eric; Chauffert, Bruno; Michel, Pierre; Montoto-Grillot, Christine; Ducreux, Michel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1817-1825</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as compared with gemcitabine as first-line therapy in patients with metastatic pancreatic cancer.  METHODS We randomly assigned 342 patients with an Eastern Cooperative Oncol. Group performance status score of 0 or 1 (on a scale of 0 to 5, with higher scores indicating a greater severity of illness) to receive FOLFIRINOX (oxaliplatin, 85 mg per square meter of body-surface area; irinotecan, 180 mg per square meter; leucovorin, 400 mg per square meter; and fluorouracil, 400 mg per square meter given as a bolus followed by 2400 mg per square meter given as a 46-h continuous infusion, every 2 wk) or gemcitabine at a dose of 1000 mg per square meter weekly for 7 of 8 wk and then weekly for 3 of 4 wk.  Six months of chemotherapy were recommended in both groups in patients who had a response.  The primary end point was overall survival.  RESULTS The median overall survival was 11.1 mo in the FOLFIRINOX group as compared with 6.8 mo in the gemcitabine group (hazard ratio for death, 0.57; 95% confidence interval [CI], 0.45 to 0.73; P < 0.001).  Median progression-free survival was 6.4 mo in the FOLFIRINOX group and 3.3 mo in the gemcitabine group (hazard ratio for disease progression, 0.47; 95% CI, 0.37 to 0.59; P < 0.001).  The objective response rate was 31.60% in the FOLFIRINOX group vs. 9.4% in the gemcitabine group (P < 0.001).  More adverse events were noted in the FOLFIRINOX group; 5.4% of patients in this group had febrile neutropenia.  At 6 mo, 31% of the patients in the FOLFIRINOX group had a definitive degrdn. of the quality of life vs. 66% in the gemcitabine group (hazard ratio, 0.47; 95% CI, 0.30 to 0.70; P < 0.001).  CONCLUSIONS As compared with gemcitabine, FOLFIRINOX was assocd. with a survival advantage and had increased toxicity.  FOLFIRINOX is an option for the treatment of patients with metastatic pancreatic cancer and good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGyDR85GUgOrVg90H21EOLACvtfcHk0ljPMm61A1OJXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D&md5=a1a7135a6c97c4dc47233465ce0defd5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1011923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1011923%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DDesseigne%26aufirst%3DF.%26aulast%3DYchou%26aufirst%3DM.%26aulast%3DBouch%25C3%25A9%26aufirst%3DO.%26aulast%3DGuimbaud%26aufirst%3DR.%26aulast%3DB%25C3%25A9couarn%26aufirst%3DY.%26aulast%3DAdenis%26aufirst%3DA.%26aulast%3DRaoul%26aufirst%3DJ.-L.%26aulast%3DGourgou-Bourgade%26aufirst%3DS.%26aulast%3Dde%2Bla%2BFouchardi%25C3%25A8re%26aufirst%3DC.%26aulast%3DBennouna%26aufirst%3DJ.%26aulast%3DBachet%26aufirst%3DJ.-B.%26aulast%3DKhemissa-Akouz%26aufirst%3DF.%26aulast%3DP%25C3%25A9r%25C3%25A9-Verg%25C3%25A9%26aufirst%3DD.%26aulast%3DDelbaldo%26aufirst%3DC.%26aulast%3DAssenat%26aufirst%3DE.%26aulast%3DChauffert%26aufirst%3DB.%26aulast%3DMichel%26aufirst%3DP.%26aulast%3DMontoto-Grillot%26aufirst%3DC.%26aulast%3DDucreux%26aufirst%3DM.%26atitle%3DFOLFIRINOX%2520versus%2520gemcitabine%2520for%2520metastatic%2520pancreatic%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1817%26epage%3D1825%26doi%3D10.1056%2Fnejmoa1011923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neoptolemos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleeff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenhalf, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, D. H.</span></span> <span> </span><span class="NLM_article-title">Therapeutic developments in pancreatic cancer: current and future perspectives</span>. <i>Nat. Rev. Gastroenterol. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1038/s41575-018-0005-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1038%2Fs41575-018-0005-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=29717230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BC1MjovVOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=333-348&author=J.+P.+Neoptolemosauthor=J.+Kleeffauthor=P.+Michlauthor=E.+Costelloauthor=W.+Greenhalfauthor=D.+H.+Palmer&title=Therapeutic+developments+in+pancreatic+cancer%3A+current+and+future+perspectives&doi=10.1038%2Fs41575-018-0005-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic developments in pancreatic cancer: current and future perspectives</span></div><div class="casAuthors">Neoptolemos John P; Kleeff Jorg; Kleeff Jorg; Costello Eithne; Greenhalf William; Palmer Daniel H; Michl Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">333-348</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The overall 5-year survival for pancreatic cancer has changed little over the past few decades, and pancreatic cancer is predicted to be the second leading cause of cancer-related mortality in the next decade in Western countries.  The past few years, however, have seen improvements in first-line and second-line palliative therapies and considerable progress in increasing survival with adjuvant treatment.  The use of biomarkers to help define treatment and the potential of neoadjuvant therapies also offer opportunities to improve outcomes.  This Review brings together information on achievements to date, what is working currently and where successes are likely to be achieved in the future.  Furthermore, we address the questions of how we should approach the development of pancreatic cancer treatments, including those for patients with metastatic, locally advanced and borderline resectable pancreatic cancer, as well as for patients with resected tumours.  In addition to embracing newer strategies comprising genomics, stromal therapies and immunotherapies, conventional approaches using chemotherapy and radiotherapy still offer considerable prospects for greater traction and synergy with evolving concepts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStGgd4rHkEDz69zv1FsJFMfW6udTcc2eZURxhRJOjUPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MjovVOguw%253D%253D&md5=d1b4ab24b72f95c7077798a8258ccf58</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fs41575-018-0005-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41575-018-0005-x%26sid%3Dliteratum%253Aachs%26aulast%3DNeoptolemos%26aufirst%3DJ.%2BP.%26aulast%3DKleeff%26aufirst%3DJ.%26aulast%3DMichl%26aufirst%3DP.%26aulast%3DCostello%26aufirst%3DE.%26aulast%3DGreenhalf%26aufirst%3DW.%26aulast%3DPalmer%26aufirst%3DD.%2BH.%26atitle%3DTherapeutic%2520developments%2520in%2520pancreatic%2520cancer%253A%2520current%2520and%2520future%2520perspectives%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2018%26volume%3D15%26spage%3D333%26epage%3D348%26doi%3D10.1038%2Fs41575-018-0005-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barry, N. P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Exploration of the medical periodic table: towards new targets</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">5106</span>– <span class="NLM_lpage">5131</span>, <span class="refDoi"> DOI: 10.1039/c3cc41143e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2Fc3cc41143e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=23636600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFaru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=5106-5131&author=N.+P.+E.+Barryauthor=P.+J.+Sadler&title=Exploration+of+the+medical+periodic+table%3A+towards+new+targets&doi=10.1039%2Fc3cc41143e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the medical periodic table: towards new targets</span></div><div class="casAuthors">Barry, Nicolas P. E.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">5106-5131</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Metallodrugs offer potential for unique mechanisms of drug action based on the choice of the metal, its oxidn. state, the types and no. of coordinated ligands and the coordination geometry.  We discuss recent progress in identifying new target sites and elucidating the mechanisms of action of anti-cancer, anti-bacterial, anti-viral, anti-parasitic, anti-inflammatory, and anti-neurodegenerative agents, as well as in the design of metal-based diagnostic agents.  Progress in identifying and defining target sites has been accelerated recently by advances in proteomics, genomics and metal speciation anal.  Examples of metal compds. and chelating agents (enzyme inhibitors) currently in clin. use, clin. trials or preclin. development are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZmY5oRnhAi7Vg90H21EOLACvtfcHk0lgzgkker8xDmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFaru7c%253D&md5=b91db5563e59a43e7f9d05860a03b3b0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2Fc3cc41143e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc41143e%26sid%3Dliteratum%253Aachs%26aulast%3DBarry%26aufirst%3DN.%2BP.%2BE.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DExploration%2520of%2520the%2520medical%2520periodic%2520table%253A%2520towards%2520new%2520targets%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D5106%26epage%3D5131%26doi%3D10.1039%2Fc3cc41143e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tisato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santini, C.</span></span> <span> </span><span class="NLM_article-title">Copper in diseases and treatments, and copper-based anticancer strategies</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1002/med.20174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1002%2Fmed.20174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=19626597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Snuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=708-749&author=F.+Tisatoauthor=C.+Marzanoauthor=M.+Porchiaauthor=M.+Pelleiauthor=C.+Santini&title=Copper+in+diseases+and+treatments%2C+and+copper-based+anticancer+strategies&doi=10.1002%2Fmed.20174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Copper in diseases and treatments, and copper-based anticancer strategies</span></div><div class="casAuthors">Tisato, Francesco; Marzano, Cristina; Porchia, Marina; Pellei, Maura; Santini, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">708-749</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Copper is found in all living organisms and is a crucial trace element in redox chem., growth and development.  It is important for the function of several enzymes and proteins involved in energy metab., respiration, and DNA synthesis, notably cytochrome oxidase, superoxide dismutase, ascorbate oxidase, and tyrosinase.  The major functions of copper-biol. mols. involve oxidn.-redn. reactions in which they react directly with mol. oxygen to produce free radicals.  Therefore, copper requires tightly regulated homeostatic mechanisms to ensure adequate supplies without any toxic effects.  Overload or deficiency of copper is assocd., resp., with Wilson disease (WD) and Menkes disease (MD), which are of genetic origin.  Researches on Menkes and Wilson disorders have provided useful insights in the field of copper homeostasis and in particular into the understanding of intracellular trafficking and distribution of copper at mol. levels.  Therapies based on metal supplementation with copper histidine or removal of copper excess by means of specific copper chelators are currently effective in treating MD and WD, resp.  Copper chelation therapy is now attracting much attention for the investigation and treatment of various neurodegenerative disorders such as Alzheimer, Parkinson and CreutzfeldtJakob.  An excess of copper appears to be an essential co-factor for angiogenesis.  Moreover, elevated levels of copper have been found in many types of human cancers, including prostate, breast, colon, lung, and brain.  On these basis, the employment of copper chelators has been reported to be of therapeutic value in the treatment of several types of cancers as anti-angiogenic mols.  More recently, mixts. of copper chelators with copper salts have been found to act as efficient proteasome inhibitors and apoptosis inducers, specifically in cancer cells.  Moreover, following the worldwide success of platinum(II) compds. in cancer chemotherapy, several families of individual copper complexes have been studied as potential antitumor agents.  These investigations, revealing the occurrence of mechanisms of action quite different from platinum drugs, head toward the development of new anticancer metallodrugs with improved specificity and decreased toxic side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf17t02r9AlbVg90H21EOLACvtfcHk0lgzgkker8xDmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Snuro%253D&md5=8f576825c072cd1e95c3675cd07c1dc8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fmed.20174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20174%26sid%3Dliteratum%253Aachs%26aulast%3DTisato%26aufirst%3DF.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DPorchia%26aufirst%3DM.%26aulast%3DPellei%26aufirst%3DM.%26aulast%3DSantini%26aufirst%3DC.%26atitle%3DCopper%2520in%2520diseases%2520and%2520treatments%252C%2520and%2520copper-based%2520anticancer%2520strategies%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2010%26volume%3D30%26spage%3D708%26epage%3D749%26doi%3D10.1002%2Fmed.20174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nasulewicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opolski, A.</span></span> <span> </span><span class="NLM_article-title">Role of copper in tumour angiogenesis—clinical implications</span>. <i>J. Trace Elem. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.jtemb.2004.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.jtemb.2004.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=15487757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVensbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1-8&author=A.+Nasulewiczauthor=A.+Mazurauthor=A.+Opolski&title=Role+of+copper+in+tumour+angiogenesis%E2%80%94clinical+implications&doi=10.1016%2Fj.jtemb.2004.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Role of copper in tumor angiogenesis - clinical implications</span></div><div class="casAuthors">Nasulewicz, Anna; Mazur, Andrzej; Opolski, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Trace Elements in Medicine and Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">JTEBFO</span>;
        ISSN:<span class="NLM_cas:issn">0946-672X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  The formation of new blood vessels is the initial step in progressive tumor development and metastasis.  The first stage in tumor angiogenesis is the activation of endothelial cells.  Copper ions stimulate proliferation and migration of endothelial cells.  It has been shown that serum copper concn. increases as the cancer disease progresses and correlates with tumor incidence and burden.  Copper ions also activate several proangiogenic factors, e.g., vascular endothelial growth factor, basic fibroblast growth factor, tumor necrosis factor alpha and interleukin 1.  This review concerns a brief introduction into the basics of tumor blood vessel development as well as the regulatory mechanisms of this process.  The role of copper ions in tumor angiogenesis is discussed.  The new antiangiogenic therapies based on a redn. of copper levels in tumor microenvironment are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1fS4EdEyufLVg90H21EOLACvtfcHk0ljP8kUpID8AWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVensbbJ&md5=9993017fb5fc2c7e09a0efffbbfbc5d6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jtemb.2004.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jtemb.2004.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DNasulewicz%26aufirst%3DA.%26aulast%3DMazur%26aufirst%3DA.%26aulast%3DOpolski%26aufirst%3DA.%26atitle%3DRole%2520of%2520copper%2520in%2520tumour%2520angiogenesis%25E2%2580%2594clinical%2520implications%26jtitle%3DJ.%2520Trace%2520Elem.%2520Med.%2520Biol.%26date%3D2004%26volume%3D18%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.jtemb.2004.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span> <span> </span><span class="NLM_article-title">Advances in copper complexes as anticancer agents</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">815</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1021/cr400135x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400135x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFygurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=815-862&author=C.+Santiniauthor=M.+Pelleiauthor=V.+Gandinauthor=M.+Porchiaauthor=F.+Tisatoauthor=C.+Marzano&title=Advances+in+copper+complexes+as+anticancer+agents&doi=10.1021%2Fcr400135x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Copper Complexes as Anticancer Agents</span></div><div class="casAuthors">Santini, Carlo; Pellei, Maura; Gandin, Valentina; Porchia, Marina; Tisato, Francesco; Marzano, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">815-862</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review describes advances in the synthesis, design, and development of copper complexes as anticancer agents in the last 4 years.  Interest in this field has rapidly grown in recent years, as illustrated by the increasing no. of publications reported since 2000.  This summary covers the period 2008-2012 and follows the authors' previous efforts in the same area.  Furthermore, the authors summarize recent findings on (i) identification of the main mol. targets and cellular pathways involved in the copper complexes-induced antiproliferative effects and (ii) the state of art of in vivo studies on the antitumor activity of copper compds.  This overview would like to be a useful tool for the research community actively involved in the copper-based anticancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPJuYrrxcT0LVg90H21EOLACvtfcHk0ljP8kUpID8AWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFygurrL&md5=6d6fca30804d7b44c2079cf30327cfc3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fcr400135x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400135x%26sid%3Dliteratum%253Aachs%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DPellei%26aufirst%3DM.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DPorchia%26aufirst%3DM.%26aulast%3DTisato%26aufirst%3DF.%26aulast%3DMarzano%26aufirst%3DC.%26atitle%3DAdvances%2520in%2520copper%2520complexes%2520as%2520anticancer%2520agents%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D815%26epage%3D862%26doi%3D10.1021%2Fcr400135x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franz, K. J.</span></span> <span> </span><span class="NLM_article-title">Application of inorganic chemistry for non-cancer therapeutics</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">6333</span>– <span class="NLM_lpage">6334</span>, <span class="refDoi"> DOI: 10.1039/c2dt90061k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2Fc2dt90061k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=22546812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1SrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=6333-6334&author=K.+J.+Franz&title=Application+of+inorganic+chemistry+for+non-cancer+therapeutics&doi=10.1039%2Fc2dt90061k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Application of inorganic chemistry for non-cancer therapeutics</span></div><div class="casAuthors">Franz, Katherine J.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6333-6334</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-m3gTchdBhrVg90H21EOLACvtfcHk0lhyrS6J7acK4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1SrsLk%253D&md5=02b9354db4b7334c929c93485457baa4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2Fc2dt90061k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2dt90061k%26sid%3Dliteratum%253Aachs%26aulast%3DFranz%26aufirst%3DK.%2BJ.%26atitle%3DApplication%2520of%2520inorganic%2520chemistry%2520for%2520non-cancer%2520therapeutics%26jtitle%3DDalton%2520Trans.%26date%3D2012%26volume%3D41%26spage%3D6333%26epage%3D6334%26doi%3D10.1039%2Fc2dt90061k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Low, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maigre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, M. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiekink, E. R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorlet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravoof, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagès, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Policar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delsuc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouse, K. A.</span></span> <span> </span><span class="NLM_article-title">New insight into the structural, electrochemical and biological aspects of macroacyclic Cu(II) complexes derived from S-substituted dithiocarbazate schiff bases</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ejmech.2016.04.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27183379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2016&pages=1-12&author=M.+L.+Lowauthor=L.+Maigreauthor=M.+I.+M.+Tahirauthor=E.+R.+T.+Tiekinkauthor=P.+Dorletauthor=R.+Guillotauthor=T.+B.+Ravoofauthor=R.+Rosliauthor=J.-M.+Pag%C3%A8sauthor=C.+Policarauthor=N.+Delsucauthor=K.+A.+Crouse&title=New+insight+into+the+structural%2C+electrochemical+and+biological+aspects+of+macroacyclic+Cu%28II%29+complexes+derived+from+S-substituted+dithiocarbazate+schiff+bases&doi=10.1016%2Fj.ejmech.2016.04.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New insight into the structural, electrochemical and biological aspects of macroacyclic Cu(II) complexes derived from S-substituted dithiocarbazate Schiff bases</span></div><div class="casAuthors">Low, May Lee; Maigre, Laure; Tahir, Mohamed Ibrahim M.; Tiekink, Edward R. T.; Dorlet, Pierre; Guillot, Regis; Ravoof, Thahira Begum; Rosli, Rozita; Pages, Jean-Marie; Policar, Clotilde; Delsuc, Nicolas; Crouse, Karen A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Copper(II) complexes synthesized from the products of condensation of S-methyl- and S-benzyldithiocarbazate with 2,5-hexanedione (SMHDH2 and SBHDH2, resp.) were characterized using various physicochem. (elemental anal., molar cond., magnetic susceptibility) and spectroscopic (IR, electronic) methods.  The structures of SMHDH2, its copper(II) complex, CuSMHD, and the related CuSBHD complex as well as a pyrrole byproduct, SBPY, were detd. by single crystal x-ray diffraction.  In order to provide more insight into the behavior of the complexes in soln., EPR and electrochem. expts. were performed.  Antibacterial activity and cytotoxicity were evaluated.  The compds., dissolved in 0.5% and 5% DMSO, showed a wide range of antibacterial activity against 10 strains of Gram-pos. and Gram-neg. bacteria.  Studies of the effects of efflux pumps and membrane penetration on antibacterial activity are reported herein.  Antiproliferation activity is enhanced by complexation with copper.  Preliminary screening showed Cu complexes are strongly active against human breast adenocarcinoma cancer cell lines MDA-MB-231 and MCF-7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB-W_5XMFV6bVg90H21EOLACvtfcHk0lhyrS6J7acK4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WqtLY%253D&md5=87663d48e19e7324787b4213d84dde8f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.027%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DM.%2BL.%26aulast%3DMaigre%26aufirst%3DL.%26aulast%3DTahir%26aufirst%3DM.%2BI.%2BM.%26aulast%3DTiekink%26aufirst%3DE.%2BR.%2BT.%26aulast%3DDorlet%26aufirst%3DP.%26aulast%3DGuillot%26aufirst%3DR.%26aulast%3DRavoof%26aufirst%3DT.%2BB.%26aulast%3DRosli%26aufirst%3DR.%26aulast%3DPag%25C3%25A8s%26aufirst%3DJ.-M.%26aulast%3DPolicar%26aufirst%3DC.%26aulast%3DDelsuc%26aufirst%3DN.%26aulast%3DCrouse%26aufirst%3DK.%2BA.%26atitle%3DNew%2520insight%2520into%2520the%2520structural%252C%2520electrochemical%2520and%2520biological%2520aspects%2520of%2520macroacyclic%2520Cu%2528II%2529%2520complexes%2520derived%2520from%2520S-substituted%2520dithiocarbazate%2520schiff%2520bases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D120%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.ejmech.2016.04.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beshir, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guchhait, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascón, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenteany, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of metal-ligand complexes that potently inhibit cell migration</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">498</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.bmcl.2007.11.099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=18240381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFWgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=498-504&author=A.+B.+Beshirauthor=S.+K.+Guchhaitauthor=J.+A.+Gasc%C3%B3nauthor=G.+Fenteany&title=Synthesis+and+structure-activity+relationships+of+metal-ligand+complexes+that+potently+inhibit+cell+migration&doi=10.1016%2Fj.bmcl.2007.11.099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationships of metal-ligand complexes that potently inhibit cell migration</span></div><div class="casAuthors">Beshir, Anwar B.; Guchhait, Sankar K.; Gascon, Jose A.; Fenteany, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">498-504</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The authors screened the National Cancer Institute Diversity Set compd. collection for small mols. that affect mammalian cell migration and identified NSC 295642 as an inhibitor of cell motility with nanomolar potency.  The authors found by LC-MS and x-ray crystallog. that NSC 295642, a Cu(II) complex of the Schiff base product of condensation of S-benzyl dithiocarbazate and 2-acetylpyridine, has a bridged dimeric Cu2Cl2(L)2 structure with distorted square pyramidal geometry.  Each of the two Cu atoms is five-coordinated to one of the two tridentate chelating ligands and both bridging Cl atoms.  To define structure-activity relations, the authors studied the bioactivity of related metal-ligand complexes derived from different metal(II) atoms and different ligands.  Complexation of the NSC 295642 ligand with Zn(II) or Ni(II), delivered as metal(II) chloride salts under conditions identical to those used for prepn. of the original Cu(II) complex, instead results in distorted octahedral bis-chelate structures, where a single metal atom is six-coordinated to two ligands.  The Zn(L)2 complex possesses a potency similar to that of the Cu2Cl2(L)2 complex, while the Ni(L)2 has no antimigratory activity at all.  The authors carried out d. functional theory calcns. to obtain the electronic ground state geometry of the complexes, both in vacuum and implicit water solvent.  The x-ray crystal and energy-minimized structures are very similar and exhibit a transoid orientation of the S-benzyl groups relative to the central metal-coordinated rings for both of the bioactive Cu2Cl2(L)2 and Zn(L)2 complexes, despite their different coordination geometries.  In contrast, the biol. inactive Ni(L)2 complex adopts a cisoid conformation.  Varying the ligand structure, hydrophobic S-alkylaryl groups are required for activity.  Complexes with a simple S-Me group, S-benzyl groups with polar substitutions or a carboxylated pyridine ring exhibit dramatically reduced activity.  The authors tested the most potent metal-ligand complex in a no. of cancer cell lines and found cell-type selectivity in its effect on cell motility.  Collectively, these results suggest that a two-ligand structure with bulky nonpolar S-substituents in a transoid conformation is important for the antimigratory activity of these metal-ligand complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWSpBJhT4LlbVg90H21EOLACvtfcHk0lj0J7ZZwA04PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFWgsg%253D%253D&md5=b104c41ee09fe0a3449ed86c9b754866</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.099%26sid%3Dliteratum%253Aachs%26aulast%3DBeshir%26aufirst%3DA.%2BB.%26aulast%3DGuchhait%26aufirst%3DS.%2BK.%26aulast%3DGasc%25C3%25B3n%26aufirst%3DJ.%2BA.%26aulast%3DFenteany%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520metal-ligand%2520complexes%2520that%2520potently%2520inhibit%2520cell%2520migration%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D498%26epage%3D504%26doi%3D10.1016%2Fj.bmcl.2007.11.099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arjmand, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muddassir, M.</span></span> <span> </span><span class="NLM_article-title">A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-tryptophan-derived metal complexes of 1,2-DACH: cleavage and antitumor activity</span>. <i>Chirality</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1002/chir.20907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1002%2Fchir.20907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=20928895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1yksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=250-259&author=F.+Arjmandauthor=M.+Muddassir&title=A+mechanistic+approach+for+the+DNA+binding+of+chiral+enantiomeric+L-+and+D-tryptophan-derived+metal+complexes+of+1%2C2-DACH%3A+cleavage+and+antitumor+activity&doi=10.1002%2Fchir.20907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-tryptophan-derived metal complexes of 1,2-DACH: Cleavage and antitumor activity</span></div><div class="casAuthors">Arjmand, Farukh; Muddassir, Mohd.</div><div class="citationInfo"><span class="NLM_cas:title">Chirality</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">250-259</span>CODEN:
                <span class="NLM_cas:coden">CHRLEP</span>;
        ISSN:<span class="NLM_cas:issn">0899-0042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A new chiral series of potential antitumor metal-based complexes 1-3(a and b) of L- and D-tryptophan have been synthesized and thoroughly characterized.  Both enantiomers of 1-3 bind DNA noncovalently via phosphate interaction with slight preference of metal center for covalent coordination to nucleobases.  The Kb values of L-enantiomer, however, possess higher propensity for DNA binding in comparison with the D-enantiomeric analogs.  The relative trend in Kb values is as follows: 2(a) > 2(b) > 3(a) > 1(a) > 3(b) > 1(b).  These observations together with the findings of circular dichoric and fluorescence studies reveal maximal potential of L-enantiomeric form of copper complex to bind DNA, thereby exerting its therapeutic effect.  The complex 2a exhibits a remarkable DNA cleavage activity with pBR322DNA in the presence of different activators such as H2O2, ascorbic acid, 3-mercaptopropionic acid, and glutathione, suggesting the involvement of active oxygen species for the DNA scission.  In vitro anticancer activity of complexes 1-3(a) were screened against 14 different human carcinoma cell lines of different histol. origin, and the results reveal that 2a shows significant antitumor activity in comparison with both 1a and 3a and is particularly selective for MIAPACA2 (pancreatic cancer cell line).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQJyTwAdcTYLVg90H21EOLACvtfcHk0lj0J7ZZwA04PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1yksbc%253D&md5=ccfa28c733875fe705e06e8cc0186171</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fchir.20907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchir.20907%26sid%3Dliteratum%253Aachs%26aulast%3DArjmand%26aufirst%3DF.%26aulast%3DMuddassir%26aufirst%3DM.%26atitle%3DA%2520mechanistic%2520approach%2520for%2520the%2520DNA%2520binding%2520of%2520chiral%2520enantiomeric%2520L-%2520and%2520D-tryptophan-derived%2520metal%2520complexes%2520of%25201%252C2-DACH%253A%2520cleavage%2520and%2520antitumor%2520activity%26jtitle%3DChirality%26date%3D2011%26volume%3D23%26spage%3D250%26epage%3D259%26doi%3D10.1002%2Fchir.20907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alagesan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhuvanesh, N. S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaraj, N.</span></span> <span> </span><span class="NLM_article-title">Potentially cytotoxic new copper(II) hydrazone complexes: synthesis, crystal structure and biological properties</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">7210</span>– <span class="NLM_lpage">7223</span>, <span class="refDoi"> DOI: 10.1039/c3dt50371b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2Fc3dt50371b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=23529726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVCisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=7210-7223&author=M.+Alagesanauthor=N.+S.+P.+Bhuvaneshauthor=N.+Dharmaraj&title=Potentially+cytotoxic+new+copper%28II%29+hydrazone+complexes%3A+synthesis%2C+crystal+structure+and+biological+properties&doi=10.1039%2Fc3dt50371b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Potentially cytotoxic new copper(II) hydrazone complexes: synthesis, crystal structure and biological properties</span></div><div class="casAuthors">Alagesan, Mani; Bhuvanesh, Nattamai S. P.; Dharmaraj, Nallasamy</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7210-7223</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">New pentacoordinated Cu(II) hydrazone complexes contg. solvated MeOH were synthesized by reacting the hydrazone ligands, 2-acetylpyridine benzoyl hydrazone (HL1) and 2-acetylpyridine thiophene-2-carboxylic acid hydrazone (HL2), with [CuCl2(DMSO)2] and characterized by different spectral methods.  Single crystal x-ray diffraction studies of the complexes revealed that both of them, [CuCl(L1)(MeOH)] (1) and [CuCl(L2)(MeOH)] (2), have square pyramidal geometry around the cupric ion, in which the hydrazone is coordinated through NNO atoms along with a mol. of MeOH in the apical position.  Interaction of the ligands HL1 and HL2 with the Cu complexes 1 and 2 with calf thymus DNA (CT-DNA) was estd. by absorption and emission titrn. methods which revealed that the compds. interacted with CT-DNA through intercalation.  Binding of the compds., i.e., free ligands and 1 and 2 with bovine serum albumin (BSA) protein studied using UV-visible, fluorescence and synchronous fluorescence spectroscopic methods indicated that there occurred strong binding of Cu complexes to BSA over the ligands.  Further, the cytotoxicity of the compds. examd. in vitro on a panel of . cancerous cell lines such as a human cervical cancer cell line (HeLa), a pancreatic cancer cell line (PANC-1), an Ehrlich ascites cancer cell line (EAC) and Dalton's lymphoma ascitic cancer cells (DLA) and a normal mouse embryonic fibroblasts cell line (NIH3) demonstrated that 1 and 2 possessed superior cytotoxicity than that of known com. anticancer drug cisplatin to the tumor cells but are less toxic to the normal cell line and have emerged as potential candidates for further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZM4DvyUOFSbVg90H21EOLACvtfcHk0lj0J7ZZwA04PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVCisrw%253D&md5=b049cf60d1a1b1a4bbd69f28e817d3b8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2Fc3dt50371b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3dt50371b%26sid%3Dliteratum%253Aachs%26aulast%3DAlagesan%26aufirst%3DM.%26aulast%3DBhuvanesh%26aufirst%3DN.%2BS.%2BP.%26aulast%3DDharmaraj%26aufirst%3DN.%26atitle%3DPotentially%2520cytotoxic%2520new%2520copper%2528II%2529%2520hydrazone%2520complexes%253A%2520synthesis%252C%2520crystal%2520structure%2520and%2520biological%2520properties%26jtitle%3DDalton%2520Trans.%26date%3D2013%26volume%3D42%26spage%3D7210%26epage%3D7223%26doi%3D10.1039%2Fc3dt50371b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zehra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavez Khan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arjmand, F.</span></span> <span> </span><span class="NLM_article-title">New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity</span>. <i>J. Biomol. Struct. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1863</span>– <span class="NLM_lpage">1879</span>, <span class="refDoi"> DOI: 10.1080/07391102.2018.1467794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1080%2F07391102.2018.1467794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=29676660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovFyrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=1863-1879&author=S.+Zehraauthor=M.+Shavez+Khanauthor=I.+Ahmadauthor=F.+Arjmand&title=New+tailored+substituted+benzothiazole+Schiff+base+Cu%28II%29%2FZn%28II%29+antitumor+drug+entities%3A+effect+of+substituents+on+DNA+binding+profile%2C+antimicrobial+and+cytotoxic+activity&doi=10.1080%2F07391102.2018.1467794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity</span></div><div class="casAuthors">Zehra, Siffeen; Shavez Khan, Mohammad; Ahmad, Iqbal; Arjmand, Farukh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Structure and Dynamics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1863-1879</span>CODEN:
                <span class="NLM_cas:coden">JBSDD6</span>;
        ISSN:<span class="NLM_cas:issn">0739-1102</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">New tailored Cu(II) & Zn(II) metal-based antitumor drug entities were synthesized from substituted benzothiazole o-vanillin Schiff base ligands.  The complexes were thoroughly characterized by elemental anal., spectroscopic studies {IR, 1H & 13C NMR, ESI-MS, EPR} and magnetic susceptibility measurements.  The structure activity relationship (SAR) studies of benzothiazole Cu(II) & Zn(II) complexes having mol. formulas [C30H22CuN5O7S2], [C30H20Cl2CuN5O7S2], [C30H20CuF2N5O7S2], [C30H22N4O4S2Zn], [C30H20Cl2N4O4S2Zn], and [C30H20F2N5O7S2Zn], with CT-DNA were performed by employing absorption, emission titrns., and hydrodynamic measurements.  The DNA binding affinity was quantified by Kb and Ksv values which gave higher binding propensity for chloro-substituted Cu(II) [C30H20Cl2CuN5O7S2] complex, suggestive of groove binding mode with subtle partial intercalation.  Mol. properties and drug likeness profile were assessed for the ligands and all the Lipinski's rules were found to be obeyed.  The antimicrobial potential of ligands and their Cu(II) & Zn(II) complexes were screened against some notably important pathogens viz., E. coli, S. aureus, P. aeruginosa, B. subtilis, and C. albicans.  The cytotoxicity of the complexes [C30H20Cl2CuN5O7S2], [C30H20CuF2N5O7S2], [C30H20Cl2N4O4S2Zn], and [C30H20F2N5O7S2Zn] were evaluated against five human cancer cell lines viz., MCF-7 (breast), MIA-PA-CA-2 (pancreatic), HeLa (cervix) and Hep-G2 (Hepatoma) and A498 (Kidney) by SRB assay which revealed that chloro-substituted [C30H20Cl2CuN5O7S2] complex, exhibited pronounced specific cytotoxicity with GI50 value of 4.8μg/mL against HeLa cell line.  Mol. docking studies were also performed to explore the binding modes and orientation of the complexes in the DNA helix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQhDB9EeRQBbVg90H21EOLACvtfcHk0lhHrWkawwbCWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovFyrsrg%253D&md5=0a85d1a783d04233d3d763dcc80db01f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1080%2F07391102.2018.1467794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2018.1467794%26sid%3Dliteratum%253Aachs%26aulast%3DZehra%26aufirst%3DS.%26aulast%3DShavez%2BKhan%26aufirst%3DM.%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DArjmand%26aufirst%3DF.%26atitle%3DNew%2520tailored%2520substituted%2520benzothiazole%2520Schiff%2520base%2520Cu%2528II%2529%252FZn%2528II%2529%2520antitumor%2520drug%2520entities%253A%2520effect%2520of%2520substituents%2520on%2520DNA%2520binding%2520profile%252C%2520antimicrobial%2520and%2520cytotoxic%2520activity%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2019%26volume%3D37%26spage%3D1863%26epage%3D1879%26doi%3D10.1080%2F07391102.2018.1467794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marengo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forciniti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dando, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalla Pozza, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsapis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagoubi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heeschen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arpicco, S.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2018.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.bbagen.2018.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=30267751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOjsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2019&pages=61-72&author=A.+Marengoauthor=S.+Forcinitiauthor=I.+Dandoauthor=E.+Dalla+Pozzaauthor=B.+Stellaauthor=N.+Tsapisauthor=N.+Yagoubiauthor=G.+Fanelliauthor=E.+Fattalauthor=C.+Heeschenauthor=M.+Palmieriauthor=S.+Arpicco&title=Pancreatic+cancer+stem+cell+proliferation+is+strongly+inhibited+by+diethyldithiocarbamate-copper+complex+loaded+into+hyaluronic+acid+decorated+liposomes&doi=10.1016%2Fj.bbagen.2018.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes</span></div><div class="casAuthors">Marengo, Alessandro; Forciniti, Stefania; Dando, Ilaria; Dalla Pozza, Elisa; Stella, Barbara; Tsapis, Nicolas; Yagoubi, Najet; Fanelli, Giuseppina; Fattal, Elias; Heeschen, Christopher; Palmieri, Marta; Arpicco, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-72</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pancreatic cancer stem cells (CSCs) are responsible for resistance to std. therapy, metastatic potential, and disease relapse following treatments.  The current therapy for pancreatic ductal adenocarcinoma (PDAC) preferentially targets the more differentiated cancer cell population, leaving CSCs as a cell source for tumor mass formation and recurrence.  For this reason, there is an urgent need to improve current therapies and develop novel CSC-targeted therapeutic approaches.  Hyaluronic acid (HA) decorated liposomes, contg. diethyldithiocarbamate-copper (Cu(DDC)2), able to target the specific CSC marker CD44 receptor were prepd. by ion gradient technique and fully characterized.  Their antiproliferative effect was evaluated on pancreatic CSCs derived from PDAC cell lines or patients.  To clarify the mechanism of action of Cu(DDC)2 liposomes, ROS level neutralization assay in the presence of N-acetyl-L-cysteine was performed.  Liposomes showed high encapsulation efficiency and Cryo-TEM anal. revealed the presence of Cu(DDC)2 crystals in the aq. core of liposomes.  In vitro test on pancreatic CSCs derived from PDAC cell lines or patients showed high ROS mediated anticancer activity of HA decorated liposomes.  The sphere formation capability of CSCs obtained from patients was drastically reduced by liposomal formulations contg. Cu(DDC)2.  The obtained results show that the encapsulation of Cu(DDC)2 complex in HA decorated liposomes strongly increases its anti-proliferative activity on pancreatic CSCs.  This paper describes for the first time the use of HA decorated liposomes contg. Cu(DDC)2 against pancreatic CSCs and opens the way to the development of nanomedicine based CSC-targeted therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemmNDNpJB_rVg90H21EOLACvtfcHk0lhHrWkawwbCWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOjsbfN&md5=e9a7f71a202fe31210cd52568d8f46c7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2018.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2018.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DMarengo%26aufirst%3DA.%26aulast%3DForciniti%26aufirst%3DS.%26aulast%3DDando%26aufirst%3DI.%26aulast%3DDalla%2BPozza%26aufirst%3DE.%26aulast%3DStella%26aufirst%3DB.%26aulast%3DTsapis%26aufirst%3DN.%26aulast%3DYagoubi%26aufirst%3DN.%26aulast%3DFanelli%26aufirst%3DG.%26aulast%3DFattal%26aufirst%3DE.%26aulast%3DHeeschen%26aufirst%3DC.%26aulast%3DPalmieri%26aufirst%3DM.%26aulast%3DArpicco%26aufirst%3DS.%26atitle%3DPancreatic%2520cancer%2520stem%2520cell%2520proliferation%2520is%2520strongly%2520inhibited%2520by%2520diethyldithiocarbamate-copper%2520complex%2520loaded%2520into%2520hyaluronic%2520acid%2520decorated%2520liposomes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2019%26volume%3D1863%26spage%3D61%26epage%3D72%26doi%3D10.1016%2Fj.bbagen.2018.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hurtado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankpal, U. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhabra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maram, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurung, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basha, R.</span></span> <span> </span><span class="NLM_article-title">Copper-tolfenamic acid: evaluation of stability and anti-cancer activity</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1007/s10637-018-0594-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1007%2Fs10637-018-0594-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=29761244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVCktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=27-34&author=M.+Hurtadoauthor=U.+T.+Sankpalauthor=J.+Chhabraauthor=D.+T.+Brownauthor=R.+Maramauthor=R.+Patelauthor=R.+K.+Gurungauthor=J.+Simeckaauthor=A.+A.+Holderauthor=R.+Basha&title=Copper-tolfenamic+acid%3A+evaluation+of+stability+and+anti-cancer+activity&doi=10.1007%2Fs10637-018-0594-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-tolfenamic acid: evaluation of stability and anti-cancer activity</span></div><div class="casAuthors">Hurtado, Myrna; Sankpal, Umesh T.; Chhabra, Jaya; Brown, Deondra T.; Maram, Rajasekhar; Patel, Rafid; Gurung, Raj K.; Simecka, Jerry; Holder, Alvin A.; Basha, Riyaz</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-34</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The non-steroidal anti-inflammatory drug, Tolfenamic acid (TA) acts as an anti-cancer agent in several adult and pediatric cancer models.  Copper (Cu) is an important element with multiple biol. functions and has gained interest in medical applications.  Recently, [Cu(TA)2(bpy)] (Cu-TA) has been synthesized in order to enhance therapeutic activity.  In this study, we synthesized Cu-TA using an established method, characterized it by UV visible spectroscopy and Fourier-transform IR spectroscopy (FTIR), and tested its anti-cancer activity using twelve cell lines representing various cancers, such as Ewing sarcoma, glioblastoma, medulloblastoma, neuroblastoma, pancreatic and prostate.  The anti-proliferative activity of Cu-TA was detd. at 48 h post-treatment and compared with the parental compd., TA.  The IC50 values were calcd. using GraphPad Prism software.  The biol. stability of Cu-TA was evaluated using twelve-month-old powder and six-month-old stock soln.  Cardiomyocytes (H9C2) were used to test the cytotoxicity in non-malignant cells.  Cu-TA showed higher anti-proliferative activity, and the IC50 values were 30 to 80% lower when compared with TA.  H9C2 cells were non-responsive to Cu-TA, suggesting that it is selective towards malignant cells.  Comparison of the twelve-month-old powder and six-month-old stock soln. using the Panc1 cell line showed similar IC50 values (<5% variation), confirming the stability of Cu-TA either in powder or soln. form.  These findings demonstrate the potential of Cu-TA as an effective anti-cancer agent.  Further studies to delineate the detailed mechanism of action of Cu-TA for specific cancer model are underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ8IluDhKMObVg90H21EOLACvtfcHk0lgPJaAxbPxCLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVCktL0%253D&md5=968ed3d7b1606e97ea0211a27f1a442c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs10637-018-0594-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-018-0594-9%26sid%3Dliteratum%253Aachs%26aulast%3DHurtado%26aufirst%3DM.%26aulast%3DSankpal%26aufirst%3DU.%2BT.%26aulast%3DChhabra%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%2BT.%26aulast%3DMaram%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DGurung%26aufirst%3DR.%2BK.%26aulast%3DSimecka%26aufirst%3DJ.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DBasha%26aufirst%3DR.%26atitle%3DCopper-tolfenamic%2520acid%253A%2520evaluation%2520of%2520stability%2520and%2520anti-cancer%2520activity%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2019%26volume%3D37%26spage%3D27%26epage%3D34%26doi%3D10.1007%2Fs10637-018-0594-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carcelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelosi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvalaio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogolino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: unravelling an unexplored pharmacological target</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">112266</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ejmech.2020.112266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=32248006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsVSnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2020&pages=112266&author=M.+Carcelliauthor=M.+Tegoniauthor=J.+Bartoliauthor=C.+Marzanoauthor=G.+Pelosiauthor=M.+Salvalaioauthor=D.+Rogolinoauthor=V.+Gandin&title=In+vitro+and+in+vivo+anticancer+activity+of+tridentate+thiosemicarbazone+copper+complexes%3A+unravelling+an+unexplored+pharmacological+target&doi=10.1016%2Fj.ejmech.2020.112266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target</span></div><div class="casAuthors">Carcelli, Mauro; Tegoni, Matteo; Bartoli, Jennifer; Marzano, Cristina; Pelosi, Giorgio; Salvalaio, Marika; Rogolino, Dominga; Gandin, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112266</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Certain metal complexes can have a great antitumor activity, as the use of cisplatin in therapy was demonstrating for the past fifty years.  Copper complexes, in particular, have attracted much attention as an example of anticancer compds. based on an endogenous metal.  The authors present the synthesis and the activity of copper(II) complexes with variously substituted salicylaldehyde thiosemicarbazone ligands.  The in vitro activity of both ligands and copper complexes was assessed on a panel of cell lines (HCT-15, LoVo and LoVo oxaliplatin resistant colon carcinoma, A375 melanoma, BxPC3 and PSN1 pancreatic adenocarcinoma, BCPAP thyroid carcinoma, 2008 ovarian carcinoma, HEK293 nontransformed embryonic kidney), highlighting remarkable activity of the metal complexes, in some cases in the low nanomolar range.  The copper(II) complexes were also screened, with good results, against 3-dimensional spheroids of colon (HCT-15) and pancreatic (PSN1) cancer cells.  Detailed investigations on the mechanism of action of the copper(II) complexes are also reported: they are able to potently inhibit Protein Disulfide Isomerase, a copper-binding protein, that is recently emerging as a new therapeutic target for cancer treatment.  Good preliminary results obtained in C57BL mice indicate that this series of metal-based compds. could be a very promising weapon in the fight against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrurXkEWmFrs7Vg90H21EOLACvtfcHk0lgPJaAxbPxCLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsVSnsbc%253D&md5=9d9343877d2df2fa42e9a9972497a7ef</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112266%26sid%3Dliteratum%253Aachs%26aulast%3DCarcelli%26aufirst%3DM.%26aulast%3DTegoni%26aufirst%3DM.%26aulast%3DBartoli%26aufirst%3DJ.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DPelosi%26aufirst%3DG.%26aulast%3DSalvalaio%26aufirst%3DM.%26aulast%3DRogolino%26aufirst%3DD.%26aulast%3DGandin%26aufirst%3DV.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520anticancer%2520activity%2520of%2520tridentate%2520thiosemicarbazone%2520copper%2520complexes%253A%2520unravelling%2520an%2520unexplored%2520pharmacological%2520target%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D194%26spage%3D112266%26doi%3D10.1016%2Fj.ejmech.2020.112266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komarnicka, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozieł, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabierowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruszyński, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesiów, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyzioł, A.</span></span> <span> </span><span class="NLM_article-title">Copper(I) complexes with phosphines P(<i>p</i>-OCH<sub>3</sub>-Ph)<sub>2</sub>CH<sub>2</sub>OH and P(<i>p</i>-OCH<sub>3</sub>-Ph)<sub>2</sub>CH<sub>2</sub>SarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitro antiproliferative activity</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">110926</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2019.110926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.jinorgbio.2019.110926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=31759264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1arsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2020&pages=110926&author=U.+K.+Komarnickaauthor=S.+Kozie%C5%82author=P.+Zabierowskiauthor=R.+Kruszy%C5%84skiauthor=M.+K.+Lesi%C3%B3wauthor=F.+Tisatoauthor=M.+Porchiaauthor=A.+Kyzio%C5%82&title=Copper%28I%29+complexes+with+phosphines+P%28p-OCH3-Ph%292CH2OH+and+P%28p-OCH3-Ph%292CH2SarGly.+Synthesis%2C+multimodal+DNA+interactions%2C+and+prooxidative+and+in+vitro+antiproliferative+activity&doi=10.1016%2Fj.jinorgbio.2019.110926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I) complexes with phosphines P(p-OCH3-Ph)2CH2OH and P(p-OCH3-Ph)2CH2SarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitro antiproliferative activity</span></div><div class="casAuthors">Komarnicka, Urszula K.; Koziel, Sandra; Zabierowski, Piotr; Kruszynski, Rafal; Lesiow, Monika K.; Tisato, Francesco; Porchia, Marina; Kyziol, Agnieszka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110926</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phosphonium salt (p-OCH3-Ph)2P(CH2OH)2Cl (MPOHC), derived phosphine ligands without and with SarGly (Sarcosine-Glycine) peptide carrier P(p-OCH3-Ph)2CH2OH (MPOH) and P(p-OCH3-Ph)2CH2SarGly (MPSG), resp., and two copper(I) complexes [Cu(I)(dmp)(MPOH)] (1-MPOH; dmp = (2,9-dimethyl-1,10-phenanthroline)) and [Cu(I)(dmp)(MPSG)] (1-MPSG) were synthesized.  The resulting compds. were characterized by elemental anal., 1-dimensional and 2-dimensional NMR and UV-visible absorption spectroscopies, mass spectrometry, cyclic voltammetry and by x-ray diffraction anal.  Cytotoxicity of all compds. was evaluated in vitro against colon, lung, breast, pancreatic, prostate tumor cell lines, as well as towards nontumor cell lines: lung, kidney and keratinocyte.  Stable in biol. medium in the presence of atm. oxygen, Cu(I) complexes exerted a cytotoxic effect higher than that elicited by cisplatin against tested cancer cell lines.  The introduction of methoxy group onto the Ph rings of the phosphine ligand coordinated to the copper(I) ion resulted in a relevant increase of cytotoxicity in the case of breast, pancreatic and prostate tumor cell lines in vitro.  Attachment of a peptide carrier significantly increased the selectivity towards cancer cells.  Fluorescence spectroscopic data (calf thymus DNA: CT-DNA) titrn., together with anal. of DNA fragmentation (gel electrophoresis) and mol. docking provided evidence for the multimodal interaction of copper compds. with DNA and showed their unusual low genotoxicity.  Addnl., copper complexes were able to generate reactive oxygen species as a result of redox processes, proved by fluorescence spectroscopy and cyclic voltamperometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNk0iHbW1uarVg90H21EOLACvtfcHk0ljIwHFouQY-GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1arsr%252FO&md5=da340706fba82392213bac7cb8885dff</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2019.110926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2019.110926%26sid%3Dliteratum%253Aachs%26aulast%3DKomarnicka%26aufirst%3DU.%2BK.%26aulast%3DKozie%25C5%2582%26aufirst%3DS.%26aulast%3DZabierowski%26aufirst%3DP.%26aulast%3DKruszy%25C5%2584ski%26aufirst%3DR.%26aulast%3DLesi%25C3%25B3w%26aufirst%3DM.%2BK.%26aulast%3DTisato%26aufirst%3DF.%26aulast%3DPorchia%26aufirst%3DM.%26aulast%3DKyzio%25C5%2582%26aufirst%3DA.%26atitle%3DCopper%2528I%2529%2520complexes%2520with%2520phosphines%2520P%2528p-OCH3-Ph%25292CH2OH%2520and%2520P%2528p-OCH3-Ph%25292CH2SarGly.%2520Synthesis%252C%2520multimodal%2520DNA%2520interactions%252C%2520and%2520prooxidative%2520and%2520in%2520vitro%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2020%26volume%3D203%26spage%3D110926%26doi%3D10.1016%2Fj.jinorgbio.2019.110926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barve, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adsule, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katiyar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anson, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, F. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3800</span>– <span class="NLM_lpage">3808</span>, <span class="refDoi"> DOI: 10.1021/jm051068y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051068y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3800-3808&author=V.+Barveauthor=F.+Ahmedauthor=S.+Adsuleauthor=S.+Banerjeeauthor=S.+Kulkarniauthor=P.+Katiyarauthor=C.+E.+Ansonauthor=A.+K.+Powellauthor=S.+Padhyeauthor=F.+H.+Sarkar&title=Synthesis%2C+molecular+characterization%2C+and+biological+activity+of+novel+synthetic+derivatives+of+chromen-4-one+in+human+cancer+cells&doi=10.1021%2Fjm051068y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Molecular Characterization, and Biological Activity of Novel Synthetic Derivatives of Chromen-4-one in Human Cancer Cells</span></div><div class="casAuthors">Barve, Vivek; Ahmed, Fakhara; Adsule, Shreelekha; Banerjee, Sanjeev; Kulkarni, Sudhir; Katiyar, Prashant; Anson, Christopher E.; Powell, Annie K.; Padhye, Subhash; Sarkar, Fazlul H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3800-3808</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and characterization of Schiff base derivs. of 3-formylchromone 3-6 (FPA-120 to FPA-123), the minimal biol. active structural motif of soy isoflavone, genistein, and their copper(II) complexes 7-10 (FPA-124 to FPA-127) are reported here.  These copper complexes possess distorted square-planar geometries capable of stabilizing Cu2+/Cu+ redox forms.  The mol. modeling study revealed that the key interaction of the metal complexes was with amino acids in the pleckstrin homol. (PH) and the kinase domain of the PKB (Akt) protein.  Copper complex 7 (I) significantly forms stronger charge interactions in the kinase domain than genistein, leading to better stabilization in the active pocket.  In vitro evaluation of copper complexes against hormone-independent and metastatic breast (BT20), prostate (PC-3), and K-ras mutant (COLO 357) and K-ras wild-type (BxPC-3) pancreatic cancer cells revealed that 7 was the most potent compd. which exhibited PKB (Akt protein) inhibitory activities and caused NF-κB inactivation in a well-established orthotopic pancreatic tumor model using COLO 357 cells.  An inverse relationship was obsd. between IC50 values of the anti-proliferative activities and the Cu2+/Cu+ redox couple for these compds., which may provide a rapid screen for evaluating the efficacy of active metallodrugs affecting redox-sensitive transcription factors such as NF-κB and its upstream target, the PKB (Akt) pathway, in multiple cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT3663-0DS5bVg90H21EOLACvtfcHk0ljIwHFouQY-GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSntbw%253D&md5=8cb10844d8e9c30393e6454206c21033</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm051068y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051068y%26sid%3Dliteratum%253Aachs%26aulast%3DBarve%26aufirst%3DV.%26aulast%3DAhmed%26aufirst%3DF.%26aulast%3DAdsule%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DKatiyar%26aufirst%3DP.%26aulast%3DAnson%26aufirst%3DC.%2BE.%26aulast%3DPowell%26aufirst%3DA.%2BK.%26aulast%3DPadhye%26aufirst%3DS.%26aulast%3DSarkar%26aufirst%3DF.%2BH.%26atitle%3DSynthesis%252C%2520molecular%2520characterization%252C%2520and%2520biological%2520activity%2520of%2520novel%2520synthetic%2520derivatives%2520of%2520chromen-4-one%2520in%2520human%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3800%26epage%3D3808%26doi%3D10.1021%2Fjm051068y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adsule, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, F. H.</span></span> <span> </span><span class="NLM_article-title">A novel copper complex of 3-benzoyl-alpha methyl benzene acetic acid with antitumor activity mediated via cyclooxygenase pathway</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1002/ijc.22383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1002%2Fijc.22383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=17131340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1elsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=734-742&author=F.+Ahmedauthor=S.+Adsuleauthor=A.+S.+Aliauthor=S.+Banerjeeauthor=S.+Aliauthor=S.+Kulkarniauthor=S.+Padhyeauthor=F.+H.+Sarkar&title=A+novel+copper+complex+of+3-benzoyl-alpha+methyl+benzene+acetic+acid+with+antitumor+activity+mediated+via+cyclooxygenase+pathway&doi=10.1002%2Fijc.22383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A novel copper complex of 3-benzoyl-α methyl benzene acetic acid with antitumor activity mediated via cyclooxygenase pathway</span></div><div class="casAuthors">Ahmed, Fakhara; Adsule, Shreelekha; Ali, Ashhar S.; Banerjee, Sanjeev; Ali, Shadan; Kulkarni, Sudhir; Padhye, Subhash; Sarkar, Fazlul H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">734-742</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Pancreatic cancer (PC) is characterized as one of the deadliest malignancies and its treatment is a great challenge to clin. oncologists.  Expression of COX-2 is detectable in 75% of PCs among which 50% showed overexpression, suggesting the importance of COX-2 enzyme and its metabolic product prostaglandin E2 (PGE2) in PC.  Here the authors report the synthesis and biol. activity of a novel COX-2 inhibitor, FPA-306, and its effects on PC cells with different levels of COX-2 expression.  Using MTT assay, the authors found a significant growth inhibition of BxPC-3 cells treated by FPA-306 with an IC50 of 10 μmol/L, which was lower than that of ketoprofen (IC50 = 35.4 μmol/L) and celecoxib (IC50 > 100 μmol/L).  There was no such effect found in MIAPaCa cell line, which does not express COX-2.  The authors also found dose dependent redn. in cell survival and induction of apoptosis by FPA-306 treatment in BxPC-3 cells but not in MIAPaCa cells.  These results were correlated with apoptosis data and secreted PGE2 levels.  The mol. modeling of FPA-306 in the COX-2 active site showed that FPA-306 is potentially able to inhibit the activity of enzyme by blocking the active site, thereby resulting in decreased PGE2 prodn.  The authors also found a significant redn. of COX-2 at the mRNA and protein levels together with downregulation of NF-κB DNA binding activity and its downstream genes, Bcl-2 and survivin.  These results suggest that FPA-306 is an effective and potent agent in inhibiting the growth of PC cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYHBmDSiYoZLVg90H21EOLACvtfcHk0lgyKjLzis_psA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1elsbo%253D&md5=260dd6152c170b5879c2eb4eefdc17e8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fijc.22383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22383%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DF.%26aulast%3DAdsule%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DA.%2BS.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DPadhye%26aufirst%3DS.%26aulast%3DSarkar%26aufirst%3DF.%2BH.%26atitle%3DA%2520novel%2520copper%2520complex%2520of%25203-benzoyl-alpha%2520methyl%2520benzene%2520acetic%2520acid%2520with%2520antitumor%2520activity%2520mediated%2520via%2520cyclooxygenase%2520pathway%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D120%26spage%3D734%26epage%3D742%26doi%3D10.1002%2Fijc.22383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ambike, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adsule, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afrasiabi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhye, S.</span></span> <span> </span><span class="NLM_article-title">Copper conjugates of nimesulide Schiff bases targeting VEGF, COX and Bcl-2 in pancreatic cancer cells</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1517</span>– <span class="NLM_lpage">1524</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2007.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.jinorgbio.2007.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=17689613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWht7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1517-1524&author=V.+Ambikeauthor=S.+Adsuleauthor=F.+Ahmedauthor=Z.+Wangauthor=Z.+Afrasiabiauthor=E.+Sinnauthor=F.+Sarkarauthor=S.+Padhye&title=Copper+conjugates+of+nimesulide+Schiff+bases+targeting+VEGF%2C+COX+and+Bcl-2+in+pancreatic+cancer+cells&doi=10.1016%2Fj.jinorgbio.2007.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Copper conjugates of nimesulide Schiff bases targeting VEGF, COX and Bcl-2 in pancreatic cancer cells</span></div><div class="casAuthors">Ambike, Vinita; Adsule, Shreelekha; Ahmed, Fakhara; Wang, Zhiwei; Afrasiabi, Zahra; Sinn, Ekkehard; Sarkar, Fazlul; Padhye, Subhash</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1517-1524</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Copper conjugates of Schiff base derivs. of nimesulide (1), a well-known cyclooxygenase-2 (COX-2) inhibitor, were synthesized, structurally characterized and evaluated for their COX selectivity indexes and cytotoxicities on pancreatic tumor, BxPC-3 (COX-2 pos.) and MiaPaCa (COX-2 neg.) cell lines.  Copper conjugates exhibit distorted square planar geometries as revealed by the single crystal x-ray structure detn. of Cu(L1)2 and show significant growth inhibition in both cell lines (IC50 values 3-26 μM for COX-2 pos. and 5-9 μM for COX-2 neg. cell line) than the parent nimesulide (35 μM for COX-2 pos. and >100 μM for COX-2 neg. cell line).  The mechanistic pathway for the biol. activity involves inhibition of vascular endothelial growth factor (VEGF) and COX inhibition, as well as down regulation of antiapoptotic Bcl-2 and Bcl-XL proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruEWvseaLBwrVg90H21EOLACvtfcHk0lhPL3Bi-kAVyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWht7nE&md5=26c22862200341541e3f0e5953a2fefd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2007.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2007.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DAmbike%26aufirst%3DV.%26aulast%3DAdsule%26aufirst%3DS.%26aulast%3DAhmed%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DAfrasiabi%26aufirst%3DZ.%26aulast%3DSinn%26aufirst%3DE.%26aulast%3DSarkar%26aufirst%3DF.%26aulast%3DPadhye%26aufirst%3DS.%26atitle%3DCopper%2520conjugates%2520of%2520nimesulide%2520Schiff%2520bases%2520targeting%2520VEGF%252C%2520COX%2520and%2520Bcl-2%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2007%26volume%3D101%26spage%3D1517%26epage%3D1524%26doi%3D10.1016%2Fj.jinorgbio.2007.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span> <span> </span><span class="NLM_article-title">A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2013.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.taap.2013.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=24060341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsl2jsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2013&pages=477-483&author=J.+Hanauthor=L.+Liuauthor=X.+Yueauthor=J.+Changauthor=W.+Shiauthor=Y.+Hua&title=A+binuclear+complex+constituted+by+diethyldithiocarbamate+and+copper%28I%29+functions+as+a+proteasome+activity+inhibitor+in+pancreatic+cancer+cultures+and+xenografts&doi=10.1016%2Fj.taap.2013.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts</span></div><div class="casAuthors">Han, Jinbin; Liu, Luming; Yue, Xiaoqiang; Chang, Jinjia; Shi, Weidong; Hua, Yongqiang</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">477-483</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">It is a therapeutic strategy for cancers including pancreatic to inhibit proteasome activity.  Disulfiram (DSF) may bind copper (Cu) to form a DSF-Cu complex.  DSF-Cu is capable of inducing apoptosis in cancer cells by inhibiting proteasome activity.  DSF is rapidly converted to diethyldithiocarbamate (DDTC) within bodies.  Copper(II) absorbed by bodies is reduced to copper(I) when it enters cells.  We found that DDTC and copper(I) could form a binuclear complex which might be entitled DDTC-Cu(I), and it had been synthesized by us in the lab.  This study is to investigate the anticancer potential of this complex on pancreatic cancer and the possible mechanism.  Pancreatic cancer cell lines, SW1990, PANC-1 and BXPC-3 were used for in vitro assays.  Female athymic nude mice grown SW1990 xenografts were used as animal models.  Cell counting kit-8 (cck-8) assay and flow cytometry were used for analyzing apoptosis in cells.  A 20S proteasome assay kit was used in proteasome activity anal.  Western blot (WB) and immunohistochem. (IHC) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays were used in tumor sample anal.  The results suggest that DDTC-Cu(I) inhibit pancreatic cancer cell proliferation and proteasome activity in vitro and in vivo.  Accumulation of ubiquitinated proteins, and increased p27 as well as decreased NF-κB expression were detected in tumor tissues of DDTC-Cu(I)-treated group.  Our data indicates that DDTC-Cu(I) is an effective proteasome activity inhibitor with the potential to be explored as a drug for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAwfQ0CZmqRbVg90H21EOLACvtfcHk0lhPL3Bi-kAVyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsl2jsL7O&md5=f60b1591a4990453aa59d8899ced34f7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DYue%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DHua%26aufirst%3DY.%26atitle%3DA%2520binuclear%2520complex%2520constituted%2520by%2520diethyldithiocarbamate%2520and%2520copper%2528I%2529%2520functions%2520as%2520a%2520proteasome%2520activity%2520inhibitor%2520in%2520pancreatic%2520cancer%2520cultures%2520and%2520xenografts%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D273%26spage%3D477%26epage%3D483%26doi%3D10.1016%2Fj.taap.2013.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montagner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erxleben, A.</span></span> <span> </span><span class="NLM_article-title">DNA damage and induction of apoptosis in pancreatic cancer cells by a new dinuclear bis(triazacyclonane) copper complex</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2015.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.jinorgbio.2015.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=25660211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslersbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2015&pages=101-107&author=D.+Montagnerauthor=V.+Gandinauthor=C.+Marzanoauthor=A.+Erxleben&title=DNA+damage+and+induction+of+apoptosis+in+pancreatic+cancer+cells+by+a+new+dinuclear+bis%28triazacyclonane%29+copper+complex&doi=10.1016%2Fj.jinorgbio.2015.01.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">DNA damage and induction of apoptosis in pancreatic cancer cells by a new dinuclear bis(triazacyclonane) copper complex</span></div><div class="casAuthors">Montagner, Diego; Gandin, Valentina; Marzano, Cristina; Erxleben, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-107</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The dinuclear copper(II) complex [Cu2{bcmp(-H)}(μ-OH)](NO3)2·H2O (1, bcmp = 2,6-bis(1,4,7-triazacyclonon-1-ylmethyl)-4-methylphenol) has been synthesized and characterized by electrospray ionization mass spectrometry, potentiometric titrn. and cyclovoltammetry.  The X-ray structure of the analogous perchlorate salt [Cu2{bcmp(-H)}(μ-OH)](ClO4)2·2.5H2O (2) was detd.  Cytotoxicity studies showed very promising activity of 1 against various pancreatic tumor cell lines with IC50 values comparable or even lower than those of cisplatin.  The Cu complex displayed low toxicity against a human non-tumor cell line (HEK 293) demonstrating selectivity for cancer cells. 1 converts supercoiled pUC19 plasmid DNA into the nicked form at micromolar concns. in the absence of added reductants.  A detailed kinetic study on the hydrolysis of the DNA model bis(2,4-dinitrophenyl) phosphate (BDNPP) has been performed, 1 hydrolyzes BDNPP with a second order rate const. of 0.047 M s- 1 at pH 8 and 40 °C.  Finally, single cell electrophoresis (comet assay) and fluorescence microscopy anal. showed that 1 interacts with cellular DNA and induces apoptotic cell death of Capan-1 pancreatic cancer cells.  Western blotting anal. indicated that the Cu complex activates the p53 dependent pathway of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl0ammGhmjg7Vg90H21EOLACvtfcHk0lhPL3Bi-kAVyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslersbg%253D&md5=61d98655db5ea30e8ed0369149d7a679</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2015.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2015.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DMontagner%26aufirst%3DD.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DErxleben%26aufirst%3DA.%26atitle%3DDNA%2520damage%2520and%2520induction%2520of%2520apoptosis%2520in%2520pancreatic%2520cancer%2520cells%2520by%2520a%2520new%2520dinuclear%2520bis%2528triazacyclonane%2529%2520copper%2520complex%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2015%26volume%3D145%26spage%3D101%26epage%3D107%26doi%3D10.1016%2Fj.jinorgbio.2015.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hurtado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankpal, U. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahammad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhabra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurung, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwanatha, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basha, R.</span></span> <span> </span><span class="NLM_article-title">Novel survivin inhibitor for suppressing pancreatic cancer cells growth via downregulating Sp1 and Sp3 transcription factors</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1894</span>– <span class="NLM_lpage">1907</span>, <span class="refDoi"> DOI: 10.1159/000495715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1159%2F000495715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=30504717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFWrtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&pages=1894-1907&author=M.+Hurtadoauthor=U.+T.+Sankpalauthor=A.+Kabaauthor=S.+Mahammadauthor=J.+Chhabraauthor=D.+T.+Brownauthor=R.+K.+Gurungauthor=A.+A.+Holderauthor=J.+K.+Vishwanathaauthor=R.+Basha&title=Novel+survivin+inhibitor+for+suppressing+pancreatic+cancer+cells+growth+via+downregulating+Sp1+and+Sp3+transcription+factors&doi=10.1159%2F000495715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors</span></div><div class="casAuthors">Hurtado, Myrna; Sankpal, Umesh T.; Kaba, Aboubacar; Mahammad, Shahela; Chhabra, Jaya; Brown, Deondra T.; Gurung, Raj K.; Holder, Alvin A.; Vishwanatha, Jamboor K.; Basha, Riyaz</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1894-1907</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">In this study, the ability of Cu-TA to inhibit survivin and its transcription factors, Specificity protein (Sp) 1 and 3 in PaCa cell lines and tumor growth in mouse xenograft model were evaluated.  Methods: Cell growth inhibition was measured in MIA PaCa-2 and Panc1 cells for 2 days using CellTiter-Glo kit.  Sp1, Sp3 and survivin expression (by Western blot and qPCR), apoptotic cells and cell cycle phase distribution (by flow cytometry) were evaluated.  A pilot study was performed using athymic nude mice [treated with vehicle/Cu-TA (25 or 50 mg/kg) 3 times/wk for 4 wk. Results: The IC50 value for Cu-TA was about half than TA.Both agents repressed the protein expression of Sp1/Sp3/survivin, Cu-TA was more effective than TA.  Esp. effect on survivin inhibition was 5.2 (MIA PaCa-2) or 6.4 (Panc1) fold higher and mRNA expression of only survivin was decreased.  Apoptotic cells increased with Cu-TA treatment in both cell lines, while Panc1 showed both effect on apoptosis and cell cycle (G2/M) arrest.  Cu-TA decreased the tumor growth in mouse xenografts (25 mg/kg: 48%; 50 mg/kg: 68%).  Addnl., there was no change obsd. in mice body wts., indicating no overt toxicity was occurring.  Conclusion: These results show that Cu-TA can serve as an effective survivin inhibitor for inhibiting PaCa cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsYtZG5AsuIrVg90H21EOLACvtfcHk0lgKff7UuJ5ukA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFWrtL%252FF&md5=8e4b56f4b7a7f534fd1feff7c4057f14</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1159%2F000495715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000495715%26sid%3Dliteratum%253Aachs%26aulast%3DHurtado%26aufirst%3DM.%26aulast%3DSankpal%26aufirst%3DU.%2BT.%26aulast%3DKaba%26aufirst%3DA.%26aulast%3DMahammad%26aufirst%3DS.%26aulast%3DChhabra%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%2BT.%26aulast%3DGurung%26aufirst%3DR.%2BK.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DVishwanatha%26aufirst%3DJ.%2BK.%26aulast%3DBasha%26aufirst%3DR.%26atitle%3DNovel%2520survivin%2520inhibitor%2520for%2520suppressing%2520pancreatic%2520cancer%2520cells%2520growth%2520via%2520downregulating%2520Sp1%2520and%2520Sp3%2520transcription%2520factors%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2018%26volume%3D51%26spage%3D1894%26epage%3D1907%26doi%3D10.1159%2F000495715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLeo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadagopan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1266</span>– <span class="NLM_lpage">1281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=31285958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFCjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1266-1281&author=X.+Zhangauthor=P.+Huauthor=S.+Y.+Dingauthor=T.+Sunauthor=L.+Liuauthor=S.+Hanauthor=A.+B.+DeLeoauthor=A.+Sadagopanauthor=W.+Guoauthor=X.+Wang&title=Induction+of+autophagy-dependent+apoptosis+in+cancer+cells+through+activation+of+ER+stress%3A+an+uncovered+anti-cancer+mechanism+by+anti-alcoholism+drug+disulfiram"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram</span></div><div class="casAuthors">Zhang, Xiao; Hu, Pan; Ding, Shi-Ying; Sun, Ting; Liu, Ling; Han, Shiwei; De Leo, Albert B.; Sadagopan, Ananthan; Guo, Wei; Wang, Xinhui</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1266-1284</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Due to its potent anticancer activity, there is interest in repurposing of the FDA-approved anti-alcoholism drug, disulfiram (DSF).  DSF forms potent complexes with copper (DSF/Cu) that induce apoptosis of many types of cancer cells.  Here, we investigated the role of DSF/Cu in autophagy, a mechanism of cell death or survival, and its interplay with DSF/Cu induced apoptosis of human pancreatic and breast cancer cells.  Methods: Levels of autophagy and apoptosis were assessed by Western blot, flow cytometry and immunofluorescence anal.  Cell viability was measured by MTT assays.  Activation of inositol-requiring enzyme 1α (IRE1α)-mRNA X-box binding protein 1 (XBP1) pathway and spliced XBP1 (XBP1s) expression were analyzed by Western blot, Phos-tag gel assay, RT-PCR, qRT-PCR and flow cytometry.  Results: The apoptosis induced by DSF/Cu in pancreatic and breast cancer cells is autophagy dependent.  This is accomplished by activating IRE1α, the sensor of unfolded protein response (UPR) via promotion of phosphorylation of IRE1α and its downstream XBP1 splicing into active XBP1s.  Conclusions: DSF/Cu induces ER-stress through activation of IRE1α-XBP1 pathway which is responsible, at least in part, for induction of autophagy-dependent apoptosis of cancer cells.  Insight into the ER-stress inducing ability by DSF/Cu may open a new research area for rational design of innovative therapeutic strategies for pancreatic and breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVhV7MC5KyhrVg90H21EOLACvtfcHk0lgKff7UuJ5ukA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFCjtLk%253D&md5=aab0b61fe7b99d009143e30edb4d1175</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DP.%26aulast%3DDing%26aufirst%3DS.%2BY.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DDeLeo%26aufirst%3DA.%2BB.%26aulast%3DSadagopan%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DInduction%2520of%2520autophagy-dependent%2520apoptosis%2520in%2520cancer%2520cells%2520through%2520activation%2520of%2520ER%2520stress%253A%2520an%2520uncovered%2520anti-cancer%2520mechanism%2520by%2520anti-alcoholism%2520drug%2520disulfiram%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2019%26volume%3D9%26spage%3D1266%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müerköster, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, H.</span></span> <span> </span><span class="NLM_article-title">Targeting apoptosis pathways in pancreatic cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>332</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2010.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.canlet.2010.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21078544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVWgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2013&pages=346-358&author=A.+Arltauthor=S.+S.+M%C3%BCerk%C3%B6sterauthor=H.+Sch%C3%A4fer&title=Targeting+apoptosis+pathways+in+pancreatic+cancer&doi=10.1016%2Fj.canlet.2010.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting apoptosis pathways in pancreatic cancer</span></div><div class="casAuthors">Arlt, Alexander; Mueerkoester, Susanne Sebens; Schaefer, Heiner</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">346-358</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer - here in particular pancreatic ductal adenocarcinoma (PDAC) - is still a highly therapy refractory disease.  Amongst the mechanisms by which PDAC cells could escape any non-surgical therapy, anti-apoptotic protection seems to be the most relevant one.  PDAC cells have acquired resistance to apoptotic stimuli such as death ligands (FasL, TRAIL) or anti-cancer drugs (gemcitabine) by a great no. of mol. alterations either disrupting an apoptosis inducing signal or counteracting the execution of apoptosis.  Thus, PDAC cells exhibit alterations in the EGFR/MAPK/Ras/raf1-, PI3K/Akt-, TRAIL/TRAF2-, or IKK/NF-κB pathway accompanied by deregulations in the expression of apoptosis regulators such as cIAP, Bcl2, XIAP or survivin.  Along with protection against apoptosis, PDAC cells also overexpress histone deacetylases (HDACs) giving rise to epigenetic patterns of chemoresistance and to acetylation of other regulatory proteins, as well.  With respect to the multitude of anti-apoptotic pathways, a great no. of mol. targets might be of high potential in novel therapy strategies.  Thus, natural compds. as well as novel synthetic drugs are considered to be used in single or combined therapy of PDAC.  A no. of proteasome and HDAC inhibitors or selective inhibitors of IKK, EGFR, Akt and mTOR have been widely explored in preclin. settings and clin. studies.  Even though these early studies encouraged an application in a clin. setting, most of the trials have been rather disappointing yet.  Thus, new mol. targets and novel concepts of combination therapies need to get access into clin. trials - either in neoadjuvant/adjuvant or in palliative treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2EEFfLoso_bVg90H21EOLACvtfcHk0lgKff7UuJ5ukA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVWgtbc%253D&md5=ceff2d9db91ec8285f7dfb2402433892</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2010.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2010.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DArlt%26aufirst%3DA.%26aulast%3DM%25C3%25BCerk%25C3%25B6ster%26aufirst%3DS.%2BS.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DH.%26atitle%3DTargeting%2520apoptosis%2520pathways%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D332%26spage%3D346%26epage%3D358%26doi%3D10.1016%2Fj.canlet.2010.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Apoptosis pathways and their therapeutic exploitation in pancreatic cancer</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1221</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1111/j.1582-4934.2009.00748.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1111%2Fj.1582-4934.2009.00748.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=19382915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BD1Mrms12qtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=1221-1227&author=S.+Fulda&title=Apoptosis+pathways+and+their+therapeutic+exploitation+in+pancreatic+cancer&doi=10.1111%2Fj.1582-4934.2009.00748.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis pathways and their therapeutic exploitation in pancreatic cancer</span></div><div class="casAuthors">Fulda Simone</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular and molecular medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1221-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Resistance to apoptosis (programmed cell death) is a characteristic feature of human malignancies including pancreatic cancer, which is one of the leading causes of cancer deaths in the western world.  Defects in this intrinsic cell death program can contribute to the multistep process of tumorigenesis, because too little cell death can disturb tissue homeostasis.  Further, blockade of apoptosis pathways can cause treatment failure, because intact apoptosis signalling cascades largely mediate therapy-induced cytotoxicity.  The elucidation of apoptosis pathways in pancreatic carcinoma over the last decade has resulted in the identification of various molecular defects.  How apoptosis pathways can be exploited for the treatment of pancreatic cancer will be discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOqrOqwhp34WGmni0r9GoKfW6udTcc2eYeK5ItxFd017ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mrms12qtg%253D%253D&md5=08b1b02da3bd3bce9d7ab20052f89020</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2009.00748.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2009.00748.x%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DApoptosis%2520pathways%2520and%2520their%2520therapeutic%2520exploitation%2520in%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2009%26volume%3D13%26spage%3D1221%26epage%3D1227%26doi%3D10.1111%2Fj.1582-4934.2009.00748.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis, a new form of cell death, and its relationships with tumourous diseases</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">657</span>, <span class="refDoi"> DOI: 10.1111/jcmm.13008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1111%2Fjcmm.13008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27860262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFSisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=648-657&author=H.+Yuauthor=P.+Guoauthor=X.+Xieauthor=Y.+Wangauthor=G.+Chen&title=Ferroptosis%2C+a+new+form+of+cell+death%2C+and+its+relationships+with+tumourous+diseases&doi=10.1111%2Fjcmm.13008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis, a new form of cell death, and its relationships with tumourous diseases</span></div><div class="casAuthors">Yu, Haitao; Guo, Pengyi; Xie, Xiaozai; Wang, Yi; Chen, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">648-657</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a newly discovered type of cell death that differs from traditional apoptosis and necrosis and results from iron-dependent lipid peroxide accumulation.  Ferroptotic cell death is characterized by cytol. changes, including cell vol. shrinkage and increased mitochondrial membrane d.  Ferroptosis can be induced by two classes of small-mol. substances known as class 1 (system Xc- inhibitors) and class 2 ferroptosis inducers [glutathione peroxidase 4 (GPx4) inhibitors].  In addn. to these small-mol. substances, a no. of drugs (e.g. sorafenib, artemisinin and its derivs.) can induce ferroptosis.  Various factors, such as the mevalonate (MVA) and sulfur-transfer pathways, play pivotal roles in the regulation of ferroptosis.  Ferroptosis plays an unneglectable role in regulating the growth and proliferation of some types of tumor cells, such as lymphocytoma, ductal cell cancer of the pancreas, renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC).  Here, we will first introduce the discovery of and research pertaining to ferroptosis; then summarize the induction mechanisms and regulatory pathways of ferroptosis; and finally, further elucidate the roles of ferroptosis in human tumorous diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqonDgZpPWiSrVg90H21EOLACvtfcHk0lhUsDSzP_CoDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFSisbs%253D&md5=4e771be1d22292c9bdd96c28c61c278b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.13008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.13008%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26atitle%3DFerroptosis%252C%2520a%2520new%2520form%2520of%2520cell%2520death%252C%2520and%2520its%2520relationships%2520with%2520tumourous%2520diseases%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2017%26volume%3D21%26spage%3D648%26epage%3D657%26doi%3D10.1111%2Fjcmm.13008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemberg, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaitsev, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleason, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: an iron-dependent form of nonapoptotic cell death</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.cell.2012.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=22632970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1060-1072&author=S.+J.+Dixonauthor=K.+M.+Lembergauthor=M.+R.+Lamprechtauthor=R.+Skoutaauthor=E.+M.+Zaitsevauthor=C.+E.+Gleasonauthor=D.+N.+Patelauthor=A.+J.+Bauerauthor=A.+M.+Cantleyauthor=W.+S.+Yangauthor=B.+Morrisonauthor=B.+R.+Stockwell&title=Ferroptosis%3A+an+iron-dependent+form+of+nonapoptotic+cell+death&doi=10.1016%2Fj.cell.2012.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death</span></div><div class="casAuthors">Dixon, Scott J.; Lemberg, Kathryn M.; Lamprecht, Michael R.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Morrison, Barclay; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathol. states.  The oncogenic RAS-selective lethal small mol. erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis.  Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphol., biochem., and genetically distinct from apoptosis, necrosis, and autophagy.  We identify the small mol. ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes.  Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system xc-), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death.  Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzDzMapViBQ7Vg90H21EOLACvtfcHk0lhUsDSzP_CoDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D&md5=5d3b8c55a053dfde7e758cc1701ef71b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DLemberg%26aufirst%3DK.%2BM.%26aulast%3DLamprecht%26aufirst%3DM.%2BR.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DZaitsev%26aufirst%3DE.%2BM.%26aulast%3DGleason%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DD.%2BN.%26aulast%3DBauer%26aufirst%3DA.%2BJ.%26aulast%3DCantley%26aufirst%3DA.%2BM.%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520an%2520iron-dependent%2520form%2520of%2520nonapoptotic%2520cell%2520death%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1060%26epage%3D1072%26doi%3D10.1016%2Fj.cell.2012.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span> <span> </span><span class="NLM_article-title">Recent progress in ferroptosis inducers for cancer therapy</span>. <i>Adv. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1904197</span>, <span class="refDoi"> DOI: 10.1002/adma.201904197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1002%2Fadma.201904197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCnu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2019&pages=1904197&author=C.+Liangauthor=X.+Zhangauthor=M.+Yangauthor=X.+Dong&title=Recent+progress+in+ferroptosis+inducers+for+cancer+therapy&doi=10.1002%2Fadma.201904197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in Ferroptosis Inducers for Cancer Therapy</span></div><div class="casAuthors">Liang, Chen; Zhang, Xinglin; Yang, Mengsu; Dong, Xiaochen</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Materials (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">1904197</span>CODEN:
                <span class="NLM_cas:coden">ADVMEW</span>;
        ISSN:<span class="NLM_cas:issn">0935-9648</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a newly discovered form of regulated cell death that is the nexus between metab., redox biol., and human health.  Emerging evidence shows the potential of triggering ferroptosis for cancer therapy, particularly for eradicating aggressive malignancies that are resistant to traditional therapies.  Recently, there has been a great deal of effort to design and develop anticancer drugs based on ferroptosis induction.  Recent advances of ferroptosis-inducing agents at the intersection of chem., materials science, and cancer biol. are presented.  The basis of ferroptosis is summarized first to highlight the feasibility and characteristics of triggering ferroptosis for cancer therapy.  A literature review of ferroptosis inducers (including small mols. and nanomaterials) is then presented to delineate their design, action mechanisms, and anticancer applications.  Finally, some considerations for research on ferroptosis inducers are spotlighted, followed by a discussion on the challenges and future development directions of this burgeoning field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon1qimBGm0YrVg90H21EOLACvtfcHk0li-6J1I6Gzbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCnu7rK&md5=c1c95f9a5231bf2e121752ecf2535cad</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fadma.201904197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadma.201904197%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DX.%26atitle%3DRecent%2520progress%2520in%2520ferroptosis%2520inducers%2520for%2520cancer%2520therapy%26jtitle%3DAdv.%2520Mater.%26date%3D2019%26volume%3D31%26spage%3D1904197%26doi%3D10.1002%2Fadma.201904197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis, a new form of cell death, and its relationships with tumourous diseases</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">657</span>, <span class="refDoi"> DOI: 10.1111/jcmm.13008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1111%2Fjcmm.13008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27860262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFSisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=648-657&author=H.+Yuauthor=P.+Guoauthor=X.+Xieauthor=Y.+Wangauthor=G.+Chen&title=Ferroptosis%2C+a+new+form+of+cell+death%2C+and+its+relationships+with+tumourous+diseases&doi=10.1111%2Fjcmm.13008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis, a new form of cell death, and its relationships with tumourous diseases</span></div><div class="casAuthors">Yu, Haitao; Guo, Pengyi; Xie, Xiaozai; Wang, Yi; Chen, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">648-657</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a newly discovered type of cell death that differs from traditional apoptosis and necrosis and results from iron-dependent lipid peroxide accumulation.  Ferroptotic cell death is characterized by cytol. changes, including cell vol. shrinkage and increased mitochondrial membrane d.  Ferroptosis can be induced by two classes of small-mol. substances known as class 1 (system Xc- inhibitors) and class 2 ferroptosis inducers [glutathione peroxidase 4 (GPx4) inhibitors].  In addn. to these small-mol. substances, a no. of drugs (e.g. sorafenib, artemisinin and its derivs.) can induce ferroptosis.  Various factors, such as the mevalonate (MVA) and sulfur-transfer pathways, play pivotal roles in the regulation of ferroptosis.  Ferroptosis plays an unneglectable role in regulating the growth and proliferation of some types of tumor cells, such as lymphocytoma, ductal cell cancer of the pancreas, renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC).  Here, we will first introduce the discovery of and research pertaining to ferroptosis; then summarize the induction mechanisms and regulatory pathways of ferroptosis; and finally, further elucidate the roles of ferroptosis in human tumorous diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqonDgZpPWiSrVg90H21EOLACvtfcHk0li-6J1I6Gzbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFSisbs%253D&md5=4e771be1d22292c9bdd96c28c61c278b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.13008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.13008%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26atitle%3DFerroptosis%252C%2520a%2520new%2520form%2520of%2520cell%2520death%252C%2520and%2520its%2520relationships%2520with%2520tumourous%2520diseases%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2017%26volume%3D21%26spage%3D648%26epage%3D657%26doi%3D10.1111%2Fjcmm.13008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: Final destination for cancer?</span>. <i>Cell Prolif.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>53</i></span>, <span class="NLM_elocation-id">e12761</span> <span class="refDoi"> DOI: 10.1111/cpr.12761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1111%2Fcpr.12761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=32100402" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2020&author=Z.+Yeauthor=W.+Liuauthor=Q.+Zhuoauthor=Q.+Huauthor=M.+Liuauthor=Q.+Sunauthor=Z.+Zhangauthor=G.+Fanauthor=W.+Xuauthor=S.+Jiauthor=X.+Yuauthor=Y.+Qinauthor=X.+Xu&title=Ferroptosis%3A+Final+destination+for+cancer%3F&doi=10.1111%2Fcpr.12761"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fcpr.12761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcpr.12761%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhuo%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DFerroptosis%253A%2520Final%2520destination%2520for%2520cancer%253F%26jtitle%3DCell%2520Prolif.%26date%3D2020%26volume%3D53%26doi%3D10.1111%2Fcpr.12761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, C.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.-H.</span></span> <span> </span><span class="NLM_article-title">Conformation restriction of nonplanar di-2-pyrimidyl sulfide with intramolecular N···C interaction and its supramolecular silver(I) complexes</span>. <i>Cryst. Growth Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1021/cg201184x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cg201184x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=376-386&author=C.-Q.+Wanauthor=Z.-J.+Wangauthor=G.+Wangauthor=H.+Liuauthor=Y.-H.+Dengauthor=Q.-H.+Jin&title=Conformation+restriction+of+nonplanar+di-2-pyrimidyl+sulfide+with+intramolecular+N%C2%B7%C2%B7%C2%B7C+interaction+and+its+supramolecular+silver%28I%29+complexes&doi=10.1021%2Fcg201184x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Conformation Restriction of Nonplanar Di-2-pyrimidyl Sulfide with Intramolecular N···C Interaction and Its Supramolecular Silver(I) Complexes</span></div><div class="casAuthors">Wan, Chong-Qing; Wang, Zi-Jia; Wang, Guo; Liu, Hao; Deng, Yu-Heng; Jin, Qiong-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Crystal Growth & Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">376-386</span>CODEN:
                <span class="NLM_cas:coden">CGDEFU</span>;
        ISSN:<span class="NLM_cas:issn">1528-7483</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Silver(I) complexes with semirigid di-2-pyrimidyl sulfide (DprS), namely, {[Ag2(DprS)2(CF3CO2)](CF3CO2)·2H2O}∞ (1), {[Ag6(DprS)6(CF3SO3)5](CF3SO3)·3.5H2O}∞ (2), {[Ag2(DprS)(C2F5CO2)2]}∞ (3), [Ag(DprS)(NO3)]∞ (4), and {[Ag3(DprS)3](ClO4)3}∞ (5), were synthesized and characterized by single-crystal x-ray anal.  The silver(I) complexes 1-2 and 4-5 exhibit 1-dimensional tape-like coordination polymers with different topol. structures, while complex 3 has a two-dimensional coordination network.  In these complexes, the two pyrimidyl rings of each DprS are almost in an orthogonal orientation, a rigid nonplanar conformation, and the multidentate ligand adopts an unvaried N,N',N''-μ3 ligation mode despite the different anions (CH3COO- in 1, CF3SO3- in 2, C2F5COO- in 3, NO3- in 4, and ClO4- in 5).  Attractive intramol. Npyrimidyl···Cpyrimidyl interaction between a 1-positional N atom of one pyrimidyl ring and an electrophilic 2-positional C atom of the other ring of DprS is a common dominant interaction, which drives and stabilizes the nonplanar ligand conformation in these cryst. structures.  Calcn. through the SCF crystal orbital method based on d. functional theory indicates the N···C contact, a nucleophile-electrophile affinity.  Unconventional anion-πpyrimidyl interactions engaged in the construction of the supramol. architectures of 1-5 also are presented and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNZvuoQbWM4rVg90H21EOLACvtfcHk0ljDHGV2lpTaeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtb%252FF&md5=dc4f1a40efe746b53b9a9546599adbad</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fcg201184x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcg201184x%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DC.-Q.%26aulast%3DWang%26aufirst%3DZ.-J.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DY.-H.%26aulast%3DJin%26aufirst%3DQ.-H.%26atitle%3DConformation%2520restriction%2520of%2520nonplanar%2520di-2-pyrimidyl%2520sulfide%2520with%2520intramolecular%2520N%25C2%25B7%25C2%25B7%25C2%25B7C%2520interaction%2520and%2520its%2520supramolecular%2520silver%2528I%2529%2520complexes%26jtitle%3DCryst.%2520Growth%2520Des.%26date%3D2012%26volume%3D12%26spage%3D376%26epage%3D386%26doi%3D10.1021%2Fcg201184x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodić, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leovac, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanović, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spasojević, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joksović, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanojković, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matić, I. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vojinović-Ješić, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marković, V.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, cytotoxicity and antiangiogenic activity of copper(II) complexes with 1-adamantoyl hydrazone bearing pyridine rings</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ejmech.2016.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27084495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFKksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=75-81&author=M.+V.+Rodi%C4%87author=V.+M.+Leovacauthor=L.+S.+Jovanovi%C4%87author=V.+Spasojevi%C4%87author=M.+D.+Joksovi%C4%87author=T.+Stanojkovi%C4%87author=I.+Z.+Mati%C4%87author=L.+S.+Vojinovi%C4%87-Je%C5%A1i%C4%87author=V.+Markovi%C4%87&title=Synthesis%2C+characterization%2C+cytotoxicity+and+antiangiogenic+activity+of+copper%28II%29+complexes+with+1-adamantoyl+hydrazone+bearing+pyridine+rings&doi=10.1016%2Fj.ejmech.2016.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization, cytotoxicity and antiangiogenic activity of copper(II) complexes with 1-adamantyl hydrazone bearing pyridine rings</span></div><div class="casAuthors">Rodic, Marko V.; Leovac, Vukadin M.; Jovanovic, Ljiljana S.; Spasojevic, Vojislav; Joksovic, Milan D.; Stanojkovic, Tatjana; Matic, Ivana Z.; Vojinovic-Jesic, Ljiljana S.; Markovic, Violeta</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-81</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Three novel copper complexes with tridentate N2O ligand di(2-pyridil) ketone 1-adamantyl hydrazone (Addpy) of the formula [CuII2CuI2(Addpy)2Br2(μ-Br4)] (1), catena-poly[CuCl(μ-Addpy)(μ-Cl)CuCl2]n (2) and [Cu(Addpy)(NCS)2] (3) were synthesized.  Complexes were characterized by x-ray crystallog., spectral (UV-visible, FTIR), electrochem. (CV) analyses, and magnetochem. measurements.  Study of anticancer potential of Cu(II) complexes, mode of cell death, apoptosis, and inhibition of angiogenesis were performed.  All tested malignant cell lines (HeLa, LS174, A549, K562, and MDA-MB-231) showed high sensitivity to the examd. Cu(II) complexes.  The complexes induce apoptosis in the caspase 3-dependent manner, whereas the anti-angiogenic effects of 1, 2, and 3 were confirmed in EA.hy926 cells using a tube formation assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozWG6KkCPR1bVg90H21EOLACvtfcHk0ljDHGV2lpTaeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFKksr4%253D&md5=df04444062dda07626701807210ae224</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DRodi%25C4%2587%26aufirst%3DM.%2BV.%26aulast%3DLeovac%26aufirst%3DV.%2BM.%26aulast%3DJovanovi%25C4%2587%26aufirst%3DL.%2BS.%26aulast%3DSpasojevi%25C4%2587%26aufirst%3DV.%26aulast%3DJoksovi%25C4%2587%26aufirst%3DM.%2BD.%26aulast%3DStanojkovi%25C4%2587%26aufirst%3DT.%26aulast%3DMati%25C4%2587%26aufirst%3DI.%2BZ.%26aulast%3DVojinovi%25C4%2587-Je%25C5%25A1i%25C4%2587%26aufirst%3DL.%2BS.%26aulast%3DMarkovi%25C4%2587%26aufirst%3DV.%26atitle%3DSynthesis%252C%2520characterization%252C%2520cytotoxicity%2520and%2520antiangiogenic%2520activity%2520of%2520copper%2528II%2529%2520complexes%2520with%25201-adamantoyl%2520hydrazone%2520bearing%2520pyridine%2520rings%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D75%26epage%3D81%26doi%3D10.1016%2Fj.ejmech.2016.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akbar
Ali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bujang, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamid, M. H. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, P. V.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and X-ray crystallographic structural study of copper(II) and nickel(II) complexes of the 2-quinoline carboxaldehyde Schiff base of S-methyldithiocarbazate (Hqaldsme)</span>. <i>Polyhedron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3245</span>– <span class="NLM_lpage">3252</span>, <span class="refDoi"> DOI: 10.1016/j.poly.2006.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.poly.2006.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WqtbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=3245-3252&author=M.+Akbar%0AAliauthor=A.+H.+Mirzaauthor=F.+H.+Bujangauthor=M.+H.+S.+A.+Hamidauthor=P.+V.+Bernhardt&title=Synthesis%2C+characterization+and+X-ray+crystallographic+structural+study+of+copper%28II%29+and+nickel%28II%29+complexes+of+the+2-quinoline+carboxaldehyde+Schiff+base+of+S-methyldithiocarbazate+%28Hqaldsme%29&doi=10.1016%2Fj.poly.2006.05.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization and X-ray crystallographic structural study of copper(II) and nickel(II) complexes of the 2-quinolinecarboxaldehyde Schiff base of S-methyldithiocarbazate (Hqaldsme)</span></div><div class="casAuthors">Akbar Ali, M.; Mirza, A. H.; Bujang, Fatriah Hj; Hamid, Malai Haniti S. A.; Bernhardt, Paul V.</div><div class="citationInfo"><span class="NLM_cas:title">Polyhedron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3245-3252</span>CODEN:
                <span class="NLM_cas:coden">PLYHDE</span>;
        ISSN:<span class="NLM_cas:issn">0277-5387</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">[Cu(qaldsme)(X)(MeOH)n] and [Ni(qaldsme)2]·0.5MeCN (qaldsme = anionic form of the 2-quinoline carboxaldehyde Schiff base of S-methyldithiocarbazate; X = NCS-, I-, NO3- ; n = 0 or 1) were synthesized and characterized by magnetic and spectroscopic techniques.  X-ray crystal structure detn. of [Cu(qaldsme)(ONO2)(MeOH)] (1), [Cu(qaldsme)(NCS)]2 (2) and [Ni(qaldsme)2]·0.5MeCN (4) shows that the nitrato-complex of Cu (1) is monomeric and five-coordinate and the thiocyanato-complex (2) has a novel thiolate S-bridged dimeric structure in which each of the Cu(II) ions adopts a five-coordinate, approx. square-pyramidal geometry, with a CuN3S2 coordination kernel.  The Ni(II) complex (4) has a distorted octahedral geometry with meridional dispositions of the two uninegatively charged tridentate NNS ligands.  In all these complexes, the Schiff bases are coordinated in their iminothiolate forms via the quinoline N atom, the azomethine N atom and the thiolate S atom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0wKPrUtSWtrVg90H21EOLACvtfcHk0lhJa6GZ0AcHtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WqtbjP&md5=70f9647278098667893725912c1e9958</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2006.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2006.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DAkbar%2BAli%26aufirst%3DM.%26aulast%3DMirza%26aufirst%3DA.%2BH.%26aulast%3DBujang%26aufirst%3DF.%2BH.%26aulast%3DHamid%26aufirst%3DM.%2BH.%2BS.%2BA.%26aulast%3DBernhardt%26aufirst%3DP.%2BV.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520X-ray%2520crystallographic%2520structural%2520study%2520of%2520copper%2528II%2529%2520and%2520nickel%2528II%2529%2520complexes%2520of%2520the%25202-quinoline%2520carboxaldehyde%2520Schiff%2520base%2520of%2520S-methyldithiocarbazate%2520%2528Hqaldsme%2529%26jtitle%3DPolyhedron%26date%3D2006%26volume%3D25%26spage%3D3245%26epage%3D3252%26doi%3D10.1016%2Fj.poly.2006.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akbar
Ali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karim, M. R.</span></span> <span> </span><span class="NLM_article-title">Self-assembling dicopper(II) complexes of di-2-pyridyl ketone Schiff base ligands derived from S-alkyldithiocarbazates</span>. <i>Polyhedron</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1486</span>, <span class="refDoi"> DOI: 10.1016/j.poly.2011.02.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.poly.2011.02.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslWltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=1478-1486&author=M.+Akbar%0AAliauthor=A.+H.+Mirzaauthor=R.+J.+Butcherauthor=P.+V.+Bernhardtauthor=M.+R.+Karim&title=Self-assembling+dicopper%28II%29+complexes+of+di-2-pyridyl+ketone+Schiff+base+ligands+derived+from+S-alkyldithiocarbazates&doi=10.1016%2Fj.poly.2011.02.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Self-assembling dicopper(II) complexes of di-2-pyridyl ketone Schiff base ligands derived from S-alkyldithiocarbazates</span></div><div class="casAuthors">Akbar Ali, Mohammad; Mirza, Aminul H.; Butcher, Ray J.; Bernhardt, Paul V.; Karim, Mohammad Rezaul</div><div class="citationInfo"><span class="NLM_cas:title">Polyhedron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1478-1486</span>CODEN:
                <span class="NLM_cas:coden">PLYHDE</span>;
        ISSN:<span class="NLM_cas:issn">0277-5387</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Condensation of di-2-pyridyl ketone with S-methyldithiocarbazate or S-benzyldithiocarbazate yields potentially bridging ligands of the form Py2C:NNHC(S)SR; Hdpksme (R = Me; the di-2-pyridyl ketone Schiff base of S-methyldithiocarbazate) and Hdpksbz (R = Bz; the di-2-pyridyl ketone Schiff base of S-benzyldithiocarbazate).  Complexation of these ligands with Cu(II) in a 1:1 M ratio gives dinuclear complexes of the general formula [Cu(NNNS)X]2 (X = Cl-, NO3-, H2O).  X-ray crystallog. structure detns. show that each ligand provides three donor atoms (NNS) in a meridional configuration to one metal, viz. one of the pyridine nitrogen atoms, the azomethine nitrogen atom and the thiolate sulfur, while the nitrogen atom of the second pyridyl group forms a bridge to another copper(II) ion within the dimer.  The coordination geometry around each copper(II) ion is approx. square pyramidal, the basal plane of which is composed of one of the pyridine nitrogen atoms, the azomethine nitrogen atom and a chloro, nitrato or aqua ligand.  The apical position of the square pyramid is always occupied by the pyridine nitrogen atom of the second ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdOeRNV7S1rVg90H21EOLACvtfcHk0lhJa6GZ0AcHtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslWltrg%253D&md5=0ffe31541f9f48104bc63178b754aba0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2011.02.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2011.02.048%26sid%3Dliteratum%253Aachs%26aulast%3DAkbar%2BAli%26aufirst%3DM.%26aulast%3DMirza%26aufirst%3DA.%2BH.%26aulast%3DButcher%26aufirst%3DR.%2BJ.%26aulast%3DBernhardt%26aufirst%3DP.%2BV.%26aulast%3DKarim%26aufirst%3DM.%2BR.%26atitle%3DSelf-assembling%2520dicopper%2528II%2529%2520complexes%2520of%2520di-2-pyridyl%2520ketone%2520Schiff%2520base%2520ligands%2520derived%2520from%2520S-alkyldithiocarbazates%26jtitle%3DPolyhedron%26date%3D2011%26volume%3D30%26spage%3D1478%26epage%3D1486%26doi%3D10.1016%2Fj.poly.2011.02.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-localizing N-heterocyclic thiosemicarbazone copper complexes with good cytotoxicity and high antimetastatic activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">654</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.01.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ejmech.2019.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=30641446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVartLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2019&pages=654-664&author=S.+Guauthor=P.+Yuauthor=J.+Huauthor=Y.+Liuauthor=Z.+Liauthor=Y.+Qianauthor=Y.+Wangauthor=Y.+Gouauthor=F.+Yang&title=Mitochondria-localizing+N-heterocyclic+thiosemicarbazone+copper+complexes+with+good+cytotoxicity+and+high+antimetastatic+activity&doi=10.1016%2Fj.ejmech.2019.01.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-localizing N-heterocyclic thiosemicarbazone copper complexes with good cytotoxicity and high antimetastatic activity</span></div><div class="casAuthors">Gu, Shan Shan; Yu, Ping; Hu, Jia Nan; Liu, Yani; Li, Zuo Wen; Qian, Yong; Wang, Ya; Gou, Yi; Yang, Feng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">654-664</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Although many N-heterocyclic thiosemicarbazone Cu complexes are proposed as potential anticancer agents, little is known about their intracellular localization in cells.  The authors synthesized two fluorescent N-heterocyclic thiosemicarbazone Cu complexes, ([CuII(L)(Br)] (1) and [CuII2CuI(L)2(Br)3] (2), where HL is (E)-N,N-dimethyl-2-(quinolin-8-ylmethylene)hydrazinecarbothioamide), to assess their intracellular distribution.  Fluorescence studies demonstrated that complex 1 showed an intense emission band at ∼510 nm (λex = 405 nm) similar to that of complex 2, albeit with about four times lower emission intensity.  Both Cu complexes showed significantly greater cytotoxicity toward several tumor cell-types with better IC50 (0.27-0.91 μM) than the HL ligand and cisplatin.  Scratching wound healing assay and invasion assay were performed, revealing that the Cu complexes have good antimetastatic activity.  Confocal fluorescence imaging allowed ascertaining that complex 2 was primarily localized to mitochondria.  Further studies revealed that the anticancer mechanisms of complex 2 might involve the mitochondrial-mediated apoptotic pathway, probably caused by the reducing mitochondrial membrane potential and induction of ROS (reactive O species) prodn.  Also, complex 2 exhibited promising cytostatic effects in a three-dimensional HeLa spheroid model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGaYvUymTwMbVg90H21EOLACvtfcHk0lhJa6GZ0AcHtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVartLY%253D&md5=5b3fb80e75c0e1d397fc94536ae7927a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGou%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26atitle%3DMitochondria-localizing%2520N-heterocyclic%2520thiosemicarbazone%2520copper%2520complexes%2520with%2520good%2520cytotoxicity%2520and%2520high%2520antimetastatic%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D164%26spage%3D654%26epage%3D664%26doi%3D10.1016%2Fj.ejmech.2019.01.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.-S.</span></span> <span> </span><span class="NLM_article-title">Anion-controlled assembly of silver(I)/aminobenzonitrile compounds: syntheses, crystal structures, and photoluminescence properties</span>. <i>Cryst. Growth Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">354</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.1021/cg201159z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cg201159z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKiu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=354-361&author=F.-J.+Liuauthor=D.+Sunauthor=H.-J.+Haoauthor=R.-B.+Huangauthor=L.-S.+Zheng&title=Anion-controlled+assembly+of+silver%28I%29%2Faminobenzonitrile+compounds%3A+syntheses%2C+crystal+structures%2C+and+photoluminescence+properties&doi=10.1021%2Fcg201159z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Anion-Controlled Assembly of Silver(I)/Aminobenzonitrile Compounds: Syntheses, Crystal Structures, and Photoluminescence Properties</span></div><div class="casAuthors">Liu, Fu-Jing; Sun, Di; Hao, Hong-Jun; Huang, Rong-Bin; Zheng, Lan-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Crystal Growth & Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">354-361</span>CODEN:
                <span class="NLM_cas:coden">CGDEFU</span>;
        ISSN:<span class="NLM_cas:issn">1528-7483</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Five coordination compds. (CCs) {[Ag(m-abn)2]·NO3}n (1), {[Ag2(m-abn)6]·(ClO4)2} (2), {[Ag(o-abn)2]·NO3}n (3), [Ag(o-abn)(NO2)]n (4), and {[Ag(o-abn)2]·PF6}n (5) (m-abn = 3-aminobenzonitrile, and o-abn = 2-aminobenzonitrile) were synthesized and structurally characterized by element anal., IR, powder x-ray diffraction, and X-ray single-crystal diffraction.  Structural anal. reveals that aminobenzonitrile acts as bidentate μ2-N,N' or monodentate μ1-N ligands in 1-5.  Complex 1 is a 1-dimensional chain comprised of C2-sym. [Ag(m-abn)]2 14-membered rings.  The uncoordinated NO3- anions interact with the 1-dimensional chain to form a resulting 2-dimensional supramol. sheet through N-O···N hydrogen bond.  Complex 2 is a discrete binuclear Ag(I) CC incorporating concurrent bidentate μ2-N,N' and monodentate μ1-N m-abn ligands.  The variation of anions from NO3- to ClO4- results in the dimensionalities of 1 and 2 decreasing from 1-dimensional to 0D.  When using o-abn, complexes 3-5 were obtained as 1-dimensional chain with C2-sym. [Ag(o-abn)]2 12-membered rings, 2-dimensional sheet with coordinated μ2-η1:η2 NO2- anions, and 1-dimensional chain with centrosym. [Ag(o-abn)]2 12-membered rings, resp.  Supramol. interactions such as hydrogen bonding and π···π stacking are also proven effective in shaping the dimensionalities of the solid state structures of 1-5.  The results demonstrate that the anions are driving forces for the selection of different structures.  Also, results about emissive behaviors and thermal stabilities of them are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnkOfmHpTzP7Vg90H21EOLACvtfcHk0ljiYMAG9B7B8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKiu7vO&md5=8dd6295095bc776fb52229699bab0d49</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fcg201159z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcg201159z%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.-J.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DHao%26aufirst%3DH.-J.%26aulast%3DHuang%26aufirst%3DR.-B.%26aulast%3DZheng%26aufirst%3DL.-S.%26atitle%3DAnion-controlled%2520assembly%2520of%2520silver%2528I%2529%252Faminobenzonitrile%2520compounds%253A%2520syntheses%252C%2520crystal%2520structures%252C%2520and%2520photoluminescence%2520properties%26jtitle%3DCryst.%2520Growth%2520Des.%26date%3D2012%26volume%3D12%26spage%3D354%26epage%3D361%26doi%3D10.1021%2Fcg201159z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pascu, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waghorn, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conry, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betts, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilworth, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokrovska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aigbirhio, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, J. E.</span></span> <span> </span><span class="NLM_article-title">Designing Zn(ii) and Cu(ii) derivatives as probes for in vitro fluorescence imaging</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_fpage">4988</span>– <span class="NLM_lpage">4997</span>, <span class="refDoi"> DOI: 10.1039/b705227h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2Fb705227h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=17992284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1eht7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=4988-4997&author=S.+I.+Pascuauthor=P.+A.+Waghornauthor=T.+D.+Conryauthor=H.+M.+Bettsauthor=J.+R.+Dilworthauthor=G.+C.+Churchillauthor=T.+Pokrovskaauthor=M.+Christliebauthor=F.+I.+Aigbirhioauthor=J.+E.+Warren&title=Designing+Zn%28ii%29+and+Cu%28ii%29+derivatives+as+probes+for+in+vitro+fluorescence+imaging&doi=10.1039%2Fb705227h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Designing Zn(II) and Cu(II) derivatives as probes for in vitro fluorescence imaging</span></div><div class="casAuthors">Pascu, Sofia I.; Waghorn, Philip A.; Conry, Timothy D.; Betts, Helen M.; Dilworth, Jonathan R.; Churchill, Grant C.; Pokrovska, Tzveta; Christlieb, Martin; Aigbirhio, Franklin I.; Warren, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">4988-4997</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">New M(II) bis(thiosemicarbazonato) complexes (M = Ni(II), Cu(II) and Zn(II)) featuring allyl groups at the exocyclic nitrogens were synthesized.  The complexes were characterized in soln. by spectroscopic methods and their solid state structures detd. by single crystal x-ray diffraction using synchrotron radiation.  The Zn(II) complex is intrinsically fluorescent and sol. in biocompatible media.  The uptake of this Zn(II) complex in HeLa, MCF-7 and IGROV cancer cells was monitored by fluorescence microscopies (epi- and confocal fluorescence imaging).  The radiolabelling to 64Cu(II) bis(thiosemicarbazonato) complex was performed cleanly by transmetalation from the corresponding Zn(II) species using 64Cu(OAc)2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4k1zjJvU0dbVg90H21EOLACvtfcHk0ljiYMAG9B7B8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1eht7rP&md5=abb4c7ca24085b5b390b50fc9c175656</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2Fb705227h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb705227h%26sid%3Dliteratum%253Aachs%26aulast%3DPascu%26aufirst%3DS.%2BI.%26aulast%3DWaghorn%26aufirst%3DP.%2BA.%26aulast%3DConry%26aufirst%3DT.%2BD.%26aulast%3DBetts%26aufirst%3DH.%2BM.%26aulast%3DDilworth%26aufirst%3DJ.%2BR.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26aulast%3DPokrovska%26aufirst%3DT.%26aulast%3DChristlieb%26aufirst%3DM.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26aulast%3DWarren%26aufirst%3DJ.%2BE.%26atitle%3DDesigning%2520Zn%2528ii%2529%2520and%2520Cu%2528ii%2529%2520derivatives%2520as%2520probes%2520for%2520in%2520vitro%2520fluorescence%2520imaging%26jtitle%3DDalton%2520Trans.%26date%3D2007%26spage%3D4988%26epage%3D4997%26doi%3D10.1039%2Fb705227h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bag, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharadwaj, P. K.</span></span> <span> </span><span class="NLM_article-title">Perturbation of the PET process in fluorophore-spacer-receptor systems through structural modification: transition metal induced fluorescence enhancement and selectivity</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4377</span>– <span class="NLM_lpage">4390</span>, <span class="refDoi"> DOI: 10.1021/jp047557b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp047557b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtl2msrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2005&pages=4377-4390&author=B.+Bagauthor=P.+K.+Bharadwaj&title=Perturbation+of+the+PET+process+in+fluorophore-spacer-receptor+systems+through+structural+modification%3A+transition+metal+induced+fluorescence+enhancement+and+selectivity&doi=10.1021%2Fjp047557b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Perturbation of the PET Process in Fluorophore-Spacer-Receptor Systems through Structural Modification: Transition Metal Induced Fluorescence Enhancement and Selectivity</span></div><div class="casAuthors">Bag, Bamaprasad; Bharadwaj, Parimal K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4377-4390</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-6106</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several fluorescent signaling systems are built in the format fluorophore-spacer-receptor with ethylenediamine or N,N-dimethylethylenediamine as the receptor, anthracene as the fluorophore, and a methylene group as the spacer.  The receptors are derivatized with different electron-withdrawing groups such as 4-nitrobenzene, 4-nitro-2-pyridine, and 2,4-dinitrobenzene, to perturb the photoinduced intramol. electron transfer (PET) process from the nitrogen lone-pair to the fluorophore.  The photophys. properties of these supramol. systems and their fluorescence responses toward a no. of quenching transition metal ions are reported.  It is shown that the PET is highly efficient in the absence of a metal ion.  With a metal ion input, the fluorescence can be recovered to a different extent depending on the nature of the metal and on the overall architecture of the system as well.  Despite the possibility of strong interaction between the fluorophore and the metal ion, significant fluorescence enhancement is obsd. with quenching of paramagnetic transition metal ions.  The complex stability data show that the stability consts. for the metal ions showing fluorescence enhancement are of the order of 104 M-1.  This study shows that structurally simple fluorescent signaling systems for quenching transition metal ions can be built by maximizing the PET.  It is also shown here that simple structural modification can make these systems highly specific for particular transition metal ions for potential applications in several contemporary areas of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1kMowZZZt_LVg90H21EOLACvtfcHk0ljiYMAG9B7B8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtl2msrw%253D&md5=3653e79705c5cd649c814967cd91398f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjp047557b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp047557b%26sid%3Dliteratum%253Aachs%26aulast%3DBag%26aufirst%3DB.%26aulast%3DBharadwaj%26aufirst%3DP.%2BK.%26atitle%3DPerturbation%2520of%2520the%2520PET%2520process%2520in%2520fluorophore-spacer-receptor%2520systems%2520through%2520structural%2520modification%253A%2520transition%2520metal%2520induced%2520fluorescence%2520enhancement%2520and%2520selectivity%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2005%26volume%3D109%26spage%3D4377%26epage%3D4390%26doi%3D10.1021%2Fjp047557b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stacy, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palanimuthu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowski, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">Zinc(II)-thiosemicarbazone complexes are localized to the lysosomal compartment where they transmetallate with copper ions to induce cytotoxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4965</span>– <span class="NLM_lpage">4984</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00238</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00238" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFGmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4965-4984&author=A.+E.+Stacyauthor=D.+Palanimuthuauthor=P.+V.+Bernhardtauthor=D.+S.+Kalinowskiauthor=P.+J.+Janssonauthor=D.+R.+Richardson&title=Zinc%28II%29-thiosemicarbazone+complexes+are+localized+to+the+lysosomal+compartment+where+they+transmetallate+with+copper+ions+to+induce+cytotoxicity&doi=10.1021%2Facs.jmedchem.6b00238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc(II)-Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity</span></div><div class="casAuthors">Stacy, Alexandra E.; Palanimuthu, Duraippandi; Bernhardt, Paul V.; Kalinowski, Danuta S.; Jansson, Patric J.; Richardson, Des R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4965-4984</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As the di-2-pyridylketone thiosemicarbazone (DpT) and 2-acetylpyridine thiosemicarbazone (ApT) series show potent antitumor activity in vitro and in vivo, we synthesized their fluorescent zinc(II) complexes to assess their intracellular distribution.  The Zn(II) complexes generally showed significantly greater cytotoxicity than the thiosemicarbazones alone in several tumor cell-types.  Notably, specific structure-activity relationships demonstrated the importance of the di-2-pyridyl pharmacophore in their activity.  Confocal fluorescence imaging and live cell microscopy showed that the Zn(II) complex of our lead compd., di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), which is scheduled to enter clin. trials, was localized to lysosomes.  Under lysosomal conditions, the Zn(II) complexes were shown to transmetallate with copper ions, leading to redox-active copper complexes that induced lysosomal membrane permeabilization (LMP) and cytotoxicity.  This is the first study to demonstrate direct lysosomal targeting of our novel Zn(II)-thiosemicarbazone complexes that mediate their activity via transmetalation with copper ions and LMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYGqXGFjD7AbVg90H21EOLACvtfcHk0liDsIWYjiNegQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFGmsrw%253D&md5=128885a199b67c69cfafa84c1c7be1f2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00238%26sid%3Dliteratum%253Aachs%26aulast%3DStacy%26aufirst%3DA.%2BE.%26aulast%3DPalanimuthu%26aufirst%3DD.%26aulast%3DBernhardt%26aufirst%3DP.%2BV.%26aulast%3DKalinowski%26aufirst%3DD.%2BS.%26aulast%3DJansson%26aufirst%3DP.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DZinc%2528II%2529-thiosemicarbazone%2520complexes%2520are%2520localized%2520to%2520the%2520lysosomal%2520compartment%2520where%2520they%2520transmetallate%2520with%2520copper%2520ions%2520to%2520induce%2520cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4965%26epage%3D4984%26doi%3D10.1021%2Facs.jmedchem.6b00238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langdon-Jones, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symonds, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coles, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, S. J. A.</span></span> <span> </span><span class="NLM_article-title">Fluorescent rhenium-naphthalimide conjugates as cellular imaging agents</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3788</span>– <span class="NLM_lpage">3797</span>, <span class="refDoi"> DOI: 10.1021/ic500142z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic500142z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlentb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=3788-3797&author=E.+E.+Langdon-Jonesauthor=N.+O.+Symondsauthor=S.+E.+Yatesauthor=A.+J.+Hayesauthor=D.+Lloydauthor=R.+Williamsauthor=S.+J.+Colesauthor=P.+N.+Hortonauthor=S.+J.+A.+Pope&title=Fluorescent+rhenium-naphthalimide+conjugates+as+cellular+imaging+agents&doi=10.1021%2Fic500142z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent Rhenium-Naphthalimide Conjugates as Cellular Imaging Agents</span></div><div class="casAuthors">Langdon-Jones, Emily E.; Symonds, Nadine O.; Yates, Sara E.; Hayes, Anthony J.; Lloyd, David; Williams, Rebecca; Coles, Simon J.; Horton, Peter N.; Pope, Simon J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3788-3797</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A range of biol. compatible, fluorescent rhenium-naphthalimide conjugates, based upon the rhenium fac-tricarbonyl core, has been synthesized.  The fluorescent ligands are based upon a N-functionalized, 4-amino-derived 1,8-naphthalimide core and incorporate a dipicolyl amine binding unit to chelate Re(I); the structural variations accord to the nature of the alkylated imide with Et ester glycine (L), 3-propanol (L), diethylene glycol (L), and benzyl alc. (L) variants.  The species are fluorescent in the visible region between 505 and 537 nm through a naphthalimide-localized intramol. charge transfer, with corresponding fluorescent lifetimes of up to 9.8 ns.  The ligands and complexes were studied for their potential as imaging agents for human osteoarthritic cells and protistan fish parasite Spironucleus vortens using confocal fluorescence microscopy.  The specific nature of the naphthalimide structure serves to control the uptake and intracellular localization of these imaging agents.  Significant differences were noted between the free ligands and complexes, with the Re(I) complex of L showing hydrogenosomal localization in S. vortens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpORtizlG29irVg90H21EOLACvtfcHk0liDsIWYjiNegQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlentb8%253D&md5=0ccdc9963dc02ccdc32996de3cc1f620</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fic500142z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic500142z%26sid%3Dliteratum%253Aachs%26aulast%3DLangdon-Jones%26aufirst%3DE.%2BE.%26aulast%3DSymonds%26aufirst%3DN.%2BO.%26aulast%3DYates%26aufirst%3DS.%2BE.%26aulast%3DHayes%26aufirst%3DA.%2BJ.%26aulast%3DLloyd%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DColes%26aufirst%3DS.%2BJ.%26aulast%3DHorton%26aufirst%3DP.%2BN.%26aulast%3DPope%26aufirst%3DS.%2BJ.%2BA.%26atitle%3DFluorescent%2520rhenium-naphthalimide%2520conjugates%2520as%2520cellular%2520imaging%2520agents%26jtitle%3DInorg.%2520Chem.%26date%3D2014%26volume%3D53%26spage%3D3788%26epage%3D3797%26doi%3D10.1021%2Fic500142z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Moreira, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorp-Greenwood, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coogan, M. P.</span></span> <span> </span><span class="NLM_article-title">Application of d<sup>6</sup> transition metal complexes in fluorescence cell imaging</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1039/b917757d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2FB917757D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=20024327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGms7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=186-202&author=V.+Fern%C3%A1ndez-Moreiraauthor=F.+L.+Thorp-Greenwoodauthor=M.+P.+Coogan&title=Application+of+d6+transition+metal+complexes+in+fluorescence+cell+imaging&doi=10.1039%2Fb917757d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Application of d6 transition metal complexes in fluorescence cell imaging</span></div><div class="casAuthors">Fernandez-Moreira, Vanesa; Thorp-Greenwood, Flora L.; Coogan, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-202</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Luminescent d6 transition metal complexes have often been proposed as useful fluorophores for cell imaging due to their attractive photophys. attributes, but until very recently their actual applications have been scarce, and largely limited to ruthenium complexes in DNA and oxygen sensing.  In the last few years, however, there has been an increasing no. of reports of the design and application in cellular studies of a diverse range of Ir, Re and Ru complexes tailor-made for imaging applications.  The design principles, uptake and cellular localization of this new class of imaging agents are presented in context in this feature article.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJGEdUIYFc9bVg90H21EOLACvtfcHk0lhpC1YqMt_atw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGms7nI&md5=f63d2d3cd382ea0baca2c16566f0df5e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2FB917757D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB917757D%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Moreira%26aufirst%3DV.%26aulast%3DThorp-Greenwood%26aufirst%3DF.%2BL.%26aulast%3DCoogan%26aufirst%3DM.%2BP.%26atitle%3DApplication%2520of%2520d6%2520transition%2520metal%2520complexes%2520in%2520fluorescence%2520cell%2520imaging%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D186%26epage%3D202%26doi%3D10.1039%2Fb917757d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharyya, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharyya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondaiah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, A. R.</span></span> <span> </span><span class="NLM_article-title">Curcumin “drug” stabilized in oxidovanadium(IV)-BODIPY conjugates for mitochondria-targeted photocytotoxicity</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">12457</span>– <span class="NLM_lpage">12468</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.7b01924</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b01924" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFykt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=12457-12468&author=U.+Bhattacharyyaauthor=B.+Kumarauthor=A.+Garaiauthor=A.+Bhattacharyyaauthor=A.+Kumarauthor=S.+Banerjeeauthor=P.+Kondaiahauthor=A.+R.+Chakravarty&title=Curcumin+%E2%80%9Cdrug%E2%80%9D+stabilized+in+oxidovanadium%28IV%29-BODIPY+conjugates+for+mitochondria-targeted+photocytotoxicity&doi=10.1021%2Facs.inorgchem.7b01924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity</span></div><div class="casAuthors">Bhattacharyya, Utso; Kumar, Brijesh; Garai, Aditya; Bhattacharyya, Arnab; Kumar, Arun; Banerjee, Samya; Kondaiah, Paturu; Chakravarty, Akhil R.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12457-12468</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ternary oxidovanadium(IV) complexes of curcumin (Hcur), dipicolylamine (dpa) base, and its derivs. having pendant noniodinated and di-iodinated boron-dipyrromethene (BODIPY) moiety (L1 and L2, resp.), namely, [VO(dpa)(cur)]ClO4 (1), [VO(L1)(cur)]ClO4 (2), and [VO(L2)(cur)]ClO4 (3) and their chloride salts (1a-3a) were prepd., characterized, and studied for anticancer activity.  The chloride salts were used for biol. studies due to their aq. soly.  Complex 1 was structurally characterized by single-crystal x-ray crystallog.  The complex has a VO2+ moiety bound to dpa ligand showing N,N,N-coordination in a facial mode, and curcumin is bound in its mono-anionic enolic form.  The V-O(cur) distances are 1.950(18) and 1.977(16) Å, while the V-N bond lengths are 2.090(2), 2.130(2), and 2.290(2) Å.  The bond trans to V=O is long due to trans effect.  The complexes are stable in a soln. phase over a long period of time of 48 h without showing any apparent degrdn. of the curcumin ligand.  The diiodo-BODIPY ligand (L2) or Hcur alone showed limited soln. stability in dark.  The emissive BODIPY (L1) contg. complex 2a showed preferential mitochondrial localization in MCF-7 cells in cellular imaging expts.  The cytotoxicity of the complexes was studied by MTT assay.  The BODIPY complex 3a showed excellent photodynamic therapy effect in visible light (400-700 nm) giving IC50 values of 2-6 μM in HeLa and MCF-7 cancer cells, while being less toxic in dark (∼100 μM).  The cell death was apoptotic in nature involving reactive oxygen species (ROS).  Mechanistic data from pUC19 DNA photocleavage studies revealed photogenerated ROS as primarily 1O2 from the BODIPY moiety and ·OH radicals from the curcumin ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsNFd8ChcFibVg90H21EOLACvtfcHk0lhpC1YqMt_atw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFykt7rL&md5=b1cf3f793081fbdd66c968abfc2dd7ed</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b01924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b01924%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharyya%26aufirst%3DU.%26aulast%3DKumar%26aufirst%3DB.%26aulast%3DGarai%26aufirst%3DA.%26aulast%3DBhattacharyya%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DKondaiah%26aufirst%3DP.%26aulast%3DChakravarty%26aufirst%3DA.%2BR.%26atitle%3DCurcumin%2520%25E2%2580%259Cdrug%25E2%2580%259D%2520stabilized%2520in%2520oxidovanadium%2528IV%2529-BODIPY%2520conjugates%2520for%2520mitochondria-targeted%2520photocytotoxicity%26jtitle%3DInorg.%2520Chem.%26date%3D2017%26volume%3D56%26spage%3D12457%26epage%3D12468%26doi%3D10.1021%2Facs.inorgchem.7b01924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aslam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nisar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurshid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasool, M. H.</span></span> <span> </span><span class="NLM_article-title">Proteomics: technologies and their applications</span>. <i>J. Chromatogr. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1093/chromsci/bmw167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1093%2Fchromsci%2Fbmw167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=28087761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFaktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2017&pages=182-196&author=B.+Aslamauthor=M.+Basitauthor=M.+A.+Nisarauthor=M.+Khurshidauthor=M.+H.+Rasool&title=Proteomics%3A+technologies+and+their+applications&doi=10.1093%2Fchromsci%2Fbmw167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomics: technologies and their applications</span></div><div class="casAuthors">Aslam, Bilal; Basit, Madiha; Nisar, Muhammad Atif; Khurshid, Mohsin; Rasool, Muhammad Hidayat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatographic Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-196</span>CODEN:
                <span class="NLM_cas:coden">JCHSBZ</span>;
        ISSN:<span class="NLM_cas:issn">1945-239X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Proteomics involves the applications of technologies for the identification and quantification of overall proteins present content of a cell, tissue or an organism.  It supplements the other "omics" technologies such as genomic and transcriptomics to expound the identity of proteins of an organism, and to cognize the structure and functions of a particular protein.  Proteomics-based technologies are utilized in various capacities for different research settings such as detection of various diagnostic markers, candidates for vaccine prodn., understanding pathogenicity mechanisms, alteration of expression patterns in response to different signals and interpretation of functional protein pathways in different diseases.  Proteomics is practically intricate because it includes the anal. and categorization of overall protein signatures of a genome.  Mass spectrometry with LC-MS-MS and MALDI-TOF/TOF being widely used equipment is the central among current proteomics.  However, utilization of proteomics facilities including the software for equipment, databases and the requirement of skilled personnel substantially increase the costs, therefore limit their wider use esp. in the developing world.  Furthermore, the proteome is highly dynamic because of complex regulatory systems that control the expression levels of proteins.  This review efforts to describe the various proteomics approaches, the recent developments and their application in research and anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL--Tuk4G697Vg90H21EOLACvtfcHk0lhpC1YqMt_atw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFaktbk%253D&md5=0d69fa2515dfd694c147631d1c10c346</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1093%2Fchromsci%2Fbmw167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fchromsci%252Fbmw167%26sid%3Dliteratum%253Aachs%26aulast%3DAslam%26aufirst%3DB.%26aulast%3DBasit%26aufirst%3DM.%26aulast%3DNisar%26aufirst%3DM.%2BA.%26aulast%3DKhurshid%26aufirst%3DM.%26aulast%3DRasool%26aufirst%3DM.%2BH.%26atitle%3DProteomics%253A%2520technologies%2520and%2520their%2520applications%26jtitle%3DJ.%2520Chromatogr.%2520Sci.%26date%3D2017%26volume%3D55%26spage%3D182%26epage%3D196%26doi%3D10.1093%2Fchromsci%2Fbmw167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanehisa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furumichi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishima, K.</span></span> <span> </span><span class="NLM_article-title">KEGG: new perspectives on genomes, pathways, diseases and drugs</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">D353</span>– <span class="NLM_lpage">d361</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw1092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1093%2Fnar%2Fgkw1092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27899662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D353-d361&author=M.+Kanehisaauthor=M.+Furumichiauthor=M.+Tanabeauthor=Y.+Satoauthor=K.+Morishima&title=KEGG%3A+new+perspectives+on+genomes%2C+pathways%2C+diseases+and+drugs&doi=10.1093%2Fnar%2Fgkw1092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">KEGG: new perspectives on genomes, pathways, diseases and drugs</span></div><div class="casAuthors">Kanehisa, Minoru; Furumichi, Miho; Tanabe, Mao; Sato, Yoko; Morishima, Kanae</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D353-D361</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">KEGG (http://www.kegg.jp/ or http://www.genome.jp/ kegg/) is an encyclopedia of genes and genomes.  Assigning functional meanings to genes and genomes both at the mol. and higher levels is the primary objective of the KEGG database project.  Mol. level functions are stored in the KO (KEGG Orthol.) database, where each KO is defined as a functional ortholog of genes and proteins.  Higher-level functions are represented by networks of mol. interactions, reactions and relations in the forms of KEGG pathway maps, BRITE hierarchies and KEGG modules.  In the past the KO database was developed for the purpose of defining nodes of mol. networks, but now the content has been expanded and the quality improved irresp. of whether or not the KOs appear in the three mol. network databases.  The newly introduced addendum category of the GENES database is a collection of individual proteins whose functions are exptl. characterized and from which an increasing no. of KOs are defined.  Furthermore, the DISEASE and DRUG databases have been improved by systematic anal. of drug labels for better integration of diseases and drugs with the KEGG mol. networks.  KEGG is moving towards becoming a comprehensive knowledge base for both functional interpretation and practical application of genomic information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofdadmOxosa7Vg90H21EOLACvtfcHk0lgWs4xhXXZ5oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWgsrw%253D&md5=39d8cf6367f4fb35eb23670a910535ec</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1092%26sid%3Dliteratum%253Aachs%26aulast%3DKanehisa%26aufirst%3DM.%26aulast%3DFurumichi%26aufirst%3DM.%26aulast%3DTanabe%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DMorishima%26aufirst%3DK.%26atitle%3DKEGG%253A%2520new%2520perspectives%2520on%2520genomes%252C%2520pathways%252C%2520diseases%2520and%2520drugs%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26spage%3DD353%26epage%3Dd361%26doi%3D10.1093%2Fnar%2Fgkw1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: process and function</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1038/cdd.2015.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1038%2Fcdd.2015.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=26794443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=369-379&author=Y.+Xieauthor=W.+Houauthor=X.+Songauthor=Y.+Yuauthor=J.+Huangauthor=X.+Sunauthor=R.+Kangauthor=D.+Tang&title=Ferroptosis%3A+process+and+function&doi=10.1038%2Fcdd.2015.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: process and function</span></div><div class="casAuthors">Xie, Y.; Hou, W.; Song, X.; Yu, Y.; Huang, J.; Sun, X.; Kang, R.; Tang, D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-379</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a recently recognized form of regulated cell death.  It is characterized morphol. by the presence of smaller than normal mitochondria with condensed mitochondrial membrane densities, redn. or vanishing of mitochondria crista, and outer mitochondrial membrane rupture.  It can be induced by exptl. compds. (e.g., erastin, Ras-selective lethal small mol. 3, and buthionine sulfoximine) or clin. drugs (e.g., sulfasalazine, sorafenib, and artesunate) in cancer cells and certain normal cells (e.g., kidney tubule cells, neurons, fibroblasts, and T cells).  Activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate antiporter is involved in the induction of ferroptosis.  This process is characterized by the accumulation of lipid peroxidn. products and lethal reactive oxygen species (ROS) derived from iron metab. and can be pharmacol. inhibited by iron chelators (e.g., deferoxamine and desferrioxamine mesylate) and lipid peroxidn. inhibitors (e.g., ferrostatin, liproxstatin, and zileuton).  Glutathione peroxidase 4, heat shock protein beta-1, and nuclear factor erythroid 2-related factor 2 function as neg. regulators of ferroptosis by limiting ROS prodn. and reducing cellular iron uptake, resp.  In contrast, NADPH oxidase and p53 (esp. acetylation-defective mutant p53) act as pos. regulators of ferroptosis by promotion of ROS prodn. and inhibition of expression of SLC7A11 (a specific light-chain subunit of the cystine/glutamate antiporter), resp.  Misregulated ferroptosis has been implicated in multiple physiol. and pathol. processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity.  In this review, we summarize the regulation mechanisms and signaling pathways of ferroptosis and discuss the role of ferroptosis in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPYoAemdpXQrVg90H21EOLACvtfcHk0lgWs4xhXXZ5oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D&md5=1d0b55e47c4ed56444149c7ba35efb58</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2015.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2015.158%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DD.%26atitle%3DFerroptosis%253A%2520process%2520and%2520function%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D369%26epage%3D379%26doi%3D10.1038%2Fcdd.2015.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proneth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurina, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panzilius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingold, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irmler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aichler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokisch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trümbach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Füllekrug, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurst, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeli, J. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span> <span> </span><span class="NLM_article-title">ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1038%2Fnchembio.2239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27842070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGgtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=91-98&author=S.+Dollauthor=B.+Pronethauthor=Y.+Y.+Tyurinaauthor=E.+Panziliusauthor=S.+Kobayashiauthor=I.+Ingoldauthor=M.+Irmlerauthor=J.+Beckersauthor=M.+Aichlerauthor=A.+Walchauthor=H.+Prokischauthor=D.+Tr%C3%BCmbachauthor=G.+Maoauthor=F.+Quauthor=H.+Bayirauthor=J.+F%C3%BCllekrugauthor=C.+H.+Scheelauthor=W.+Wurstauthor=J.+A.+Schickauthor=V.+E.+Kaganauthor=J.+P.+F.+Angeliauthor=M.+Conrad&title=ACSL4+dictates+ferroptosis+sensitivity+by+shaping+cellular+lipid+composition&doi=10.1038%2Fnchembio.2239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition</span></div><div class="casAuthors">Doll, Sebastian; Proneth, Bettina; Tyurina, Yulia Y.; Panzilius, Elena; Kobayashi, Sho; Ingold, Irina; Irmler, Martin; Beckers, Johannes; Aichler, Michaela; Walch, Axel; Prokisch, Holger; Truembach, Dietrich; Mao, Gaowei; Qu, Feng; Bayir, Hulya; Fuellekrug, Joachim; Scheel, Christina H.; Wurst, Wolfgang; Schick, Joel A.; Kagan, Valerian E.; Angeli, Jose Pedro Friedmann; Conrad, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a form of regulated necrotic cell death controlled by glutathione peroxidase 4 (GPX4).  At present, mechanisms that could predict sensitivity and/or resistance and that may be exploited to modulate ferroptosis are needed.  We applied two independent approaches - a genome-wide CRISPR-based genetic screen and microarray anal. of ferroptosis-resistant cell lines - to uncover acyl-CoA synthetase long-chain family member 4 (ACSL4) as an essential component for ferroptosis execution.  Specifically, Gpx4-Acsl4 double-knockout cells showed marked resistance to ferroptosis.  Mechanistically, ACSL4 enriched cellular membranes with long polyunsatd. ω6 fatty acids.  Moreover, ACSL4 was preferentially expressed in a panel of basal-like breast cancer cell lines and predicted their sensitivity to ferroptosis.  Pharmacol. targeting of ACSL4 with thiazolidinediones, a class of antidiabetic compd., ameliorated tissue demise in a mouse model of ferroptosis, suggesting that ACSL4 inhibition is a viable therapeutic approach to preventing ferroptosis-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF9sohkXFtabVg90H21EOLACvtfcHk0lgspQZ_46X6zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGgtLrL&md5=5f416d16d2361711e8206c4a3b8b86eb</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2239%26sid%3Dliteratum%253Aachs%26aulast%3DDoll%26aufirst%3DS.%26aulast%3DProneth%26aufirst%3DB.%26aulast%3DTyurina%26aufirst%3DY.%2BY.%26aulast%3DPanzilius%26aufirst%3DE.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DIngold%26aufirst%3DI.%26aulast%3DIrmler%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DJ.%26aulast%3DAichler%26aufirst%3DM.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DProkisch%26aufirst%3DH.%26aulast%3DTr%25C3%25BCmbach%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DQu%26aufirst%3DF.%26aulast%3DBayir%26aufirst%3DH.%26aulast%3DF%25C3%25BCllekrug%26aufirst%3DJ.%26aulast%3DScheel%26aufirst%3DC.%2BH.%26aulast%3DWurst%26aufirst%3DW.%26aulast%3DSchick%26aufirst%3DJ.%2BA.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DAngeli%26aufirst%3DJ.%2BP.%2BF.%26aulast%3DConrad%26aufirst%3DM.%26atitle%3DACSL4%2520dictates%2520ferroptosis%2520sensitivity%2520by%2520shaping%2520cellular%2520lipid%2520composition%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26spage%3D91%26epage%3D98%26doi%3D10.1038%2Fnchembio.2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassannia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiernicki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingold, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Herck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurina, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayır, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abhari, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeli, J. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyninck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declerck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirumamilla, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahtela-Kakkonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Camp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krysko, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekert, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Geest, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span> <span> </span><span class="NLM_article-title">Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">3341</span>– <span class="NLM_lpage">3355</span>, <span class="refDoi"> DOI: 10.1172/jci99032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1172%2FJCI99032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=29939160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FhsVOhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=3341-3355&author=B.+Hassanniaauthor=B.+Wiernickiauthor=I.+Ingoldauthor=F.+Quauthor=S.+Van+Herckauthor=Y.+Y.+Tyurinaauthor=H.+Bay%C4%B1rauthor=B.+A.+Abhariauthor=J.+P.+F.+Angeliauthor=S.+M.+Choiauthor=E.+Meulauthor=K.+Heyninckauthor=K.+Declerckauthor=C.+S.+Chirumamillaauthor=M.+Lahtela-Kakkonenauthor=G.+Van+Campauthor=D.+V.+Kryskoauthor=P.+G.+Ekertauthor=S.+Fuldaauthor=B.+G.+De+Geestauthor=M.+Conradauthor=V.+E.+Kaganauthor=W.+Vanden+Bergheauthor=P.+Vandenabeeleauthor=T.+Vanden+Berghe&title=Nano-targeted+induction+of+dual+ferroptotic+mechanisms+eradicates+high-risk+neuroblastoma&doi=10.1172%2Fjci99032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma</span></div><div class="casAuthors">Hassannia Behrouz; Wiernicki Bartosz; Choi Sze Men; Meul Eline; Krysko Dmitri V; Vandenabeele Peter; Vanden Berghe Tom; Hassannia Behrouz; Wiernicki Bartosz; Choi Sze Men; Meul Eline; Krysko Dmitri V; Vandenabeele Peter; Vanden Berghe Tom; Ingold Irina; Conrad Marcus; Qu Feng; Tyurina Yulia Y; Bayir Hulya; Kagan Valerian E; Van Herck Simon; De Geest Bruno G; Abhari Behnaz A; Fulda Simone; Angeli Jose Pedro Friedmann; Heyninck Karen; Vanden Berghe Wim; Declerck Ken; Chirumamilla Chandra Sekhar; Vanden Berghe Wim; Lahtela-Kakkonen Maija; Van Camp Guy; Ekert Paul G; Fulda Simone; Vandenabeele Peter</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3341-3355</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High-risk neuroblastoma is a devastating malignancy with very limited therapeutic options.  Here, we identify withaferin A (WA) as a natural ferroptosis-inducing agent in neuroblastoma, which acts through a novel double-edged mechanism.  WA dose-dependently either activates the nuclear factor-like 2 pathway through targeting of Kelch-like ECH-associated protein 1 (noncanonical ferroptosis induction) or inactivates glutathione peroxidase 4 (canonical ferroptosis induction).  Noncanonical ferroptosis induction is characterized by an increase in intracellular labile Fe(II) upon excessive activation of heme oxygenase-1, which is sufficient to induce ferroptosis.  This double-edged mechanism might explain the superior efficacy of WA as compared with etoposide or cisplatin in killing a heterogeneous panel of high-risk neuroblastoma cells, and in suppressing the growth and relapse rate of neuroblastoma xenografts.  Nano-targeting of WA allows systemic application and suppressed tumor growth due to an enhanced accumulation at the tumor site.  Collectively, our data propose a novel therapeutic strategy to efficiently kill cancer cells by ferroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsc0g5SKGdDBpyrDyM_m9cfW6udTcc2eZMKmI2RioM4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FhsVOhsg%253D%253D&md5=b7cf06ff11c2324dd9ce83d81b146d71</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1172%2FJCI99032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI99032%26sid%3Dliteratum%253Aachs%26aulast%3DHassannia%26aufirst%3DB.%26aulast%3DWiernicki%26aufirst%3DB.%26aulast%3DIngold%26aufirst%3DI.%26aulast%3DQu%26aufirst%3DF.%26aulast%3DVan%2BHerck%26aufirst%3DS.%26aulast%3DTyurina%26aufirst%3DY.%2BY.%26aulast%3DBay%25C4%25B1r%26aufirst%3DH.%26aulast%3DAbhari%26aufirst%3DB.%2BA.%26aulast%3DAngeli%26aufirst%3DJ.%2BP.%2BF.%26aulast%3DChoi%26aufirst%3DS.%2BM.%26aulast%3DMeul%26aufirst%3DE.%26aulast%3DHeyninck%26aufirst%3DK.%26aulast%3DDeclerck%26aufirst%3DK.%26aulast%3DChirumamilla%26aufirst%3DC.%2BS.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26aulast%3DVan%2BCamp%26aufirst%3DG.%26aulast%3DKrysko%26aufirst%3DD.%2BV.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DDe%2BGeest%26aufirst%3DB.%2BG.%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DVanden%2BBerghe%26aufirst%3DW.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26atitle%3DNano-targeted%2520induction%2520of%2520dual%2520ferroptotic%2520mechanisms%2520eradicates%2520high-risk%2520neuroblastoma%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26spage%3D3341%26epage%3D3355%26doi%3D10.1172%2Fjci99032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G.</span></span> <span> </span><span class="NLM_article-title">Mitochondria regulation in ferroptosis</span>. <i>Eur. J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">151058</span>, <span class="refDoi"> DOI: 10.1016/j.ejcb.2019.151058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ejcb.2019.151058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=31810634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlSqtb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2020&pages=151058&author=H.+Wangauthor=C.+Liuauthor=Y.+Zhaoauthor=G.+Gao&title=Mitochondria+regulation+in+ferroptosis&doi=10.1016%2Fj.ejcb.2019.151058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria regulation in ferroptosis</span></div><div class="casAuthors">Wang, Hai; Liu, Can; Zhao, Yongxin; Gao, Ge</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151058</span>CODEN:
                <span class="NLM_cas:coden">EJCBDN</span>;
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Ferroptosis is recognized as a new form of regulated cell death which is initiated by severe lipid peroxidn. relying on reactive oxygen species (ROS) generation and iron overload.  This iron-dependent cell death manifests evident morphol., biochem. and genetic differences from other forms of regulated cell death, such as apoptosis, autophagy, necrosis and pyroptosis.  Ferroptosis was primarily characterized by condensed mitochondrial membrane densities and smaller vol. than normal mitochondria, as well as the diminished or vanished of mitochondria crista and outer membrane ruptured.  Mitochondria take the center role in iron metab., as well as substance and energy metab. as it's the major organelle in iron utilization, catabolic and anabolic pathways.  Interference of key regulators of mitochondrial lipid metab. (e.g., ASCF2 and CS), iron homeostasis (e.g., ferritin, mitoferrin1/2 and NEET proteins), glutamine metab. and other signaling pathways make a difference to ferroptotic sensitivity.  Targeted induction of ferroptosis was also considered as a potential therapeutic strategy to some oxidative stress diseases, including neurodegenerative disorders, ischemia-reperfusion injury, traumatic spinal cord injury.  However, the pertinence between mitochondria and ferroptosis is still in dispute.  Here we systematic elucidate the morphol. characteristics and metabolic regulation of mitochondria in the regulation of ferroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonXH7F5LOWgrVg90H21EOLACvtfcHk0ljZ9xbz7EpOog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlSqtb3M&md5=e0f953511f44555bc0634fc6fe7b6521</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejcb.2019.151058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejcb.2019.151058%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DG.%26atitle%3DMitochondria%2520regulation%2520in%2520ferroptosis%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D2020%26volume%3D99%26spage%3D151058%26doi%3D10.1016%2Fj.ejcb.2019.151058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of ferroptosis</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">2195</span>– <span class="NLM_lpage">2209</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2194-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1007%2Fs00018-016-2194-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27048822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsValurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=2195-2209&author=J.+Y.+Caoauthor=S.+J.+Dixon&title=Mechanisms+of+ferroptosis&doi=10.1007%2Fs00018-016-2194-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of ferroptosis</span></div><div class="casAuthors">Cao, Jennifer Yinuo; Dixon, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">2195-2209</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Ferroptosis is a non-apoptotic form of cell death that can be triggered by small mols. or conditions that inhibit glutathione biosynthesis or the glutathione-dependent antioxidant enzyme glutathione peroxidase 4 (GPX4).  This lethal process is defined by the iron-dependent accumulation of lipid reactive oxygen species and depletion of plasma membrane polyunsatd. fatty acids.  Cancer cells with high level RAS-RAF-MEK pathway activity or p53 expression may be sensitized to this process.  Conversely, a no. of small mol. inhibitors of ferroptosis have been identified, including ferrostatin-1 and liproxstatin-1, which can block pathol. cell death events in brain, kidney and other tissues.  Recent work has identified a no. of genes required for ferroptosis, including those involved in lipid and amino acid metab.  Outstanding questions include the relationship between ferroptosis and other forms of cell death, and whether activation or inhibition of ferroptosis can be exploited to achieve desirable therapeutic ends.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroCXfv3RUEq7Vg90H21EOLACvtfcHk0ljZ9xbz7EpOog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsValurw%253D&md5=350d3b1fcb3a5701db5be6eb556aad11</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2194-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2194-1%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%2BY.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26atitle%3DMechanisms%2520of%2520ferroptosis%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D2195%26epage%3D2209%26doi%3D10.1007%2Fs00018-016-2194-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacid, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the MAPK pathway in KRAS-driven tumors</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2020.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ccell.2020.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=32289276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlSis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2020&pages=543-550&author=M.+Drostenauthor=M.+Barbacid&title=Targeting+the+MAPK+pathway+in+KRAS-driven+tumors&doi=10.1016%2Fj.ccell.2020.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the MAPK Pathway in KRAS-Driven Tumors</span></div><div class="casAuthors">Drosten, Matthias; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-550</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  KRAS mutations occur in a quarter of all of human cancers, yet no selective drug has been approved to treat these tumors.  Despite the recent development of drugs that block KRASG12C, the majority of KRAS oncoproteins remain undruggable.  Here, we review recent efforts to validate individual components of the mitogen-activated protein kinase (MAPK) pathway as targets to treat KRAS-mutant cancers by comparing genetic information derived from exptl. mouse models of KRAS-driven lung and pancreatic tumors with the outcome of selective MAPK inhibitors in clin. trials.  We also review the potential of RAF1 as a key target to block KRAS-mutant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0-lpaiyoK8rVg90H21EOLACvtfcHk0liesNJodD4FBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlSis70%253D&md5=e87ef5abce0f714559b55777aaa3bd77</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2020.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2020.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DDrosten%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520MAPK%2520pathway%2520in%2520KRAS-driven%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2020%26volume%3D37%26spage%3D543%26epage%3D550%26doi%3D10.1016%2Fj.ccell.2020.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, X.</span></span> <span> </span><span class="NLM_article-title">The MAPK pathway-based drug therapeutic targets in pituitary adenomas</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">330</span>, <span class="refDoi"> DOI: 10.3389/fendo.2019.00330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.3389%2Ffendo.2019.00330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=31231308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BB3M3pvFGiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=330&author=M.+Luauthor=Y.+Wangauthor=X.+Zhan&title=The+MAPK+pathway-based+drug+therapeutic+targets+in+pituitary+adenomas&doi=10.3389%2Ffendo.2019.00330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas</span></div><div class="casAuthors">Lu Miaolong; Wang Ya; Zhan Xianquan; Lu Miaolong; Wang Ya; Zhan Xianquan; Lu Miaolong; Wang Ya; Zhan Xianquan; Zhan Xianquan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">330</span>
        ISSN:<span class="NLM_cas:issn">1664-2392</span>.
    </div><div class="casAbstract">Mitogen-activated protein kinases (MAPKs) include ERK, p38, and JNK MAPK subfamilies, which are crucial regulators of cellular physiology, cell pathology, and many diseases including cancers.  For the MAPK signaling system in pituitary adenomas (PAs), the activation of ERK signaling is generally thought to promote cell proliferation and growth; whereas the activations of p38 and JNK signaling are generally thought to promote cell apoptosis.  The role of MAPK in treatment of PAs is demonstrated through the effects of currently used medications such as somatostatin analogs such as SOM230 and OCT, dopamine agonists such as cabergoline and bromocriptine, and retinoic acid which inhibit the MAPK pathway.  Further, there are potential novel therapies based on putative molecular targets of the MAPK pathway, including 18beta-glycyrrhetinic acid (GA), dopamine-somatostatin chimeric compound (BIM-23A760), ursolic acid (UA), fulvestrant, Raf kinase inhibitory protein (RKIP), epidermal growth factor pathway substrate number 8 (Eps8), transmembrane protein with EGF-like and two follistatin-like domains (TMEFF2), cold inducible RNA-binding protein (CIRP), miR-16, and mammaliansterile-20-like kinase (MST4).  The combined use of ERK inhibitor (e.g., SOM230, OCT, or dopamine) plus p38 activator (e.g., cabergoline, bromocriptine, and fulvestrant) and/or JNK activator (e.g., UA), or the development of single drug (e.g., BIM-23A760) to target both ERK and p38 or JNK pathways, might produce better anti-tumor effects on PAs.  This article reviews the advances in understanding the role of MAPK signaling in pituitary tumorigenesis, and the MAPK pathway-based potential therapeutic drugs for PAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJnOfna8HA0jjk2McQZ6XmfW6udTcc2eY1cvkPyhu4A7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3pvFGiug%253D%253D&md5=e7cbcd022982ddd659a967026c3033f9</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2019.00330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2019.00330%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DX.%26atitle%3DThe%2520MAPK%2520pathway-based%2520drug%2520therapeutic%2520targets%2520in%2520pituitary%2520adenomas%26jtitle%3DFront.%2520Endocrinol.%26date%3D2019%26volume%3D10%26spage%3D330%26doi%3D10.3389%2Ffendo.2019.00330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span> <span> </span><span class="NLM_article-title">Structure-guided discovery of a luminescent theranostic toolkit for living cancer cells and the imaging behavior effect</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">11404</span>– <span class="NLM_lpage">11412</span>, <span class="refDoi"> DOI: 10.1039/d0sc04576d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2FD0SC04576D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFajt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=11404-11412&author=C.+Wuauthor=K.-J.+Wuauthor=J.-B.+Liuauthor=W.+Wangauthor=C.-H.+Leungauthor=D.-L.+Ma&title=Structure-guided+discovery+of+a+luminescent+theranostic+toolkit+for+living+cancer+cells+and+the+imaging+behavior+effect&doi=10.1039%2Fd0sc04576d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided discovery of a luminescent theranostic toolkit for living cancer cells and the imaging behavior effect</span></div><div class="casAuthors">Wu, Chun; Wu, Ke-Jia; Liu, Jin-Biao; Wang, Wanhe; Leung, Chung-Hang; Ma, Dik-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">11404-11412</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Dual-functional theranostics are powerful tools that can allow for the in-field understanding of cancer pathol., yet their use is held back by the paucity of suitable theranostics for living systems.  Moreover, typical in vitro screening conditions for probe mols. do not necessarily generate candidates that can function effectively in the natural in cellulo environment, limiting their follow-up use in living systems.  We introduce herein a general strategy for the development of an iridium(III) theranostic by grafting a well-known inhibitor as a "binding unit" onto an iridium(III) complex precursor as a "signaling unit".  To further optimize their emissive properties, we explored the effect of imaging behavior by incorporating different substituents onto the parental "signaling unit".  This design concept was validated by a series of tailored iridium(III) theranostics 2a-2h for the visualization and inhibition of EGFR in living cancer cells.  By comprehensively assessing the theranostic potency of 2a-2h in both in vitro and in cellulo contexts, probe 2f contg. electron-donating methoxy groups on the "signaling unit" was discovered to be the most promising candidate theranostic with desirable photophys./chem. properties.  Probe 2f selectively bound to EGFR in vitro and in cellulo, enabling it to selectively discriminate living EGFR-overexpressing cancer cells from normal cells that express low levels of EGFR with an "always-on" luminescence signal output.  In particular, its long-lived lifetime enabled its luminescence signal to be readily distinguished from the interfering fluorescence of org. dyes by using time-resolved techniques.  Complex 2f simultaneously visualized and inhibited EGFR in a dose-dependent manner, leading to a redn. in the phosphorylation of downstream proteins ERK and MEK, and inhibition of the activity of downstream transcription factor AP1.  Notably, complex 2f is comparable to the parental EGFR inhibitor 1b, in terms of both inhibitory activity against EGFR and cytotoxicity against EGFR-overexpressing cancer cells.  This tailored dual-functional iridium(III) theranostic toolkit provides an alternative strategy for the personalized diagnosis and treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriLwAOvFZx8rVg90H21EOLACvtfcHk0liesNJodD4FBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFajt7%252FK&md5=9aa4e59d479452d662043f2f283954ee</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1039%2FD0SC04576D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0SC04576D%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DK.-J.%26aulast%3DLiu%26aufirst%3DJ.-B.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLeung%26aufirst%3DC.-H.%26aulast%3DMa%26aufirst%3DD.-L.%26atitle%3DStructure-guided%2520discovery%2520of%2520a%2520luminescent%2520theranostic%2520toolkit%2520for%2520living%2520cancer%2520cells%2520and%2520the%2520imaging%2520behavior%2520effect%26jtitle%3DChem.%2520Sci.%26date%3D2020%26volume%3D11%26spage%3D11404%26epage%3D11412%26doi%3D10.1039%2Fd0sc04576d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cargnello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, P. P.</span></span> <span> </span><span class="NLM_article-title">Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1128/mmbr.00031-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1128%2FMMBR.00031-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21372320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVequ78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2011&pages=50-83&author=M.+Cargnelloauthor=P.+P.+Roux&title=Activation+and+function+of+the+MAPKs+and+their+substrates%2C+the+MAPK-activated+protein+kinases&doi=10.1128%2Fmmbr.00031-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases</span></div><div class="casAuthors">Cargnello, Marie; Roux, Philippe P.</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-83</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review. The mitogen-activated protein (MAP) kinases (MAPKs) regulate diverse cellular programs by relaying extracellular signals to intracellular responses.  In mammals, there are more than a dozen MAPKs that coordinately regulate cell proliferation, differentiation, motility, and survival.  The best known are the conventional MAPKs, which include the extracellular signal-regulated kinases 1 and 2 (ERK1/2), c-Jun N-terminal kinases 1-3 (JNK1 to JNK3), p38 (α, β, γ, and δ), and ERK5 families.  There are addnl., atypical MAPKs, including ERK3/4, ERK7/8, and Nemo-like kinase (NLK), which have distinct regulation and functions.  Together, the MAPKs regulate a large no. of substrates, including members of a family of protein Ser/Thr kinases termed MAPK-activated protein kinases (MAPKAPKs).  The MAPKAPKs are related enzymes that respond to extracellular stimulation through direct MAPK-dependent activation loop phosphorylation and kinase activation.  There are five MAPKAPK subfamilies: p90 ribosomal S6 kinase (RSK), mitogen- and stress-activated kinase (MSK), MAPK-interacting kinase (MNK), MAPK-activated protein kinase 2/3 (MK2/3), and MK5 (also known as p38-regulated/activated protein kinase).  These enzymes have diverse biol. functions, including regulation of nucleosome and gene expression, mRNA stability and translation, and cell proliferation and survival.  Here,the authors review the mechanisms of MAPKAPK activation by the different MAPKs and discuss their physiol. roles based on established substrates and recent discoveries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWcx7oIOM6lLVg90H21EOLACvtfcHk0liesNJodD4FBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVequ78%253D&md5=e074f5af1f56957f0f10b2ecd837e69c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00031-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00031-10%26sid%3Dliteratum%253Aachs%26aulast%3DCargnello%26aufirst%3DM.%26aulast%3DRoux%26aufirst%3DP.%2BP.%26atitle%3DActivation%2520and%2520function%2520of%2520the%2520MAPKs%2520and%2520their%2520substrates%252C%2520the%2520MAPK-activated%2520protein%2520kinases%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2011%26volume%3D75%26spage%3D50%26epage%3D83%26doi%3D10.1128%2Fmmbr.00031-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Mammalian MAP kinase signalling cascades</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>410</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1038/35065000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1038%2F35065000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=11242034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvVSgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2001&pages=37-40&author=L.+Changauthor=M.+Karin&title=Mammalian+MAP+kinase+signalling+cascades&doi=10.1038%2F35065000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian MAP kinase signalling cascades</span></div><div class="casAuthors">Chang, Lufen; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue">6824</span>),
    <span class="NLM_cas:pages">37-40</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 52 refs.  Mitogen-activated protein kinases (MAPKs) are important signal transducing enzymes, unique to eukaryotes, that are involved in many facets of cellular regulation.  Initial research concd. on defining the components and organization of MAPK signaling cascades, but recent studies have begun to shed light on the physiol. functions of these cascades in the control of gene expression, cell proliferation, and programmed cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHwmx2Bk-5dbVg90H21EOLACvtfcHk0ljmDwACYB5CXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvVSgs7k%253D&md5=486ff61090fc371dff36b307b4e75c88</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2F35065000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35065000%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DMammalian%2520MAP%2520kinase%2520signalling%2520cascades%26jtitle%3DNature%26date%3D2001%26volume%3D410%26spage%3D37%26epage%3D40%26doi%3D10.1038%2F35065000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.-F.</span></span> <span> </span><span class="NLM_article-title">Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis</span>. <i>J. Recept. Signal Transduction Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">600</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.3109/10799893.2015.1030412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.3109%2F10799893.2015.1030412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=26096166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BC2MblsFCgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=600-604&author=Y.+Sunauthor=W.-Z.+Liuauthor=T.+Liuauthor=X.+Fengauthor=N.+Yangauthor=H.-F.+Zhou&title=Signaling+pathway+of+MAPK%2FERK+in+cell+proliferation%2C+differentiation%2C+migration%2C+senescence+and+apoptosis&doi=10.3109%2F10799893.2015.1030412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis</span></div><div class="casAuthors">Sun Yu; Liu Wen-Zhou; Liu Tao; Feng Xu; Yang Nuo; Zhou Hua-Fu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of receptor and signal transduction research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">600-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The generic mitogen-activated protein kinases (MAPK) signaling pathway is shared by four distinct cascades, including the extracellular signal-related kinases (ERK1/2), Jun amino-terminal kinases (JNK1/2/3), p38-MAPK and ERK5.  Mitogen-activated protein kinases/extracellular signal-regulated kinase (MAPK/ERK) pathway is reported to be associated with the cell proliferation, differentiation, migration, senescence and apoptosis.  The literatures were searched extensively and this review was performed to review the role of MAPK/ERK signaling pathway in cell proliferation, differentiation, migration, senescence and apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWdgOjMha0H_6BottYdIAWfW6udTcc2eZs6p7E2_I66rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MblsFCgtw%253D%253D&md5=ac2b1874f42681c52912d7108578e49e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.3109%2F10799893.2015.1030412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10799893.2015.1030412%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.-Z.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DZhou%26aufirst%3DH.-F.%26atitle%3DSignaling%2520pathway%2520of%2520MAPK%252FERK%2520in%2520cell%2520proliferation%252C%2520differentiation%252C%2520migration%252C%2520senescence%2520and%2520apoptosis%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2015%26volume%3D35%26spage%3D600%26epage%3D604%26doi%3D10.3109%2F10799893.2015.1030412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.-J.</span></span> <span> </span><span class="NLM_article-title">Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2014.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.neuint.2014.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=25481090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2mt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=60-71&author=H.-C.+Panauthor=Q.+Jiangauthor=Y.+Yuauthor=J.-P.+Meiauthor=Y.-K.+Cuiauthor=W.-J.+Zhao&title=Quercetin+promotes+cell+apoptosis+and+inhibits+the+expression+of+MMP-9+and+fibronectin+via+the+AKT+and+ERK+signalling+pathways+in+human+glioma+cells&doi=10.1016%2Fj.neuint.2014.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells</span></div><div class="casAuthors">Pan, Hong-Chao; Jiang, Qiong; Yu, Yang; Mei, Jin-Ping; Cui, Yu-Kun; Zhao, Wei-Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60-71</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Gliomas are the most common and malignant primary brain tumors and are assocd. with a poor prognosis despite the availability of multiple therapeutic options.  Quercetin, a traditional Chinese medicinal herb, is an important flavonoid and has anti-cancer activity.  Here, we evaluated whether quercetin could inhibit glioma cell viability and migration and promote apoptosis.  The treatment of U87-MG glioblastoma and U251 and SHG44 glioma cell lines with different concns. of quercetin inhibited cell viability in a dose-dependent manner.  Wound healing assays indicated that quercetin significantly decreased glioma cell migration. β-galactosidase staining, DNA staining and Annexin V-EGF/PI double staining assays demonstrated that quercetin promoted cell senescence and apoptosis.  In addn., the protein levels of p-AKT, p-ERK, Bcl-2, matrix metallopeptidase 9 (MMP-9) and fibronectin (FN) were significantly reduced following quercetin treatment.  Therefore, we conclude that quercetin might inhibit the viability and migration and promote the senescence and apoptosis of glioma cells by suppressing the Ras/MAPK/ERK and PI3K/AKT signalling pathways.  Quercetin might be a potential candidate for the clin. treatment of glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFlWET5z_WkrVg90H21EOLACvtfcHk0ljmDwACYB5CXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2mt77I&md5=cdb79eccf03b1ef8950c9e4589d9457e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2014.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2014.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DH.-C.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DMei%26aufirst%3DJ.-P.%26aulast%3DCui%26aufirst%3DY.-K.%26aulast%3DZhao%26aufirst%3DW.-J.%26atitle%3DQuercetin%2520promotes%2520cell%2520apoptosis%2520and%2520inhibits%2520the%2520expression%2520of%2520MMP-9%2520and%2520fibronectin%2520via%2520the%2520AKT%2520and%2520ERK%2520signalling%2520pathways%2520in%2520human%2520glioma%2520cells%26jtitle%3DNeurochem.%2520Int.%26date%3D2015%26volume%3D80%26spage%3D60%26epage%3D71%26doi%3D10.1016%2Fj.neuint.2014.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Zijl, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupitza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulits, W.</span></span> <span> </span><span class="NLM_article-title">Initial steps of metastasis: cell invasion and endothelial transmigration</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>728</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.mrrev.2011.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.mrrev.2011.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21605699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaisrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=728&publication_year=2011&pages=23-34&author=F.+van%0AZijlauthor=G.+Krupitzaauthor=W.+Mikulits&title=Initial+steps+of+metastasis%3A+cell+invasion+and+endothelial+transmigration&doi=10.1016%2Fj.mrrev.2011.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Initial steps of metastasis: Cell invasion and endothelial transmigration</span></div><div class="casAuthors">van Zijl, Franziska; Krupitza, Georg; Mikulits, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Reviews in Mutation Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">728</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">23-34</span>CODEN:
                <span class="NLM_cas:coden">MRRRFK</span>;
        ISSN:<span class="NLM_cas:issn">1383-5742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Metastasis is the leading cause of cancer mortality.  The metastatic cascade represents a multi-step process which includes local tumor cell invasion, entry into the vasculature followed by the exit of carcinoma cells from the circulation and colonization at the distal sites.  At the earliest stage of successful cancer cell dissemination, the primary cancer adapts the secondary site of tumor colonization involving the tumor-stroma crosstalk.  The migration and plasticity of cancer cells as well as the surrounding environment such as stromal and endothelial cells are mandatory.  Consequently, the mechanisms of cell movement are of utmost relevance for targeted intervention of which three different types have been reported.  Tumor cells can migrate either collectively, in a mesenchymal or in an amoeboid type of movement and intravasate the blood or lymph vasculature.  Intravasation by the interaction of tumor cells with the vascular endothelium is mechanistically poorly understood.  Changes in the epithelial plasticity enable carcinoma cells to switch between these types of motility.  The types of migration may change depending on the intervention thereby increasing the velocity and aggressiveness of invading cancer cells.  Interference with collective or mesenchymal cell invasion by targeting integrin expression or metalloproteinase activity, resp., resulted in an amoeboid cell phenotype as the ultimate exit strategy of cancer cells.  There are little mechanistic details reported in vivo showing that the amoeboid behavior can be either reversed or efficiently inhibited.  Future concepts of metastasis intervention must simultaneously address the collective, mesenchymal and amoeboid mechanisms of cell invasion in order to advance in anti-metastatic strategies as these different types of movement can coexist and cooperate.  Beyond the targeting of cell movements, the adhesion of cancer cells to the stroma in heterotypic circulating tumor cell emboli is of paramount relevance for anti-metastatic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnMrXZjAQ1MbVg90H21EOLACvtfcHk0lgDCc0O81lypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaisrzL&md5=da67b0c12f4d8d93f8ea57f575254d40</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.mrrev.2011.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrrev.2011.05.002%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BZijl%26aufirst%3DF.%26aulast%3DKrupitza%26aufirst%3DG.%26aulast%3DMikulits%26aufirst%3DW.%26atitle%3DInitial%2520steps%2520of%2520metastasis%253A%2520cell%2520invasion%2520and%2520endothelial%2520transmigration%26jtitle%3DMutat.%2520Res.%26date%3D2011%26volume%3D728%26spage%3D23%26epage%3D34%26doi%3D10.1016%2Fj.mrrev.2011.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badarau, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costache, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caruntu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihai, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didilescu, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagu, M.</span></span> <span> </span><span class="NLM_article-title">The role of matrix metalloproteinases in the epithelial-mesenchymal transition of hepatocellular carcinoma</span>. <i>Anal. Cell. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">9423907</span>, <span class="refDoi"> DOI: 10.1155/2019/9423907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1155%2F2019%2F9423907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BB3MbkvFOhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=9423907&author=C.+Scheauauthor=I.+A.+Badarauauthor=R.+Costacheauthor=C.+Caruntuauthor=G.+L.+Mihaiauthor=A.+C.+Didilescuauthor=C.+Constantinauthor=M.+Neagu&title=The+role+of+matrix+metalloproteinases+in+the+epithelial-mesenchymal+transition+of+hepatocellular+carcinoma&doi=10.1155%2F2019%2F9423907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma</span></div><div class="casAuthors">Scheau Cristian; Badarau Ioana Anca; Caruntu Constantin; Mihai Gratiela Livia; Costache Raluca; Caruntu Constantin; Didilescu Andreea Cristiana; Constantin Carolina; Neagu Monica; Constantin Carolina; Neagu Monica; Neagu Monica</div><div class="citationInfo"><span class="NLM_cas:title">Analytical cellular pathology (Amsterdam)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9423907</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The epithelial-mesenchymal transition (EMT) is a transformation process mandatory for the local and distant progression of many malignant tumors, including hepatocellular carcinoma (HCC).  Matrix metalloproteinases (MMPs) play significant roles in cellular regeneration, programmed death, angiogenesis, and many other essential tissular functions, involved in the normal development and also in pathological processes, such as the EMT.  This paper reviews the roles of MMPs in the EMT involved in HCC invasion, as well as the ancillary roles that MMP cross-activation and tissue inhibitors play in modulating this process.  While gelatinases MMP-2 and MMP-9 are the MMPs commonly cited in the EMT of HCC, MMPs belonging to other classes have been proven to be involved in this process, favoring not only invasion and metastasis (MMP-1, MMP-3, MMP-7, MMP-10, MMP-11, MMP-13, MMP-14, MMP-16, MMP-26, and MMP-28) but also angiogenesis (MMP-8 and MMP-10).  There is also data suggesting that other MMPs with a suspected or demonstrated role in the EMT of other cancers may also have some degree of involvement in HCC.  The auto- and cross-activation of MMPs may complicate this issue, as pinpointing the extent of implication of each MMP may be extremely difficult.  The homeostasis between MMPs and their tissue inhibitors is essential in preventing tumor progression, and the disturbance of this stability is another entailed factor in the EMT of HCC, which is addressed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaRPIzNrrhgFm8bhe6roZYfW6udTcc2eaKp3CQGCstMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MbkvFOhug%253D%253D&md5=b2366bab1de74dfb01d61fef928c6a61</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1155%2F2019%2F9423907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2019%252F9423907%26sid%3Dliteratum%253Aachs%26aulast%3DScheau%26aufirst%3DC.%26aulast%3DBadarau%26aufirst%3DI.%2BA.%26aulast%3DCostache%26aufirst%3DR.%26aulast%3DCaruntu%26aufirst%3DC.%26aulast%3DMihai%26aufirst%3DG.%2BL.%26aulast%3DDidilescu%26aufirst%3DA.%2BC.%26aulast%3DConstantin%26aufirst%3DC.%26aulast%3DNeagu%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520matrix%2520metalloproteinases%2520in%2520the%2520epithelial-mesenchymal%2520transition%2520of%2520hepatocellular%2520carcinoma%26jtitle%3DAnal.%2520Cell.%2520Pathol.%26date%3D2019%26volume%3D2019%26spage%3D9423907%26doi%3D10.1155%2F2019%2F9423907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span> <span> </span><span class="NLM_article-title">Reducing interstitial fluid pressure and inhibiting pulmonary metastasis of breast cancer by gelatin modified cationic lipid nanoparticles</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">29457</span>– <span class="NLM_lpage">29468</span>, <span class="refDoi"> DOI: 10.1021/acsami.7b05119</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.7b05119" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWhsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=29457-29468&author=X.+Gaoauthor=J.+Zhangauthor=Z.+Huangauthor=T.+Zuoauthor=Q.+Luauthor=G.+Wuauthor=Q.+Shen&title=Reducing+interstitial+fluid+pressure+and+inhibiting+pulmonary+metastasis+of+breast+cancer+by+gelatin+modified+cationic+lipid+nanoparticles&doi=10.1021%2Facsami.7b05119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing Interstitial Fluid Pressure and Inhibiting Pulmonary Metastasis of Breast Cancer by Gelatin Modified Cationic Lipid Nanoparticles</span></div><div class="casAuthors">Gao, Xuan; Zhang, Jun; Huang, Zun; Zuo, Tiantian; Lu, Qing; Wu, Guangyu; Shen, Qi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">29457-29468</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Interstitial fluid pressure (IFP) in tumor is much higher than that in normal tissue, and it constitutes a great obstacle for the delivery of antitumor drugs, thus becoming a potential target for cancer therapy.  In this study, cationic nanostructured lipid carriers (NLCs) were modified by low mol. wt. gelatin to achieve the desirable redn. of tumor IFP and improve the drug delivery.  In this way, the chemotherapy of formulations on tumor proliferation and pulmonary metastasis was further improved.  The nanoparticles were used to load three drugs, docetaxel (DTX), quercetin (Qu), and imatinib (IMA), with high encapsulation efficiency of 89.54%, 96.45%, and 60.13%, resp.  GNP-DTX/Qu/IMA nanoparticles exhibited an enzyme-sensitive drug release behavior, and the release rate could be mediated by matrix metalloproteinases (MMP-9).  Cellular uptake and MTT assays showed that the obtained GNP-DTX/Qu/IMA could be internalized into human breast 4T1 cells effectively and exhibited the strongest cytotoxicity.  Moreover, GNP-DTX/Qu/IMA demonstrated obvious advantages in inducing apoptosis and mediating the expression of apoptosis-related proteins (Caspase 3, Caspase 9, and bcl-2).  In the wound-healing assay, GNP-DTX/Qu/IMA exhibited evidently inhibition of cell migration.  The benefits of tumor IFP redn. induced by GNP-DTX/Qu/IMA were further proved after a continuous administration to 4T1 tumor-bearing mice.  Finally, in the in vivo antitumor assays, GNP-DTX/Qu/IMA displayed stronger antitumor efficiency as well as suppression on pulmonary metastasis.  In conclusion, the GNP-DTX/Qu/IMA system might be a promising strategy for metastatic breast cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaLfbSj4PmLVg90H21EOLACvtfcHk0lgDCc0O81lypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWhsLvM&md5=af3e2e700b6c923545fef8af61b8ca89</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Facsami.7b05119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.7b05119%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZuo%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DQ.%26atitle%3DReducing%2520interstitial%2520fluid%2520pressure%2520and%2520inhibiting%2520pulmonary%2520metastasis%2520of%2520breast%2520cancer%2520by%2520gelatin%2520modified%2520cationic%2520lipid%2520nanoparticles%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2017%26volume%3D9%26spage%3D29457%26epage%3D29468%26doi%3D10.1021%2Facsami.7b05119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeted lupane triterpenoid derivatives and their selective apoptosis-inducing anticancer mechanisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6353</span>– <span class="NLM_lpage">6363</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00679</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00679" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6353-6363&author=Y.+Yeauthor=T.+Zhangauthor=H.+Yuanauthor=D.+Liauthor=H.+Louauthor=P.+Fan&title=Mitochondria-targeted+lupane+triterpenoid+derivatives+and+their+selective+apoptosis-inducing+anticancer+mechanisms&doi=10.1021%2Facs.jmedchem.7b00679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Lupane Triterpenoid Derivatives and Their Selective Apoptosis-Inducing Anticancer Mechanisms</span></div><div class="casAuthors">Ye, Yaqing; Zhang, Tao; Yuan, Huiqing; Li, Defeng; Lou, Hongxiang; Fan, Peihong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6353-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Betulin and betulinic acid have been widely studied for their anticancer activities.  However, their further development is limited due to low bioavailability, poor aq. soly., and limited intracellular accumulation.  In the present study, a triphenylphosphonium cation moiety was linked to betulin and betulinic acid to specifically target them to cancer cell mitochondria.  Biol. characterization established that uptake of mitochondria-targeted compd. 1a in the mitochondria of cancer cells was increased compared to betulin.  The mitochondria-targeted derivs. of betulin and betulinic acid showed stronger cytotoxicity than their parent drugs and exhibited more cytotoxic effects in cancer cells than normal cells.  The mechanisms may involve the mitochondrial apoptotic pathway, probably caused by the induction of reactive oxygen species prodn. and reducing mitochondrial membrane potential.  More importantly, 1a significantly inhibited cancer cell proliferation and migration in an in vivo zebrafish xenograft model.  Collectively, these results encourage further study of 1a analogs as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotxRCv4fRMcbVg90H21EOLACvtfcHk0ljlrKgi5Nb-qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr3E&md5=b1461bf97acb75e7c68e976462804065</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00679%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLou%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DP.%26atitle%3DMitochondria-targeted%2520lupane%2520triterpenoid%2520derivatives%2520and%2520their%2520selective%2520apoptosis-inducing%2520anticancer%2520mechanisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6353%26epage%3D6363%26doi%3D10.1021%2Facs.jmedchem.7b00679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brocker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebert, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiliou, V.</span></span> <span> </span><span class="NLM_article-title">Evolutionary divergence and functions of the human interleukin (IL) gene family</span>. <i>Hum. Genomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1186/1479-7364-5-1-30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1186%2F1479-7364-5-1-30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21106488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVeks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=30-55&author=C.+Brockerauthor=D.+Thompsonauthor=A.+Matsumotoauthor=D.+W.+Nebertauthor=V.+Vasiliou&title=Evolutionary+divergence+and+functions+of+the+human+interleukin+%28IL%29+gene+family&doi=10.1186%2F1479-7364-5-1-30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutionary divergence and functions of the human interleukin (IL) gene family</span></div><div class="casAuthors">Brocker, Chad; Thompson, David; Matsumoto, Akiko; Nebert, Daniel W.; Vasiliou, Vasilis</div><div class="citationInfo"><span class="NLM_cas:title">Human Genomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-55</span>CODEN:
                <span class="NLM_cas:coden">HGUEAT</span>;
        ISSN:<span class="NLM_cas:issn">1479-7364</span>.
    
            (<span class="NLM_cas:orgname">Henry Stewart Publications</span>)
        </div><div class="casAbstract">A review.  Cytokines play a very important role in nearly all aspects of inflammation and immunity.  The term "interleukin" (IL) has been used to describe a group of cytokines with complex immunomodulatory functions - including cell proliferation, maturation, migration and adhesion.  These cytokines also play an important role in immune cell differentiation and activation.  Detg. the exact function of a particular cytokine is complicated by the influence of the producing cell type, the responding cell type and the phase of the immune response.  ILs can also have pro- and anti-inflammatory effects, further complicating their characterization.  These mols. are under const. pressure to evolve due to continual competition between the host's immune system and infecting organisms; as such, ILs have undergone significant evolution.  This has resulted in little amino acid conservation between orthologous proteins, which further complicates the gene family organization.  Within the literature there are a no. of overlapping nomenclature and classification systems derived from biol. function, receptor-binding properties and originating cell type.  Detg. evolutionary relationships between ILs therefore can be confusing.  More recently, crystallog. data and the identification of common structural motifs have led to a more accurate classification system.  To date, the known ILs can be divided into four major groups based on distinguishing structural features.  These groups include the genes encoding the IL1-like cytokines, the class I helical cytokines (IL4-like, γ-chain and IL6/12-Iike), the class II helical cytokines (IL10-like and IL28-like) and the ILI7-like cytokines.  In addn., there are a no. of ILs that do not fit into any of the above groups, due either to their unique structural features or lack of structural information.  This suggests that the gene family organization may be subject to further change in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRTpHngdAqJrVg90H21EOLACvtfcHk0ljlrKgi5Nb-qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVeks7w%253D&md5=6d19ce1b43c6b556fd38964eef457b89</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1186%2F1479-7364-5-1-30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-7364-5-1-30%26sid%3Dliteratum%253Aachs%26aulast%3DBrocker%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DMatsumoto%26aufirst%3DA.%26aulast%3DNebert%26aufirst%3DD.%2BW.%26aulast%3DVasiliou%26aufirst%3DV.%26atitle%3DEvolutionary%2520divergence%2520and%2520functions%2520of%2520the%2520human%2520interleukin%2520%2528IL%2529%2520gene%2520family%26jtitle%3DHum.%2520Genomics%26date%3D2010%26volume%3D5%26spage%3D30%26epage%3D55%26doi%3D10.1186%2F1479-7364-5-1-30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Melo-Diogo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, I. J.</span></span> <span> </span><span class="NLM_article-title">3D tumor spheroids: an overview on the tools and techniques used for their analysis</span>. <i>Biotechnol. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1427</span>– <span class="NLM_lpage">1441</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2016.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.biotechadv.2016.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27845258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BC2snmt1SrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=1427-1441&author=E.+C.+Costaauthor=A.+F.+Moreiraauthor=D.+de+Melo-Diogoauthor=V.+M.+Gasparauthor=M.+P.+Carvalhoauthor=I.+J.+Correia&title=3D+tumor+spheroids%3A+an+overview+on+the+tools+and+techniques+used+for+their+analysis&doi=10.1016%2Fj.biotechadv.2016.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">3D tumor spheroids: an overview on the tools and techniques used for their analysis</span></div><div class="casAuthors">Costa Elisabete C; Moreira Andre F; de Melo-Diogo Duarte; Gaspar Vitor M; Carvalho Marco P; Correia Ilidio J</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1427-1441</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In comparison with 2D cell culture models, 3D spheroids are able to accurately mimic some features of solid tumors, such as their spatial architecture, physiological responses, secretion of soluble mediators, gene expression patterns and drug resistance mechanisms.  These unique characteristics highlight the potential of 3D cellular aggregates to be used as in vitro models for screening new anticancer therapeutics, both at a small and large scale.  Nevertheless, few reports have focused on describing the tools and techniques currently available to extract significant biological data from these models.  Such information will be fundamental to drug and therapeutic discovery process using 3D cell culture models.  The present review provides an overview of the techniques that can be employed to characterize and evaluate the efficacy of anticancer therapeutics in 3D tumor spheroids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcrj9sPTzAo8rRqEXsZufAfW6udTcc2ebkozwmd6t5arntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snmt1SrtQ%253D%253D&md5=7df22d1121bd823c148b48f530d58da2</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2016.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DE.%2BC.%26aulast%3DMoreira%26aufirst%3DA.%2BF.%26aulast%3Dde%2BMelo-Diogo%26aufirst%3DD.%26aulast%3DGaspar%26aufirst%3DV.%2BM.%26aulast%3DCarvalho%26aufirst%3DM.%2BP.%26aulast%3DCorreia%26aufirst%3DI.%2BJ.%26atitle%3D3D%2520tumor%2520spheroids%253A%2520an%2520overview%2520on%2520the%2520tools%2520and%2520techniques%2520used%2520for%2520their%2520analysis%26jtitle%3DBiotechnol.%2520Adv.%26date%3D2016%26volume%3D34%26spage%3D1427%26epage%3D1441%26doi%3D10.1016%2Fj.biotechadv.2016.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, Y.</span></span> <span> </span><span class="NLM_article-title">Is it time to start transitioning from 2D to 3D cell culture?</span>. <i>Front. Mol. Biosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.3389/fmolb.2020.00033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.3389%2Ffmolb.2020.00033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=32211418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVaktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2020&pages=33&author=C.+Jensenauthor=Y.+Teng&title=Is+it+time+to+start+transitioning+from+2D+to+3D+cell+culture%3F&doi=10.3389%2Ffmolb.2020.00033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Is it time to start transitioning from 2D to 3D cell culture?</span></div><div class="casAuthors">Jensen, Caleb; Teng, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Biosciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33</span>CODEN:
                <span class="NLM_cas:coden">FMBRBS</span>;
        ISSN:<span class="NLM_cas:issn">2296-889X</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Cell culture is an important and necessary process in drug discovery, cancer research, as well as stem cell study.  Most cells are currently cultured using two-dimensional (2D) methods but new and improved methods that implement three-dimensional (3D) cell culturing techniques suggest compelling evidence that much more advanced expts. can be performed yielding valuable insights.  When performing 3D cell culture expts., the cell environment can be manipulated to mimic that of a cell in vivo and provide more accurate data about cell-to-cell interactions, tumor characteristics, drug discovery, metabolic profiling, stem cell research, and other types of diseases.  Scaffold based techniques such as hydrogel-based support, polymeric hard material-based support, hydrophilic glass fiber, and organoids are employed, and each provide their own advantages and applications.  Likewise, there are also scaffold free techniques used such as hanging drop microplates, magnetic levitation, and spheroid microplates with ultra-low attachment coating.  3D Cell culture has the potential to provide alternative ways to study organ behavior via the use of organoids and is expected to eventually bridge the gap between 2D cell culture and animal models.  The present review compares 2D cell culture to 3D cell culture, provides the details surrounding the different 3D culture techniques, as well as focuses on the present and future applications of 3D cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLHsbSDucaUbVg90H21EOLACvtfcHk0lgTC_1_KFYl6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVaktbvI&md5=98ec480800e43a8e793a40f428f7eded</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.3389%2Ffmolb.2020.00033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmolb.2020.00033%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DTeng%26aufirst%3DY.%26atitle%3DIs%2520it%2520time%2520to%2520start%2520transitioning%2520from%25202D%2520to%25203D%2520cell%2520culture%253F%26jtitle%3DFront.%2520Mol.%2520Biosci.%26date%3D2020%26volume%3D7%26spage%3D33%26doi%3D10.3389%2Ffmolb.2020.00033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolomanov, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourhis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildea, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, J. A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puschmann, H.</span></span> <span> </span><span class="NLM_article-title">OLEX2: a complete structure solution, refinement and analysis program</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1107/s0021889808042726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1107%2FS0021889808042726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=339-341&author=O.+V.+Dolomanovauthor=L.+J.+Bourhisauthor=R.+J.+Gildeaauthor=J.+A.+K.+Howardauthor=H.+Puschmann&title=OLEX2%3A+a+complete+structure+solution%2C+refinement+and+analysis+program&doi=10.1107%2Fs0021889808042726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">OLEX2: a complete structure solution, refinement and analysis program</span></div><div class="casAuthors">Dolomanov, Oleg V.; Bourhis, Luc J.; Gildea, Richard J.; Howard, Judith A. K.; Puschmann, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-341</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">New software, OLEX2, was developed for the detn., visualization and anal. of mol. crystal structures.  The software has a portable mouse-driven workflow-oriented and fully comprehensive graphical user interface for structure soln., refinement and report generation, as well as novel tools for structure anal.  OLEX2 seamlessly links all aspects of the structure soln., refinement and publication process and presents them in a single workflow-driven package, with the ultimate goal of producing an application which will be useful to both chemists and crystallographers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIYSUbyzIgxbVg90H21EOLACvtfcHk0lgTC_1_KFYl6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D&md5=7a2f9697b13b8e76de0e7dc5074ab229</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1107%2FS0021889808042726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889808042726%26sid%3Dliteratum%253Aachs%26aulast%3DDolomanov%26aufirst%3DO.%2BV.%26aulast%3DBourhis%26aufirst%3DL.%2BJ.%26aulast%3DGildea%26aufirst%3DR.%2BJ.%26aulast%3DHoward%26aufirst%3DJ.%2BA.%2BK.%26aulast%3DPuschmann%26aufirst%3DH.%26atitle%3DOLEX2%253A%2520a%2520complete%2520structure%2520solution%252C%2520refinement%2520and%2520analysis%2520program%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2009%26volume%3D42%26spage%3D339%26epage%3D341%26doi%3D10.1107%2Fs0021889808042726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, L.</span></span> <span> </span><span class="NLM_article-title">Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">12310</span>– <span class="NLM_lpage">12322</span>, <span class="refDoi"> DOI: 10.1021/nn5062386</span> </span><div class="citationLinks">[<a href="/doi/10.1021/nn5062386" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVamsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=12310-12322&author=Z.+Shengauthor=D.+Huauthor=M.+Zhengauthor=P.+Zhaoauthor=H.+Liuauthor=D.+Gaoauthor=P.+Gongauthor=G.+Gaoauthor=P.+Zhangauthor=Y.+Maauthor=L.+Cai&title=Smart+human+serum+albumin-indocyanine+green+nanoparticles+generated+by+programmed+assembly+for+dual-modal+imaging-guided+cancer+synergistic+phototherapy&doi=10.1021%2Fnn5062386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Smart Human Serum Albumin-Indocyanine Green Nanoparticles Generated by Programmed Assembly for Dual-Modal Imaging-Guided Cancer Synergistic Phototherapy</span></div><div class="casAuthors">Sheng, Zonghai; Hu, Dehong; Zheng, Mingbin; Zhao, Pengfei; Liu, Huilong; Gao, Duyang; Gong, Ping; Gao, Guanhui; Zhang, Pengfei; Ma, Yifan; Cai, Lintao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">12310-12322</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phototherapy, including photodynamic therapy (PDT) and photothermal therapy (PTT), is a light-activated local treatment modality that is under intensive preclin. and clin. investigations for cancer.  To enhance the treatment efficiency of phototherapy and reduce the light-assocd. side effects, it is highly desirable to improve drug accumulation and precision guided phototherapy for efficient conversion of the absorbed light energy to reactive oxygen species (ROS) and local hyperthermia.  In the present study, a programmed assembly strategy was developed for the prepn. of human serum albumin (HSA)-indocyanine green (ICG) nanoparticles (HSA-ICG NPs) by intermol. disulfide conjugations.  This study indicated that HSA-ICG NPs had a high accumulation with tumor-to-normal tissue ratio of 36.12 ± 5.12 at 24 h and a long-term retention with more than 7 days in 4T1 tumor-bearing mice, where the tumor and its margin, normal tissue were clearly identified via ICG-based in vivo near-IR (NIR) fluorescence and photoacoustic dual-modal imaging and spectrum-resolved technol.  Meanwhile, HSA-ICG NPs efficiently induced ROS and local hyperthermia simultaneously for synergetic PDT/PTT treatments under a single NIR laser irradn.  After an i.v. injection of HSA-ICG NPs followed by imaging-guided precision phototherapy (808 nm, 0.8 W/cm2 for 5 min), the tumor was completely suppressed, no tumor recurrence and treatments-induced toxicity were obsd.  The results suggest that HSA-ICG NPs generated by programmed assembly as smart theranostic nanoplatforms are highly potential for imaging-guided cancer phototherapy with PDT/PTT synergistic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp15mG1gXKiR7Vg90H21EOLACvtfcHk0lipkh2zU85svA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVamsr3J&md5=60a1cf56658644f07c983d09d1551196</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fnn5062386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnn5062386%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DGong%26aufirst%3DP.%26aulast%3DGao%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DL.%26atitle%3DSmart%2520human%2520serum%2520albumin-indocyanine%2520green%2520nanoparticles%2520generated%2520by%2520programmed%2520assembly%2520for%2520dual-modal%2520imaging-guided%2520cancer%2520synergistic%2520phototherapy%26jtitle%3DACS%2520Nano%26date%3D2014%26volume%3D8%26spage%3D12310%26epage%3D12322%26doi%3D10.1021%2Fnn5062386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Tailoring particle size of mesoporous silica nanosystem to antagonize glioblastoma and overcome blood-brain barrier</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">6811</span>– <span class="NLM_lpage">6825</span>, <span class="refDoi"> DOI: 10.1021/acsami.5b11730</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.5b11730" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFKgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=6811-6825&author=J.+Moauthor=L.+Heauthor=B.+Maauthor=T.+Chen&title=Tailoring+particle+size+of+mesoporous+silica+nanosystem+to+antagonize+glioblastoma+and+overcome+blood-brain+barrier&doi=10.1021%2Facsami.5b11730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier</span></div><div class="casAuthors">Mo, Jianbin; He, Lizhen; Ma, Bin; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6811-6825</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) is the main bottleneck to prevent some macromol. substance entering the cerebral circulation, resulting the failure of chemotherapy in the treatment of glioma.  Cancer nanotechnol. displays potent applications in glioma therapy owing to their penetration across BBB and accumulation into the tumor core.  In this study, we have tailored the particle size of mesoporous silica nanoparticles (MSNs) through controlling the hydrolysis rate and polycondensation degree of reactants, and optimized the nanosystem that could effectively penetrate BBB and target the tumor tissue to achieve enhanced antiglioma efficacy.  The nanoparticle was conjugated with cRGD peptide to enhance its cancer targeting effect, and then used to load antineoplastic doxorubicin.  Therefore, the functionalized nanosystem (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="89cdc6d1c9c4dac7fa">[email protected]</a>) selectively recognizes and binds to the U87 cells with higher expression level of ανβ3 integrin, sequentially enhancing the cellular uptake and inhibition to giloma cells, esp. the particle size at 40 nm.  This particle could rapidly enter cancer cells and was difficult to excrete outside the cells, thus leading to high drug accumulation.  Furthermore, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="0e4a41564e435d407d">[email protected]</a> exhibited much higher selectivity and anticancer activity than free DOX and induced the glioma cells apoptosis through triggering ROS overprodn.  Interestingly, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="a5e1eafde5e8f6ebd6">[email protected]</a> at about 40 nm exhibited stronger permeability across the BBB, and could disrupt the VM-capability of glioma cells by regulating the expression of E-cadherin, FAK, and MMP-2, thus achieving satisfactory antiglioblastoma efficacy and avoiding the unwanted toxic side effects to normal brain tissue.  Taken together, these results suggest that tailoring the particle size of MSNs nanosystem could be an effective strategy to antagonize glioblastoma and overcome BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5URgccbcrIbVg90H21EOLACvtfcHk0liGaLfsoq7-mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFKgtLg%253D&md5=9a9a90aaab36b12dd2beb25402f4fb51</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Facsami.5b11730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.5b11730%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DTailoring%2520particle%2520size%2520of%2520mesoporous%2520silica%2520nanosystem%2520to%2520antagonize%2520glioblastoma%2520and%2520overcome%2520blood-brain%2520barrier%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2016%26volume%3D8%26spage%3D6811%26epage%3D6825%26doi%3D10.1021%2Facsami.5b11730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Copper Complexes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Local coordination environments of <b>1–3</b>, H atoms are omitted for clarity. (A) Complex <b>1</b>. (B) Complex <b>2</b>, symmetry code: <i>i</i> = 1 – <i>x</i>, 1 – <i>y</i>, and 1 – <i>z</i>. (C) Complex <b>3</b>, symmetry code: <i>i</i> = −<i>x</i>, <i>y</i>, 1.5 – <i>z</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Plots of χ<sub>M</sub><i>T vs T</i> for complexes <b>1–3</b>. The insets show the thermal dependence of inverse magnetic susceptibility. (B) Absorption spectra of the HL ligand (5 μM) and the copper complexes (5 μM) measured in water containing DMSO (10% v/v). (C) Fluorescence spectra of the HL ligand (5 μM) and the copper complexes (5 μM) recorded in water containing DMSO (10% v/v) followed by excitation at 415 nm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A–E) Confocal fluorescence images of living ASPC-1 cells costained with complex <b>3</b> and DRAQ5, Golgi-Tracker Red, ER-Tracker Red, LysoTracker Red, or MitoTracker Deep Red FM. Scale bar: 10 μm. (A) Microscope images of the ASPC-1 cells incubated with complex <b>3</b> and far red nuclear stain DRAQ5: red fluorescence from DRAQ5 (λ<sub>ex</sub> = 638 nm), green fluorescence from complex <b>3</b> (λ<sub>ex</sub> = 405 nm). (B) Microscope images of the ASPC-1 cells incubated with complex <b>3</b> (green fluorescence, λ<sub>ex</sub> = 405 nm) and Golgi-Tracker Red (red fluorescence, λ<sub>ex</sub> = 589 nm). (C) Microscope images of the ASPC-1 cells incubated with complex <b>3</b> (green fluorescence, λ<sub>ex</sub> = 405 nm) and ER-Tracker Red (red fluorescence, λ<sub>ex</sub> = 587 nm). (D) Microscope images of the ASPC-1 cells incubated with complex <b>3</b> (green fluorescence, λ<sub>ex</sub> = 405 nm) and LysoTracker Red (red fluorescence, λ<sub>ex</sub> = 577 nm). (E) Microscope images of the ASPC-1 cells incubated with complex <b>3</b> (green fluorescence, λ<sub>ex</sub> = 405 nm) and MitoTracker Deep Red FM (red fluorescence, λ<sub>ex</sub> = 638 nm) and yellow fluorescence from merged the images. (F) <i>In vivo</i> fluorescence images (λ<sub>ex</sub> 455–495 nm, λ<sub>em</sub> 535 nm) of a BALB/c mouse after intraperitoneal injection of complex <b>3</b> (200 μL, 3 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Pathway analysis of differentially expressed proteins was based on the KEGG database. (B) Western blot analysis of the protein expression levels of HMOX1 and ACSL4 in ASPC-1 cells. (C) Measurement of cellular lipid ROS levels in ASPC-1 cells by using BODIPY-C11 after exposure to complex <b>3</b> for 24 h. (D) Representative transmission electron microscopy images showing the mitochondria morphology of ASPC-1 cells treated with control and complex <b>3</b> (0.4 μM) for 24 h. (E) <i>In vitro</i> cytotoxicity of complex <b>3</b> against ASPC-1 cells in the absence and presence of ferroptosis inhibitor, liproxstatin-1 (1 μM), after 48 h incubation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Western blot analysis of the protein expression levels of TGFB3, FOS and P-ERK in ASPC-1 cells. (B) Antimigratory effect of on ASPC-1 cells by wound healing assay. Scale bar: 200 μm. (C) After treatment with or without complex <b>3</b> for 24 h, ASPC-1 cell invasion ability was detected by transwell assay. Scale bar: 200 μm. (D) Western blot analysis of the protein expression levels of MMP-2 and MMP-9 in ASPC-1 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Flow cytometry analysis for apoptosis of ASPC-1 cells induced by complex <b>3</b> for 24 h. (B) Effects of complex <b>3</b> on mitochondrial membrane potential of ASPC-1 cells analyzed by flow cytometry and JC-1 staining. (C) Western blot analysis of the protein expression levels of cytochrome <i>c</i> in the mitochondria of ASPC-1 cells. (D) Western blot analysis of the protein expression levels of caspase-9 in the mitochondria of ASPC-1 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Morphology of 3D ASPC-1 tumor spheroids treated with complex <b>3</b> on at the indicated concentrations for 7 days. Scale bar: 500 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/medium/jm0c01936_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Changes of tumor volume after intraperitoneal injection of complex <b>3</b> (1.5 and 3 mg/kg) in ASPC-1 tumor-bearing nude mice. *<i>p</i> < 0.05, **<i>p</i> < 0.001. (B) Effects of complex <b>3</b> on body weight of ASPC-1 tumor-bearing mice. (C) <i>Ex vivo</i> biodistribution studies of complex <b>3</b> at 2 h after injection. (D) H&E staining analysis of kidney, tumor, and liver treated with complex <b>3</b>. Scale bar: 50 μm. (E) Tumors are sectioned and stained with TUNEL. Apoptotic cells appear green. Scale bar: 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01936/20210506/images/large/jm0c01936_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01936&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 73 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahib, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleshman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matrisian, L. M.</span></span> <span> </span><span class="NLM_article-title">Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2913</span>– <span class="NLM_lpage">2921</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-14-0155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1158%2F0008-5472.CAN-14-0155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=24840647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=2913-2921&author=L.+Rahibauthor=B.+D.+Smithauthor=R.+Aizenbergauthor=A.+B.+Rosenzweigauthor=J.+M.+Fleshmanauthor=L.+M.+Matrisian&title=Projecting+cancer+incidence+and+deaths+to+2030%3A+the+unexpected+burden+of+thyroid%2C+liver%2C+and+pancreas+cancers+in+the+United+States&doi=10.1158%2F0008-5472.can-14-0155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States</span></div><div class="casAuthors">Rahib, Lola; Smith, Benjamin D.; Aizenberg, Rhonda; Rosenzweig, Allison B.; Fleshman, Julie M.; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2913-2921</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the av. annual percentage changes in incidence and death rates.  Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common cancers, resp.  Lung cancer is projected to remain the top cancer killer throughout this time period.  However, pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, resp.  Advances in screening, prevention, and treatment can change cancer incidence and/or death rates, but it will require a concerted effort by the research and healthcare communities now to effect a substantial change for the future.  Cancer Res; 74(11); 2913-21. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHGt66quENkbVg90H21EOLACvtfcHk0lgRPgcTK0Suaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFalur0%253D&md5=893d688f1ccba88ee094b743f7e4f152</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0155%26sid%3Dliteratum%253Aachs%26aulast%3DRahib%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DAizenberg%26aufirst%3DR.%26aulast%3DRosenzweig%26aufirst%3DA.%2BB.%26aulast%3DFleshman%26aufirst%3DJ.%2BM.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DProjecting%2520cancer%2520incidence%2520and%2520deaths%2520to%25202030%253A%2520the%2520unexpected%2520burden%2520of%2520thyroid%252C%2520liver%252C%2520and%2520pancreas%2520cancers%2520in%2520the%2520United%2520States%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D2913%26epage%3D2921%26doi%3D10.1158%2F0008-5472.can-14-0155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggins, M.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(10)62307-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2FS0140-6736%2810%2962307-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21620466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BC3MjlvFOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2011&pages=607-620&author=A.+Vincentauthor=J.+Hermanauthor=R.+Schulickauthor=R.+H.+Hrubanauthor=M.+Goggins&title=Pancreatic+cancer&doi=10.1016%2Fs0140-6736%2810%2962307-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer</span></div><div class="casAuthors">Vincent Audrey; Herman Joseph; Schulick Rich; Hruban Ralph H; Goggins Michael</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">9791</span>),
    <span class="NLM_cas:pages">607-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Substantial progress has been made in our understanding of the biology of pancreatic cancer, and advances in patients' management have also taken place.  Evidence is beginning to show that screening first-degree relatives of individuals with several family members affected by pancreatic cancer can identify non-invasive precursors of this malignant disease.  The incidence of and number of deaths caused by pancreatic tumours have been gradually rising, even as incidence and mortality of other common cancers have been declining.  Despite developments in detection and management of pancreatic cancer, only about 4% of patients will live 5 years after diagnosis.  Survival is better for those with malignant disease localised to the pancreas, because surgical resection at present offers the only chance of cure.  Unfortunately, 80-85% of patients present with advanced unresectable disease.  Furthermore, pancreatic cancer responds poorly to most chemotherapeutic agents.  Hence, we need to understand the biological mechanisms that contribute to development and progression of pancreatic tumours.  In this Seminar we will discuss the most common and deadly form of pancreatic cancer, pancreatic ductal adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_Px7QoMFLVGhHGZei4OW9fW6udTcc2eaE6COBgzPSlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjlvFOmsg%253D%253D&md5=fb7f79c8c02f2f2bad5e5ad7a9b09096</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2962307-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252962307-0%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DA.%26aulast%3DHerman%26aufirst%3DJ.%26aulast%3DSchulick%26aufirst%3DR.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DGoggins%26aufirst%3DM.%26atitle%3DPancreatic%2520cancer%26jtitle%3DLancet%26date%3D2011%26volume%3D378%26spage%3D607%26epage%3D620%26doi%3D10.1016%2Fs0140-6736%2810%2962307-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2016</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.3322/caac.21332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.3322%2Fcaac.21332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=26742998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2016&doi=10.3322%2Fcaac.21332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2016</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States.  Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009-2012), much of which is because of recent rapid declines in prostate cancer diagnoses.  The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012.  Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease.  Among children and adolescents (aged birth-19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia.  Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKAn5ROFAaRS86Js-BCLiifW6udTcc2eaE6COBgzPSlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D&md5=2d4030a531945c5ebaaab181bfd80457</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21332%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202016%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2016%26volume%3D66%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cleary, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gryfe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guindi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallinger, S.</span></span> <span> </span><span class="NLM_article-title">Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors</span>. <i>J. Am. Coll. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1016/j.jamcollsurg.2004.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.jamcollsurg.2004.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=15110805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BD2c3htlWksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2004&pages=722-731&author=S.+P.+Clearyauthor=R.+Gryfeauthor=M.+Guindiauthor=P.+Greigauthor=L.+Smithauthor=R.+Mackenzieauthor=S.+Strasbergauthor=S.+Hannaauthor=B.+Taylorauthor=B.+Langerauthor=S.+Gallinger&title=Prognostic+factors+in+resected+pancreatic+adenocarcinoma%3A+analysis+of+actual+5-year+survivors&doi=10.1016%2Fj.jamcollsurg.2004.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors</span></div><div class="casAuthors">Cleary Sean P; Gryfe Robert; Guindi Maha; Greig Paul; Smith Lloyd; Mackenzie Robert; Strasberg Steven; Hanna Sherif; Taylor Bryce; Langer Bernard; Gallinger Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Surgeons</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">722-31</span>
        ISSN:<span class="NLM_cas:issn">1072-7515</span>.
    </div><div class="casAbstract">BACKGROUND:  Pancreatic cancer is a rapidly fatal disease with very few 5-year survivors even after aggressive surgical treatment.  Our objective was to determine the actual 5-year survival rate of patients with pancreatic adenocarcinoma who underwent a resection with curative intent in 5 teaching hospitals within the University of Toronto system.  We then sought to determine clinical and histopathologic features of 5-year survivors to determine factors associated with a favorable prognosis.  STUDY DESIGN:  A retrospective chart review was performed using surgeon and hospital databases to identify patients who had a surgical resection for pancreatic adenocarcinoma between January 1, 1988, and December 31, 1996.  RESULTS:  One hundred twenty-three patients who had a resection and a pathologic diagnosis of pancreatic adenocarcinoma with complete followup were identified from seven surgical practices.  Mean survival (+/- standard error) in this series was 31.7 +/- 3.5 months (median 13.6 months).  There were 18 5-year survivors (14.6%), including 5 patients (4.1%) who survived longer than 10 years.  The survivors included 13 patients who had undergone a Whipple resection, 4 who had undergone a distal pancreatectomy, and 1 who had undergone a total pancreatectomy.  Tumor size, lack of jaundice at presentation, negative nodal disease, low tumor grade, and a low tumor stage were all significant predictors of survival in univariate analysis (all p < 0.05).  Only tumor stage (hazard ratio [95% confidence interval]: stage IIA 1.5 [0.8 to 2.8], stage IIB 2.6 [1.4 to 4.7], stage III 1.8 [0.8 to 4.3]) and tumor grade (hazard ratio [95% confidence interval]: moderately differentiated 1.6 [0.9 to 2.9], and poorly differentiated 3.1 [1.6 to 6.2]) were independently associated with survival differences in a multivariate Cox proportional hazards model.  CONCLUSIONS:  We conclude that longterm survival from pancreatic adenocarcinoma is possible if the disease is identified in its early stages.  These and other similar data should provide further stimulus for the development and evaluation of novel screening strategies to improve early detection of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqP6DNXoczi8KL0FlyGHDofW6udTcc2eYTVe5RCPFoobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3htlWksQ%253D%253D&md5=e9cc57f6bc22c656ed5e30112fbe1740</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jamcollsurg.2004.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jamcollsurg.2004.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DCleary%26aufirst%3DS.%2BP.%26aulast%3DGryfe%26aufirst%3DR.%26aulast%3DGuindi%26aufirst%3DM.%26aulast%3DGreig%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DMackenzie%26aufirst%3DR.%26aulast%3DStrasberg%26aufirst%3DS.%26aulast%3DHanna%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DB.%26aulast%3DLanger%26aufirst%3DB.%26aulast%3DGallinger%26aufirst%3DS.%26atitle%3DPrognostic%2520factors%2520in%2520resected%2520pancreatic%2520adenocarcinoma%253A%2520analysis%2520of%2520actual%25205-year%2520survivors%26jtitle%3DJ.%2520Am.%2520Coll.%2520Surg.%26date%3D2004%26volume%3D198%26spage%3D722%26epage%3D731%26doi%3D10.1016%2Fj.jamcollsurg.2004.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel reactive oxygen species inducers for the treatment of pancreatic ductal adenocarcinoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1576</span>– <span class="NLM_lpage">1594</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVyqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1576-1594&author=Y.+Kuangauthor=M.+Sechiauthor=S.+Nurraauthor=M.+Ljungmanauthor=N.+Neamati&title=Design+and+synthesis+of+novel+reactive+oxygen+species+inducers+for+the+treatment+of+pancreatic+ductal+adenocarcinoma&doi=10.1021%2Facs.jmedchem.7b01463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Kuang, Yuting; Sechi, Mario; Nurra, Salvatore; Ljungman, Mats; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1576-1594</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinazolinediones such as I were prepd. as inducers of reactive oxygen species (ROS) for potential use as antitumor agents for the treatment of pancreatic ductal adenocarcinoma (PDAC); the inhibition of human PDAC cells was detd. for all of the compds. and the toxicities of selected compds. to normal pancreatic cells, and the effects on various cellular systems was detd. for selected compds.  I was the most potent redox modulator candidate of the tested compds., inducing substantial ROS prodn. in PDAC cells.  Nascent RNA sequencing following treatments with quinazolinediones revealed induction of stress responses in nucleus, endoplasmic reticulum, and mitochondria of pancreatic cancer cells; the quinazolinedione also induced Nrf2-mediated oxidative stress and unfolded protein responses as demonstrated by dose-dependent increases in RNA synthesis of representative genes such as NQO1, HMOX1, DDIT3, and HSPA5.  At 5.0 μM, I blocked mitochondrial function by inhibiting mtDNA transcription and downregulating the mtDNA-encoded OXPHOS enzymes.  Treatment with I was well tolerated in vivo and significantly delayed tumor growth in mice; I was also tested in combination with the current pancreatic cancer agent gemcitabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4BeZNm8i3TLVg90H21EOLACvtfcHk0ljKJk2f1GJnzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVyqtA%253D%253D&md5=ec0cb6c8914a7841c7ff8906cf53ef49</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01463%26sid%3Dliteratum%253Aachs%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DNurra%26aufirst%3DS.%26aulast%3DLjungman%26aufirst%3DM.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520reactive%2520oxygen%2520species%2520inducers%2520for%2520the%2520treatment%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1576%26epage%3D1594%26doi%3D10.1021%2Facs.jmedchem.7b01463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span> <span> </span><span class="NLM_article-title">Pancreatic adenocarcinoma</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1056/nejmra1404198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1056%2FNEJMra1404198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=25207767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Olt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=1039-1049&author=D.+P.+Ryanauthor=T.+S.+Hongauthor=N.+Bardeesy&title=Pancreatic+adenocarcinoma&doi=10.1056%2Fnejmra1404198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic adenocarcinoma</span></div><div class="casAuthors">Ryan, David P.; Hong, Theodore S.; Bardeesy, Nabeel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1049, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ1-TPh2I8RbVg90H21EOLACvtfcHk0lhnjwjHpOyiEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Olt7rK&md5=c916814b3ce1e14f3a93b9a0b05cd286</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1404198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1404198%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DD.%2BP.%26aulast%3DHong%26aufirst%3DT.%2BS.%26aulast%3DBardeesy%26aufirst%3DN.%26atitle%3DPancreatic%2520adenocarcinoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D1039%26epage%3D1049%26doi%3D10.1056%2Fnejmra1404198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Von
Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ervin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiorean, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjulandin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laheru, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahary, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Cutsem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iglesias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renschler, M. F.</span></span> <span> </span><span class="NLM_article-title">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1304369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1056%2FNEJMoa1304369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=24131140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=1691-1703&author=D.+D.+Von%0AHoffauthor=T.+Ervinauthor=F.+P.+Arenaauthor=E.+G.+Chioreanauthor=J.+Infanteauthor=M.+Mooreauthor=T.+Seayauthor=S.+A.+Tjulandinauthor=W.+W.+Maauthor=M.+N.+Salehauthor=M.+Harrisauthor=M.+Reniauthor=S.+Dowdenauthor=D.+Laheruauthor=N.+Baharyauthor=R.+K.+Ramanathanauthor=J.+Taberneroauthor=M.+Hidalgoauthor=D.+Goldsteinauthor=E.+Van+Cutsemauthor=X.+Weiauthor=J.+Iglesiasauthor=M.+F.+Renschler&title=Increased+survival+in+pancreatic+cancer+with+nab-paclitaxel+plus+gemcitabine&doi=10.1056%2Fnejmoa1304369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span></div><div class="casAuthors">Von Hoff, Daniel D.; Ervin, Thomas; Arena, Francis P.; Chiorean, E. Gabriela; Infante, Jeffrey; Moore, Malcolm; Seay, Thomas; Tjulandin, Sergei A.; Ma, Wen Wee; Saleh, Mansoor N.; Harris, Marion; Reni, Michele; Dowden, Scot; Laheru, Daniel; Bahary, Nathan; Ramanathan, Ramesh K.; Tabernero, Josep; Hidalgo, Manuel; Goldstein, David; Van Cutsem, Eric; Wei, Xinyu; Iglesias, Jose; Renschler, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: In a phase 1-2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clin. activity was noted in patients with advanced pancreatic cancer.  We conducted a phase 3 study of the efficacy and safety of the combination vs. gemcitabine monotherapy in patients with metastatic pancreatic cancer.  METHODS: We randomly assigned patients with a Karnofsky performance-status score of 70 or more (on a scale from 0 to 100, with higher scores indicating better performance status) to nab-paclitaxel (125 mg per square meter of body-surface area) followed by gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 wk or gemcitabine monotherapy (1000 mg per square meter) weekly for 7 of 8 wk (cycle 1) and then on days 1, 8, and 15 every 4 wk (cycle 2 and subsequent cycles).  Patients received the study treatment until disease progression.  The primary end point was overall survival; secondary end points were progression-free survival and overall response rate.  RESULTS: A total of 861 patients were randomly assigned to nab-paclitaxel plus gemcitabine (431 patients) or gemcitabine (430).  The median overall survival was 8.5 mo in the nab-paclitaxel-gemcitabine group as compared with 6.7 mo in the gemcitabine group (hazard ratio for death, 0.72; 95% confidence interval [CI], 0.62 to 0.83; P<0.001).  The survival rate was 35% in the nab-paclitaxel-gemcitabine group vs. 22% in the gemcitabine group at 1 yr, and 9% vs. 4% at 2 years.  The median progression-free survival was 5.5 mo in the nab-paclitaxel-gemcitabine group, as compared with 3.7 mo in the gemcitabine group (hazard ratio for disease progression or death, 0.69; 95% CI, 0.58 to 0.82; P<0.001); the response rate according to independent review was 23% vs. 7% in the two groups (P<0.001).  The most common adverse events of grade 3 or higher were neutropenia (38% in the nab-paclitaxel-gemcitabine group vs. 27% in the gemcitabine group), fatigue (17% vs. 7%), and neuropathy (17% vs. 1%).  Febrile neutropenia occurred in 3% vs. 1% of the patients in the two groups.  In the nab-paclitaxel-gemcitabine group, neuropathy of grade 3 or higher improved to grade 1 or lower in a median of 29 days.  CONCLUSIONS: In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but rates of peripheral neuropathy and myelosuppression were increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCXpODbQZ6dLVg90H21EOLACvtfcHk0lhnjwjHpOyiEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I&md5=b1169c7e9879c08061dd9e9389dc36fe</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1304369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1304369%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DErvin%26aufirst%3DT.%26aulast%3DArena%26aufirst%3DF.%2BP.%26aulast%3DChiorean%26aufirst%3DE.%2BG.%26aulast%3DInfante%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DSeay%26aufirst%3DT.%26aulast%3DTjulandin%26aufirst%3DS.%2BA.%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DSaleh%26aufirst%3DM.%2BN.%26aulast%3DHarris%26aufirst%3DM.%26aulast%3DReni%26aufirst%3DM.%26aulast%3DDowden%26aufirst%3DS.%26aulast%3DLaheru%26aufirst%3DD.%26aulast%3DBahary%26aufirst%3DN.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DIglesias%26aufirst%3DJ.%26aulast%3DRenschler%26aufirst%3DM.%2BF.%26atitle%3DIncreased%2520survival%2520in%2520pancreatic%2520cancer%2520with%2520nab-paclitaxel%2520plus%2520gemcitabine%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2Fnejmoa1304369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desseigne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ychou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouché, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimbaud, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bécouarn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adenis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raoul, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourgou-Bourgade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Fouchardière, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennouna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachet, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khemissa-Akouz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Péré-Vergé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assenat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauffert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoto-Grillot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducreux, M.</span></span> <span> </span><span class="NLM_article-title">FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>364</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1825</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1011923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1056%2FNEJMoa1011923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21561347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1817-1825&author=T.+Conroyauthor=F.+Desseigneauthor=M.+Ychouauthor=O.+Bouch%C3%A9author=R.+Guimbaudauthor=Y.+B%C3%A9couarnauthor=A.+Adenisauthor=J.-L.+Raoulauthor=S.+Gourgou-Bourgadeauthor=C.+de+la+Fouchardi%C3%A8reauthor=J.+Bennounaauthor=J.-B.+Bachetauthor=F.+Khemissa-Akouzauthor=D.+P%C3%A9r%C3%A9-Verg%C3%A9author=C.+Delbaldoauthor=E.+Assenatauthor=B.+Chauffertauthor=P.+Michelauthor=C.+Montoto-Grillotauthor=M.+Ducreux&title=FOLFIRINOX+versus+gemcitabine+for+metastatic+pancreatic+cancer&doi=10.1056%2Fnejmoa1011923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">FOLFIRINOX versus gemcitabine or metastatic pancreatic cancer</span></div><div class="casAuthors">Conroy, Thierry; Desseigne, Francoise; Ychou, Marc; Bouche, Olivier; Guimbaud, Rosine; Becouarn, Yves; Adenis, Antoine; Raoul, Jean-Luc; Gourgou-Bourgade, Sophie; de la Fouchardiere, Christelle; Bennouna, Jaafar; Bachet, Jean-Baptiste; Khemissa-Akouz, Faiza; Pere-Verge, Denis; Delbaldo, Catherine; Assenat, Eric; Chauffert, Bruno; Michel, Pierre; Montoto-Grillot, Christine; Ducreux, Michel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1817-1825</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as compared with gemcitabine as first-line therapy in patients with metastatic pancreatic cancer.  METHODS We randomly assigned 342 patients with an Eastern Cooperative Oncol. Group performance status score of 0 or 1 (on a scale of 0 to 5, with higher scores indicating a greater severity of illness) to receive FOLFIRINOX (oxaliplatin, 85 mg per square meter of body-surface area; irinotecan, 180 mg per square meter; leucovorin, 400 mg per square meter; and fluorouracil, 400 mg per square meter given as a bolus followed by 2400 mg per square meter given as a 46-h continuous infusion, every 2 wk) or gemcitabine at a dose of 1000 mg per square meter weekly for 7 of 8 wk and then weekly for 3 of 4 wk.  Six months of chemotherapy were recommended in both groups in patients who had a response.  The primary end point was overall survival.  RESULTS The median overall survival was 11.1 mo in the FOLFIRINOX group as compared with 6.8 mo in the gemcitabine group (hazard ratio for death, 0.57; 95% confidence interval [CI], 0.45 to 0.73; P < 0.001).  Median progression-free survival was 6.4 mo in the FOLFIRINOX group and 3.3 mo in the gemcitabine group (hazard ratio for disease progression, 0.47; 95% CI, 0.37 to 0.59; P < 0.001).  The objective response rate was 31.60% in the FOLFIRINOX group vs. 9.4% in the gemcitabine group (P < 0.001).  More adverse events were noted in the FOLFIRINOX group; 5.4% of patients in this group had febrile neutropenia.  At 6 mo, 31% of the patients in the FOLFIRINOX group had a definitive degrdn. of the quality of life vs. 66% in the gemcitabine group (hazard ratio, 0.47; 95% CI, 0.30 to 0.70; P < 0.001).  CONCLUSIONS As compared with gemcitabine, FOLFIRINOX was assocd. with a survival advantage and had increased toxicity.  FOLFIRINOX is an option for the treatment of patients with metastatic pancreatic cancer and good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGyDR85GUgOrVg90H21EOLACvtfcHk0ljrFJqpxbi0TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D&md5=a1a7135a6c97c4dc47233465ce0defd5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1011923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1011923%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DDesseigne%26aufirst%3DF.%26aulast%3DYchou%26aufirst%3DM.%26aulast%3DBouch%25C3%25A9%26aufirst%3DO.%26aulast%3DGuimbaud%26aufirst%3DR.%26aulast%3DB%25C3%25A9couarn%26aufirst%3DY.%26aulast%3DAdenis%26aufirst%3DA.%26aulast%3DRaoul%26aufirst%3DJ.-L.%26aulast%3DGourgou-Bourgade%26aufirst%3DS.%26aulast%3Dde%2Bla%2BFouchardi%25C3%25A8re%26aufirst%3DC.%26aulast%3DBennouna%26aufirst%3DJ.%26aulast%3DBachet%26aufirst%3DJ.-B.%26aulast%3DKhemissa-Akouz%26aufirst%3DF.%26aulast%3DP%25C3%25A9r%25C3%25A9-Verg%25C3%25A9%26aufirst%3DD.%26aulast%3DDelbaldo%26aufirst%3DC.%26aulast%3DAssenat%26aufirst%3DE.%26aulast%3DChauffert%26aufirst%3DB.%26aulast%3DMichel%26aufirst%3DP.%26aulast%3DMontoto-Grillot%26aufirst%3DC.%26aulast%3DDucreux%26aufirst%3DM.%26atitle%3DFOLFIRINOX%2520versus%2520gemcitabine%2520for%2520metastatic%2520pancreatic%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1817%26epage%3D1825%26doi%3D10.1056%2Fnejmoa1011923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neoptolemos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleeff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenhalf, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, D. H.</span></span> <span> </span><span class="NLM_article-title">Therapeutic developments in pancreatic cancer: current and future perspectives</span>. <i>Nat. Rev. Gastroenterol. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1038/s41575-018-0005-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1038%2Fs41575-018-0005-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=29717230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BC1MjovVOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=333-348&author=J.+P.+Neoptolemosauthor=J.+Kleeffauthor=P.+Michlauthor=E.+Costelloauthor=W.+Greenhalfauthor=D.+H.+Palmer&title=Therapeutic+developments+in+pancreatic+cancer%3A+current+and+future+perspectives&doi=10.1038%2Fs41575-018-0005-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic developments in pancreatic cancer: current and future perspectives</span></div><div class="casAuthors">Neoptolemos John P; Kleeff Jorg; Kleeff Jorg; Costello Eithne; Greenhalf William; Palmer Daniel H; Michl Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">333-348</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The overall 5-year survival for pancreatic cancer has changed little over the past few decades, and pancreatic cancer is predicted to be the second leading cause of cancer-related mortality in the next decade in Western countries.  The past few years, however, have seen improvements in first-line and second-line palliative therapies and considerable progress in increasing survival with adjuvant treatment.  The use of biomarkers to help define treatment and the potential of neoadjuvant therapies also offer opportunities to improve outcomes.  This Review brings together information on achievements to date, what is working currently and where successes are likely to be achieved in the future.  Furthermore, we address the questions of how we should approach the development of pancreatic cancer treatments, including those for patients with metastatic, locally advanced and borderline resectable pancreatic cancer, as well as for patients with resected tumours.  In addition to embracing newer strategies comprising genomics, stromal therapies and immunotherapies, conventional approaches using chemotherapy and radiotherapy still offer considerable prospects for greater traction and synergy with evolving concepts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStGgd4rHkEDz69zv1FsJFMfW6udTcc2eakan45Z-n3ubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MjovVOguw%253D%253D&md5=d1b4ab24b72f95c7077798a8258ccf58</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fs41575-018-0005-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41575-018-0005-x%26sid%3Dliteratum%253Aachs%26aulast%3DNeoptolemos%26aufirst%3DJ.%2BP.%26aulast%3DKleeff%26aufirst%3DJ.%26aulast%3DMichl%26aufirst%3DP.%26aulast%3DCostello%26aufirst%3DE.%26aulast%3DGreenhalf%26aufirst%3DW.%26aulast%3DPalmer%26aufirst%3DD.%2BH.%26atitle%3DTherapeutic%2520developments%2520in%2520pancreatic%2520cancer%253A%2520current%2520and%2520future%2520perspectives%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2018%26volume%3D15%26spage%3D333%26epage%3D348%26doi%3D10.1038%2Fs41575-018-0005-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barry, N. P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Exploration of the medical periodic table: towards new targets</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">5106</span>– <span class="NLM_lpage">5131</span>, <span class="refDoi"> DOI: 10.1039/c3cc41143e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2Fc3cc41143e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=23636600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFaru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=5106-5131&author=N.+P.+E.+Barryauthor=P.+J.+Sadler&title=Exploration+of+the+medical+periodic+table%3A+towards+new+targets&doi=10.1039%2Fc3cc41143e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the medical periodic table: towards new targets</span></div><div class="casAuthors">Barry, Nicolas P. E.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">5106-5131</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Metallodrugs offer potential for unique mechanisms of drug action based on the choice of the metal, its oxidn. state, the types and no. of coordinated ligands and the coordination geometry.  We discuss recent progress in identifying new target sites and elucidating the mechanisms of action of anti-cancer, anti-bacterial, anti-viral, anti-parasitic, anti-inflammatory, and anti-neurodegenerative agents, as well as in the design of metal-based diagnostic agents.  Progress in identifying and defining target sites has been accelerated recently by advances in proteomics, genomics and metal speciation anal.  Examples of metal compds. and chelating agents (enzyme inhibitors) currently in clin. use, clin. trials or preclin. development are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZmY5oRnhAi7Vg90H21EOLACvtfcHk0ljECG2j_-HSHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFaru7c%253D&md5=b91db5563e59a43e7f9d05860a03b3b0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2Fc3cc41143e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc41143e%26sid%3Dliteratum%253Aachs%26aulast%3DBarry%26aufirst%3DN.%2BP.%2BE.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DExploration%2520of%2520the%2520medical%2520periodic%2520table%253A%2520towards%2520new%2520targets%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D5106%26epage%3D5131%26doi%3D10.1039%2Fc3cc41143e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tisato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santini, C.</span></span> <span> </span><span class="NLM_article-title">Copper in diseases and treatments, and copper-based anticancer strategies</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1002/med.20174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1002%2Fmed.20174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=19626597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Snuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=708-749&author=F.+Tisatoauthor=C.+Marzanoauthor=M.+Porchiaauthor=M.+Pelleiauthor=C.+Santini&title=Copper+in+diseases+and+treatments%2C+and+copper-based+anticancer+strategies&doi=10.1002%2Fmed.20174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Copper in diseases and treatments, and copper-based anticancer strategies</span></div><div class="casAuthors">Tisato, Francesco; Marzano, Cristina; Porchia, Marina; Pellei, Maura; Santini, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">708-749</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Copper is found in all living organisms and is a crucial trace element in redox chem., growth and development.  It is important for the function of several enzymes and proteins involved in energy metab., respiration, and DNA synthesis, notably cytochrome oxidase, superoxide dismutase, ascorbate oxidase, and tyrosinase.  The major functions of copper-biol. mols. involve oxidn.-redn. reactions in which they react directly with mol. oxygen to produce free radicals.  Therefore, copper requires tightly regulated homeostatic mechanisms to ensure adequate supplies without any toxic effects.  Overload or deficiency of copper is assocd., resp., with Wilson disease (WD) and Menkes disease (MD), which are of genetic origin.  Researches on Menkes and Wilson disorders have provided useful insights in the field of copper homeostasis and in particular into the understanding of intracellular trafficking and distribution of copper at mol. levels.  Therapies based on metal supplementation with copper histidine or removal of copper excess by means of specific copper chelators are currently effective in treating MD and WD, resp.  Copper chelation therapy is now attracting much attention for the investigation and treatment of various neurodegenerative disorders such as Alzheimer, Parkinson and CreutzfeldtJakob.  An excess of copper appears to be an essential co-factor for angiogenesis.  Moreover, elevated levels of copper have been found in many types of human cancers, including prostate, breast, colon, lung, and brain.  On these basis, the employment of copper chelators has been reported to be of therapeutic value in the treatment of several types of cancers as anti-angiogenic mols.  More recently, mixts. of copper chelators with copper salts have been found to act as efficient proteasome inhibitors and apoptosis inducers, specifically in cancer cells.  Moreover, following the worldwide success of platinum(II) compds. in cancer chemotherapy, several families of individual copper complexes have been studied as potential antitumor agents.  These investigations, revealing the occurrence of mechanisms of action quite different from platinum drugs, head toward the development of new anticancer metallodrugs with improved specificity and decreased toxic side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf17t02r9AlbVg90H21EOLACvtfcHk0ljECG2j_-HSHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Snuro%253D&md5=8f576825c072cd1e95c3675cd07c1dc8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fmed.20174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20174%26sid%3Dliteratum%253Aachs%26aulast%3DTisato%26aufirst%3DF.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DPorchia%26aufirst%3DM.%26aulast%3DPellei%26aufirst%3DM.%26aulast%3DSantini%26aufirst%3DC.%26atitle%3DCopper%2520in%2520diseases%2520and%2520treatments%252C%2520and%2520copper-based%2520anticancer%2520strategies%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2010%26volume%3D30%26spage%3D708%26epage%3D749%26doi%3D10.1002%2Fmed.20174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nasulewicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opolski, A.</span></span> <span> </span><span class="NLM_article-title">Role of copper in tumour angiogenesis—clinical implications</span>. <i>J. Trace Elem. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.jtemb.2004.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.jtemb.2004.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=15487757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVensbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1-8&author=A.+Nasulewiczauthor=A.+Mazurauthor=A.+Opolski&title=Role+of+copper+in+tumour+angiogenesis%E2%80%94clinical+implications&doi=10.1016%2Fj.jtemb.2004.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Role of copper in tumor angiogenesis - clinical implications</span></div><div class="casAuthors">Nasulewicz, Anna; Mazur, Andrzej; Opolski, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Trace Elements in Medicine and Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">JTEBFO</span>;
        ISSN:<span class="NLM_cas:issn">0946-672X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  The formation of new blood vessels is the initial step in progressive tumor development and metastasis.  The first stage in tumor angiogenesis is the activation of endothelial cells.  Copper ions stimulate proliferation and migration of endothelial cells.  It has been shown that serum copper concn. increases as the cancer disease progresses and correlates with tumor incidence and burden.  Copper ions also activate several proangiogenic factors, e.g., vascular endothelial growth factor, basic fibroblast growth factor, tumor necrosis factor alpha and interleukin 1.  This review concerns a brief introduction into the basics of tumor blood vessel development as well as the regulatory mechanisms of this process.  The role of copper ions in tumor angiogenesis is discussed.  The new antiangiogenic therapies based on a redn. of copper levels in tumor microenvironment are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1fS4EdEyufLVg90H21EOLACvtfcHk0lhioSOB9uQKDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVensbbJ&md5=9993017fb5fc2c7e09a0efffbbfbc5d6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jtemb.2004.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jtemb.2004.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DNasulewicz%26aufirst%3DA.%26aulast%3DMazur%26aufirst%3DA.%26aulast%3DOpolski%26aufirst%3DA.%26atitle%3DRole%2520of%2520copper%2520in%2520tumour%2520angiogenesis%25E2%2580%2594clinical%2520implications%26jtitle%3DJ.%2520Trace%2520Elem.%2520Med.%2520Biol.%26date%3D2004%26volume%3D18%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.jtemb.2004.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span> <span> </span><span class="NLM_article-title">Advances in copper complexes as anticancer agents</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">815</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1021/cr400135x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400135x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFygurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=815-862&author=C.+Santiniauthor=M.+Pelleiauthor=V.+Gandinauthor=M.+Porchiaauthor=F.+Tisatoauthor=C.+Marzano&title=Advances+in+copper+complexes+as+anticancer+agents&doi=10.1021%2Fcr400135x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Copper Complexes as Anticancer Agents</span></div><div class="casAuthors">Santini, Carlo; Pellei, Maura; Gandin, Valentina; Porchia, Marina; Tisato, Francesco; Marzano, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">815-862</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review describes advances in the synthesis, design, and development of copper complexes as anticancer agents in the last 4 years.  Interest in this field has rapidly grown in recent years, as illustrated by the increasing no. of publications reported since 2000.  This summary covers the period 2008-2012 and follows the authors' previous efforts in the same area.  Furthermore, the authors summarize recent findings on (i) identification of the main mol. targets and cellular pathways involved in the copper complexes-induced antiproliferative effects and (ii) the state of art of in vivo studies on the antitumor activity of copper compds.  This overview would like to be a useful tool for the research community actively involved in the copper-based anticancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPJuYrrxcT0LVg90H21EOLACvtfcHk0lhioSOB9uQKDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFygurrL&md5=6d6fca30804d7b44c2079cf30327cfc3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fcr400135x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400135x%26sid%3Dliteratum%253Aachs%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DPellei%26aufirst%3DM.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DPorchia%26aufirst%3DM.%26aulast%3DTisato%26aufirst%3DF.%26aulast%3DMarzano%26aufirst%3DC.%26atitle%3DAdvances%2520in%2520copper%2520complexes%2520as%2520anticancer%2520agents%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D815%26epage%3D862%26doi%3D10.1021%2Fcr400135x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franz, K. J.</span></span> <span> </span><span class="NLM_article-title">Application of inorganic chemistry for non-cancer therapeutics</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">6333</span>– <span class="NLM_lpage">6334</span>, <span class="refDoi"> DOI: 10.1039/c2dt90061k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2Fc2dt90061k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=22546812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1SrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=6333-6334&author=K.+J.+Franz&title=Application+of+inorganic+chemistry+for+non-cancer+therapeutics&doi=10.1039%2Fc2dt90061k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Application of inorganic chemistry for non-cancer therapeutics</span></div><div class="casAuthors">Franz, Katherine J.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6333-6334</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-m3gTchdBhrVg90H21EOLACvtfcHk0lgWbSN-Nzg4NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1SrsLk%253D&md5=02b9354db4b7334c929c93485457baa4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2Fc2dt90061k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2dt90061k%26sid%3Dliteratum%253Aachs%26aulast%3DFranz%26aufirst%3DK.%2BJ.%26atitle%3DApplication%2520of%2520inorganic%2520chemistry%2520for%2520non-cancer%2520therapeutics%26jtitle%3DDalton%2520Trans.%26date%3D2012%26volume%3D41%26spage%3D6333%26epage%3D6334%26doi%3D10.1039%2Fc2dt90061k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Low, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maigre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, M. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiekink, E. R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorlet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravoof, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagès, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Policar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delsuc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouse, K. A.</span></span> <span> </span><span class="NLM_article-title">New insight into the structural, electrochemical and biological aspects of macroacyclic Cu(II) complexes derived from S-substituted dithiocarbazate schiff bases</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ejmech.2016.04.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27183379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2016&pages=1-12&author=M.+L.+Lowauthor=L.+Maigreauthor=M.+I.+M.+Tahirauthor=E.+R.+T.+Tiekinkauthor=P.+Dorletauthor=R.+Guillotauthor=T.+B.+Ravoofauthor=R.+Rosliauthor=J.-M.+Pag%C3%A8sauthor=C.+Policarauthor=N.+Delsucauthor=K.+A.+Crouse&title=New+insight+into+the+structural%2C+electrochemical+and+biological+aspects+of+macroacyclic+Cu%28II%29+complexes+derived+from+S-substituted+dithiocarbazate+schiff+bases&doi=10.1016%2Fj.ejmech.2016.04.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New insight into the structural, electrochemical and biological aspects of macroacyclic Cu(II) complexes derived from S-substituted dithiocarbazate Schiff bases</span></div><div class="casAuthors">Low, May Lee; Maigre, Laure; Tahir, Mohamed Ibrahim M.; Tiekink, Edward R. T.; Dorlet, Pierre; Guillot, Regis; Ravoof, Thahira Begum; Rosli, Rozita; Pages, Jean-Marie; Policar, Clotilde; Delsuc, Nicolas; Crouse, Karen A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Copper(II) complexes synthesized from the products of condensation of S-methyl- and S-benzyldithiocarbazate with 2,5-hexanedione (SMHDH2 and SBHDH2, resp.) were characterized using various physicochem. (elemental anal., molar cond., magnetic susceptibility) and spectroscopic (IR, electronic) methods.  The structures of SMHDH2, its copper(II) complex, CuSMHD, and the related CuSBHD complex as well as a pyrrole byproduct, SBPY, were detd. by single crystal x-ray diffraction.  In order to provide more insight into the behavior of the complexes in soln., EPR and electrochem. expts. were performed.  Antibacterial activity and cytotoxicity were evaluated.  The compds., dissolved in 0.5% and 5% DMSO, showed a wide range of antibacterial activity against 10 strains of Gram-pos. and Gram-neg. bacteria.  Studies of the effects of efflux pumps and membrane penetration on antibacterial activity are reported herein.  Antiproliferation activity is enhanced by complexation with copper.  Preliminary screening showed Cu complexes are strongly active against human breast adenocarcinoma cancer cell lines MDA-MB-231 and MCF-7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB-W_5XMFV6bVg90H21EOLACvtfcHk0lgWbSN-Nzg4NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WqtLY%253D&md5=87663d48e19e7324787b4213d84dde8f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.027%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DM.%2BL.%26aulast%3DMaigre%26aufirst%3DL.%26aulast%3DTahir%26aufirst%3DM.%2BI.%2BM.%26aulast%3DTiekink%26aufirst%3DE.%2BR.%2BT.%26aulast%3DDorlet%26aufirst%3DP.%26aulast%3DGuillot%26aufirst%3DR.%26aulast%3DRavoof%26aufirst%3DT.%2BB.%26aulast%3DRosli%26aufirst%3DR.%26aulast%3DPag%25C3%25A8s%26aufirst%3DJ.-M.%26aulast%3DPolicar%26aufirst%3DC.%26aulast%3DDelsuc%26aufirst%3DN.%26aulast%3DCrouse%26aufirst%3DK.%2BA.%26atitle%3DNew%2520insight%2520into%2520the%2520structural%252C%2520electrochemical%2520and%2520biological%2520aspects%2520of%2520macroacyclic%2520Cu%2528II%2529%2520complexes%2520derived%2520from%2520S-substituted%2520dithiocarbazate%2520schiff%2520bases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D120%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.ejmech.2016.04.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beshir, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guchhait, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascón, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenteany, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of metal-ligand complexes that potently inhibit cell migration</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">498</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.bmcl.2007.11.099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=18240381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFWgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=498-504&author=A.+B.+Beshirauthor=S.+K.+Guchhaitauthor=J.+A.+Gasc%C3%B3nauthor=G.+Fenteany&title=Synthesis+and+structure-activity+relationships+of+metal-ligand+complexes+that+potently+inhibit+cell+migration&doi=10.1016%2Fj.bmcl.2007.11.099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationships of metal-ligand complexes that potently inhibit cell migration</span></div><div class="casAuthors">Beshir, Anwar B.; Guchhait, Sankar K.; Gascon, Jose A.; Fenteany, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">498-504</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The authors screened the National Cancer Institute Diversity Set compd. collection for small mols. that affect mammalian cell migration and identified NSC 295642 as an inhibitor of cell motility with nanomolar potency.  The authors found by LC-MS and x-ray crystallog. that NSC 295642, a Cu(II) complex of the Schiff base product of condensation of S-benzyl dithiocarbazate and 2-acetylpyridine, has a bridged dimeric Cu2Cl2(L)2 structure with distorted square pyramidal geometry.  Each of the two Cu atoms is five-coordinated to one of the two tridentate chelating ligands and both bridging Cl atoms.  To define structure-activity relations, the authors studied the bioactivity of related metal-ligand complexes derived from different metal(II) atoms and different ligands.  Complexation of the NSC 295642 ligand with Zn(II) or Ni(II), delivered as metal(II) chloride salts under conditions identical to those used for prepn. of the original Cu(II) complex, instead results in distorted octahedral bis-chelate structures, where a single metal atom is six-coordinated to two ligands.  The Zn(L)2 complex possesses a potency similar to that of the Cu2Cl2(L)2 complex, while the Ni(L)2 has no antimigratory activity at all.  The authors carried out d. functional theory calcns. to obtain the electronic ground state geometry of the complexes, both in vacuum and implicit water solvent.  The x-ray crystal and energy-minimized structures are very similar and exhibit a transoid orientation of the S-benzyl groups relative to the central metal-coordinated rings for both of the bioactive Cu2Cl2(L)2 and Zn(L)2 complexes, despite their different coordination geometries.  In contrast, the biol. inactive Ni(L)2 complex adopts a cisoid conformation.  Varying the ligand structure, hydrophobic S-alkylaryl groups are required for activity.  Complexes with a simple S-Me group, S-benzyl groups with polar substitutions or a carboxylated pyridine ring exhibit dramatically reduced activity.  The authors tested the most potent metal-ligand complex in a no. of cancer cell lines and found cell-type selectivity in its effect on cell motility.  Collectively, these results suggest that a two-ligand structure with bulky nonpolar S-substituents in a transoid conformation is important for the antimigratory activity of these metal-ligand complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWSpBJhT4LlbVg90H21EOLACvtfcHk0lgWbSN-Nzg4NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFWgsg%253D%253D&md5=b104c41ee09fe0a3449ed86c9b754866</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.099%26sid%3Dliteratum%253Aachs%26aulast%3DBeshir%26aufirst%3DA.%2BB.%26aulast%3DGuchhait%26aufirst%3DS.%2BK.%26aulast%3DGasc%25C3%25B3n%26aufirst%3DJ.%2BA.%26aulast%3DFenteany%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520metal-ligand%2520complexes%2520that%2520potently%2520inhibit%2520cell%2520migration%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D498%26epage%3D504%26doi%3D10.1016%2Fj.bmcl.2007.11.099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arjmand, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muddassir, M.</span></span> <span> </span><span class="NLM_article-title">A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-tryptophan-derived metal complexes of 1,2-DACH: cleavage and antitumor activity</span>. <i>Chirality</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1002/chir.20907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1002%2Fchir.20907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=20928895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1yksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=250-259&author=F.+Arjmandauthor=M.+Muddassir&title=A+mechanistic+approach+for+the+DNA+binding+of+chiral+enantiomeric+L-+and+D-tryptophan-derived+metal+complexes+of+1%2C2-DACH%3A+cleavage+and+antitumor+activity&doi=10.1002%2Fchir.20907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-tryptophan-derived metal complexes of 1,2-DACH: Cleavage and antitumor activity</span></div><div class="casAuthors">Arjmand, Farukh; Muddassir, Mohd.</div><div class="citationInfo"><span class="NLM_cas:title">Chirality</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">250-259</span>CODEN:
                <span class="NLM_cas:coden">CHRLEP</span>;
        ISSN:<span class="NLM_cas:issn">0899-0042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A new chiral series of potential antitumor metal-based complexes 1-3(a and b) of L- and D-tryptophan have been synthesized and thoroughly characterized.  Both enantiomers of 1-3 bind DNA noncovalently via phosphate interaction with slight preference of metal center for covalent coordination to nucleobases.  The Kb values of L-enantiomer, however, possess higher propensity for DNA binding in comparison with the D-enantiomeric analogs.  The relative trend in Kb values is as follows: 2(a) > 2(b) > 3(a) > 1(a) > 3(b) > 1(b).  These observations together with the findings of circular dichoric and fluorescence studies reveal maximal potential of L-enantiomeric form of copper complex to bind DNA, thereby exerting its therapeutic effect.  The complex 2a exhibits a remarkable DNA cleavage activity with pBR322DNA in the presence of different activators such as H2O2, ascorbic acid, 3-mercaptopropionic acid, and glutathione, suggesting the involvement of active oxygen species for the DNA scission.  In vitro anticancer activity of complexes 1-3(a) were screened against 14 different human carcinoma cell lines of different histol. origin, and the results reveal that 2a shows significant antitumor activity in comparison with both 1a and 3a and is particularly selective for MIAPACA2 (pancreatic cancer cell line).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQJyTwAdcTYLVg90H21EOLACvtfcHk0lh4bZXOcC6njA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1yksbc%253D&md5=ccfa28c733875fe705e06e8cc0186171</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fchir.20907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchir.20907%26sid%3Dliteratum%253Aachs%26aulast%3DArjmand%26aufirst%3DF.%26aulast%3DMuddassir%26aufirst%3DM.%26atitle%3DA%2520mechanistic%2520approach%2520for%2520the%2520DNA%2520binding%2520of%2520chiral%2520enantiomeric%2520L-%2520and%2520D-tryptophan-derived%2520metal%2520complexes%2520of%25201%252C2-DACH%253A%2520cleavage%2520and%2520antitumor%2520activity%26jtitle%3DChirality%26date%3D2011%26volume%3D23%26spage%3D250%26epage%3D259%26doi%3D10.1002%2Fchir.20907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alagesan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhuvanesh, N. S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaraj, N.</span></span> <span> </span><span class="NLM_article-title">Potentially cytotoxic new copper(II) hydrazone complexes: synthesis, crystal structure and biological properties</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">7210</span>– <span class="NLM_lpage">7223</span>, <span class="refDoi"> DOI: 10.1039/c3dt50371b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2Fc3dt50371b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=23529726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVCisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=7210-7223&author=M.+Alagesanauthor=N.+S.+P.+Bhuvaneshauthor=N.+Dharmaraj&title=Potentially+cytotoxic+new+copper%28II%29+hydrazone+complexes%3A+synthesis%2C+crystal+structure+and+biological+properties&doi=10.1039%2Fc3dt50371b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Potentially cytotoxic new copper(II) hydrazone complexes: synthesis, crystal structure and biological properties</span></div><div class="casAuthors">Alagesan, Mani; Bhuvanesh, Nattamai S. P.; Dharmaraj, Nallasamy</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7210-7223</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">New pentacoordinated Cu(II) hydrazone complexes contg. solvated MeOH were synthesized by reacting the hydrazone ligands, 2-acetylpyridine benzoyl hydrazone (HL1) and 2-acetylpyridine thiophene-2-carboxylic acid hydrazone (HL2), with [CuCl2(DMSO)2] and characterized by different spectral methods.  Single crystal x-ray diffraction studies of the complexes revealed that both of them, [CuCl(L1)(MeOH)] (1) and [CuCl(L2)(MeOH)] (2), have square pyramidal geometry around the cupric ion, in which the hydrazone is coordinated through NNO atoms along with a mol. of MeOH in the apical position.  Interaction of the ligands HL1 and HL2 with the Cu complexes 1 and 2 with calf thymus DNA (CT-DNA) was estd. by absorption and emission titrn. methods which revealed that the compds. interacted with CT-DNA through intercalation.  Binding of the compds., i.e., free ligands and 1 and 2 with bovine serum albumin (BSA) protein studied using UV-visible, fluorescence and synchronous fluorescence spectroscopic methods indicated that there occurred strong binding of Cu complexes to BSA over the ligands.  Further, the cytotoxicity of the compds. examd. in vitro on a panel of . cancerous cell lines such as a human cervical cancer cell line (HeLa), a pancreatic cancer cell line (PANC-1), an Ehrlich ascites cancer cell line (EAC) and Dalton's lymphoma ascitic cancer cells (DLA) and a normal mouse embryonic fibroblasts cell line (NIH3) demonstrated that 1 and 2 possessed superior cytotoxicity than that of known com. anticancer drug cisplatin to the tumor cells but are less toxic to the normal cell line and have emerged as potential candidates for further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZM4DvyUOFSbVg90H21EOLACvtfcHk0lh4bZXOcC6njA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVCisrw%253D&md5=b049cf60d1a1b1a4bbd69f28e817d3b8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2Fc3dt50371b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3dt50371b%26sid%3Dliteratum%253Aachs%26aulast%3DAlagesan%26aufirst%3DM.%26aulast%3DBhuvanesh%26aufirst%3DN.%2BS.%2BP.%26aulast%3DDharmaraj%26aufirst%3DN.%26atitle%3DPotentially%2520cytotoxic%2520new%2520copper%2528II%2529%2520hydrazone%2520complexes%253A%2520synthesis%252C%2520crystal%2520structure%2520and%2520biological%2520properties%26jtitle%3DDalton%2520Trans.%26date%3D2013%26volume%3D42%26spage%3D7210%26epage%3D7223%26doi%3D10.1039%2Fc3dt50371b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zehra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavez Khan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arjmand, F.</span></span> <span> </span><span class="NLM_article-title">New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity</span>. <i>J. Biomol. Struct. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1863</span>– <span class="NLM_lpage">1879</span>, <span class="refDoi"> DOI: 10.1080/07391102.2018.1467794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1080%2F07391102.2018.1467794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=29676660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovFyrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=1863-1879&author=S.+Zehraauthor=M.+Shavez+Khanauthor=I.+Ahmadauthor=F.+Arjmand&title=New+tailored+substituted+benzothiazole+Schiff+base+Cu%28II%29%2FZn%28II%29+antitumor+drug+entities%3A+effect+of+substituents+on+DNA+binding+profile%2C+antimicrobial+and+cytotoxic+activity&doi=10.1080%2F07391102.2018.1467794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity</span></div><div class="casAuthors">Zehra, Siffeen; Shavez Khan, Mohammad; Ahmad, Iqbal; Arjmand, Farukh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Structure and Dynamics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1863-1879</span>CODEN:
                <span class="NLM_cas:coden">JBSDD6</span>;
        ISSN:<span class="NLM_cas:issn">0739-1102</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">New tailored Cu(II) & Zn(II) metal-based antitumor drug entities were synthesized from substituted benzothiazole o-vanillin Schiff base ligands.  The complexes were thoroughly characterized by elemental anal., spectroscopic studies {IR, 1H & 13C NMR, ESI-MS, EPR} and magnetic susceptibility measurements.  The structure activity relationship (SAR) studies of benzothiazole Cu(II) & Zn(II) complexes having mol. formulas [C30H22CuN5O7S2], [C30H20Cl2CuN5O7S2], [C30H20CuF2N5O7S2], [C30H22N4O4S2Zn], [C30H20Cl2N4O4S2Zn], and [C30H20F2N5O7S2Zn], with CT-DNA were performed by employing absorption, emission titrns., and hydrodynamic measurements.  The DNA binding affinity was quantified by Kb and Ksv values which gave higher binding propensity for chloro-substituted Cu(II) [C30H20Cl2CuN5O7S2] complex, suggestive of groove binding mode with subtle partial intercalation.  Mol. properties and drug likeness profile were assessed for the ligands and all the Lipinski's rules were found to be obeyed.  The antimicrobial potential of ligands and their Cu(II) & Zn(II) complexes were screened against some notably important pathogens viz., E. coli, S. aureus, P. aeruginosa, B. subtilis, and C. albicans.  The cytotoxicity of the complexes [C30H20Cl2CuN5O7S2], [C30H20CuF2N5O7S2], [C30H20Cl2N4O4S2Zn], and [C30H20F2N5O7S2Zn] were evaluated against five human cancer cell lines viz., MCF-7 (breast), MIA-PA-CA-2 (pancreatic), HeLa (cervix) and Hep-G2 (Hepatoma) and A498 (Kidney) by SRB assay which revealed that chloro-substituted [C30H20Cl2CuN5O7S2] complex, exhibited pronounced specific cytotoxicity with GI50 value of 4.8μg/mL against HeLa cell line.  Mol. docking studies were also performed to explore the binding modes and orientation of the complexes in the DNA helix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQhDB9EeRQBbVg90H21EOLACvtfcHk0lib14NeEZ0Nng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovFyrsrg%253D&md5=0a85d1a783d04233d3d763dcc80db01f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1080%2F07391102.2018.1467794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2018.1467794%26sid%3Dliteratum%253Aachs%26aulast%3DZehra%26aufirst%3DS.%26aulast%3DShavez%2BKhan%26aufirst%3DM.%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DArjmand%26aufirst%3DF.%26atitle%3DNew%2520tailored%2520substituted%2520benzothiazole%2520Schiff%2520base%2520Cu%2528II%2529%252FZn%2528II%2529%2520antitumor%2520drug%2520entities%253A%2520effect%2520of%2520substituents%2520on%2520DNA%2520binding%2520profile%252C%2520antimicrobial%2520and%2520cytotoxic%2520activity%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2019%26volume%3D37%26spage%3D1863%26epage%3D1879%26doi%3D10.1080%2F07391102.2018.1467794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marengo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forciniti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dando, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalla Pozza, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsapis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagoubi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heeschen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arpicco, S.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2018.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.bbagen.2018.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=30267751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOjsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2019&pages=61-72&author=A.+Marengoauthor=S.+Forcinitiauthor=I.+Dandoauthor=E.+Dalla+Pozzaauthor=B.+Stellaauthor=N.+Tsapisauthor=N.+Yagoubiauthor=G.+Fanelliauthor=E.+Fattalauthor=C.+Heeschenauthor=M.+Palmieriauthor=S.+Arpicco&title=Pancreatic+cancer+stem+cell+proliferation+is+strongly+inhibited+by+diethyldithiocarbamate-copper+complex+loaded+into+hyaluronic+acid+decorated+liposomes&doi=10.1016%2Fj.bbagen.2018.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes</span></div><div class="casAuthors">Marengo, Alessandro; Forciniti, Stefania; Dando, Ilaria; Dalla Pozza, Elisa; Stella, Barbara; Tsapis, Nicolas; Yagoubi, Najet; Fanelli, Giuseppina; Fattal, Elias; Heeschen, Christopher; Palmieri, Marta; Arpicco, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-72</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pancreatic cancer stem cells (CSCs) are responsible for resistance to std. therapy, metastatic potential, and disease relapse following treatments.  The current therapy for pancreatic ductal adenocarcinoma (PDAC) preferentially targets the more differentiated cancer cell population, leaving CSCs as a cell source for tumor mass formation and recurrence.  For this reason, there is an urgent need to improve current therapies and develop novel CSC-targeted therapeutic approaches.  Hyaluronic acid (HA) decorated liposomes, contg. diethyldithiocarbamate-copper (Cu(DDC)2), able to target the specific CSC marker CD44 receptor were prepd. by ion gradient technique and fully characterized.  Their antiproliferative effect was evaluated on pancreatic CSCs derived from PDAC cell lines or patients.  To clarify the mechanism of action of Cu(DDC)2 liposomes, ROS level neutralization assay in the presence of N-acetyl-L-cysteine was performed.  Liposomes showed high encapsulation efficiency and Cryo-TEM anal. revealed the presence of Cu(DDC)2 crystals in the aq. core of liposomes.  In vitro test on pancreatic CSCs derived from PDAC cell lines or patients showed high ROS mediated anticancer activity of HA decorated liposomes.  The sphere formation capability of CSCs obtained from patients was drastically reduced by liposomal formulations contg. Cu(DDC)2.  The obtained results show that the encapsulation of Cu(DDC)2 complex in HA decorated liposomes strongly increases its anti-proliferative activity on pancreatic CSCs.  This paper describes for the first time the use of HA decorated liposomes contg. Cu(DDC)2 against pancreatic CSCs and opens the way to the development of nanomedicine based CSC-targeted therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemmNDNpJB_rVg90H21EOLACvtfcHk0lib14NeEZ0Nng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOjsbfN&md5=e9a7f71a202fe31210cd52568d8f46c7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2018.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2018.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DMarengo%26aufirst%3DA.%26aulast%3DForciniti%26aufirst%3DS.%26aulast%3DDando%26aufirst%3DI.%26aulast%3DDalla%2BPozza%26aufirst%3DE.%26aulast%3DStella%26aufirst%3DB.%26aulast%3DTsapis%26aufirst%3DN.%26aulast%3DYagoubi%26aufirst%3DN.%26aulast%3DFanelli%26aufirst%3DG.%26aulast%3DFattal%26aufirst%3DE.%26aulast%3DHeeschen%26aufirst%3DC.%26aulast%3DPalmieri%26aufirst%3DM.%26aulast%3DArpicco%26aufirst%3DS.%26atitle%3DPancreatic%2520cancer%2520stem%2520cell%2520proliferation%2520is%2520strongly%2520inhibited%2520by%2520diethyldithiocarbamate-copper%2520complex%2520loaded%2520into%2520hyaluronic%2520acid%2520decorated%2520liposomes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2019%26volume%3D1863%26spage%3D61%26epage%3D72%26doi%3D10.1016%2Fj.bbagen.2018.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hurtado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankpal, U. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhabra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maram, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurung, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basha, R.</span></span> <span> </span><span class="NLM_article-title">Copper-tolfenamic acid: evaluation of stability and anti-cancer activity</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1007/s10637-018-0594-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1007%2Fs10637-018-0594-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=29761244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVCktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=27-34&author=M.+Hurtadoauthor=U.+T.+Sankpalauthor=J.+Chhabraauthor=D.+T.+Brownauthor=R.+Maramauthor=R.+Patelauthor=R.+K.+Gurungauthor=J.+Simeckaauthor=A.+A.+Holderauthor=R.+Basha&title=Copper-tolfenamic+acid%3A+evaluation+of+stability+and+anti-cancer+activity&doi=10.1007%2Fs10637-018-0594-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-tolfenamic acid: evaluation of stability and anti-cancer activity</span></div><div class="casAuthors">Hurtado, Myrna; Sankpal, Umesh T.; Chhabra, Jaya; Brown, Deondra T.; Maram, Rajasekhar; Patel, Rafid; Gurung, Raj K.; Simecka, Jerry; Holder, Alvin A.; Basha, Riyaz</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-34</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The non-steroidal anti-inflammatory drug, Tolfenamic acid (TA) acts as an anti-cancer agent in several adult and pediatric cancer models.  Copper (Cu) is an important element with multiple biol. functions and has gained interest in medical applications.  Recently, [Cu(TA)2(bpy)] (Cu-TA) has been synthesized in order to enhance therapeutic activity.  In this study, we synthesized Cu-TA using an established method, characterized it by UV visible spectroscopy and Fourier-transform IR spectroscopy (FTIR), and tested its anti-cancer activity using twelve cell lines representing various cancers, such as Ewing sarcoma, glioblastoma, medulloblastoma, neuroblastoma, pancreatic and prostate.  The anti-proliferative activity of Cu-TA was detd. at 48 h post-treatment and compared with the parental compd., TA.  The IC50 values were calcd. using GraphPad Prism software.  The biol. stability of Cu-TA was evaluated using twelve-month-old powder and six-month-old stock soln.  Cardiomyocytes (H9C2) were used to test the cytotoxicity in non-malignant cells.  Cu-TA showed higher anti-proliferative activity, and the IC50 values were 30 to 80% lower when compared with TA.  H9C2 cells were non-responsive to Cu-TA, suggesting that it is selective towards malignant cells.  Comparison of the twelve-month-old powder and six-month-old stock soln. using the Panc1 cell line showed similar IC50 values (<5% variation), confirming the stability of Cu-TA either in powder or soln. form.  These findings demonstrate the potential of Cu-TA as an effective anti-cancer agent.  Further studies to delineate the detailed mechanism of action of Cu-TA for specific cancer model are underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ8IluDhKMObVg90H21EOLACvtfcHk0ljqFDCkWYjkVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVCktL0%253D&md5=968ed3d7b1606e97ea0211a27f1a442c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs10637-018-0594-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-018-0594-9%26sid%3Dliteratum%253Aachs%26aulast%3DHurtado%26aufirst%3DM.%26aulast%3DSankpal%26aufirst%3DU.%2BT.%26aulast%3DChhabra%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%2BT.%26aulast%3DMaram%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DGurung%26aufirst%3DR.%2BK.%26aulast%3DSimecka%26aufirst%3DJ.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DBasha%26aufirst%3DR.%26atitle%3DCopper-tolfenamic%2520acid%253A%2520evaluation%2520of%2520stability%2520and%2520anti-cancer%2520activity%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2019%26volume%3D37%26spage%3D27%26epage%3D34%26doi%3D10.1007%2Fs10637-018-0594-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carcelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelosi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvalaio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogolino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: unravelling an unexplored pharmacological target</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">112266</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ejmech.2020.112266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=32248006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsVSnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2020&pages=112266&author=M.+Carcelliauthor=M.+Tegoniauthor=J.+Bartoliauthor=C.+Marzanoauthor=G.+Pelosiauthor=M.+Salvalaioauthor=D.+Rogolinoauthor=V.+Gandin&title=In+vitro+and+in+vivo+anticancer+activity+of+tridentate+thiosemicarbazone+copper+complexes%3A+unravelling+an+unexplored+pharmacological+target&doi=10.1016%2Fj.ejmech.2020.112266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target</span></div><div class="casAuthors">Carcelli, Mauro; Tegoni, Matteo; Bartoli, Jennifer; Marzano, Cristina; Pelosi, Giorgio; Salvalaio, Marika; Rogolino, Dominga; Gandin, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112266</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Certain metal complexes can have a great antitumor activity, as the use of cisplatin in therapy was demonstrating for the past fifty years.  Copper complexes, in particular, have attracted much attention as an example of anticancer compds. based on an endogenous metal.  The authors present the synthesis and the activity of copper(II) complexes with variously substituted salicylaldehyde thiosemicarbazone ligands.  The in vitro activity of both ligands and copper complexes was assessed on a panel of cell lines (HCT-15, LoVo and LoVo oxaliplatin resistant colon carcinoma, A375 melanoma, BxPC3 and PSN1 pancreatic adenocarcinoma, BCPAP thyroid carcinoma, 2008 ovarian carcinoma, HEK293 nontransformed embryonic kidney), highlighting remarkable activity of the metal complexes, in some cases in the low nanomolar range.  The copper(II) complexes were also screened, with good results, against 3-dimensional spheroids of colon (HCT-15) and pancreatic (PSN1) cancer cells.  Detailed investigations on the mechanism of action of the copper(II) complexes are also reported: they are able to potently inhibit Protein Disulfide Isomerase, a copper-binding protein, that is recently emerging as a new therapeutic target for cancer treatment.  Good preliminary results obtained in C57BL mice indicate that this series of metal-based compds. could be a very promising weapon in the fight against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrurXkEWmFrs7Vg90H21EOLACvtfcHk0ljqFDCkWYjkVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsVSnsbc%253D&md5=9d9343877d2df2fa42e9a9972497a7ef</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112266%26sid%3Dliteratum%253Aachs%26aulast%3DCarcelli%26aufirst%3DM.%26aulast%3DTegoni%26aufirst%3DM.%26aulast%3DBartoli%26aufirst%3DJ.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DPelosi%26aufirst%3DG.%26aulast%3DSalvalaio%26aufirst%3DM.%26aulast%3DRogolino%26aufirst%3DD.%26aulast%3DGandin%26aufirst%3DV.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520anticancer%2520activity%2520of%2520tridentate%2520thiosemicarbazone%2520copper%2520complexes%253A%2520unravelling%2520an%2520unexplored%2520pharmacological%2520target%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D194%26spage%3D112266%26doi%3D10.1016%2Fj.ejmech.2020.112266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komarnicka, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozieł, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabierowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruszyński, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesiów, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyzioł, A.</span></span> <span> </span><span class="NLM_article-title">Copper(I) complexes with phosphines P(<i>p</i>-OCH<sub>3</sub>-Ph)<sub>2</sub>CH<sub>2</sub>OH and P(<i>p</i>-OCH<sub>3</sub>-Ph)<sub>2</sub>CH<sub>2</sub>SarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitro antiproliferative activity</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">110926</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2019.110926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.jinorgbio.2019.110926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=31759264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1arsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2020&pages=110926&author=U.+K.+Komarnickaauthor=S.+Kozie%C5%82author=P.+Zabierowskiauthor=R.+Kruszy%C5%84skiauthor=M.+K.+Lesi%C3%B3wauthor=F.+Tisatoauthor=M.+Porchiaauthor=A.+Kyzio%C5%82&title=Copper%28I%29+complexes+with+phosphines+P%28p-OCH3-Ph%292CH2OH+and+P%28p-OCH3-Ph%292CH2SarGly.+Synthesis%2C+multimodal+DNA+interactions%2C+and+prooxidative+and+in+vitro+antiproliferative+activity&doi=10.1016%2Fj.jinorgbio.2019.110926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I) complexes with phosphines P(p-OCH3-Ph)2CH2OH and P(p-OCH3-Ph)2CH2SarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitro antiproliferative activity</span></div><div class="casAuthors">Komarnicka, Urszula K.; Koziel, Sandra; Zabierowski, Piotr; Kruszynski, Rafal; Lesiow, Monika K.; Tisato, Francesco; Porchia, Marina; Kyziol, Agnieszka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110926</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phosphonium salt (p-OCH3-Ph)2P(CH2OH)2Cl (MPOHC), derived phosphine ligands without and with SarGly (Sarcosine-Glycine) peptide carrier P(p-OCH3-Ph)2CH2OH (MPOH) and P(p-OCH3-Ph)2CH2SarGly (MPSG), resp., and two copper(I) complexes [Cu(I)(dmp)(MPOH)] (1-MPOH; dmp = (2,9-dimethyl-1,10-phenanthroline)) and [Cu(I)(dmp)(MPSG)] (1-MPSG) were synthesized.  The resulting compds. were characterized by elemental anal., 1-dimensional and 2-dimensional NMR and UV-visible absorption spectroscopies, mass spectrometry, cyclic voltammetry and by x-ray diffraction anal.  Cytotoxicity of all compds. was evaluated in vitro against colon, lung, breast, pancreatic, prostate tumor cell lines, as well as towards nontumor cell lines: lung, kidney and keratinocyte.  Stable in biol. medium in the presence of atm. oxygen, Cu(I) complexes exerted a cytotoxic effect higher than that elicited by cisplatin against tested cancer cell lines.  The introduction of methoxy group onto the Ph rings of the phosphine ligand coordinated to the copper(I) ion resulted in a relevant increase of cytotoxicity in the case of breast, pancreatic and prostate tumor cell lines in vitro.  Attachment of a peptide carrier significantly increased the selectivity towards cancer cells.  Fluorescence spectroscopic data (calf thymus DNA: CT-DNA) titrn., together with anal. of DNA fragmentation (gel electrophoresis) and mol. docking provided evidence for the multimodal interaction of copper compds. with DNA and showed their unusual low genotoxicity.  Addnl., copper complexes were able to generate reactive oxygen species as a result of redox processes, proved by fluorescence spectroscopy and cyclic voltamperometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNk0iHbW1uarVg90H21EOLACvtfcHk0li4dIhDtHsFEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1arsr%252FO&md5=da340706fba82392213bac7cb8885dff</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2019.110926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2019.110926%26sid%3Dliteratum%253Aachs%26aulast%3DKomarnicka%26aufirst%3DU.%2BK.%26aulast%3DKozie%25C5%2582%26aufirst%3DS.%26aulast%3DZabierowski%26aufirst%3DP.%26aulast%3DKruszy%25C5%2584ski%26aufirst%3DR.%26aulast%3DLesi%25C3%25B3w%26aufirst%3DM.%2BK.%26aulast%3DTisato%26aufirst%3DF.%26aulast%3DPorchia%26aufirst%3DM.%26aulast%3DKyzio%25C5%2582%26aufirst%3DA.%26atitle%3DCopper%2528I%2529%2520complexes%2520with%2520phosphines%2520P%2528p-OCH3-Ph%25292CH2OH%2520and%2520P%2528p-OCH3-Ph%25292CH2SarGly.%2520Synthesis%252C%2520multimodal%2520DNA%2520interactions%252C%2520and%2520prooxidative%2520and%2520in%2520vitro%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2020%26volume%3D203%26spage%3D110926%26doi%3D10.1016%2Fj.jinorgbio.2019.110926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barve, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adsule, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katiyar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anson, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, F. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3800</span>– <span class="NLM_lpage">3808</span>, <span class="refDoi"> DOI: 10.1021/jm051068y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051068y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3800-3808&author=V.+Barveauthor=F.+Ahmedauthor=S.+Adsuleauthor=S.+Banerjeeauthor=S.+Kulkarniauthor=P.+Katiyarauthor=C.+E.+Ansonauthor=A.+K.+Powellauthor=S.+Padhyeauthor=F.+H.+Sarkar&title=Synthesis%2C+molecular+characterization%2C+and+biological+activity+of+novel+synthetic+derivatives+of+chromen-4-one+in+human+cancer+cells&doi=10.1021%2Fjm051068y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Molecular Characterization, and Biological Activity of Novel Synthetic Derivatives of Chromen-4-one in Human Cancer Cells</span></div><div class="casAuthors">Barve, Vivek; Ahmed, Fakhara; Adsule, Shreelekha; Banerjee, Sanjeev; Kulkarni, Sudhir; Katiyar, Prashant; Anson, Christopher E.; Powell, Annie K.; Padhye, Subhash; Sarkar, Fazlul H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3800-3808</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and characterization of Schiff base derivs. of 3-formylchromone 3-6 (FPA-120 to FPA-123), the minimal biol. active structural motif of soy isoflavone, genistein, and their copper(II) complexes 7-10 (FPA-124 to FPA-127) are reported here.  These copper complexes possess distorted square-planar geometries capable of stabilizing Cu2+/Cu+ redox forms.  The mol. modeling study revealed that the key interaction of the metal complexes was with amino acids in the pleckstrin homol. (PH) and the kinase domain of the PKB (Akt) protein.  Copper complex 7 (I) significantly forms stronger charge interactions in the kinase domain than genistein, leading to better stabilization in the active pocket.  In vitro evaluation of copper complexes against hormone-independent and metastatic breast (BT20), prostate (PC-3), and K-ras mutant (COLO 357) and K-ras wild-type (BxPC-3) pancreatic cancer cells revealed that 7 was the most potent compd. which exhibited PKB (Akt protein) inhibitory activities and caused NF-κB inactivation in a well-established orthotopic pancreatic tumor model using COLO 357 cells.  An inverse relationship was obsd. between IC50 values of the anti-proliferative activities and the Cu2+/Cu+ redox couple for these compds., which may provide a rapid screen for evaluating the efficacy of active metallodrugs affecting redox-sensitive transcription factors such as NF-κB and its upstream target, the PKB (Akt) pathway, in multiple cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT3663-0DS5bVg90H21EOLACvtfcHk0li4dIhDtHsFEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSntbw%253D&md5=8cb10844d8e9c30393e6454206c21033</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm051068y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051068y%26sid%3Dliteratum%253Aachs%26aulast%3DBarve%26aufirst%3DV.%26aulast%3DAhmed%26aufirst%3DF.%26aulast%3DAdsule%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DKatiyar%26aufirst%3DP.%26aulast%3DAnson%26aufirst%3DC.%2BE.%26aulast%3DPowell%26aufirst%3DA.%2BK.%26aulast%3DPadhye%26aufirst%3DS.%26aulast%3DSarkar%26aufirst%3DF.%2BH.%26atitle%3DSynthesis%252C%2520molecular%2520characterization%252C%2520and%2520biological%2520activity%2520of%2520novel%2520synthetic%2520derivatives%2520of%2520chromen-4-one%2520in%2520human%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3800%26epage%3D3808%26doi%3D10.1021%2Fjm051068y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adsule, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, F. H.</span></span> <span> </span><span class="NLM_article-title">A novel copper complex of 3-benzoyl-alpha methyl benzene acetic acid with antitumor activity mediated via cyclooxygenase pathway</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1002/ijc.22383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1002%2Fijc.22383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=17131340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1elsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=734-742&author=F.+Ahmedauthor=S.+Adsuleauthor=A.+S.+Aliauthor=S.+Banerjeeauthor=S.+Aliauthor=S.+Kulkarniauthor=S.+Padhyeauthor=F.+H.+Sarkar&title=A+novel+copper+complex+of+3-benzoyl-alpha+methyl+benzene+acetic+acid+with+antitumor+activity+mediated+via+cyclooxygenase+pathway&doi=10.1002%2Fijc.22383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A novel copper complex of 3-benzoyl-α methyl benzene acetic acid with antitumor activity mediated via cyclooxygenase pathway</span></div><div class="casAuthors">Ahmed, Fakhara; Adsule, Shreelekha; Ali, Ashhar S.; Banerjee, Sanjeev; Ali, Shadan; Kulkarni, Sudhir; Padhye, Subhash; Sarkar, Fazlul H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">734-742</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Pancreatic cancer (PC) is characterized as one of the deadliest malignancies and its treatment is a great challenge to clin. oncologists.  Expression of COX-2 is detectable in 75% of PCs among which 50% showed overexpression, suggesting the importance of COX-2 enzyme and its metabolic product prostaglandin E2 (PGE2) in PC.  Here the authors report the synthesis and biol. activity of a novel COX-2 inhibitor, FPA-306, and its effects on PC cells with different levels of COX-2 expression.  Using MTT assay, the authors found a significant growth inhibition of BxPC-3 cells treated by FPA-306 with an IC50 of 10 μmol/L, which was lower than that of ketoprofen (IC50 = 35.4 μmol/L) and celecoxib (IC50 > 100 μmol/L).  There was no such effect found in MIAPaCa cell line, which does not express COX-2.  The authors also found dose dependent redn. in cell survival and induction of apoptosis by FPA-306 treatment in BxPC-3 cells but not in MIAPaCa cells.  These results were correlated with apoptosis data and secreted PGE2 levels.  The mol. modeling of FPA-306 in the COX-2 active site showed that FPA-306 is potentially able to inhibit the activity of enzyme by blocking the active site, thereby resulting in decreased PGE2 prodn.  The authors also found a significant redn. of COX-2 at the mRNA and protein levels together with downregulation of NF-κB DNA binding activity and its downstream genes, Bcl-2 and survivin.  These results suggest that FPA-306 is an effective and potent agent in inhibiting the growth of PC cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYHBmDSiYoZLVg90H21EOLACvtfcHk0limb8NwaxW2fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1elsbo%253D&md5=260dd6152c170b5879c2eb4eefdc17e8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fijc.22383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22383%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DF.%26aulast%3DAdsule%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DA.%2BS.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DPadhye%26aufirst%3DS.%26aulast%3DSarkar%26aufirst%3DF.%2BH.%26atitle%3DA%2520novel%2520copper%2520complex%2520of%25203-benzoyl-alpha%2520methyl%2520benzene%2520acetic%2520acid%2520with%2520antitumor%2520activity%2520mediated%2520via%2520cyclooxygenase%2520pathway%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D120%26spage%3D734%26epage%3D742%26doi%3D10.1002%2Fijc.22383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ambike, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adsule, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afrasiabi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhye, S.</span></span> <span> </span><span class="NLM_article-title">Copper conjugates of nimesulide Schiff bases targeting VEGF, COX and Bcl-2 in pancreatic cancer cells</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1517</span>– <span class="NLM_lpage">1524</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2007.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.jinorgbio.2007.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=17689613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWht7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1517-1524&author=V.+Ambikeauthor=S.+Adsuleauthor=F.+Ahmedauthor=Z.+Wangauthor=Z.+Afrasiabiauthor=E.+Sinnauthor=F.+Sarkarauthor=S.+Padhye&title=Copper+conjugates+of+nimesulide+Schiff+bases+targeting+VEGF%2C+COX+and+Bcl-2+in+pancreatic+cancer+cells&doi=10.1016%2Fj.jinorgbio.2007.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Copper conjugates of nimesulide Schiff bases targeting VEGF, COX and Bcl-2 in pancreatic cancer cells</span></div><div class="casAuthors">Ambike, Vinita; Adsule, Shreelekha; Ahmed, Fakhara; Wang, Zhiwei; Afrasiabi, Zahra; Sinn, Ekkehard; Sarkar, Fazlul; Padhye, Subhash</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1517-1524</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Copper conjugates of Schiff base derivs. of nimesulide (1), a well-known cyclooxygenase-2 (COX-2) inhibitor, were synthesized, structurally characterized and evaluated for their COX selectivity indexes and cytotoxicities on pancreatic tumor, BxPC-3 (COX-2 pos.) and MiaPaCa (COX-2 neg.) cell lines.  Copper conjugates exhibit distorted square planar geometries as revealed by the single crystal x-ray structure detn. of Cu(L1)2 and show significant growth inhibition in both cell lines (IC50 values 3-26 μM for COX-2 pos. and 5-9 μM for COX-2 neg. cell line) than the parent nimesulide (35 μM for COX-2 pos. and >100 μM for COX-2 neg. cell line).  The mechanistic pathway for the biol. activity involves inhibition of vascular endothelial growth factor (VEGF) and COX inhibition, as well as down regulation of antiapoptotic Bcl-2 and Bcl-XL proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruEWvseaLBwrVg90H21EOLACvtfcHk0limb8NwaxW2fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWht7nE&md5=26c22862200341541e3f0e5953a2fefd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2007.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2007.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DAmbike%26aufirst%3DV.%26aulast%3DAdsule%26aufirst%3DS.%26aulast%3DAhmed%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DAfrasiabi%26aufirst%3DZ.%26aulast%3DSinn%26aufirst%3DE.%26aulast%3DSarkar%26aufirst%3DF.%26aulast%3DPadhye%26aufirst%3DS.%26atitle%3DCopper%2520conjugates%2520of%2520nimesulide%2520Schiff%2520bases%2520targeting%2520VEGF%252C%2520COX%2520and%2520Bcl-2%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2007%26volume%3D101%26spage%3D1517%26epage%3D1524%26doi%3D10.1016%2Fj.jinorgbio.2007.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span> <span> </span><span class="NLM_article-title">A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2013.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.taap.2013.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=24060341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsl2jsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2013&pages=477-483&author=J.+Hanauthor=L.+Liuauthor=X.+Yueauthor=J.+Changauthor=W.+Shiauthor=Y.+Hua&title=A+binuclear+complex+constituted+by+diethyldithiocarbamate+and+copper%28I%29+functions+as+a+proteasome+activity+inhibitor+in+pancreatic+cancer+cultures+and+xenografts&doi=10.1016%2Fj.taap.2013.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts</span></div><div class="casAuthors">Han, Jinbin; Liu, Luming; Yue, Xiaoqiang; Chang, Jinjia; Shi, Weidong; Hua, Yongqiang</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">477-483</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">It is a therapeutic strategy for cancers including pancreatic to inhibit proteasome activity.  Disulfiram (DSF) may bind copper (Cu) to form a DSF-Cu complex.  DSF-Cu is capable of inducing apoptosis in cancer cells by inhibiting proteasome activity.  DSF is rapidly converted to diethyldithiocarbamate (DDTC) within bodies.  Copper(II) absorbed by bodies is reduced to copper(I) when it enters cells.  We found that DDTC and copper(I) could form a binuclear complex which might be entitled DDTC-Cu(I), and it had been synthesized by us in the lab.  This study is to investigate the anticancer potential of this complex on pancreatic cancer and the possible mechanism.  Pancreatic cancer cell lines, SW1990, PANC-1 and BXPC-3 were used for in vitro assays.  Female athymic nude mice grown SW1990 xenografts were used as animal models.  Cell counting kit-8 (cck-8) assay and flow cytometry were used for analyzing apoptosis in cells.  A 20S proteasome assay kit was used in proteasome activity anal.  Western blot (WB) and immunohistochem. (IHC) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays were used in tumor sample anal.  The results suggest that DDTC-Cu(I) inhibit pancreatic cancer cell proliferation and proteasome activity in vitro and in vivo.  Accumulation of ubiquitinated proteins, and increased p27 as well as decreased NF-κB expression were detected in tumor tissues of DDTC-Cu(I)-treated group.  Our data indicates that DDTC-Cu(I) is an effective proteasome activity inhibitor with the potential to be explored as a drug for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAwfQ0CZmqRbVg90H21EOLACvtfcHk0lixOpwbr5ryug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsl2jsL7O&md5=f60b1591a4990453aa59d8899ced34f7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DYue%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DHua%26aufirst%3DY.%26atitle%3DA%2520binuclear%2520complex%2520constituted%2520by%2520diethyldithiocarbamate%2520and%2520copper%2528I%2529%2520functions%2520as%2520a%2520proteasome%2520activity%2520inhibitor%2520in%2520pancreatic%2520cancer%2520cultures%2520and%2520xenografts%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D273%26spage%3D477%26epage%3D483%26doi%3D10.1016%2Fj.taap.2013.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montagner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erxleben, A.</span></span> <span> </span><span class="NLM_article-title">DNA damage and induction of apoptosis in pancreatic cancer cells by a new dinuclear bis(triazacyclonane) copper complex</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2015.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.jinorgbio.2015.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=25660211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslersbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2015&pages=101-107&author=D.+Montagnerauthor=V.+Gandinauthor=C.+Marzanoauthor=A.+Erxleben&title=DNA+damage+and+induction+of+apoptosis+in+pancreatic+cancer+cells+by+a+new+dinuclear+bis%28triazacyclonane%29+copper+complex&doi=10.1016%2Fj.jinorgbio.2015.01.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">DNA damage and induction of apoptosis in pancreatic cancer cells by a new dinuclear bis(triazacyclonane) copper complex</span></div><div class="casAuthors">Montagner, Diego; Gandin, Valentina; Marzano, Cristina; Erxleben, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-107</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The dinuclear copper(II) complex [Cu2{bcmp(-H)}(μ-OH)](NO3)2·H2O (1, bcmp = 2,6-bis(1,4,7-triazacyclonon-1-ylmethyl)-4-methylphenol) has been synthesized and characterized by electrospray ionization mass spectrometry, potentiometric titrn. and cyclovoltammetry.  The X-ray structure of the analogous perchlorate salt [Cu2{bcmp(-H)}(μ-OH)](ClO4)2·2.5H2O (2) was detd.  Cytotoxicity studies showed very promising activity of 1 against various pancreatic tumor cell lines with IC50 values comparable or even lower than those of cisplatin.  The Cu complex displayed low toxicity against a human non-tumor cell line (HEK 293) demonstrating selectivity for cancer cells. 1 converts supercoiled pUC19 plasmid DNA into the nicked form at micromolar concns. in the absence of added reductants.  A detailed kinetic study on the hydrolysis of the DNA model bis(2,4-dinitrophenyl) phosphate (BDNPP) has been performed, 1 hydrolyzes BDNPP with a second order rate const. of 0.047 M s- 1 at pH 8 and 40 °C.  Finally, single cell electrophoresis (comet assay) and fluorescence microscopy anal. showed that 1 interacts with cellular DNA and induces apoptotic cell death of Capan-1 pancreatic cancer cells.  Western blotting anal. indicated that the Cu complex activates the p53 dependent pathway of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl0ammGhmjg7Vg90H21EOLACvtfcHk0lixOpwbr5ryug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslersbg%253D&md5=61d98655db5ea30e8ed0369149d7a679</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2015.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2015.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DMontagner%26aufirst%3DD.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DErxleben%26aufirst%3DA.%26atitle%3DDNA%2520damage%2520and%2520induction%2520of%2520apoptosis%2520in%2520pancreatic%2520cancer%2520cells%2520by%2520a%2520new%2520dinuclear%2520bis%2528triazacyclonane%2529%2520copper%2520complex%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2015%26volume%3D145%26spage%3D101%26epage%3D107%26doi%3D10.1016%2Fj.jinorgbio.2015.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hurtado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankpal, U. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahammad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhabra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurung, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwanatha, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basha, R.</span></span> <span> </span><span class="NLM_article-title">Novel survivin inhibitor for suppressing pancreatic cancer cells growth via downregulating Sp1 and Sp3 transcription factors</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1894</span>– <span class="NLM_lpage">1907</span>, <span class="refDoi"> DOI: 10.1159/000495715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1159%2F000495715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=30504717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFWrtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&pages=1894-1907&author=M.+Hurtadoauthor=U.+T.+Sankpalauthor=A.+Kabaauthor=S.+Mahammadauthor=J.+Chhabraauthor=D.+T.+Brownauthor=R.+K.+Gurungauthor=A.+A.+Holderauthor=J.+K.+Vishwanathaauthor=R.+Basha&title=Novel+survivin+inhibitor+for+suppressing+pancreatic+cancer+cells+growth+via+downregulating+Sp1+and+Sp3+transcription+factors&doi=10.1159%2F000495715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors</span></div><div class="casAuthors">Hurtado, Myrna; Sankpal, Umesh T.; Kaba, Aboubacar; Mahammad, Shahela; Chhabra, Jaya; Brown, Deondra T.; Gurung, Raj K.; Holder, Alvin A.; Vishwanatha, Jamboor K.; Basha, Riyaz</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1894-1907</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">In this study, the ability of Cu-TA to inhibit survivin and its transcription factors, Specificity protein (Sp) 1 and 3 in PaCa cell lines and tumor growth in mouse xenograft model were evaluated.  Methods: Cell growth inhibition was measured in MIA PaCa-2 and Panc1 cells for 2 days using CellTiter-Glo kit.  Sp1, Sp3 and survivin expression (by Western blot and qPCR), apoptotic cells and cell cycle phase distribution (by flow cytometry) were evaluated.  A pilot study was performed using athymic nude mice [treated with vehicle/Cu-TA (25 or 50 mg/kg) 3 times/wk for 4 wk. Results: The IC50 value for Cu-TA was about half than TA.Both agents repressed the protein expression of Sp1/Sp3/survivin, Cu-TA was more effective than TA.  Esp. effect on survivin inhibition was 5.2 (MIA PaCa-2) or 6.4 (Panc1) fold higher and mRNA expression of only survivin was decreased.  Apoptotic cells increased with Cu-TA treatment in both cell lines, while Panc1 showed both effect on apoptosis and cell cycle (G2/M) arrest.  Cu-TA decreased the tumor growth in mouse xenografts (25 mg/kg: 48%; 50 mg/kg: 68%).  Addnl., there was no change obsd. in mice body wts., indicating no overt toxicity was occurring.  Conclusion: These results show that Cu-TA can serve as an effective survivin inhibitor for inhibiting PaCa cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsYtZG5AsuIrVg90H21EOLACvtfcHk0ljlMHP2o6soXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFWrtL%252FF&md5=8e4b56f4b7a7f534fd1feff7c4057f14</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1159%2F000495715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000495715%26sid%3Dliteratum%253Aachs%26aulast%3DHurtado%26aufirst%3DM.%26aulast%3DSankpal%26aufirst%3DU.%2BT.%26aulast%3DKaba%26aufirst%3DA.%26aulast%3DMahammad%26aufirst%3DS.%26aulast%3DChhabra%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%2BT.%26aulast%3DGurung%26aufirst%3DR.%2BK.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DVishwanatha%26aufirst%3DJ.%2BK.%26aulast%3DBasha%26aufirst%3DR.%26atitle%3DNovel%2520survivin%2520inhibitor%2520for%2520suppressing%2520pancreatic%2520cancer%2520cells%2520growth%2520via%2520downregulating%2520Sp1%2520and%2520Sp3%2520transcription%2520factors%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2018%26volume%3D51%26spage%3D1894%26epage%3D1907%26doi%3D10.1159%2F000495715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLeo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadagopan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1266</span>– <span class="NLM_lpage">1281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=31285958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFCjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1266-1281&author=X.+Zhangauthor=P.+Huauthor=S.+Y.+Dingauthor=T.+Sunauthor=L.+Liuauthor=S.+Hanauthor=A.+B.+DeLeoauthor=A.+Sadagopanauthor=W.+Guoauthor=X.+Wang&title=Induction+of+autophagy-dependent+apoptosis+in+cancer+cells+through+activation+of+ER+stress%3A+an+uncovered+anti-cancer+mechanism+by+anti-alcoholism+drug+disulfiram"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram</span></div><div class="casAuthors">Zhang, Xiao; Hu, Pan; Ding, Shi-Ying; Sun, Ting; Liu, Ling; Han, Shiwei; De Leo, Albert B.; Sadagopan, Ananthan; Guo, Wei; Wang, Xinhui</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1266-1284</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Due to its potent anticancer activity, there is interest in repurposing of the FDA-approved anti-alcoholism drug, disulfiram (DSF).  DSF forms potent complexes with copper (DSF/Cu) that induce apoptosis of many types of cancer cells.  Here, we investigated the role of DSF/Cu in autophagy, a mechanism of cell death or survival, and its interplay with DSF/Cu induced apoptosis of human pancreatic and breast cancer cells.  Methods: Levels of autophagy and apoptosis were assessed by Western blot, flow cytometry and immunofluorescence anal.  Cell viability was measured by MTT assays.  Activation of inositol-requiring enzyme 1α (IRE1α)-mRNA X-box binding protein 1 (XBP1) pathway and spliced XBP1 (XBP1s) expression were analyzed by Western blot, Phos-tag gel assay, RT-PCR, qRT-PCR and flow cytometry.  Results: The apoptosis induced by DSF/Cu in pancreatic and breast cancer cells is autophagy dependent.  This is accomplished by activating IRE1α, the sensor of unfolded protein response (UPR) via promotion of phosphorylation of IRE1α and its downstream XBP1 splicing into active XBP1s.  Conclusions: DSF/Cu induces ER-stress through activation of IRE1α-XBP1 pathway which is responsible, at least in part, for induction of autophagy-dependent apoptosis of cancer cells.  Insight into the ER-stress inducing ability by DSF/Cu may open a new research area for rational design of innovative therapeutic strategies for pancreatic and breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVhV7MC5KyhrVg90H21EOLACvtfcHk0ljlMHP2o6soXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFCjtLk%253D&md5=aab0b61fe7b99d009143e30edb4d1175</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DP.%26aulast%3DDing%26aufirst%3DS.%2BY.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DDeLeo%26aufirst%3DA.%2BB.%26aulast%3DSadagopan%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DInduction%2520of%2520autophagy-dependent%2520apoptosis%2520in%2520cancer%2520cells%2520through%2520activation%2520of%2520ER%2520stress%253A%2520an%2520uncovered%2520anti-cancer%2520mechanism%2520by%2520anti-alcoholism%2520drug%2520disulfiram%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2019%26volume%3D9%26spage%3D1266%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müerköster, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, H.</span></span> <span> </span><span class="NLM_article-title">Targeting apoptosis pathways in pancreatic cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>332</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2010.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.canlet.2010.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21078544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVWgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2013&pages=346-358&author=A.+Arltauthor=S.+S.+M%C3%BCerk%C3%B6sterauthor=H.+Sch%C3%A4fer&title=Targeting+apoptosis+pathways+in+pancreatic+cancer&doi=10.1016%2Fj.canlet.2010.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting apoptosis pathways in pancreatic cancer</span></div><div class="casAuthors">Arlt, Alexander; Mueerkoester, Susanne Sebens; Schaefer, Heiner</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">346-358</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer - here in particular pancreatic ductal adenocarcinoma (PDAC) - is still a highly therapy refractory disease.  Amongst the mechanisms by which PDAC cells could escape any non-surgical therapy, anti-apoptotic protection seems to be the most relevant one.  PDAC cells have acquired resistance to apoptotic stimuli such as death ligands (FasL, TRAIL) or anti-cancer drugs (gemcitabine) by a great no. of mol. alterations either disrupting an apoptosis inducing signal or counteracting the execution of apoptosis.  Thus, PDAC cells exhibit alterations in the EGFR/MAPK/Ras/raf1-, PI3K/Akt-, TRAIL/TRAF2-, or IKK/NF-κB pathway accompanied by deregulations in the expression of apoptosis regulators such as cIAP, Bcl2, XIAP or survivin.  Along with protection against apoptosis, PDAC cells also overexpress histone deacetylases (HDACs) giving rise to epigenetic patterns of chemoresistance and to acetylation of other regulatory proteins, as well.  With respect to the multitude of anti-apoptotic pathways, a great no. of mol. targets might be of high potential in novel therapy strategies.  Thus, natural compds. as well as novel synthetic drugs are considered to be used in single or combined therapy of PDAC.  A no. of proteasome and HDAC inhibitors or selective inhibitors of IKK, EGFR, Akt and mTOR have been widely explored in preclin. settings and clin. studies.  Even though these early studies encouraged an application in a clin. setting, most of the trials have been rather disappointing yet.  Thus, new mol. targets and novel concepts of combination therapies need to get access into clin. trials - either in neoadjuvant/adjuvant or in palliative treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2EEFfLoso_bVg90H21EOLACvtfcHk0lgo_q1fuyQPVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVWgtbc%253D&md5=ceff2d9db91ec8285f7dfb2402433892</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2010.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2010.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DArlt%26aufirst%3DA.%26aulast%3DM%25C3%25BCerk%25C3%25B6ster%26aufirst%3DS.%2BS.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DH.%26atitle%3DTargeting%2520apoptosis%2520pathways%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D332%26spage%3D346%26epage%3D358%26doi%3D10.1016%2Fj.canlet.2010.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Apoptosis pathways and their therapeutic exploitation in pancreatic cancer</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1221</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1111/j.1582-4934.2009.00748.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1111%2Fj.1582-4934.2009.00748.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=19382915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BD1Mrms12qtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=1221-1227&author=S.+Fulda&title=Apoptosis+pathways+and+their+therapeutic+exploitation+in+pancreatic+cancer&doi=10.1111%2Fj.1582-4934.2009.00748.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis pathways and their therapeutic exploitation in pancreatic cancer</span></div><div class="casAuthors">Fulda Simone</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular and molecular medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1221-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Resistance to apoptosis (programmed cell death) is a characteristic feature of human malignancies including pancreatic cancer, which is one of the leading causes of cancer deaths in the western world.  Defects in this intrinsic cell death program can contribute to the multistep process of tumorigenesis, because too little cell death can disturb tissue homeostasis.  Further, blockade of apoptosis pathways can cause treatment failure, because intact apoptosis signalling cascades largely mediate therapy-induced cytotoxicity.  The elucidation of apoptosis pathways in pancreatic carcinoma over the last decade has resulted in the identification of various molecular defects.  How apoptosis pathways can be exploited for the treatment of pancreatic cancer will be discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOqrOqwhp34WGmni0r9GoKfW6udTcc2eaP48We1KqlqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mrms12qtg%253D%253D&md5=08b1b02da3bd3bce9d7ab20052f89020</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2009.00748.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2009.00748.x%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DApoptosis%2520pathways%2520and%2520their%2520therapeutic%2520exploitation%2520in%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2009%26volume%3D13%26spage%3D1221%26epage%3D1227%26doi%3D10.1111%2Fj.1582-4934.2009.00748.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis, a new form of cell death, and its relationships with tumourous diseases</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">657</span>, <span class="refDoi"> DOI: 10.1111/jcmm.13008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1111%2Fjcmm.13008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27860262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFSisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=648-657&author=H.+Yuauthor=P.+Guoauthor=X.+Xieauthor=Y.+Wangauthor=G.+Chen&title=Ferroptosis%2C+a+new+form+of+cell+death%2C+and+its+relationships+with+tumourous+diseases&doi=10.1111%2Fjcmm.13008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis, a new form of cell death, and its relationships with tumourous diseases</span></div><div class="casAuthors">Yu, Haitao; Guo, Pengyi; Xie, Xiaozai; Wang, Yi; Chen, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">648-657</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a newly discovered type of cell death that differs from traditional apoptosis and necrosis and results from iron-dependent lipid peroxide accumulation.  Ferroptotic cell death is characterized by cytol. changes, including cell vol. shrinkage and increased mitochondrial membrane d.  Ferroptosis can be induced by two classes of small-mol. substances known as class 1 (system Xc- inhibitors) and class 2 ferroptosis inducers [glutathione peroxidase 4 (GPx4) inhibitors].  In addn. to these small-mol. substances, a no. of drugs (e.g. sorafenib, artemisinin and its derivs.) can induce ferroptosis.  Various factors, such as the mevalonate (MVA) and sulfur-transfer pathways, play pivotal roles in the regulation of ferroptosis.  Ferroptosis plays an unneglectable role in regulating the growth and proliferation of some types of tumor cells, such as lymphocytoma, ductal cell cancer of the pancreas, renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC).  Here, we will first introduce the discovery of and research pertaining to ferroptosis; then summarize the induction mechanisms and regulatory pathways of ferroptosis; and finally, further elucidate the roles of ferroptosis in human tumorous diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqonDgZpPWiSrVg90H21EOLACvtfcHk0lgo_q1fuyQPVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFSisbs%253D&md5=4e771be1d22292c9bdd96c28c61c278b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.13008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.13008%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26atitle%3DFerroptosis%252C%2520a%2520new%2520form%2520of%2520cell%2520death%252C%2520and%2520its%2520relationships%2520with%2520tumourous%2520diseases%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2017%26volume%3D21%26spage%3D648%26epage%3D657%26doi%3D10.1111%2Fjcmm.13008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemberg, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaitsev, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleason, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: an iron-dependent form of nonapoptotic cell death</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.cell.2012.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=22632970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1060-1072&author=S.+J.+Dixonauthor=K.+M.+Lembergauthor=M.+R.+Lamprechtauthor=R.+Skoutaauthor=E.+M.+Zaitsevauthor=C.+E.+Gleasonauthor=D.+N.+Patelauthor=A.+J.+Bauerauthor=A.+M.+Cantleyauthor=W.+S.+Yangauthor=B.+Morrisonauthor=B.+R.+Stockwell&title=Ferroptosis%3A+an+iron-dependent+form+of+nonapoptotic+cell+death&doi=10.1016%2Fj.cell.2012.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death</span></div><div class="casAuthors">Dixon, Scott J.; Lemberg, Kathryn M.; Lamprecht, Michael R.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Morrison, Barclay; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathol. states.  The oncogenic RAS-selective lethal small mol. erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis.  Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphol., biochem., and genetically distinct from apoptosis, necrosis, and autophagy.  We identify the small mol. ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes.  Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system xc-), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death.  Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzDzMapViBQ7Vg90H21EOLACvtfcHk0liFni5GdAWdQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D&md5=5d3b8c55a053dfde7e758cc1701ef71b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DLemberg%26aufirst%3DK.%2BM.%26aulast%3DLamprecht%26aufirst%3DM.%2BR.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DZaitsev%26aufirst%3DE.%2BM.%26aulast%3DGleason%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DD.%2BN.%26aulast%3DBauer%26aufirst%3DA.%2BJ.%26aulast%3DCantley%26aufirst%3DA.%2BM.%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520an%2520iron-dependent%2520form%2520of%2520nonapoptotic%2520cell%2520death%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1060%26epage%3D1072%26doi%3D10.1016%2Fj.cell.2012.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span> <span> </span><span class="NLM_article-title">Recent progress in ferroptosis inducers for cancer therapy</span>. <i>Adv. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1904197</span>, <span class="refDoi"> DOI: 10.1002/adma.201904197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1002%2Fadma.201904197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCnu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2019&pages=1904197&author=C.+Liangauthor=X.+Zhangauthor=M.+Yangauthor=X.+Dong&title=Recent+progress+in+ferroptosis+inducers+for+cancer+therapy&doi=10.1002%2Fadma.201904197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in Ferroptosis Inducers for Cancer Therapy</span></div><div class="casAuthors">Liang, Chen; Zhang, Xinglin; Yang, Mengsu; Dong, Xiaochen</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Materials (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">1904197</span>CODEN:
                <span class="NLM_cas:coden">ADVMEW</span>;
        ISSN:<span class="NLM_cas:issn">0935-9648</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a newly discovered form of regulated cell death that is the nexus between metab., redox biol., and human health.  Emerging evidence shows the potential of triggering ferroptosis for cancer therapy, particularly for eradicating aggressive malignancies that are resistant to traditional therapies.  Recently, there has been a great deal of effort to design and develop anticancer drugs based on ferroptosis induction.  Recent advances of ferroptosis-inducing agents at the intersection of chem., materials science, and cancer biol. are presented.  The basis of ferroptosis is summarized first to highlight the feasibility and characteristics of triggering ferroptosis for cancer therapy.  A literature review of ferroptosis inducers (including small mols. and nanomaterials) is then presented to delineate their design, action mechanisms, and anticancer applications.  Finally, some considerations for research on ferroptosis inducers are spotlighted, followed by a discussion on the challenges and future development directions of this burgeoning field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon1qimBGm0YrVg90H21EOLACvtfcHk0liFni5GdAWdQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCnu7rK&md5=c1c95f9a5231bf2e121752ecf2535cad</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fadma.201904197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadma.201904197%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DX.%26atitle%3DRecent%2520progress%2520in%2520ferroptosis%2520inducers%2520for%2520cancer%2520therapy%26jtitle%3DAdv.%2520Mater.%26date%3D2019%26volume%3D31%26spage%3D1904197%26doi%3D10.1002%2Fadma.201904197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis, a new form of cell death, and its relationships with tumourous diseases</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">657</span>, <span class="refDoi"> DOI: 10.1111/jcmm.13008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1111%2Fjcmm.13008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27860262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFSisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=648-657&author=H.+Yuauthor=P.+Guoauthor=X.+Xieauthor=Y.+Wangauthor=G.+Chen&title=Ferroptosis%2C+a+new+form+of+cell+death%2C+and+its+relationships+with+tumourous+diseases&doi=10.1111%2Fjcmm.13008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis, a new form of cell death, and its relationships with tumourous diseases</span></div><div class="casAuthors">Yu, Haitao; Guo, Pengyi; Xie, Xiaozai; Wang, Yi; Chen, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">648-657</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a newly discovered type of cell death that differs from traditional apoptosis and necrosis and results from iron-dependent lipid peroxide accumulation.  Ferroptotic cell death is characterized by cytol. changes, including cell vol. shrinkage and increased mitochondrial membrane d.  Ferroptosis can be induced by two classes of small-mol. substances known as class 1 (system Xc- inhibitors) and class 2 ferroptosis inducers [glutathione peroxidase 4 (GPx4) inhibitors].  In addn. to these small-mol. substances, a no. of drugs (e.g. sorafenib, artemisinin and its derivs.) can induce ferroptosis.  Various factors, such as the mevalonate (MVA) and sulfur-transfer pathways, play pivotal roles in the regulation of ferroptosis.  Ferroptosis plays an unneglectable role in regulating the growth and proliferation of some types of tumor cells, such as lymphocytoma, ductal cell cancer of the pancreas, renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC).  Here, we will first introduce the discovery of and research pertaining to ferroptosis; then summarize the induction mechanisms and regulatory pathways of ferroptosis; and finally, further elucidate the roles of ferroptosis in human tumorous diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqonDgZpPWiSrVg90H21EOLACvtfcHk0lgGg7zozoKBng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFSisbs%253D&md5=4e771be1d22292c9bdd96c28c61c278b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.13008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.13008%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26atitle%3DFerroptosis%252C%2520a%2520new%2520form%2520of%2520cell%2520death%252C%2520and%2520its%2520relationships%2520with%2520tumourous%2520diseases%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2017%26volume%3D21%26spage%3D648%26epage%3D657%26doi%3D10.1111%2Fjcmm.13008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: Final destination for cancer?</span>. <i>Cell Prolif.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>53</i></span>, <span class="NLM_elocation-id">e12761</span> <span class="refDoi"> DOI: 10.1111/cpr.12761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1111%2Fcpr.12761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=32100402" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2020&author=Z.+Yeauthor=W.+Liuauthor=Q.+Zhuoauthor=Q.+Huauthor=M.+Liuauthor=Q.+Sunauthor=Z.+Zhangauthor=G.+Fanauthor=W.+Xuauthor=S.+Jiauthor=X.+Yuauthor=Y.+Qinauthor=X.+Xu&title=Ferroptosis%3A+Final+destination+for+cancer%3F&doi=10.1111%2Fcpr.12761"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fcpr.12761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcpr.12761%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhuo%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DFerroptosis%253A%2520Final%2520destination%2520for%2520cancer%253F%26jtitle%3DCell%2520Prolif.%26date%3D2020%26volume%3D53%26doi%3D10.1111%2Fcpr.12761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, C.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.-H.</span></span> <span> </span><span class="NLM_article-title">Conformation restriction of nonplanar di-2-pyrimidyl sulfide with intramolecular N···C interaction and its supramolecular silver(I) complexes</span>. <i>Cryst. Growth Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1021/cg201184x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cg201184x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=376-386&author=C.-Q.+Wanauthor=Z.-J.+Wangauthor=G.+Wangauthor=H.+Liuauthor=Y.-H.+Dengauthor=Q.-H.+Jin&title=Conformation+restriction+of+nonplanar+di-2-pyrimidyl+sulfide+with+intramolecular+N%C2%B7%C2%B7%C2%B7C+interaction+and+its+supramolecular+silver%28I%29+complexes&doi=10.1021%2Fcg201184x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Conformation Restriction of Nonplanar Di-2-pyrimidyl Sulfide with Intramolecular N···C Interaction and Its Supramolecular Silver(I) Complexes</span></div><div class="casAuthors">Wan, Chong-Qing; Wang, Zi-Jia; Wang, Guo; Liu, Hao; Deng, Yu-Heng; Jin, Qiong-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Crystal Growth & Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">376-386</span>CODEN:
                <span class="NLM_cas:coden">CGDEFU</span>;
        ISSN:<span class="NLM_cas:issn">1528-7483</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Silver(I) complexes with semirigid di-2-pyrimidyl sulfide (DprS), namely, {[Ag2(DprS)2(CF3CO2)](CF3CO2)·2H2O}∞ (1), {[Ag6(DprS)6(CF3SO3)5](CF3SO3)·3.5H2O}∞ (2), {[Ag2(DprS)(C2F5CO2)2]}∞ (3), [Ag(DprS)(NO3)]∞ (4), and {[Ag3(DprS)3](ClO4)3}∞ (5), were synthesized and characterized by single-crystal x-ray anal.  The silver(I) complexes 1-2 and 4-5 exhibit 1-dimensional tape-like coordination polymers with different topol. structures, while complex 3 has a two-dimensional coordination network.  In these complexes, the two pyrimidyl rings of each DprS are almost in an orthogonal orientation, a rigid nonplanar conformation, and the multidentate ligand adopts an unvaried N,N',N''-μ3 ligation mode despite the different anions (CH3COO- in 1, CF3SO3- in 2, C2F5COO- in 3, NO3- in 4, and ClO4- in 5).  Attractive intramol. Npyrimidyl···Cpyrimidyl interaction between a 1-positional N atom of one pyrimidyl ring and an electrophilic 2-positional C atom of the other ring of DprS is a common dominant interaction, which drives and stabilizes the nonplanar ligand conformation in these cryst. structures.  Calcn. through the SCF crystal orbital method based on d. functional theory indicates the N···C contact, a nucleophile-electrophile affinity.  Unconventional anion-πpyrimidyl interactions engaged in the construction of the supramol. architectures of 1-5 also are presented and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNZvuoQbWM4rVg90H21EOLACvtfcHk0lgGg7zozoKBng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtb%252FF&md5=dc4f1a40efe746b53b9a9546599adbad</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fcg201184x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcg201184x%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DC.-Q.%26aulast%3DWang%26aufirst%3DZ.-J.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DY.-H.%26aulast%3DJin%26aufirst%3DQ.-H.%26atitle%3DConformation%2520restriction%2520of%2520nonplanar%2520di-2-pyrimidyl%2520sulfide%2520with%2520intramolecular%2520N%25C2%25B7%25C2%25B7%25C2%25B7C%2520interaction%2520and%2520its%2520supramolecular%2520silver%2528I%2529%2520complexes%26jtitle%3DCryst.%2520Growth%2520Des.%26date%3D2012%26volume%3D12%26spage%3D376%26epage%3D386%26doi%3D10.1021%2Fcg201184x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodić, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leovac, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanović, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spasojević, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joksović, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanojković, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matić, I. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vojinović-Ješić, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marković, V.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, cytotoxicity and antiangiogenic activity of copper(II) complexes with 1-adamantoyl hydrazone bearing pyridine rings</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ejmech.2016.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27084495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFKksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=75-81&author=M.+V.+Rodi%C4%87author=V.+M.+Leovacauthor=L.+S.+Jovanovi%C4%87author=V.+Spasojevi%C4%87author=M.+D.+Joksovi%C4%87author=T.+Stanojkovi%C4%87author=I.+Z.+Mati%C4%87author=L.+S.+Vojinovi%C4%87-Je%C5%A1i%C4%87author=V.+Markovi%C4%87&title=Synthesis%2C+characterization%2C+cytotoxicity+and+antiangiogenic+activity+of+copper%28II%29+complexes+with+1-adamantoyl+hydrazone+bearing+pyridine+rings&doi=10.1016%2Fj.ejmech.2016.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization, cytotoxicity and antiangiogenic activity of copper(II) complexes with 1-adamantyl hydrazone bearing pyridine rings</span></div><div class="casAuthors">Rodic, Marko V.; Leovac, Vukadin M.; Jovanovic, Ljiljana S.; Spasojevic, Vojislav; Joksovic, Milan D.; Stanojkovic, Tatjana; Matic, Ivana Z.; Vojinovic-Jesic, Ljiljana S.; Markovic, Violeta</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-81</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Three novel copper complexes with tridentate N2O ligand di(2-pyridil) ketone 1-adamantyl hydrazone (Addpy) of the formula [CuII2CuI2(Addpy)2Br2(μ-Br4)] (1), catena-poly[CuCl(μ-Addpy)(μ-Cl)CuCl2]n (2) and [Cu(Addpy)(NCS)2] (3) were synthesized.  Complexes were characterized by x-ray crystallog., spectral (UV-visible, FTIR), electrochem. (CV) analyses, and magnetochem. measurements.  Study of anticancer potential of Cu(II) complexes, mode of cell death, apoptosis, and inhibition of angiogenesis were performed.  All tested malignant cell lines (HeLa, LS174, A549, K562, and MDA-MB-231) showed high sensitivity to the examd. Cu(II) complexes.  The complexes induce apoptosis in the caspase 3-dependent manner, whereas the anti-angiogenic effects of 1, 2, and 3 were confirmed in EA.hy926 cells using a tube formation assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozWG6KkCPR1bVg90H21EOLACvtfcHk0lgZcbYWDOM4TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFKksr4%253D&md5=df04444062dda07626701807210ae224</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DRodi%25C4%2587%26aufirst%3DM.%2BV.%26aulast%3DLeovac%26aufirst%3DV.%2BM.%26aulast%3DJovanovi%25C4%2587%26aufirst%3DL.%2BS.%26aulast%3DSpasojevi%25C4%2587%26aufirst%3DV.%26aulast%3DJoksovi%25C4%2587%26aufirst%3DM.%2BD.%26aulast%3DStanojkovi%25C4%2587%26aufirst%3DT.%26aulast%3DMati%25C4%2587%26aufirst%3DI.%2BZ.%26aulast%3DVojinovi%25C4%2587-Je%25C5%25A1i%25C4%2587%26aufirst%3DL.%2BS.%26aulast%3DMarkovi%25C4%2587%26aufirst%3DV.%26atitle%3DSynthesis%252C%2520characterization%252C%2520cytotoxicity%2520and%2520antiangiogenic%2520activity%2520of%2520copper%2528II%2529%2520complexes%2520with%25201-adamantoyl%2520hydrazone%2520bearing%2520pyridine%2520rings%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D75%26epage%3D81%26doi%3D10.1016%2Fj.ejmech.2016.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akbar
Ali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bujang, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamid, M. H. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, P. V.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and X-ray crystallographic structural study of copper(II) and nickel(II) complexes of the 2-quinoline carboxaldehyde Schiff base of S-methyldithiocarbazate (Hqaldsme)</span>. <i>Polyhedron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3245</span>– <span class="NLM_lpage">3252</span>, <span class="refDoi"> DOI: 10.1016/j.poly.2006.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.poly.2006.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WqtbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=3245-3252&author=M.+Akbar%0AAliauthor=A.+H.+Mirzaauthor=F.+H.+Bujangauthor=M.+H.+S.+A.+Hamidauthor=P.+V.+Bernhardt&title=Synthesis%2C+characterization+and+X-ray+crystallographic+structural+study+of+copper%28II%29+and+nickel%28II%29+complexes+of+the+2-quinoline+carboxaldehyde+Schiff+base+of+S-methyldithiocarbazate+%28Hqaldsme%29&doi=10.1016%2Fj.poly.2006.05.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization and X-ray crystallographic structural study of copper(II) and nickel(II) complexes of the 2-quinolinecarboxaldehyde Schiff base of S-methyldithiocarbazate (Hqaldsme)</span></div><div class="casAuthors">Akbar Ali, M.; Mirza, A. H.; Bujang, Fatriah Hj; Hamid, Malai Haniti S. A.; Bernhardt, Paul V.</div><div class="citationInfo"><span class="NLM_cas:title">Polyhedron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3245-3252</span>CODEN:
                <span class="NLM_cas:coden">PLYHDE</span>;
        ISSN:<span class="NLM_cas:issn">0277-5387</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">[Cu(qaldsme)(X)(MeOH)n] and [Ni(qaldsme)2]·0.5MeCN (qaldsme = anionic form of the 2-quinoline carboxaldehyde Schiff base of S-methyldithiocarbazate; X = NCS-, I-, NO3- ; n = 0 or 1) were synthesized and characterized by magnetic and spectroscopic techniques.  X-ray crystal structure detn. of [Cu(qaldsme)(ONO2)(MeOH)] (1), [Cu(qaldsme)(NCS)]2 (2) and [Ni(qaldsme)2]·0.5MeCN (4) shows that the nitrato-complex of Cu (1) is monomeric and five-coordinate and the thiocyanato-complex (2) has a novel thiolate S-bridged dimeric structure in which each of the Cu(II) ions adopts a five-coordinate, approx. square-pyramidal geometry, with a CuN3S2 coordination kernel.  The Ni(II) complex (4) has a distorted octahedral geometry with meridional dispositions of the two uninegatively charged tridentate NNS ligands.  In all these complexes, the Schiff bases are coordinated in their iminothiolate forms via the quinoline N atom, the azomethine N atom and the thiolate S atom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0wKPrUtSWtrVg90H21EOLACvtfcHk0lgZcbYWDOM4TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WqtbjP&md5=70f9647278098667893725912c1e9958</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2006.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2006.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DAkbar%2BAli%26aufirst%3DM.%26aulast%3DMirza%26aufirst%3DA.%2BH.%26aulast%3DBujang%26aufirst%3DF.%2BH.%26aulast%3DHamid%26aufirst%3DM.%2BH.%2BS.%2BA.%26aulast%3DBernhardt%26aufirst%3DP.%2BV.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520X-ray%2520crystallographic%2520structural%2520study%2520of%2520copper%2528II%2529%2520and%2520nickel%2528II%2529%2520complexes%2520of%2520the%25202-quinoline%2520carboxaldehyde%2520Schiff%2520base%2520of%2520S-methyldithiocarbazate%2520%2528Hqaldsme%2529%26jtitle%3DPolyhedron%26date%3D2006%26volume%3D25%26spage%3D3245%26epage%3D3252%26doi%3D10.1016%2Fj.poly.2006.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akbar
Ali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karim, M. R.</span></span> <span> </span><span class="NLM_article-title">Self-assembling dicopper(II) complexes of di-2-pyridyl ketone Schiff base ligands derived from S-alkyldithiocarbazates</span>. <i>Polyhedron</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1486</span>, <span class="refDoi"> DOI: 10.1016/j.poly.2011.02.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.poly.2011.02.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslWltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=1478-1486&author=M.+Akbar%0AAliauthor=A.+H.+Mirzaauthor=R.+J.+Butcherauthor=P.+V.+Bernhardtauthor=M.+R.+Karim&title=Self-assembling+dicopper%28II%29+complexes+of+di-2-pyridyl+ketone+Schiff+base+ligands+derived+from+S-alkyldithiocarbazates&doi=10.1016%2Fj.poly.2011.02.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Self-assembling dicopper(II) complexes of di-2-pyridyl ketone Schiff base ligands derived from S-alkyldithiocarbazates</span></div><div class="casAuthors">Akbar Ali, Mohammad; Mirza, Aminul H.; Butcher, Ray J.; Bernhardt, Paul V.; Karim, Mohammad Rezaul</div><div class="citationInfo"><span class="NLM_cas:title">Polyhedron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1478-1486</span>CODEN:
                <span class="NLM_cas:coden">PLYHDE</span>;
        ISSN:<span class="NLM_cas:issn">0277-5387</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Condensation of di-2-pyridyl ketone with S-methyldithiocarbazate or S-benzyldithiocarbazate yields potentially bridging ligands of the form Py2C:NNHC(S)SR; Hdpksme (R = Me; the di-2-pyridyl ketone Schiff base of S-methyldithiocarbazate) and Hdpksbz (R = Bz; the di-2-pyridyl ketone Schiff base of S-benzyldithiocarbazate).  Complexation of these ligands with Cu(II) in a 1:1 M ratio gives dinuclear complexes of the general formula [Cu(NNNS)X]2 (X = Cl-, NO3-, H2O).  X-ray crystallog. structure detns. show that each ligand provides three donor atoms (NNS) in a meridional configuration to one metal, viz. one of the pyridine nitrogen atoms, the azomethine nitrogen atom and the thiolate sulfur, while the nitrogen atom of the second pyridyl group forms a bridge to another copper(II) ion within the dimer.  The coordination geometry around each copper(II) ion is approx. square pyramidal, the basal plane of which is composed of one of the pyridine nitrogen atoms, the azomethine nitrogen atom and a chloro, nitrato or aqua ligand.  The apical position of the square pyramid is always occupied by the pyridine nitrogen atom of the second ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdOeRNV7S1rVg90H21EOLACvtfcHk0lh9ffzG4GHH1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslWltrg%253D&md5=0ffe31541f9f48104bc63178b754aba0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2011.02.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2011.02.048%26sid%3Dliteratum%253Aachs%26aulast%3DAkbar%2BAli%26aufirst%3DM.%26aulast%3DMirza%26aufirst%3DA.%2BH.%26aulast%3DButcher%26aufirst%3DR.%2BJ.%26aulast%3DBernhardt%26aufirst%3DP.%2BV.%26aulast%3DKarim%26aufirst%3DM.%2BR.%26atitle%3DSelf-assembling%2520dicopper%2528II%2529%2520complexes%2520of%2520di-2-pyridyl%2520ketone%2520Schiff%2520base%2520ligands%2520derived%2520from%2520S-alkyldithiocarbazates%26jtitle%3DPolyhedron%26date%3D2011%26volume%3D30%26spage%3D1478%26epage%3D1486%26doi%3D10.1016%2Fj.poly.2011.02.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-localizing N-heterocyclic thiosemicarbazone copper complexes with good cytotoxicity and high antimetastatic activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">654</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.01.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ejmech.2019.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=30641446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVartLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2019&pages=654-664&author=S.+Guauthor=P.+Yuauthor=J.+Huauthor=Y.+Liuauthor=Z.+Liauthor=Y.+Qianauthor=Y.+Wangauthor=Y.+Gouauthor=F.+Yang&title=Mitochondria-localizing+N-heterocyclic+thiosemicarbazone+copper+complexes+with+good+cytotoxicity+and+high+antimetastatic+activity&doi=10.1016%2Fj.ejmech.2019.01.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-localizing N-heterocyclic thiosemicarbazone copper complexes with good cytotoxicity and high antimetastatic activity</span></div><div class="casAuthors">Gu, Shan Shan; Yu, Ping; Hu, Jia Nan; Liu, Yani; Li, Zuo Wen; Qian, Yong; Wang, Ya; Gou, Yi; Yang, Feng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">654-664</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Although many N-heterocyclic thiosemicarbazone Cu complexes are proposed as potential anticancer agents, little is known about their intracellular localization in cells.  The authors synthesized two fluorescent N-heterocyclic thiosemicarbazone Cu complexes, ([CuII(L)(Br)] (1) and [CuII2CuI(L)2(Br)3] (2), where HL is (E)-N,N-dimethyl-2-(quinolin-8-ylmethylene)hydrazinecarbothioamide), to assess their intracellular distribution.  Fluorescence studies demonstrated that complex 1 showed an intense emission band at ∼510 nm (λex = 405 nm) similar to that of complex 2, albeit with about four times lower emission intensity.  Both Cu complexes showed significantly greater cytotoxicity toward several tumor cell-types with better IC50 (0.27-0.91 μM) than the HL ligand and cisplatin.  Scratching wound healing assay and invasion assay were performed, revealing that the Cu complexes have good antimetastatic activity.  Confocal fluorescence imaging allowed ascertaining that complex 2 was primarily localized to mitochondria.  Further studies revealed that the anticancer mechanisms of complex 2 might involve the mitochondrial-mediated apoptotic pathway, probably caused by the reducing mitochondrial membrane potential and induction of ROS (reactive O species) prodn.  Also, complex 2 exhibited promising cytostatic effects in a three-dimensional HeLa spheroid model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGaYvUymTwMbVg90H21EOLACvtfcHk0lh9ffzG4GHH1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVartLY%253D&md5=5b3fb80e75c0e1d397fc94536ae7927a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGou%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26atitle%3DMitochondria-localizing%2520N-heterocyclic%2520thiosemicarbazone%2520copper%2520complexes%2520with%2520good%2520cytotoxicity%2520and%2520high%2520antimetastatic%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D164%26spage%3D654%26epage%3D664%26doi%3D10.1016%2Fj.ejmech.2019.01.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.-S.</span></span> <span> </span><span class="NLM_article-title">Anion-controlled assembly of silver(I)/aminobenzonitrile compounds: syntheses, crystal structures, and photoluminescence properties</span>. <i>Cryst. Growth Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">354</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.1021/cg201159z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cg201159z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKiu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=354-361&author=F.-J.+Liuauthor=D.+Sunauthor=H.-J.+Haoauthor=R.-B.+Huangauthor=L.-S.+Zheng&title=Anion-controlled+assembly+of+silver%28I%29%2Faminobenzonitrile+compounds%3A+syntheses%2C+crystal+structures%2C+and+photoluminescence+properties&doi=10.1021%2Fcg201159z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Anion-Controlled Assembly of Silver(I)/Aminobenzonitrile Compounds: Syntheses, Crystal Structures, and Photoluminescence Properties</span></div><div class="casAuthors">Liu, Fu-Jing; Sun, Di; Hao, Hong-Jun; Huang, Rong-Bin; Zheng, Lan-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Crystal Growth & Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">354-361</span>CODEN:
                <span class="NLM_cas:coden">CGDEFU</span>;
        ISSN:<span class="NLM_cas:issn">1528-7483</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Five coordination compds. (CCs) {[Ag(m-abn)2]·NO3}n (1), {[Ag2(m-abn)6]·(ClO4)2} (2), {[Ag(o-abn)2]·NO3}n (3), [Ag(o-abn)(NO2)]n (4), and {[Ag(o-abn)2]·PF6}n (5) (m-abn = 3-aminobenzonitrile, and o-abn = 2-aminobenzonitrile) were synthesized and structurally characterized by element anal., IR, powder x-ray diffraction, and X-ray single-crystal diffraction.  Structural anal. reveals that aminobenzonitrile acts as bidentate μ2-N,N' or monodentate μ1-N ligands in 1-5.  Complex 1 is a 1-dimensional chain comprised of C2-sym. [Ag(m-abn)]2 14-membered rings.  The uncoordinated NO3- anions interact with the 1-dimensional chain to form a resulting 2-dimensional supramol. sheet through N-O···N hydrogen bond.  Complex 2 is a discrete binuclear Ag(I) CC incorporating concurrent bidentate μ2-N,N' and monodentate μ1-N m-abn ligands.  The variation of anions from NO3- to ClO4- results in the dimensionalities of 1 and 2 decreasing from 1-dimensional to 0D.  When using o-abn, complexes 3-5 were obtained as 1-dimensional chain with C2-sym. [Ag(o-abn)]2 12-membered rings, 2-dimensional sheet with coordinated μ2-η1:η2 NO2- anions, and 1-dimensional chain with centrosym. [Ag(o-abn)]2 12-membered rings, resp.  Supramol. interactions such as hydrogen bonding and π···π stacking are also proven effective in shaping the dimensionalities of the solid state structures of 1-5.  The results demonstrate that the anions are driving forces for the selection of different structures.  Also, results about emissive behaviors and thermal stabilities of them are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnkOfmHpTzP7Vg90H21EOLACvtfcHk0lh9ffzG4GHH1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKiu7vO&md5=8dd6295095bc776fb52229699bab0d49</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fcg201159z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcg201159z%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.-J.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DHao%26aufirst%3DH.-J.%26aulast%3DHuang%26aufirst%3DR.-B.%26aulast%3DZheng%26aufirst%3DL.-S.%26atitle%3DAnion-controlled%2520assembly%2520of%2520silver%2528I%2529%252Faminobenzonitrile%2520compounds%253A%2520syntheses%252C%2520crystal%2520structures%252C%2520and%2520photoluminescence%2520properties%26jtitle%3DCryst.%2520Growth%2520Des.%26date%3D2012%26volume%3D12%26spage%3D354%26epage%3D361%26doi%3D10.1021%2Fcg201159z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pascu, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waghorn, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conry, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betts, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilworth, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokrovska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aigbirhio, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, J. E.</span></span> <span> </span><span class="NLM_article-title">Designing Zn(ii) and Cu(ii) derivatives as probes for in vitro fluorescence imaging</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_fpage">4988</span>– <span class="NLM_lpage">4997</span>, <span class="refDoi"> DOI: 10.1039/b705227h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2Fb705227h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=17992284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1eht7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=4988-4997&author=S.+I.+Pascuauthor=P.+A.+Waghornauthor=T.+D.+Conryauthor=H.+M.+Bettsauthor=J.+R.+Dilworthauthor=G.+C.+Churchillauthor=T.+Pokrovskaauthor=M.+Christliebauthor=F.+I.+Aigbirhioauthor=J.+E.+Warren&title=Designing+Zn%28ii%29+and+Cu%28ii%29+derivatives+as+probes+for+in+vitro+fluorescence+imaging&doi=10.1039%2Fb705227h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Designing Zn(II) and Cu(II) derivatives as probes for in vitro fluorescence imaging</span></div><div class="casAuthors">Pascu, Sofia I.; Waghorn, Philip A.; Conry, Timothy D.; Betts, Helen M.; Dilworth, Jonathan R.; Churchill, Grant C.; Pokrovska, Tzveta; Christlieb, Martin; Aigbirhio, Franklin I.; Warren, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">4988-4997</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">New M(II) bis(thiosemicarbazonato) complexes (M = Ni(II), Cu(II) and Zn(II)) featuring allyl groups at the exocyclic nitrogens were synthesized.  The complexes were characterized in soln. by spectroscopic methods and their solid state structures detd. by single crystal x-ray diffraction using synchrotron radiation.  The Zn(II) complex is intrinsically fluorescent and sol. in biocompatible media.  The uptake of this Zn(II) complex in HeLa, MCF-7 and IGROV cancer cells was monitored by fluorescence microscopies (epi- and confocal fluorescence imaging).  The radiolabelling to 64Cu(II) bis(thiosemicarbazonato) complex was performed cleanly by transmetalation from the corresponding Zn(II) species using 64Cu(OAc)2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4k1zjJvU0dbVg90H21EOLACvtfcHk0ljkKYQlVXDxhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1eht7rP&md5=abb4c7ca24085b5b390b50fc9c175656</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2Fb705227h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb705227h%26sid%3Dliteratum%253Aachs%26aulast%3DPascu%26aufirst%3DS.%2BI.%26aulast%3DWaghorn%26aufirst%3DP.%2BA.%26aulast%3DConry%26aufirst%3DT.%2BD.%26aulast%3DBetts%26aufirst%3DH.%2BM.%26aulast%3DDilworth%26aufirst%3DJ.%2BR.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26aulast%3DPokrovska%26aufirst%3DT.%26aulast%3DChristlieb%26aufirst%3DM.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26aulast%3DWarren%26aufirst%3DJ.%2BE.%26atitle%3DDesigning%2520Zn%2528ii%2529%2520and%2520Cu%2528ii%2529%2520derivatives%2520as%2520probes%2520for%2520in%2520vitro%2520fluorescence%2520imaging%26jtitle%3DDalton%2520Trans.%26date%3D2007%26spage%3D4988%26epage%3D4997%26doi%3D10.1039%2Fb705227h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bag, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharadwaj, P. K.</span></span> <span> </span><span class="NLM_article-title">Perturbation of the PET process in fluorophore-spacer-receptor systems through structural modification: transition metal induced fluorescence enhancement and selectivity</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4377</span>– <span class="NLM_lpage">4390</span>, <span class="refDoi"> DOI: 10.1021/jp047557b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp047557b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtl2msrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2005&pages=4377-4390&author=B.+Bagauthor=P.+K.+Bharadwaj&title=Perturbation+of+the+PET+process+in+fluorophore-spacer-receptor+systems+through+structural+modification%3A+transition+metal+induced+fluorescence+enhancement+and+selectivity&doi=10.1021%2Fjp047557b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Perturbation of the PET Process in Fluorophore-Spacer-Receptor Systems through Structural Modification: Transition Metal Induced Fluorescence Enhancement and Selectivity</span></div><div class="casAuthors">Bag, Bamaprasad; Bharadwaj, Parimal K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4377-4390</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-6106</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several fluorescent signaling systems are built in the format fluorophore-spacer-receptor with ethylenediamine or N,N-dimethylethylenediamine as the receptor, anthracene as the fluorophore, and a methylene group as the spacer.  The receptors are derivatized with different electron-withdrawing groups such as 4-nitrobenzene, 4-nitro-2-pyridine, and 2,4-dinitrobenzene, to perturb the photoinduced intramol. electron transfer (PET) process from the nitrogen lone-pair to the fluorophore.  The photophys. properties of these supramol. systems and their fluorescence responses toward a no. of quenching transition metal ions are reported.  It is shown that the PET is highly efficient in the absence of a metal ion.  With a metal ion input, the fluorescence can be recovered to a different extent depending on the nature of the metal and on the overall architecture of the system as well.  Despite the possibility of strong interaction between the fluorophore and the metal ion, significant fluorescence enhancement is obsd. with quenching of paramagnetic transition metal ions.  The complex stability data show that the stability consts. for the metal ions showing fluorescence enhancement are of the order of 104 M-1.  This study shows that structurally simple fluorescent signaling systems for quenching transition metal ions can be built by maximizing the PET.  It is also shown here that simple structural modification can make these systems highly specific for particular transition metal ions for potential applications in several contemporary areas of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1kMowZZZt_LVg90H21EOLACvtfcHk0ljkKYQlVXDxhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtl2msrw%253D&md5=3653e79705c5cd649c814967cd91398f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjp047557b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp047557b%26sid%3Dliteratum%253Aachs%26aulast%3DBag%26aufirst%3DB.%26aulast%3DBharadwaj%26aufirst%3DP.%2BK.%26atitle%3DPerturbation%2520of%2520the%2520PET%2520process%2520in%2520fluorophore-spacer-receptor%2520systems%2520through%2520structural%2520modification%253A%2520transition%2520metal%2520induced%2520fluorescence%2520enhancement%2520and%2520selectivity%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2005%26volume%3D109%26spage%3D4377%26epage%3D4390%26doi%3D10.1021%2Fjp047557b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stacy, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palanimuthu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowski, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">Zinc(II)-thiosemicarbazone complexes are localized to the lysosomal compartment where they transmetallate with copper ions to induce cytotoxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4965</span>– <span class="NLM_lpage">4984</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00238</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00238" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFGmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4965-4984&author=A.+E.+Stacyauthor=D.+Palanimuthuauthor=P.+V.+Bernhardtauthor=D.+S.+Kalinowskiauthor=P.+J.+Janssonauthor=D.+R.+Richardson&title=Zinc%28II%29-thiosemicarbazone+complexes+are+localized+to+the+lysosomal+compartment+where+they+transmetallate+with+copper+ions+to+induce+cytotoxicity&doi=10.1021%2Facs.jmedchem.6b00238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc(II)-Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity</span></div><div class="casAuthors">Stacy, Alexandra E.; Palanimuthu, Duraippandi; Bernhardt, Paul V.; Kalinowski, Danuta S.; Jansson, Patric J.; Richardson, Des R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4965-4984</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As the di-2-pyridylketone thiosemicarbazone (DpT) and 2-acetylpyridine thiosemicarbazone (ApT) series show potent antitumor activity in vitro and in vivo, we synthesized their fluorescent zinc(II) complexes to assess their intracellular distribution.  The Zn(II) complexes generally showed significantly greater cytotoxicity than the thiosemicarbazones alone in several tumor cell-types.  Notably, specific structure-activity relationships demonstrated the importance of the di-2-pyridyl pharmacophore in their activity.  Confocal fluorescence imaging and live cell microscopy showed that the Zn(II) complex of our lead compd., di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), which is scheduled to enter clin. trials, was localized to lysosomes.  Under lysosomal conditions, the Zn(II) complexes were shown to transmetallate with copper ions, leading to redox-active copper complexes that induced lysosomal membrane permeabilization (LMP) and cytotoxicity.  This is the first study to demonstrate direct lysosomal targeting of our novel Zn(II)-thiosemicarbazone complexes that mediate their activity via transmetalation with copper ions and LMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYGqXGFjD7AbVg90H21EOLACvtfcHk0lhIkgJFsRdNbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFGmsrw%253D&md5=128885a199b67c69cfafa84c1c7be1f2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00238%26sid%3Dliteratum%253Aachs%26aulast%3DStacy%26aufirst%3DA.%2BE.%26aulast%3DPalanimuthu%26aufirst%3DD.%26aulast%3DBernhardt%26aufirst%3DP.%2BV.%26aulast%3DKalinowski%26aufirst%3DD.%2BS.%26aulast%3DJansson%26aufirst%3DP.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DZinc%2528II%2529-thiosemicarbazone%2520complexes%2520are%2520localized%2520to%2520the%2520lysosomal%2520compartment%2520where%2520they%2520transmetallate%2520with%2520copper%2520ions%2520to%2520induce%2520cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4965%26epage%3D4984%26doi%3D10.1021%2Facs.jmedchem.6b00238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langdon-Jones, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symonds, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coles, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, S. J. A.</span></span> <span> </span><span class="NLM_article-title">Fluorescent rhenium-naphthalimide conjugates as cellular imaging agents</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3788</span>– <span class="NLM_lpage">3797</span>, <span class="refDoi"> DOI: 10.1021/ic500142z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic500142z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlentb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=3788-3797&author=E.+E.+Langdon-Jonesauthor=N.+O.+Symondsauthor=S.+E.+Yatesauthor=A.+J.+Hayesauthor=D.+Lloydauthor=R.+Williamsauthor=S.+J.+Colesauthor=P.+N.+Hortonauthor=S.+J.+A.+Pope&title=Fluorescent+rhenium-naphthalimide+conjugates+as+cellular+imaging+agents&doi=10.1021%2Fic500142z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent Rhenium-Naphthalimide Conjugates as Cellular Imaging Agents</span></div><div class="casAuthors">Langdon-Jones, Emily E.; Symonds, Nadine O.; Yates, Sara E.; Hayes, Anthony J.; Lloyd, David; Williams, Rebecca; Coles, Simon J.; Horton, Peter N.; Pope, Simon J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3788-3797</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A range of biol. compatible, fluorescent rhenium-naphthalimide conjugates, based upon the rhenium fac-tricarbonyl core, has been synthesized.  The fluorescent ligands are based upon a N-functionalized, 4-amino-derived 1,8-naphthalimide core and incorporate a dipicolyl amine binding unit to chelate Re(I); the structural variations accord to the nature of the alkylated imide with Et ester glycine (L), 3-propanol (L), diethylene glycol (L), and benzyl alc. (L) variants.  The species are fluorescent in the visible region between 505 and 537 nm through a naphthalimide-localized intramol. charge transfer, with corresponding fluorescent lifetimes of up to 9.8 ns.  The ligands and complexes were studied for their potential as imaging agents for human osteoarthritic cells and protistan fish parasite Spironucleus vortens using confocal fluorescence microscopy.  The specific nature of the naphthalimide structure serves to control the uptake and intracellular localization of these imaging agents.  Significant differences were noted between the free ligands and complexes, with the Re(I) complex of L showing hydrogenosomal localization in S. vortens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpORtizlG29irVg90H21EOLACvtfcHk0lhIkgJFsRdNbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlentb8%253D&md5=0ccdc9963dc02ccdc32996de3cc1f620</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fic500142z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic500142z%26sid%3Dliteratum%253Aachs%26aulast%3DLangdon-Jones%26aufirst%3DE.%2BE.%26aulast%3DSymonds%26aufirst%3DN.%2BO.%26aulast%3DYates%26aufirst%3DS.%2BE.%26aulast%3DHayes%26aufirst%3DA.%2BJ.%26aulast%3DLloyd%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DColes%26aufirst%3DS.%2BJ.%26aulast%3DHorton%26aufirst%3DP.%2BN.%26aulast%3DPope%26aufirst%3DS.%2BJ.%2BA.%26atitle%3DFluorescent%2520rhenium-naphthalimide%2520conjugates%2520as%2520cellular%2520imaging%2520agents%26jtitle%3DInorg.%2520Chem.%26date%3D2014%26volume%3D53%26spage%3D3788%26epage%3D3797%26doi%3D10.1021%2Fic500142z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Moreira, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorp-Greenwood, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coogan, M. P.</span></span> <span> </span><span class="NLM_article-title">Application of d<sup>6</sup> transition metal complexes in fluorescence cell imaging</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1039/b917757d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2FB917757D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=20024327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGms7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=186-202&author=V.+Fern%C3%A1ndez-Moreiraauthor=F.+L.+Thorp-Greenwoodauthor=M.+P.+Coogan&title=Application+of+d6+transition+metal+complexes+in+fluorescence+cell+imaging&doi=10.1039%2Fb917757d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Application of d6 transition metal complexes in fluorescence cell imaging</span></div><div class="casAuthors">Fernandez-Moreira, Vanesa; Thorp-Greenwood, Flora L.; Coogan, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-202</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Luminescent d6 transition metal complexes have often been proposed as useful fluorophores for cell imaging due to their attractive photophys. attributes, but until very recently their actual applications have been scarce, and largely limited to ruthenium complexes in DNA and oxygen sensing.  In the last few years, however, there has been an increasing no. of reports of the design and application in cellular studies of a diverse range of Ir, Re and Ru complexes tailor-made for imaging applications.  The design principles, uptake and cellular localization of this new class of imaging agents are presented in context in this feature article.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJGEdUIYFc9bVg90H21EOLACvtfcHk0lhm6iicetKSRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGms7nI&md5=f63d2d3cd382ea0baca2c16566f0df5e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2FB917757D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB917757D%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Moreira%26aufirst%3DV.%26aulast%3DThorp-Greenwood%26aufirst%3DF.%2BL.%26aulast%3DCoogan%26aufirst%3DM.%2BP.%26atitle%3DApplication%2520of%2520d6%2520transition%2520metal%2520complexes%2520in%2520fluorescence%2520cell%2520imaging%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D186%26epage%3D202%26doi%3D10.1039%2Fb917757d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharyya, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharyya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondaiah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, A. R.</span></span> <span> </span><span class="NLM_article-title">Curcumin “drug” stabilized in oxidovanadium(IV)-BODIPY conjugates for mitochondria-targeted photocytotoxicity</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">12457</span>– <span class="NLM_lpage">12468</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.7b01924</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b01924" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFykt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=12457-12468&author=U.+Bhattacharyyaauthor=B.+Kumarauthor=A.+Garaiauthor=A.+Bhattacharyyaauthor=A.+Kumarauthor=S.+Banerjeeauthor=P.+Kondaiahauthor=A.+R.+Chakravarty&title=Curcumin+%E2%80%9Cdrug%E2%80%9D+stabilized+in+oxidovanadium%28IV%29-BODIPY+conjugates+for+mitochondria-targeted+photocytotoxicity&doi=10.1021%2Facs.inorgchem.7b01924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity</span></div><div class="casAuthors">Bhattacharyya, Utso; Kumar, Brijesh; Garai, Aditya; Bhattacharyya, Arnab; Kumar, Arun; Banerjee, Samya; Kondaiah, Paturu; Chakravarty, Akhil R.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12457-12468</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ternary oxidovanadium(IV) complexes of curcumin (Hcur), dipicolylamine (dpa) base, and its derivs. having pendant noniodinated and di-iodinated boron-dipyrromethene (BODIPY) moiety (L1 and L2, resp.), namely, [VO(dpa)(cur)]ClO4 (1), [VO(L1)(cur)]ClO4 (2), and [VO(L2)(cur)]ClO4 (3) and their chloride salts (1a-3a) were prepd., characterized, and studied for anticancer activity.  The chloride salts were used for biol. studies due to their aq. soly.  Complex 1 was structurally characterized by single-crystal x-ray crystallog.  The complex has a VO2+ moiety bound to dpa ligand showing N,N,N-coordination in a facial mode, and curcumin is bound in its mono-anionic enolic form.  The V-O(cur) distances are 1.950(18) and 1.977(16) Å, while the V-N bond lengths are 2.090(2), 2.130(2), and 2.290(2) Å.  The bond trans to V=O is long due to trans effect.  The complexes are stable in a soln. phase over a long period of time of 48 h without showing any apparent degrdn. of the curcumin ligand.  The diiodo-BODIPY ligand (L2) or Hcur alone showed limited soln. stability in dark.  The emissive BODIPY (L1) contg. complex 2a showed preferential mitochondrial localization in MCF-7 cells in cellular imaging expts.  The cytotoxicity of the complexes was studied by MTT assay.  The BODIPY complex 3a showed excellent photodynamic therapy effect in visible light (400-700 nm) giving IC50 values of 2-6 μM in HeLa and MCF-7 cancer cells, while being less toxic in dark (∼100 μM).  The cell death was apoptotic in nature involving reactive oxygen species (ROS).  Mechanistic data from pUC19 DNA photocleavage studies revealed photogenerated ROS as primarily 1O2 from the BODIPY moiety and ·OH radicals from the curcumin ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsNFd8ChcFibVg90H21EOLACvtfcHk0lhm6iicetKSRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFykt7rL&md5=b1cf3f793081fbdd66c968abfc2dd7ed</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b01924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b01924%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharyya%26aufirst%3DU.%26aulast%3DKumar%26aufirst%3DB.%26aulast%3DGarai%26aufirst%3DA.%26aulast%3DBhattacharyya%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DKondaiah%26aufirst%3DP.%26aulast%3DChakravarty%26aufirst%3DA.%2BR.%26atitle%3DCurcumin%2520%25E2%2580%259Cdrug%25E2%2580%259D%2520stabilized%2520in%2520oxidovanadium%2528IV%2529-BODIPY%2520conjugates%2520for%2520mitochondria-targeted%2520photocytotoxicity%26jtitle%3DInorg.%2520Chem.%26date%3D2017%26volume%3D56%26spage%3D12457%26epage%3D12468%26doi%3D10.1021%2Facs.inorgchem.7b01924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aslam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nisar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurshid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasool, M. H.</span></span> <span> </span><span class="NLM_article-title">Proteomics: technologies and their applications</span>. <i>J. Chromatogr. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1093/chromsci/bmw167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1093%2Fchromsci%2Fbmw167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=28087761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFaktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2017&pages=182-196&author=B.+Aslamauthor=M.+Basitauthor=M.+A.+Nisarauthor=M.+Khurshidauthor=M.+H.+Rasool&title=Proteomics%3A+technologies+and+their+applications&doi=10.1093%2Fchromsci%2Fbmw167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomics: technologies and their applications</span></div><div class="casAuthors">Aslam, Bilal; Basit, Madiha; Nisar, Muhammad Atif; Khurshid, Mohsin; Rasool, Muhammad Hidayat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatographic Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-196</span>CODEN:
                <span class="NLM_cas:coden">JCHSBZ</span>;
        ISSN:<span class="NLM_cas:issn">1945-239X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Proteomics involves the applications of technologies for the identification and quantification of overall proteins present content of a cell, tissue or an organism.  It supplements the other "omics" technologies such as genomic and transcriptomics to expound the identity of proteins of an organism, and to cognize the structure and functions of a particular protein.  Proteomics-based technologies are utilized in various capacities for different research settings such as detection of various diagnostic markers, candidates for vaccine prodn., understanding pathogenicity mechanisms, alteration of expression patterns in response to different signals and interpretation of functional protein pathways in different diseases.  Proteomics is practically intricate because it includes the anal. and categorization of overall protein signatures of a genome.  Mass spectrometry with LC-MS-MS and MALDI-TOF/TOF being widely used equipment is the central among current proteomics.  However, utilization of proteomics facilities including the software for equipment, databases and the requirement of skilled personnel substantially increase the costs, therefore limit their wider use esp. in the developing world.  Furthermore, the proteome is highly dynamic because of complex regulatory systems that control the expression levels of proteins.  This review efforts to describe the various proteomics approaches, the recent developments and their application in research and anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL--Tuk4G697Vg90H21EOLACvtfcHk0lhm6iicetKSRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFaktbk%253D&md5=0d69fa2515dfd694c147631d1c10c346</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1093%2Fchromsci%2Fbmw167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fchromsci%252Fbmw167%26sid%3Dliteratum%253Aachs%26aulast%3DAslam%26aufirst%3DB.%26aulast%3DBasit%26aufirst%3DM.%26aulast%3DNisar%26aufirst%3DM.%2BA.%26aulast%3DKhurshid%26aufirst%3DM.%26aulast%3DRasool%26aufirst%3DM.%2BH.%26atitle%3DProteomics%253A%2520technologies%2520and%2520their%2520applications%26jtitle%3DJ.%2520Chromatogr.%2520Sci.%26date%3D2017%26volume%3D55%26spage%3D182%26epage%3D196%26doi%3D10.1093%2Fchromsci%2Fbmw167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanehisa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furumichi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishima, K.</span></span> <span> </span><span class="NLM_article-title">KEGG: new perspectives on genomes, pathways, diseases and drugs</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">D353</span>– <span class="NLM_lpage">d361</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw1092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1093%2Fnar%2Fgkw1092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27899662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D353-d361&author=M.+Kanehisaauthor=M.+Furumichiauthor=M.+Tanabeauthor=Y.+Satoauthor=K.+Morishima&title=KEGG%3A+new+perspectives+on+genomes%2C+pathways%2C+diseases+and+drugs&doi=10.1093%2Fnar%2Fgkw1092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">KEGG: new perspectives on genomes, pathways, diseases and drugs</span></div><div class="casAuthors">Kanehisa, Minoru; Furumichi, Miho; Tanabe, Mao; Sato, Yoko; Morishima, Kanae</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D353-D361</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">KEGG (http://www.kegg.jp/ or http://www.genome.jp/ kegg/) is an encyclopedia of genes and genomes.  Assigning functional meanings to genes and genomes both at the mol. and higher levels is the primary objective of the KEGG database project.  Mol. level functions are stored in the KO (KEGG Orthol.) database, where each KO is defined as a functional ortholog of genes and proteins.  Higher-level functions are represented by networks of mol. interactions, reactions and relations in the forms of KEGG pathway maps, BRITE hierarchies and KEGG modules.  In the past the KO database was developed for the purpose of defining nodes of mol. networks, but now the content has been expanded and the quality improved irresp. of whether or not the KOs appear in the three mol. network databases.  The newly introduced addendum category of the GENES database is a collection of individual proteins whose functions are exptl. characterized and from which an increasing no. of KOs are defined.  Furthermore, the DISEASE and DRUG databases have been improved by systematic anal. of drug labels for better integration of diseases and drugs with the KEGG mol. networks.  KEGG is moving towards becoming a comprehensive knowledge base for both functional interpretation and practical application of genomic information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofdadmOxosa7Vg90H21EOLACvtfcHk0ljbSZGe7LrGtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWgsrw%253D&md5=39d8cf6367f4fb35eb23670a910535ec</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1092%26sid%3Dliteratum%253Aachs%26aulast%3DKanehisa%26aufirst%3DM.%26aulast%3DFurumichi%26aufirst%3DM.%26aulast%3DTanabe%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DMorishima%26aufirst%3DK.%26atitle%3DKEGG%253A%2520new%2520perspectives%2520on%2520genomes%252C%2520pathways%252C%2520diseases%2520and%2520drugs%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26spage%3DD353%26epage%3Dd361%26doi%3D10.1093%2Fnar%2Fgkw1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: process and function</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1038/cdd.2015.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1038%2Fcdd.2015.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=26794443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=369-379&author=Y.+Xieauthor=W.+Houauthor=X.+Songauthor=Y.+Yuauthor=J.+Huangauthor=X.+Sunauthor=R.+Kangauthor=D.+Tang&title=Ferroptosis%3A+process+and+function&doi=10.1038%2Fcdd.2015.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: process and function</span></div><div class="casAuthors">Xie, Y.; Hou, W.; Song, X.; Yu, Y.; Huang, J.; Sun, X.; Kang, R.; Tang, D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-379</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a recently recognized form of regulated cell death.  It is characterized morphol. by the presence of smaller than normal mitochondria with condensed mitochondrial membrane densities, redn. or vanishing of mitochondria crista, and outer mitochondrial membrane rupture.  It can be induced by exptl. compds. (e.g., erastin, Ras-selective lethal small mol. 3, and buthionine sulfoximine) or clin. drugs (e.g., sulfasalazine, sorafenib, and artesunate) in cancer cells and certain normal cells (e.g., kidney tubule cells, neurons, fibroblasts, and T cells).  Activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate antiporter is involved in the induction of ferroptosis.  This process is characterized by the accumulation of lipid peroxidn. products and lethal reactive oxygen species (ROS) derived from iron metab. and can be pharmacol. inhibited by iron chelators (e.g., deferoxamine and desferrioxamine mesylate) and lipid peroxidn. inhibitors (e.g., ferrostatin, liproxstatin, and zileuton).  Glutathione peroxidase 4, heat shock protein beta-1, and nuclear factor erythroid 2-related factor 2 function as neg. regulators of ferroptosis by limiting ROS prodn. and reducing cellular iron uptake, resp.  In contrast, NADPH oxidase and p53 (esp. acetylation-defective mutant p53) act as pos. regulators of ferroptosis by promotion of ROS prodn. and inhibition of expression of SLC7A11 (a specific light-chain subunit of the cystine/glutamate antiporter), resp.  Misregulated ferroptosis has been implicated in multiple physiol. and pathol. processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity.  In this review, we summarize the regulation mechanisms and signaling pathways of ferroptosis and discuss the role of ferroptosis in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPYoAemdpXQrVg90H21EOLACvtfcHk0ljbSZGe7LrGtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D&md5=1d0b55e47c4ed56444149c7ba35efb58</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2015.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2015.158%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DD.%26atitle%3DFerroptosis%253A%2520process%2520and%2520function%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D369%26epage%3D379%26doi%3D10.1038%2Fcdd.2015.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proneth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurina, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panzilius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingold, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irmler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aichler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokisch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trümbach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Füllekrug, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurst, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeli, J. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span> <span> </span><span class="NLM_article-title">ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1038%2Fnchembio.2239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27842070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGgtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=91-98&author=S.+Dollauthor=B.+Pronethauthor=Y.+Y.+Tyurinaauthor=E.+Panziliusauthor=S.+Kobayashiauthor=I.+Ingoldauthor=M.+Irmlerauthor=J.+Beckersauthor=M.+Aichlerauthor=A.+Walchauthor=H.+Prokischauthor=D.+Tr%C3%BCmbachauthor=G.+Maoauthor=F.+Quauthor=H.+Bayirauthor=J.+F%C3%BCllekrugauthor=C.+H.+Scheelauthor=W.+Wurstauthor=J.+A.+Schickauthor=V.+E.+Kaganauthor=J.+P.+F.+Angeliauthor=M.+Conrad&title=ACSL4+dictates+ferroptosis+sensitivity+by+shaping+cellular+lipid+composition&doi=10.1038%2Fnchembio.2239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition</span></div><div class="casAuthors">Doll, Sebastian; Proneth, Bettina; Tyurina, Yulia Y.; Panzilius, Elena; Kobayashi, Sho; Ingold, Irina; Irmler, Martin; Beckers, Johannes; Aichler, Michaela; Walch, Axel; Prokisch, Holger; Truembach, Dietrich; Mao, Gaowei; Qu, Feng; Bayir, Hulya; Fuellekrug, Joachim; Scheel, Christina H.; Wurst, Wolfgang; Schick, Joel A.; Kagan, Valerian E.; Angeli, Jose Pedro Friedmann; Conrad, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a form of regulated necrotic cell death controlled by glutathione peroxidase 4 (GPX4).  At present, mechanisms that could predict sensitivity and/or resistance and that may be exploited to modulate ferroptosis are needed.  We applied two independent approaches - a genome-wide CRISPR-based genetic screen and microarray anal. of ferroptosis-resistant cell lines - to uncover acyl-CoA synthetase long-chain family member 4 (ACSL4) as an essential component for ferroptosis execution.  Specifically, Gpx4-Acsl4 double-knockout cells showed marked resistance to ferroptosis.  Mechanistically, ACSL4 enriched cellular membranes with long polyunsatd. ω6 fatty acids.  Moreover, ACSL4 was preferentially expressed in a panel of basal-like breast cancer cell lines and predicted their sensitivity to ferroptosis.  Pharmacol. targeting of ACSL4 with thiazolidinediones, a class of antidiabetic compd., ameliorated tissue demise in a mouse model of ferroptosis, suggesting that ACSL4 inhibition is a viable therapeutic approach to preventing ferroptosis-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF9sohkXFtabVg90H21EOLACvtfcHk0lhF6TkVFeECag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGgtLrL&md5=5f416d16d2361711e8206c4a3b8b86eb</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2239%26sid%3Dliteratum%253Aachs%26aulast%3DDoll%26aufirst%3DS.%26aulast%3DProneth%26aufirst%3DB.%26aulast%3DTyurina%26aufirst%3DY.%2BY.%26aulast%3DPanzilius%26aufirst%3DE.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DIngold%26aufirst%3DI.%26aulast%3DIrmler%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DJ.%26aulast%3DAichler%26aufirst%3DM.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DProkisch%26aufirst%3DH.%26aulast%3DTr%25C3%25BCmbach%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DQu%26aufirst%3DF.%26aulast%3DBayir%26aufirst%3DH.%26aulast%3DF%25C3%25BCllekrug%26aufirst%3DJ.%26aulast%3DScheel%26aufirst%3DC.%2BH.%26aulast%3DWurst%26aufirst%3DW.%26aulast%3DSchick%26aufirst%3DJ.%2BA.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DAngeli%26aufirst%3DJ.%2BP.%2BF.%26aulast%3DConrad%26aufirst%3DM.%26atitle%3DACSL4%2520dictates%2520ferroptosis%2520sensitivity%2520by%2520shaping%2520cellular%2520lipid%2520composition%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26spage%3D91%26epage%3D98%26doi%3D10.1038%2Fnchembio.2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassannia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiernicki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingold, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Herck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurina, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayır, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abhari, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeli, J. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyninck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declerck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirumamilla, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahtela-Kakkonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Camp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krysko, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekert, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Geest, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span> <span> </span><span class="NLM_article-title">Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">3341</span>– <span class="NLM_lpage">3355</span>, <span class="refDoi"> DOI: 10.1172/jci99032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1172%2FJCI99032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=29939160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FhsVOhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=3341-3355&author=B.+Hassanniaauthor=B.+Wiernickiauthor=I.+Ingoldauthor=F.+Quauthor=S.+Van+Herckauthor=Y.+Y.+Tyurinaauthor=H.+Bay%C4%B1rauthor=B.+A.+Abhariauthor=J.+P.+F.+Angeliauthor=S.+M.+Choiauthor=E.+Meulauthor=K.+Heyninckauthor=K.+Declerckauthor=C.+S.+Chirumamillaauthor=M.+Lahtela-Kakkonenauthor=G.+Van+Campauthor=D.+V.+Kryskoauthor=P.+G.+Ekertauthor=S.+Fuldaauthor=B.+G.+De+Geestauthor=M.+Conradauthor=V.+E.+Kaganauthor=W.+Vanden+Bergheauthor=P.+Vandenabeeleauthor=T.+Vanden+Berghe&title=Nano-targeted+induction+of+dual+ferroptotic+mechanisms+eradicates+high-risk+neuroblastoma&doi=10.1172%2Fjci99032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma</span></div><div class="casAuthors">Hassannia Behrouz; Wiernicki Bartosz; Choi Sze Men; Meul Eline; Krysko Dmitri V; Vandenabeele Peter; Vanden Berghe Tom; Hassannia Behrouz; Wiernicki Bartosz; Choi Sze Men; Meul Eline; Krysko Dmitri V; Vandenabeele Peter; Vanden Berghe Tom; Ingold Irina; Conrad Marcus; Qu Feng; Tyurina Yulia Y; Bayir Hulya; Kagan Valerian E; Van Herck Simon; De Geest Bruno G; Abhari Behnaz A; Fulda Simone; Angeli Jose Pedro Friedmann; Heyninck Karen; Vanden Berghe Wim; Declerck Ken; Chirumamilla Chandra Sekhar; Vanden Berghe Wim; Lahtela-Kakkonen Maija; Van Camp Guy; Ekert Paul G; Fulda Simone; Vandenabeele Peter</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3341-3355</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High-risk neuroblastoma is a devastating malignancy with very limited therapeutic options.  Here, we identify withaferin A (WA) as a natural ferroptosis-inducing agent in neuroblastoma, which acts through a novel double-edged mechanism.  WA dose-dependently either activates the nuclear factor-like 2 pathway through targeting of Kelch-like ECH-associated protein 1 (noncanonical ferroptosis induction) or inactivates glutathione peroxidase 4 (canonical ferroptosis induction).  Noncanonical ferroptosis induction is characterized by an increase in intracellular labile Fe(II) upon excessive activation of heme oxygenase-1, which is sufficient to induce ferroptosis.  This double-edged mechanism might explain the superior efficacy of WA as compared with etoposide or cisplatin in killing a heterogeneous panel of high-risk neuroblastoma cells, and in suppressing the growth and relapse rate of neuroblastoma xenografts.  Nano-targeting of WA allows systemic application and suppressed tumor growth due to an enhanced accumulation at the tumor site.  Collectively, our data propose a novel therapeutic strategy to efficiently kill cancer cells by ferroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsc0g5SKGdDBpyrDyM_m9cfW6udTcc2eY1GWaz6IvHFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FhsVOhsg%253D%253D&md5=b7cf06ff11c2324dd9ce83d81b146d71</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1172%2FJCI99032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI99032%26sid%3Dliteratum%253Aachs%26aulast%3DHassannia%26aufirst%3DB.%26aulast%3DWiernicki%26aufirst%3DB.%26aulast%3DIngold%26aufirst%3DI.%26aulast%3DQu%26aufirst%3DF.%26aulast%3DVan%2BHerck%26aufirst%3DS.%26aulast%3DTyurina%26aufirst%3DY.%2BY.%26aulast%3DBay%25C4%25B1r%26aufirst%3DH.%26aulast%3DAbhari%26aufirst%3DB.%2BA.%26aulast%3DAngeli%26aufirst%3DJ.%2BP.%2BF.%26aulast%3DChoi%26aufirst%3DS.%2BM.%26aulast%3DMeul%26aufirst%3DE.%26aulast%3DHeyninck%26aufirst%3DK.%26aulast%3DDeclerck%26aufirst%3DK.%26aulast%3DChirumamilla%26aufirst%3DC.%2BS.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26aulast%3DVan%2BCamp%26aufirst%3DG.%26aulast%3DKrysko%26aufirst%3DD.%2BV.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DDe%2BGeest%26aufirst%3DB.%2BG.%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DVanden%2BBerghe%26aufirst%3DW.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26atitle%3DNano-targeted%2520induction%2520of%2520dual%2520ferroptotic%2520mechanisms%2520eradicates%2520high-risk%2520neuroblastoma%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26spage%3D3341%26epage%3D3355%26doi%3D10.1172%2Fjci99032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G.</span></span> <span> </span><span class="NLM_article-title">Mitochondria regulation in ferroptosis</span>. <i>Eur. J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">151058</span>, <span class="refDoi"> DOI: 10.1016/j.ejcb.2019.151058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ejcb.2019.151058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=31810634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlSqtb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2020&pages=151058&author=H.+Wangauthor=C.+Liuauthor=Y.+Zhaoauthor=G.+Gao&title=Mitochondria+regulation+in+ferroptosis&doi=10.1016%2Fj.ejcb.2019.151058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria regulation in ferroptosis</span></div><div class="casAuthors">Wang, Hai; Liu, Can; Zhao, Yongxin; Gao, Ge</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151058</span>CODEN:
                <span class="NLM_cas:coden">EJCBDN</span>;
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Ferroptosis is recognized as a new form of regulated cell death which is initiated by severe lipid peroxidn. relying on reactive oxygen species (ROS) generation and iron overload.  This iron-dependent cell death manifests evident morphol., biochem. and genetic differences from other forms of regulated cell death, such as apoptosis, autophagy, necrosis and pyroptosis.  Ferroptosis was primarily characterized by condensed mitochondrial membrane densities and smaller vol. than normal mitochondria, as well as the diminished or vanished of mitochondria crista and outer membrane ruptured.  Mitochondria take the center role in iron metab., as well as substance and energy metab. as it's the major organelle in iron utilization, catabolic and anabolic pathways.  Interference of key regulators of mitochondrial lipid metab. (e.g., ASCF2 and CS), iron homeostasis (e.g., ferritin, mitoferrin1/2 and NEET proteins), glutamine metab. and other signaling pathways make a difference to ferroptotic sensitivity.  Targeted induction of ferroptosis was also considered as a potential therapeutic strategy to some oxidative stress diseases, including neurodegenerative disorders, ischemia-reperfusion injury, traumatic spinal cord injury.  However, the pertinence between mitochondria and ferroptosis is still in dispute.  Here we systematic elucidate the morphol. characteristics and metabolic regulation of mitochondria in the regulation of ferroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonXH7F5LOWgrVg90H21EOLACvtfcHk0lgjO7ex03H9jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlSqtb3M&md5=e0f953511f44555bc0634fc6fe7b6521</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejcb.2019.151058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejcb.2019.151058%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DG.%26atitle%3DMitochondria%2520regulation%2520in%2520ferroptosis%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D2020%26volume%3D99%26spage%3D151058%26doi%3D10.1016%2Fj.ejcb.2019.151058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of ferroptosis</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">2195</span>– <span class="NLM_lpage">2209</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2194-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1007%2Fs00018-016-2194-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27048822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsValurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=2195-2209&author=J.+Y.+Caoauthor=S.+J.+Dixon&title=Mechanisms+of+ferroptosis&doi=10.1007%2Fs00018-016-2194-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of ferroptosis</span></div><div class="casAuthors">Cao, Jennifer Yinuo; Dixon, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">2195-2209</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Ferroptosis is a non-apoptotic form of cell death that can be triggered by small mols. or conditions that inhibit glutathione biosynthesis or the glutathione-dependent antioxidant enzyme glutathione peroxidase 4 (GPX4).  This lethal process is defined by the iron-dependent accumulation of lipid reactive oxygen species and depletion of plasma membrane polyunsatd. fatty acids.  Cancer cells with high level RAS-RAF-MEK pathway activity or p53 expression may be sensitized to this process.  Conversely, a no. of small mol. inhibitors of ferroptosis have been identified, including ferrostatin-1 and liproxstatin-1, which can block pathol. cell death events in brain, kidney and other tissues.  Recent work has identified a no. of genes required for ferroptosis, including those involved in lipid and amino acid metab.  Outstanding questions include the relationship between ferroptosis and other forms of cell death, and whether activation or inhibition of ferroptosis can be exploited to achieve desirable therapeutic ends.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroCXfv3RUEq7Vg90H21EOLACvtfcHk0lgjO7ex03H9jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsValurw%253D&md5=350d3b1fcb3a5701db5be6eb556aad11</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2194-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2194-1%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%2BY.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26atitle%3DMechanisms%2520of%2520ferroptosis%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D2195%26epage%3D2209%26doi%3D10.1007%2Fs00018-016-2194-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacid, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the MAPK pathway in KRAS-driven tumors</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2020.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.ccell.2020.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=32289276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlSis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2020&pages=543-550&author=M.+Drostenauthor=M.+Barbacid&title=Targeting+the+MAPK+pathway+in+KRAS-driven+tumors&doi=10.1016%2Fj.ccell.2020.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the MAPK Pathway in KRAS-Driven Tumors</span></div><div class="casAuthors">Drosten, Matthias; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-550</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  KRAS mutations occur in a quarter of all of human cancers, yet no selective drug has been approved to treat these tumors.  Despite the recent development of drugs that block KRASG12C, the majority of KRAS oncoproteins remain undruggable.  Here, we review recent efforts to validate individual components of the mitogen-activated protein kinase (MAPK) pathway as targets to treat KRAS-mutant cancers by comparing genetic information derived from exptl. mouse models of KRAS-driven lung and pancreatic tumors with the outcome of selective MAPK inhibitors in clin. trials.  We also review the potential of RAF1 as a key target to block KRAS-mutant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0-lpaiyoK8rVg90H21EOLACvtfcHk0lgjO7ex03H9jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlSis70%253D&md5=e87ef5abce0f714559b55777aaa3bd77</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2020.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2020.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DDrosten%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520MAPK%2520pathway%2520in%2520KRAS-driven%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2020%26volume%3D37%26spage%3D543%26epage%3D550%26doi%3D10.1016%2Fj.ccell.2020.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, X.</span></span> <span> </span><span class="NLM_article-title">The MAPK pathway-based drug therapeutic targets in pituitary adenomas</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">330</span>, <span class="refDoi"> DOI: 10.3389/fendo.2019.00330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.3389%2Ffendo.2019.00330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=31231308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BB3M3pvFGiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=330&author=M.+Luauthor=Y.+Wangauthor=X.+Zhan&title=The+MAPK+pathway-based+drug+therapeutic+targets+in+pituitary+adenomas&doi=10.3389%2Ffendo.2019.00330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas</span></div><div class="casAuthors">Lu Miaolong; Wang Ya; Zhan Xianquan; Lu Miaolong; Wang Ya; Zhan Xianquan; Lu Miaolong; Wang Ya; Zhan Xianquan; Zhan Xianquan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">330</span>
        ISSN:<span class="NLM_cas:issn">1664-2392</span>.
    </div><div class="casAbstract">Mitogen-activated protein kinases (MAPKs) include ERK, p38, and JNK MAPK subfamilies, which are crucial regulators of cellular physiology, cell pathology, and many diseases including cancers.  For the MAPK signaling system in pituitary adenomas (PAs), the activation of ERK signaling is generally thought to promote cell proliferation and growth; whereas the activations of p38 and JNK signaling are generally thought to promote cell apoptosis.  The role of MAPK in treatment of PAs is demonstrated through the effects of currently used medications such as somatostatin analogs such as SOM230 and OCT, dopamine agonists such as cabergoline and bromocriptine, and retinoic acid which inhibit the MAPK pathway.  Further, there are potential novel therapies based on putative molecular targets of the MAPK pathway, including 18beta-glycyrrhetinic acid (GA), dopamine-somatostatin chimeric compound (BIM-23A760), ursolic acid (UA), fulvestrant, Raf kinase inhibitory protein (RKIP), epidermal growth factor pathway substrate number 8 (Eps8), transmembrane protein with EGF-like and two follistatin-like domains (TMEFF2), cold inducible RNA-binding protein (CIRP), miR-16, and mammaliansterile-20-like kinase (MST4).  The combined use of ERK inhibitor (e.g., SOM230, OCT, or dopamine) plus p38 activator (e.g., cabergoline, bromocriptine, and fulvestrant) and/or JNK activator (e.g., UA), or the development of single drug (e.g., BIM-23A760) to target both ERK and p38 or JNK pathways, might produce better anti-tumor effects on PAs.  This article reviews the advances in understanding the role of MAPK signaling in pituitary tumorigenesis, and the MAPK pathway-based potential therapeutic drugs for PAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJnOfna8HA0jjk2McQZ6XmfW6udTcc2eZyd1FtV1b1lrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3pvFGiug%253D%253D&md5=e7cbcd022982ddd659a967026c3033f9</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2019.00330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2019.00330%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DX.%26atitle%3DThe%2520MAPK%2520pathway-based%2520drug%2520therapeutic%2520targets%2520in%2520pituitary%2520adenomas%26jtitle%3DFront.%2520Endocrinol.%26date%3D2019%26volume%3D10%26spage%3D330%26doi%3D10.3389%2Ffendo.2019.00330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span> <span> </span><span class="NLM_article-title">Structure-guided discovery of a luminescent theranostic toolkit for living cancer cells and the imaging behavior effect</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">11404</span>– <span class="NLM_lpage">11412</span>, <span class="refDoi"> DOI: 10.1039/d0sc04576d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1039%2FD0SC04576D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFajt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=11404-11412&author=C.+Wuauthor=K.-J.+Wuauthor=J.-B.+Liuauthor=W.+Wangauthor=C.-H.+Leungauthor=D.-L.+Ma&title=Structure-guided+discovery+of+a+luminescent+theranostic+toolkit+for+living+cancer+cells+and+the+imaging+behavior+effect&doi=10.1039%2Fd0sc04576d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided discovery of a luminescent theranostic toolkit for living cancer cells and the imaging behavior effect</span></div><div class="casAuthors">Wu, Chun; Wu, Ke-Jia; Liu, Jin-Biao; Wang, Wanhe; Leung, Chung-Hang; Ma, Dik-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">11404-11412</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Dual-functional theranostics are powerful tools that can allow for the in-field understanding of cancer pathol., yet their use is held back by the paucity of suitable theranostics for living systems.  Moreover, typical in vitro screening conditions for probe mols. do not necessarily generate candidates that can function effectively in the natural in cellulo environment, limiting their follow-up use in living systems.  We introduce herein a general strategy for the development of an iridium(III) theranostic by grafting a well-known inhibitor as a "binding unit" onto an iridium(III) complex precursor as a "signaling unit".  To further optimize their emissive properties, we explored the effect of imaging behavior by incorporating different substituents onto the parental "signaling unit".  This design concept was validated by a series of tailored iridium(III) theranostics 2a-2h for the visualization and inhibition of EGFR in living cancer cells.  By comprehensively assessing the theranostic potency of 2a-2h in both in vitro and in cellulo contexts, probe 2f contg. electron-donating methoxy groups on the "signaling unit" was discovered to be the most promising candidate theranostic with desirable photophys./chem. properties.  Probe 2f selectively bound to EGFR in vitro and in cellulo, enabling it to selectively discriminate living EGFR-overexpressing cancer cells from normal cells that express low levels of EGFR with an "always-on" luminescence signal output.  In particular, its long-lived lifetime enabled its luminescence signal to be readily distinguished from the interfering fluorescence of org. dyes by using time-resolved techniques.  Complex 2f simultaneously visualized and inhibited EGFR in a dose-dependent manner, leading to a redn. in the phosphorylation of downstream proteins ERK and MEK, and inhibition of the activity of downstream transcription factor AP1.  Notably, complex 2f is comparable to the parental EGFR inhibitor 1b, in terms of both inhibitory activity against EGFR and cytotoxicity against EGFR-overexpressing cancer cells.  This tailored dual-functional iridium(III) theranostic toolkit provides an alternative strategy for the personalized diagnosis and treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriLwAOvFZx8rVg90H21EOLACvtfcHk0lhy4rP_MLMa4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFajt7%252FK&md5=9aa4e59d479452d662043f2f283954ee</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1039%2FD0SC04576D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0SC04576D%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DK.-J.%26aulast%3DLiu%26aufirst%3DJ.-B.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLeung%26aufirst%3DC.-H.%26aulast%3DMa%26aufirst%3DD.-L.%26atitle%3DStructure-guided%2520discovery%2520of%2520a%2520luminescent%2520theranostic%2520toolkit%2520for%2520living%2520cancer%2520cells%2520and%2520the%2520imaging%2520behavior%2520effect%26jtitle%3DChem.%2520Sci.%26date%3D2020%26volume%3D11%26spage%3D11404%26epage%3D11412%26doi%3D10.1039%2Fd0sc04576d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cargnello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, P. P.</span></span> <span> </span><span class="NLM_article-title">Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1128/mmbr.00031-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1128%2FMMBR.00031-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21372320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVequ78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2011&pages=50-83&author=M.+Cargnelloauthor=P.+P.+Roux&title=Activation+and+function+of+the+MAPKs+and+their+substrates%2C+the+MAPK-activated+protein+kinases&doi=10.1128%2Fmmbr.00031-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases</span></div><div class="casAuthors">Cargnello, Marie; Roux, Philippe P.</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-83</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review. The mitogen-activated protein (MAP) kinases (MAPKs) regulate diverse cellular programs by relaying extracellular signals to intracellular responses.  In mammals, there are more than a dozen MAPKs that coordinately regulate cell proliferation, differentiation, motility, and survival.  The best known are the conventional MAPKs, which include the extracellular signal-regulated kinases 1 and 2 (ERK1/2), c-Jun N-terminal kinases 1-3 (JNK1 to JNK3), p38 (α, β, γ, and δ), and ERK5 families.  There are addnl., atypical MAPKs, including ERK3/4, ERK7/8, and Nemo-like kinase (NLK), which have distinct regulation and functions.  Together, the MAPKs regulate a large no. of substrates, including members of a family of protein Ser/Thr kinases termed MAPK-activated protein kinases (MAPKAPKs).  The MAPKAPKs are related enzymes that respond to extracellular stimulation through direct MAPK-dependent activation loop phosphorylation and kinase activation.  There are five MAPKAPK subfamilies: p90 ribosomal S6 kinase (RSK), mitogen- and stress-activated kinase (MSK), MAPK-interacting kinase (MNK), MAPK-activated protein kinase 2/3 (MK2/3), and MK5 (also known as p38-regulated/activated protein kinase).  These enzymes have diverse biol. functions, including regulation of nucleosome and gene expression, mRNA stability and translation, and cell proliferation and survival.  Here,the authors review the mechanisms of MAPKAPK activation by the different MAPKs and discuss their physiol. roles based on established substrates and recent discoveries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWcx7oIOM6lLVg90H21EOLACvtfcHk0lhy4rP_MLMa4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVequ78%253D&md5=e074f5af1f56957f0f10b2ecd837e69c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00031-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00031-10%26sid%3Dliteratum%253Aachs%26aulast%3DCargnello%26aufirst%3DM.%26aulast%3DRoux%26aufirst%3DP.%2BP.%26atitle%3DActivation%2520and%2520function%2520of%2520the%2520MAPKs%2520and%2520their%2520substrates%252C%2520the%2520MAPK-activated%2520protein%2520kinases%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2011%26volume%3D75%26spage%3D50%26epage%3D83%26doi%3D10.1128%2Fmmbr.00031-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Mammalian MAP kinase signalling cascades</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>410</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1038/35065000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1038%2F35065000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=11242034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvVSgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2001&pages=37-40&author=L.+Changauthor=M.+Karin&title=Mammalian+MAP+kinase+signalling+cascades&doi=10.1038%2F35065000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian MAP kinase signalling cascades</span></div><div class="casAuthors">Chang, Lufen; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue">6824</span>),
    <span class="NLM_cas:pages">37-40</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 52 refs.  Mitogen-activated protein kinases (MAPKs) are important signal transducing enzymes, unique to eukaryotes, that are involved in many facets of cellular regulation.  Initial research concd. on defining the components and organization of MAPK signaling cascades, but recent studies have begun to shed light on the physiol. functions of these cascades in the control of gene expression, cell proliferation, and programmed cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHwmx2Bk-5dbVg90H21EOLACvtfcHk0lgsFQWYAj-pSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvVSgs7k%253D&md5=486ff61090fc371dff36b307b4e75c88</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2F35065000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35065000%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DMammalian%2520MAP%2520kinase%2520signalling%2520cascades%26jtitle%3DNature%26date%3D2001%26volume%3D410%26spage%3D37%26epage%3D40%26doi%3D10.1038%2F35065000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.-F.</span></span> <span> </span><span class="NLM_article-title">Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis</span>. <i>J. Recept. Signal Transduction Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">600</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.3109/10799893.2015.1030412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.3109%2F10799893.2015.1030412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=26096166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BC2MblsFCgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=600-604&author=Y.+Sunauthor=W.-Z.+Liuauthor=T.+Liuauthor=X.+Fengauthor=N.+Yangauthor=H.-F.+Zhou&title=Signaling+pathway+of+MAPK%2FERK+in+cell+proliferation%2C+differentiation%2C+migration%2C+senescence+and+apoptosis&doi=10.3109%2F10799893.2015.1030412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis</span></div><div class="casAuthors">Sun Yu; Liu Wen-Zhou; Liu Tao; Feng Xu; Yang Nuo; Zhou Hua-Fu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of receptor and signal transduction research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">600-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The generic mitogen-activated protein kinases (MAPK) signaling pathway is shared by four distinct cascades, including the extracellular signal-related kinases (ERK1/2), Jun amino-terminal kinases (JNK1/2/3), p38-MAPK and ERK5.  Mitogen-activated protein kinases/extracellular signal-regulated kinase (MAPK/ERK) pathway is reported to be associated with the cell proliferation, differentiation, migration, senescence and apoptosis.  The literatures were searched extensively and this review was performed to review the role of MAPK/ERK signaling pathway in cell proliferation, differentiation, migration, senescence and apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWdgOjMha0H_6BottYdIAWfW6udTcc2eYcJBQUJ7hPmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MblsFCgtw%253D%253D&md5=ac2b1874f42681c52912d7108578e49e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.3109%2F10799893.2015.1030412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10799893.2015.1030412%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.-Z.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DZhou%26aufirst%3DH.-F.%26atitle%3DSignaling%2520pathway%2520of%2520MAPK%252FERK%2520in%2520cell%2520proliferation%252C%2520differentiation%252C%2520migration%252C%2520senescence%2520and%2520apoptosis%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2015%26volume%3D35%26spage%3D600%26epage%3D604%26doi%3D10.3109%2F10799893.2015.1030412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.-J.</span></span> <span> </span><span class="NLM_article-title">Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2014.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.neuint.2014.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=25481090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2mt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=60-71&author=H.-C.+Panauthor=Q.+Jiangauthor=Y.+Yuauthor=J.-P.+Meiauthor=Y.-K.+Cuiauthor=W.-J.+Zhao&title=Quercetin+promotes+cell+apoptosis+and+inhibits+the+expression+of+MMP-9+and+fibronectin+via+the+AKT+and+ERK+signalling+pathways+in+human+glioma+cells&doi=10.1016%2Fj.neuint.2014.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells</span></div><div class="casAuthors">Pan, Hong-Chao; Jiang, Qiong; Yu, Yang; Mei, Jin-Ping; Cui, Yu-Kun; Zhao, Wei-Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60-71</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Gliomas are the most common and malignant primary brain tumors and are assocd. with a poor prognosis despite the availability of multiple therapeutic options.  Quercetin, a traditional Chinese medicinal herb, is an important flavonoid and has anti-cancer activity.  Here, we evaluated whether quercetin could inhibit glioma cell viability and migration and promote apoptosis.  The treatment of U87-MG glioblastoma and U251 and SHG44 glioma cell lines with different concns. of quercetin inhibited cell viability in a dose-dependent manner.  Wound healing assays indicated that quercetin significantly decreased glioma cell migration. β-galactosidase staining, DNA staining and Annexin V-EGF/PI double staining assays demonstrated that quercetin promoted cell senescence and apoptosis.  In addn., the protein levels of p-AKT, p-ERK, Bcl-2, matrix metallopeptidase 9 (MMP-9) and fibronectin (FN) were significantly reduced following quercetin treatment.  Therefore, we conclude that quercetin might inhibit the viability and migration and promote the senescence and apoptosis of glioma cells by suppressing the Ras/MAPK/ERK and PI3K/AKT signalling pathways.  Quercetin might be a potential candidate for the clin. treatment of glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFlWET5z_WkrVg90H21EOLACvtfcHk0lgsFQWYAj-pSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2mt77I&md5=cdb79eccf03b1ef8950c9e4589d9457e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2014.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2014.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DH.-C.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DMei%26aufirst%3DJ.-P.%26aulast%3DCui%26aufirst%3DY.-K.%26aulast%3DZhao%26aufirst%3DW.-J.%26atitle%3DQuercetin%2520promotes%2520cell%2520apoptosis%2520and%2520inhibits%2520the%2520expression%2520of%2520MMP-9%2520and%2520fibronectin%2520via%2520the%2520AKT%2520and%2520ERK%2520signalling%2520pathways%2520in%2520human%2520glioma%2520cells%26jtitle%3DNeurochem.%2520Int.%26date%3D2015%26volume%3D80%26spage%3D60%26epage%3D71%26doi%3D10.1016%2Fj.neuint.2014.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Zijl, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupitza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulits, W.</span></span> <span> </span><span class="NLM_article-title">Initial steps of metastasis: cell invasion and endothelial transmigration</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>728</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.mrrev.2011.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.mrrev.2011.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21605699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaisrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=728&publication_year=2011&pages=23-34&author=F.+van%0AZijlauthor=G.+Krupitzaauthor=W.+Mikulits&title=Initial+steps+of+metastasis%3A+cell+invasion+and+endothelial+transmigration&doi=10.1016%2Fj.mrrev.2011.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Initial steps of metastasis: Cell invasion and endothelial transmigration</span></div><div class="casAuthors">van Zijl, Franziska; Krupitza, Georg; Mikulits, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Reviews in Mutation Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">728</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">23-34</span>CODEN:
                <span class="NLM_cas:coden">MRRRFK</span>;
        ISSN:<span class="NLM_cas:issn">1383-5742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Metastasis is the leading cause of cancer mortality.  The metastatic cascade represents a multi-step process which includes local tumor cell invasion, entry into the vasculature followed by the exit of carcinoma cells from the circulation and colonization at the distal sites.  At the earliest stage of successful cancer cell dissemination, the primary cancer adapts the secondary site of tumor colonization involving the tumor-stroma crosstalk.  The migration and plasticity of cancer cells as well as the surrounding environment such as stromal and endothelial cells are mandatory.  Consequently, the mechanisms of cell movement are of utmost relevance for targeted intervention of which three different types have been reported.  Tumor cells can migrate either collectively, in a mesenchymal or in an amoeboid type of movement and intravasate the blood or lymph vasculature.  Intravasation by the interaction of tumor cells with the vascular endothelium is mechanistically poorly understood.  Changes in the epithelial plasticity enable carcinoma cells to switch between these types of motility.  The types of migration may change depending on the intervention thereby increasing the velocity and aggressiveness of invading cancer cells.  Interference with collective or mesenchymal cell invasion by targeting integrin expression or metalloproteinase activity, resp., resulted in an amoeboid cell phenotype as the ultimate exit strategy of cancer cells.  There are little mechanistic details reported in vivo showing that the amoeboid behavior can be either reversed or efficiently inhibited.  Future concepts of metastasis intervention must simultaneously address the collective, mesenchymal and amoeboid mechanisms of cell invasion in order to advance in anti-metastatic strategies as these different types of movement can coexist and cooperate.  Beyond the targeting of cell movements, the adhesion of cancer cells to the stroma in heterotypic circulating tumor cell emboli is of paramount relevance for anti-metastatic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnMrXZjAQ1MbVg90H21EOLACvtfcHk0lgsVncvCqxLkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaisrzL&md5=da67b0c12f4d8d93f8ea57f575254d40</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.mrrev.2011.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrrev.2011.05.002%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BZijl%26aufirst%3DF.%26aulast%3DKrupitza%26aufirst%3DG.%26aulast%3DMikulits%26aufirst%3DW.%26atitle%3DInitial%2520steps%2520of%2520metastasis%253A%2520cell%2520invasion%2520and%2520endothelial%2520transmigration%26jtitle%3DMutat.%2520Res.%26date%3D2011%26volume%3D728%26spage%3D23%26epage%3D34%26doi%3D10.1016%2Fj.mrrev.2011.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badarau, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costache, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caruntu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihai, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didilescu, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagu, M.</span></span> <span> </span><span class="NLM_article-title">The role of matrix metalloproteinases in the epithelial-mesenchymal transition of hepatocellular carcinoma</span>. <i>Anal. Cell. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">9423907</span>, <span class="refDoi"> DOI: 10.1155/2019/9423907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1155%2F2019%2F9423907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BB3MbkvFOhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=9423907&author=C.+Scheauauthor=I.+A.+Badarauauthor=R.+Costacheauthor=C.+Caruntuauthor=G.+L.+Mihaiauthor=A.+C.+Didilescuauthor=C.+Constantinauthor=M.+Neagu&title=The+role+of+matrix+metalloproteinases+in+the+epithelial-mesenchymal+transition+of+hepatocellular+carcinoma&doi=10.1155%2F2019%2F9423907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma</span></div><div class="casAuthors">Scheau Cristian; Badarau Ioana Anca; Caruntu Constantin; Mihai Gratiela Livia; Costache Raluca; Caruntu Constantin; Didilescu Andreea Cristiana; Constantin Carolina; Neagu Monica; Constantin Carolina; Neagu Monica; Neagu Monica</div><div class="citationInfo"><span class="NLM_cas:title">Analytical cellular pathology (Amsterdam)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9423907</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The epithelial-mesenchymal transition (EMT) is a transformation process mandatory for the local and distant progression of many malignant tumors, including hepatocellular carcinoma (HCC).  Matrix metalloproteinases (MMPs) play significant roles in cellular regeneration, programmed death, angiogenesis, and many other essential tissular functions, involved in the normal development and also in pathological processes, such as the EMT.  This paper reviews the roles of MMPs in the EMT involved in HCC invasion, as well as the ancillary roles that MMP cross-activation and tissue inhibitors play in modulating this process.  While gelatinases MMP-2 and MMP-9 are the MMPs commonly cited in the EMT of HCC, MMPs belonging to other classes have been proven to be involved in this process, favoring not only invasion and metastasis (MMP-1, MMP-3, MMP-7, MMP-10, MMP-11, MMP-13, MMP-14, MMP-16, MMP-26, and MMP-28) but also angiogenesis (MMP-8 and MMP-10).  There is also data suggesting that other MMPs with a suspected or demonstrated role in the EMT of other cancers may also have some degree of involvement in HCC.  The auto- and cross-activation of MMPs may complicate this issue, as pinpointing the extent of implication of each MMP may be extremely difficult.  The homeostasis between MMPs and their tissue inhibitors is essential in preventing tumor progression, and the disturbance of this stability is another entailed factor in the EMT of HCC, which is addressed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaRPIzNrrhgFm8bhe6roZYfW6udTcc2eaUwVf6UpQUE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MbkvFOhug%253D%253D&md5=b2366bab1de74dfb01d61fef928c6a61</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1155%2F2019%2F9423907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2019%252F9423907%26sid%3Dliteratum%253Aachs%26aulast%3DScheau%26aufirst%3DC.%26aulast%3DBadarau%26aufirst%3DI.%2BA.%26aulast%3DCostache%26aufirst%3DR.%26aulast%3DCaruntu%26aufirst%3DC.%26aulast%3DMihai%26aufirst%3DG.%2BL.%26aulast%3DDidilescu%26aufirst%3DA.%2BC.%26aulast%3DConstantin%26aufirst%3DC.%26aulast%3DNeagu%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520matrix%2520metalloproteinases%2520in%2520the%2520epithelial-mesenchymal%2520transition%2520of%2520hepatocellular%2520carcinoma%26jtitle%3DAnal.%2520Cell.%2520Pathol.%26date%3D2019%26volume%3D2019%26spage%3D9423907%26doi%3D10.1155%2F2019%2F9423907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span> <span> </span><span class="NLM_article-title">Reducing interstitial fluid pressure and inhibiting pulmonary metastasis of breast cancer by gelatin modified cationic lipid nanoparticles</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">29457</span>– <span class="NLM_lpage">29468</span>, <span class="refDoi"> DOI: 10.1021/acsami.7b05119</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.7b05119" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWhsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=29457-29468&author=X.+Gaoauthor=J.+Zhangauthor=Z.+Huangauthor=T.+Zuoauthor=Q.+Luauthor=G.+Wuauthor=Q.+Shen&title=Reducing+interstitial+fluid+pressure+and+inhibiting+pulmonary+metastasis+of+breast+cancer+by+gelatin+modified+cationic+lipid+nanoparticles&doi=10.1021%2Facsami.7b05119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing Interstitial Fluid Pressure and Inhibiting Pulmonary Metastasis of Breast Cancer by Gelatin Modified Cationic Lipid Nanoparticles</span></div><div class="casAuthors">Gao, Xuan; Zhang, Jun; Huang, Zun; Zuo, Tiantian; Lu, Qing; Wu, Guangyu; Shen, Qi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">29457-29468</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Interstitial fluid pressure (IFP) in tumor is much higher than that in normal tissue, and it constitutes a great obstacle for the delivery of antitumor drugs, thus becoming a potential target for cancer therapy.  In this study, cationic nanostructured lipid carriers (NLCs) were modified by low mol. wt. gelatin to achieve the desirable redn. of tumor IFP and improve the drug delivery.  In this way, the chemotherapy of formulations on tumor proliferation and pulmonary metastasis was further improved.  The nanoparticles were used to load three drugs, docetaxel (DTX), quercetin (Qu), and imatinib (IMA), with high encapsulation efficiency of 89.54%, 96.45%, and 60.13%, resp.  GNP-DTX/Qu/IMA nanoparticles exhibited an enzyme-sensitive drug release behavior, and the release rate could be mediated by matrix metalloproteinases (MMP-9).  Cellular uptake and MTT assays showed that the obtained GNP-DTX/Qu/IMA could be internalized into human breast 4T1 cells effectively and exhibited the strongest cytotoxicity.  Moreover, GNP-DTX/Qu/IMA demonstrated obvious advantages in inducing apoptosis and mediating the expression of apoptosis-related proteins (Caspase 3, Caspase 9, and bcl-2).  In the wound-healing assay, GNP-DTX/Qu/IMA exhibited evidently inhibition of cell migration.  The benefits of tumor IFP redn. induced by GNP-DTX/Qu/IMA were further proved after a continuous administration to 4T1 tumor-bearing mice.  Finally, in the in vivo antitumor assays, GNP-DTX/Qu/IMA displayed stronger antitumor efficiency as well as suppression on pulmonary metastasis.  In conclusion, the GNP-DTX/Qu/IMA system might be a promising strategy for metastatic breast cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaLfbSj4PmLVg90H21EOLACvtfcHk0ljN9Z2Pzya5Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWhsLvM&md5=af3e2e700b6c923545fef8af61b8ca89</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Facsami.7b05119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.7b05119%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZuo%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DQ.%26atitle%3DReducing%2520interstitial%2520fluid%2520pressure%2520and%2520inhibiting%2520pulmonary%2520metastasis%2520of%2520breast%2520cancer%2520by%2520gelatin%2520modified%2520cationic%2520lipid%2520nanoparticles%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2017%26volume%3D9%26spage%3D29457%26epage%3D29468%26doi%3D10.1021%2Facsami.7b05119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeted lupane triterpenoid derivatives and their selective apoptosis-inducing anticancer mechanisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6353</span>– <span class="NLM_lpage">6363</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00679</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00679" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6353-6363&author=Y.+Yeauthor=T.+Zhangauthor=H.+Yuanauthor=D.+Liauthor=H.+Louauthor=P.+Fan&title=Mitochondria-targeted+lupane+triterpenoid+derivatives+and+their+selective+apoptosis-inducing+anticancer+mechanisms&doi=10.1021%2Facs.jmedchem.7b00679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Lupane Triterpenoid Derivatives and Their Selective Apoptosis-Inducing Anticancer Mechanisms</span></div><div class="casAuthors">Ye, Yaqing; Zhang, Tao; Yuan, Huiqing; Li, Defeng; Lou, Hongxiang; Fan, Peihong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6353-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Betulin and betulinic acid have been widely studied for their anticancer activities.  However, their further development is limited due to low bioavailability, poor aq. soly., and limited intracellular accumulation.  In the present study, a triphenylphosphonium cation moiety was linked to betulin and betulinic acid to specifically target them to cancer cell mitochondria.  Biol. characterization established that uptake of mitochondria-targeted compd. 1a in the mitochondria of cancer cells was increased compared to betulin.  The mitochondria-targeted derivs. of betulin and betulinic acid showed stronger cytotoxicity than their parent drugs and exhibited more cytotoxic effects in cancer cells than normal cells.  The mechanisms may involve the mitochondrial apoptotic pathway, probably caused by the induction of reactive oxygen species prodn. and reducing mitochondrial membrane potential.  More importantly, 1a significantly inhibited cancer cell proliferation and migration in an in vivo zebrafish xenograft model.  Collectively, these results encourage further study of 1a analogs as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotxRCv4fRMcbVg90H21EOLACvtfcHk0ljN9Z2Pzya5Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr3E&md5=b1461bf97acb75e7c68e976462804065</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00679%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLou%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DP.%26atitle%3DMitochondria-targeted%2520lupane%2520triterpenoid%2520derivatives%2520and%2520their%2520selective%2520apoptosis-inducing%2520anticancer%2520mechanisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6353%26epage%3D6363%26doi%3D10.1021%2Facs.jmedchem.7b00679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brocker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebert, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiliou, V.</span></span> <span> </span><span class="NLM_article-title">Evolutionary divergence and functions of the human interleukin (IL) gene family</span>. <i>Hum. Genomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1186/1479-7364-5-1-30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1186%2F1479-7364-5-1-30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=21106488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVeks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=30-55&author=C.+Brockerauthor=D.+Thompsonauthor=A.+Matsumotoauthor=D.+W.+Nebertauthor=V.+Vasiliou&title=Evolutionary+divergence+and+functions+of+the+human+interleukin+%28IL%29+gene+family&doi=10.1186%2F1479-7364-5-1-30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutionary divergence and functions of the human interleukin (IL) gene family</span></div><div class="casAuthors">Brocker, Chad; Thompson, David; Matsumoto, Akiko; Nebert, Daniel W.; Vasiliou, Vasilis</div><div class="citationInfo"><span class="NLM_cas:title">Human Genomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-55</span>CODEN:
                <span class="NLM_cas:coden">HGUEAT</span>;
        ISSN:<span class="NLM_cas:issn">1479-7364</span>.
    
            (<span class="NLM_cas:orgname">Henry Stewart Publications</span>)
        </div><div class="casAbstract">A review.  Cytokines play a very important role in nearly all aspects of inflammation and immunity.  The term "interleukin" (IL) has been used to describe a group of cytokines with complex immunomodulatory functions - including cell proliferation, maturation, migration and adhesion.  These cytokines also play an important role in immune cell differentiation and activation.  Detg. the exact function of a particular cytokine is complicated by the influence of the producing cell type, the responding cell type and the phase of the immune response.  ILs can also have pro- and anti-inflammatory effects, further complicating their characterization.  These mols. are under const. pressure to evolve due to continual competition between the host's immune system and infecting organisms; as such, ILs have undergone significant evolution.  This has resulted in little amino acid conservation between orthologous proteins, which further complicates the gene family organization.  Within the literature there are a no. of overlapping nomenclature and classification systems derived from biol. function, receptor-binding properties and originating cell type.  Detg. evolutionary relationships between ILs therefore can be confusing.  More recently, crystallog. data and the identification of common structural motifs have led to a more accurate classification system.  To date, the known ILs can be divided into four major groups based on distinguishing structural features.  These groups include the genes encoding the IL1-like cytokines, the class I helical cytokines (IL4-like, γ-chain and IL6/12-Iike), the class II helical cytokines (IL10-like and IL28-like) and the ILI7-like cytokines.  In addn., there are a no. of ILs that do not fit into any of the above groups, due either to their unique structural features or lack of structural information.  This suggests that the gene family organization may be subject to further change in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRTpHngdAqJrVg90H21EOLACvtfcHk0ljN9Z2Pzya5Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVeks7w%253D&md5=6d19ce1b43c6b556fd38964eef457b89</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1186%2F1479-7364-5-1-30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-7364-5-1-30%26sid%3Dliteratum%253Aachs%26aulast%3DBrocker%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DMatsumoto%26aufirst%3DA.%26aulast%3DNebert%26aufirst%3DD.%2BW.%26aulast%3DVasiliou%26aufirst%3DV.%26atitle%3DEvolutionary%2520divergence%2520and%2520functions%2520of%2520the%2520human%2520interleukin%2520%2528IL%2529%2520gene%2520family%26jtitle%3DHum.%2520Genomics%26date%3D2010%26volume%3D5%26spage%3D30%26epage%3D55%26doi%3D10.1186%2F1479-7364-5-1-30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Melo-Diogo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, I. J.</span></span> <span> </span><span class="NLM_article-title">3D tumor spheroids: an overview on the tools and techniques used for their analysis</span>. <i>Biotechnol. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1427</span>– <span class="NLM_lpage">1441</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2016.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1016%2Fj.biotechadv.2016.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=27845258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A280%3ADC%252BC2snmt1SrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=1427-1441&author=E.+C.+Costaauthor=A.+F.+Moreiraauthor=D.+de+Melo-Diogoauthor=V.+M.+Gasparauthor=M.+P.+Carvalhoauthor=I.+J.+Correia&title=3D+tumor+spheroids%3A+an+overview+on+the+tools+and+techniques+used+for+their+analysis&doi=10.1016%2Fj.biotechadv.2016.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">3D tumor spheroids: an overview on the tools and techniques used for their analysis</span></div><div class="casAuthors">Costa Elisabete C; Moreira Andre F; de Melo-Diogo Duarte; Gaspar Vitor M; Carvalho Marco P; Correia Ilidio J</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1427-1441</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In comparison with 2D cell culture models, 3D spheroids are able to accurately mimic some features of solid tumors, such as their spatial architecture, physiological responses, secretion of soluble mediators, gene expression patterns and drug resistance mechanisms.  These unique characteristics highlight the potential of 3D cellular aggregates to be used as in vitro models for screening new anticancer therapeutics, both at a small and large scale.  Nevertheless, few reports have focused on describing the tools and techniques currently available to extract significant biological data from these models.  Such information will be fundamental to drug and therapeutic discovery process using 3D cell culture models.  The present review provides an overview of the techniques that can be employed to characterize and evaluate the efficacy of anticancer therapeutics in 3D tumor spheroids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcrj9sPTzAo8rRqEXsZufAfW6udTcc2ebiUXNleeOQY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snmt1SrtQ%253D%253D&md5=7df22d1121bd823c148b48f530d58da2</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2016.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DE.%2BC.%26aulast%3DMoreira%26aufirst%3DA.%2BF.%26aulast%3Dde%2BMelo-Diogo%26aufirst%3DD.%26aulast%3DGaspar%26aufirst%3DV.%2BM.%26aulast%3DCarvalho%26aufirst%3DM.%2BP.%26aulast%3DCorreia%26aufirst%3DI.%2BJ.%26atitle%3D3D%2520tumor%2520spheroids%253A%2520an%2520overview%2520on%2520the%2520tools%2520and%2520techniques%2520used%2520for%2520their%2520analysis%26jtitle%3DBiotechnol.%2520Adv.%26date%3D2016%26volume%3D34%26spage%3D1427%26epage%3D1441%26doi%3D10.1016%2Fj.biotechadv.2016.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, Y.</span></span> <span> </span><span class="NLM_article-title">Is it time to start transitioning from 2D to 3D cell culture?</span>. <i>Front. Mol. Biosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.3389/fmolb.2020.00033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.3389%2Ffmolb.2020.00033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=32211418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVaktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2020&pages=33&author=C.+Jensenauthor=Y.+Teng&title=Is+it+time+to+start+transitioning+from+2D+to+3D+cell+culture%3F&doi=10.3389%2Ffmolb.2020.00033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Is it time to start transitioning from 2D to 3D cell culture?</span></div><div class="casAuthors">Jensen, Caleb; Teng, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Biosciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33</span>CODEN:
                <span class="NLM_cas:coden">FMBRBS</span>;
        ISSN:<span class="NLM_cas:issn">2296-889X</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Cell culture is an important and necessary process in drug discovery, cancer research, as well as stem cell study.  Most cells are currently cultured using two-dimensional (2D) methods but new and improved methods that implement three-dimensional (3D) cell culturing techniques suggest compelling evidence that much more advanced expts. can be performed yielding valuable insights.  When performing 3D cell culture expts., the cell environment can be manipulated to mimic that of a cell in vivo and provide more accurate data about cell-to-cell interactions, tumor characteristics, drug discovery, metabolic profiling, stem cell research, and other types of diseases.  Scaffold based techniques such as hydrogel-based support, polymeric hard material-based support, hydrophilic glass fiber, and organoids are employed, and each provide their own advantages and applications.  Likewise, there are also scaffold free techniques used such as hanging drop microplates, magnetic levitation, and spheroid microplates with ultra-low attachment coating.  3D Cell culture has the potential to provide alternative ways to study organ behavior via the use of organoids and is expected to eventually bridge the gap between 2D cell culture and animal models.  The present review compares 2D cell culture to 3D cell culture, provides the details surrounding the different 3D culture techniques, as well as focuses on the present and future applications of 3D cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLHsbSDucaUbVg90H21EOLACvtfcHk0lhKNz1dfuITTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVaktbvI&md5=98ec480800e43a8e793a40f428f7eded</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.3389%2Ffmolb.2020.00033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmolb.2020.00033%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DTeng%26aufirst%3DY.%26atitle%3DIs%2520it%2520time%2520to%2520start%2520transitioning%2520from%25202D%2520to%25203D%2520cell%2520culture%253F%26jtitle%3DFront.%2520Mol.%2520Biosci.%26date%3D2020%26volume%3D7%26spage%3D33%26doi%3D10.3389%2Ffmolb.2020.00033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolomanov, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourhis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildea, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, J. A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puschmann, H.</span></span> <span> </span><span class="NLM_article-title">OLEX2: a complete structure solution, refinement and analysis program</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1107/s0021889808042726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=10.1107%2FS0021889808042726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=339-341&author=O.+V.+Dolomanovauthor=L.+J.+Bourhisauthor=R.+J.+Gildeaauthor=J.+A.+K.+Howardauthor=H.+Puschmann&title=OLEX2%3A+a+complete+structure+solution%2C+refinement+and+analysis+program&doi=10.1107%2Fs0021889808042726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">OLEX2: a complete structure solution, refinement and analysis program</span></div><div class="casAuthors">Dolomanov, Oleg V.; Bourhis, Luc J.; Gildea, Richard J.; Howard, Judith A. K.; Puschmann, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-341</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">New software, OLEX2, was developed for the detn., visualization and anal. of mol. crystal structures.  The software has a portable mouse-driven workflow-oriented and fully comprehensive graphical user interface for structure soln., refinement and report generation, as well as novel tools for structure anal.  OLEX2 seamlessly links all aspects of the structure soln., refinement and publication process and presents them in a single workflow-driven package, with the ultimate goal of producing an application which will be useful to both chemists and crystallographers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIYSUbyzIgxbVg90H21EOLACvtfcHk0liCSzhsdZl0Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D&md5=7a2f9697b13b8e76de0e7dc5074ab229</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1107%2FS0021889808042726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889808042726%26sid%3Dliteratum%253Aachs%26aulast%3DDolomanov%26aufirst%3DO.%2BV.%26aulast%3DBourhis%26aufirst%3DL.%2BJ.%26aulast%3DGildea%26aufirst%3DR.%2BJ.%26aulast%3DHoward%26aufirst%3DJ.%2BA.%2BK.%26aulast%3DPuschmann%26aufirst%3DH.%26atitle%3DOLEX2%253A%2520a%2520complete%2520structure%2520solution%252C%2520refinement%2520and%2520analysis%2520program%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2009%26volume%3D42%26spage%3D339%26epage%3D341%26doi%3D10.1107%2Fs0021889808042726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, L.</span></span> <span> </span><span class="NLM_article-title">Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">12310</span>– <span class="NLM_lpage">12322</span>, <span class="refDoi"> DOI: 10.1021/nn5062386</span> </span><div class="citationLinks">[<a href="/doi/10.1021/nn5062386" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVamsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=12310-12322&author=Z.+Shengauthor=D.+Huauthor=M.+Zhengauthor=P.+Zhaoauthor=H.+Liuauthor=D.+Gaoauthor=P.+Gongauthor=G.+Gaoauthor=P.+Zhangauthor=Y.+Maauthor=L.+Cai&title=Smart+human+serum+albumin-indocyanine+green+nanoparticles+generated+by+programmed+assembly+for+dual-modal+imaging-guided+cancer+synergistic+phototherapy&doi=10.1021%2Fnn5062386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Smart Human Serum Albumin-Indocyanine Green Nanoparticles Generated by Programmed Assembly for Dual-Modal Imaging-Guided Cancer Synergistic Phototherapy</span></div><div class="casAuthors">Sheng, Zonghai; Hu, Dehong; Zheng, Mingbin; Zhao, Pengfei; Liu, Huilong; Gao, Duyang; Gong, Ping; Gao, Guanhui; Zhang, Pengfei; Ma, Yifan; Cai, Lintao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">12310-12322</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phototherapy, including photodynamic therapy (PDT) and photothermal therapy (PTT), is a light-activated local treatment modality that is under intensive preclin. and clin. investigations for cancer.  To enhance the treatment efficiency of phototherapy and reduce the light-assocd. side effects, it is highly desirable to improve drug accumulation and precision guided phototherapy for efficient conversion of the absorbed light energy to reactive oxygen species (ROS) and local hyperthermia.  In the present study, a programmed assembly strategy was developed for the prepn. of human serum albumin (HSA)-indocyanine green (ICG) nanoparticles (HSA-ICG NPs) by intermol. disulfide conjugations.  This study indicated that HSA-ICG NPs had a high accumulation with tumor-to-normal tissue ratio of 36.12 ± 5.12 at 24 h and a long-term retention with more than 7 days in 4T1 tumor-bearing mice, where the tumor and its margin, normal tissue were clearly identified via ICG-based in vivo near-IR (NIR) fluorescence and photoacoustic dual-modal imaging and spectrum-resolved technol.  Meanwhile, HSA-ICG NPs efficiently induced ROS and local hyperthermia simultaneously for synergetic PDT/PTT treatments under a single NIR laser irradn.  After an i.v. injection of HSA-ICG NPs followed by imaging-guided precision phototherapy (808 nm, 0.8 W/cm2 for 5 min), the tumor was completely suppressed, no tumor recurrence and treatments-induced toxicity were obsd.  The results suggest that HSA-ICG NPs generated by programmed assembly as smart theranostic nanoplatforms are highly potential for imaging-guided cancer phototherapy with PDT/PTT synergistic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp15mG1gXKiR7Vg90H21EOLACvtfcHk0liCSzhsdZl0Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVamsr3J&md5=60a1cf56658644f07c983d09d1551196</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fnn5062386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnn5062386%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DGong%26aufirst%3DP.%26aulast%3DGao%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DL.%26atitle%3DSmart%2520human%2520serum%2520albumin-indocyanine%2520green%2520nanoparticles%2520generated%2520by%2520programmed%2520assembly%2520for%2520dual-modal%2520imaging-guided%2520cancer%2520synergistic%2520phototherapy%26jtitle%3DACS%2520Nano%26date%3D2014%26volume%3D8%26spage%3D12310%26epage%3D12322%26doi%3D10.1021%2Fnn5062386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Tailoring particle size of mesoporous silica nanosystem to antagonize glioblastoma and overcome blood-brain barrier</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">6811</span>– <span class="NLM_lpage">6825</span>, <span class="refDoi"> DOI: 10.1021/acsami.5b11730</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.5b11730" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFKgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=6811-6825&author=J.+Moauthor=L.+Heauthor=B.+Maauthor=T.+Chen&title=Tailoring+particle+size+of+mesoporous+silica+nanosystem+to+antagonize+glioblastoma+and+overcome+blood-brain+barrier&doi=10.1021%2Facsami.5b11730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier</span></div><div class="casAuthors">Mo, Jianbin; He, Lizhen; Ma, Bin; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6811-6825</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) is the main bottleneck to prevent some macromol. substance entering the cerebral circulation, resulting the failure of chemotherapy in the treatment of glioma.  Cancer nanotechnol. displays potent applications in glioma therapy owing to their penetration across BBB and accumulation into the tumor core.  In this study, we have tailored the particle size of mesoporous silica nanoparticles (MSNs) through controlling the hydrolysis rate and polycondensation degree of reactants, and optimized the nanosystem that could effectively penetrate BBB and target the tumor tissue to achieve enhanced antiglioma efficacy.  The nanoparticle was conjugated with cRGD peptide to enhance its cancer targeting effect, and then used to load antineoplastic doxorubicin.  Therefore, the functionalized nanosystem (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="084c475048455b467b">[email protected]</a>) selectively recognizes and binds to the U87 cells with higher expression level of ανβ3 integrin, sequentially enhancing the cellular uptake and inhibition to giloma cells, esp. the particle size at 40 nm.  This particle could rapidly enter cancer cells and was difficult to excrete outside the cells, thus leading to high drug accumulation.  Furthermore, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="45010a1d0508160b36">[email protected]</a> exhibited much higher selectivity and anticancer activity than free DOX and induced the glioma cells apoptosis through triggering ROS overprodn.  Interestingly, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="0d4942554d405e437e">[email protected]</a> at about 40 nm exhibited stronger permeability across the BBB, and could disrupt the VM-capability of glioma cells by regulating the expression of E-cadherin, FAK, and MMP-2, thus achieving satisfactory antiglioblastoma efficacy and avoiding the unwanted toxic side effects to normal brain tissue.  Taken together, these results suggest that tailoring the particle size of MSNs nanosystem could be an effective strategy to antagonize glioblastoma and overcome BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5URgccbcrIbVg90H21EOLACvtfcHk0lgu-tPx8rR6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFKgtLg%253D&md5=9a9a90aaab36b12dd2beb25402f4fb51</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Facsami.5b11730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.5b11730%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DTailoring%2520particle%2520size%2520of%2520mesoporous%2520silica%2520nanosystem%2520to%2520antagonize%2520glioblastoma%2520and%2520overcome%2520blood-brain%2520barrier%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2016%26volume%3D8%26spage%3D6811%26epage%3D6825%26doi%3D10.1021%2Facsami.5b11730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01936">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_18474"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01936?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01936</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Views of the weak interactions of <b>1</b> and <b>3</b>; blood circulation curve, proteomics analysis, proposed cellular mechanism, and permeability across the blood–brain barrier of <b>3</b>; <sup>1</sup>H and <sup>13</sup>C NMR spectra of HL; fluorescence spectra of <b>3</b> under multiple excitation wavelengths; and the selected crystallographic data and related cytotoxicity for <b>1–3</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_002.csv">CSV</a>)</p></li><li><p class="inline">Crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_003.cif">CIF</a>)</p></li><li><p class="inline">Crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_004.cif">CIF</a>)</p></li><li><p class="inline">Crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_005.cif">CIF</a>)</p></li><li><p class="inline">checkCIF/PLATON report (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_006.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_001.pdf">jm0c01936_si_001.pdf (1.6 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_002.csv">jm0c01936_si_002.csv (0.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_003.cif">jm0c01936_si_003.cif (248.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_004.cif">jm0c01936_si_004.cif (260.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_005.cif">jm0c01936_si_005.cif (536.87 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01936/suppl_file/jm0c01936_si_006.pdf">jm0c01936_si_006.pdf (563.41 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01936&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-9%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01936%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01936" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a65e87c493ce2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
